rltnshp_tp,ss_strn,src_ss_d,tss_d,b_frmt,crtd_b,ss_ctgr,ss_tp,ss_tss,chmbl_d,td,ss_cll_tp,cnfdnc_scr,ss_tx_d,ss_d,ss_tst_tp,vrnt_d,dscrptn,dc_d,ss_rgnsm,ss_sbclllr_frctn,cll_d,src_d
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618647,50597,,1,10116.0,7524,In vivo,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618648,50597,,1,10116.0,7525,In vivo,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618649,50597,,1,10116.0,7526,In vivo,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618650,50597,,1,10116.0,7527,In vivo,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618651,50597,,1,10116.0,7528,In vivo,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL876497,50597,,1,10116.0,7529,In vivo,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL618652,50597,,1,10116.0,7530,In vivo,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL618653,50597,,1,10116.0,7531,In vivo,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL618654,50597,,1,10116.0,7532,In vivo,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618655,50597,,1,10116.0,7533,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,6351,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618656,50597,,1,10116.0,7534,,,Compound was tested for solubility in water,1465,Rattus norvegicus,,,1
U,,,,BAO_0000100,Intermediate,,P,,CHEMBL618657,22229,,0,,7535,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),5182,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618658,50597,,1,10116.0,7536,,,Solubility was determined,17847,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618659,50597,,1,10116.0,7537,,,solubility in water (ug/mL) at 37 degree C.,15339,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618660,50597,,1,10116.0,7538,,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,5202,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618661,50597,,1,10116.0,7539,,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,1088,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873807,50597,,1,10116.0,7540,,,Half life in rats,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618662,50597,,1,10116.0,7541,,,Half life in Dawley rat,5353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618663,50597,,1,10116.0,7542,In vivo,,Half life period after 3 mg/kg iv administration,2864,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618664,50597,,1,10116.0,7543,In vivo,,Half life period after 3 mg/kg iv administration in rat,2864,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618665,50597,,1,10116.0,7544,In vivo,,Half life period after 3 mg/kg iv administration in the rat,2864,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876498,50597,,1,10116.0,7545,,,Half life period in female Sprague-Dawley rats,6362,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618666,50597,,1,10116.0,7546,,,Half life period in rat,6249,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620440,50597,,1,10116.0,7547,,,Half-life in rats was determined,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620441,50597,,1,10116.0,7548,,,Half-life in rats with metabolic oxidation,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620442,50597,,1,10116.0,7549,,,Half-life in rats,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620443,50597,,1,10116.0,7550,In vivo,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620444,50597,,1,10116.0,7551,In vivo,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620445,50597,,1,10116.0,7552,In vivo,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620446,50597,,1,10116.0,7553,In vivo,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620447,50597,,1,10116.0,7554,,,Biological half-life measured in plasma of rat,2879,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621129,50597,,1,10116.0,7555,,,Biological half-life measured in plasma of rat; 22-25,2879,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621130,50597,,1,10116.0,7556,,,Biological half-life measured in plasma of rat; 9-16,2879,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873808,50597,,1,10116.0,7557,In vivo,,Compound was evaluated for its half life when administered intravenously in rat,3184,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876598,50597,,1,10116.0,7558,In vivo,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,4891,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621131,50597,,1,10116.0,7559,In vivo,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621132,50597,,1,10116.0,7560,In vivo,,Half life (T1/2) after oral administration in rat,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621133,50597,,1,10116.0,7561,In vivo,,Half life of compound after iv administration of 20 mg/kg dose in rat,4413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL621312,50597,,1,10116.0,7562,In vivo,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621313,50597,,1,10116.0,7563,,,Half life of compound was determined in rat,17267,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621314,50597,,1,10116.0,7564,,,Half life of compound was determined in rat blood,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621315,50597,,1,10116.0,7565,In vivo,,Half life at 1 mg/kg was determined in rat,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621316,50597,,1,10116.0,7566,In vivo,,Half life at 10 mg/kg was determined in rat,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621317,50597,,1,10116.0,7567,,,Half life in rats,401,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621318,50597,,1,10116.0,7568,,,Half life in rats in hours,4942,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621319,50597,,1,10116.0,7569,In vivo,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,17735,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621377,50597,,1,10116.0,7570,In vivo,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,6056,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621378,50597,,1,10116.0,7571,,,Half life was determined,5213,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876599,50597,,1,10116.0,7572,In vivo,,Half life after i.v. administration,6616,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621379,50597,,1,10116.0,7573,In vivo,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,5937,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621380,50597,,1,10116.0,7574,,,Half life in rat plasma,5819,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621381,50597,,1,10116.0,7575,,,Half life in rat plasma; Not detected,5819,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618515,50597,,1,10116.0,7576,,,Half life in rats,6803,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618516,50597,,1,10116.0,7577,In vivo,,Half life period of compound was determined after peroral administration,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618517,50597,,1,10116.0,7578,In vivo,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618518,50597,,1,10116.0,7579,,,Half life period in rat,5948,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618519,50597,,1,10116.0,7580,In vivo,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618698,50597,,1,10116.0,7581,In vivo,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618862,50597,,1,10116.0,7582,In vivo,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618863,50597,,1,10116.0,7583,In vivo,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618864,50597,,1,10116.0,7584,In vivo,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618865,50597,,1,10116.0,7585,In vivo,,Half life time in rat the dose of 2 mg/kg,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618866,50597,,1,10116.0,7586,In vivo,,Half-life 24 hr after 10 mg/kg iv administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618867,50597,,1,10116.0,7587,In vivo,,Half-life 24 hr after 2 mg/kg iv administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875828,50597,,1,10116.0,7588,,,Half-life consistent with the observed metabolic steady state in rats,6597,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618868,50597,,1,10116.0,7589,In vivo,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,17735,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618869,50597,,1,10116.0,7590,,,Half-life for oxidative metabolic stability was determined using male human,6597,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618870,50597,,1,10116.0,7591,In vivo,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618871,50597,,1,10116.0,7592,,,Half-life in rat plasma,1696,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618872,50597,,1,10116.0,7593,,,Half-life in rat plasma was determined,1742,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873816,50597,,1,10116.0,7594,,,Half-life in rats was determined,17800,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL618873,22224,,0,,7595,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,12923,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL621602,22224,,0,,7596,,,Area under curve after oral dose of 0.1 mg//kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621603,22224,,0,,7597,,,Area under curve after oral dose of 0.3 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621604,22224,,0,,7598,,,Area under curve after oral dose of 1 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621605,22224,,0,,7599,,,Area under curve after oral dose of 10 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621606,22224,,0,,7600,,,Area under curve after oral dose of 23.4 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621607,22224,,0,,7601,,,Area under curve after oral dose of 3 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621608,22224,,0,,7602,,,Area under curve after oral dose of 3.87 mg/kg,11954,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL621609,22224,,0,,7603,,,Area under curve was determined,5237,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621610,22224,,0,,7604,,,Area under curve at a dose of 10 mg/kg,4026,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621611,50597,,1,10116.0,7605,,,Area under curve was determined; ND=No data,5237,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621612,50597,,1,10116.0,7606,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622308,50597,,1,10116.0,7607,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622309,50597,,1,10116.0,7608,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622310,50597,,1,10116.0,7609,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622311,50597,,1,10116.0,7610,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622312,50597,,1,10116.0,7611,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622931,50597,,1,10116.0,7612,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622932,50597,,1,10116.0,7613,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622736,50597,,1,10116.0,7614,,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622737,50597,,1,10116.0,7615,,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622738,50597,,1,10116.0,7616,,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622739,50597,,1,10116.0,7617,,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622740,50597,,1,10116.0,7618,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622741,50597,,1,10116.0,7619,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622742,50597,,1,10116.0,7620,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622743,50597,,1,10116.0,7621,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622744,50594,,1,10090.0,7622,,,AUC in mice,11637,Mus musculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624134,22224,,0,,7623,,,Area under curve was measured from the graph obtained from concentration Vs time,11149,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624135,22224,,0,,7624,,,Area under curve value of compound per hour after oral administration,10016,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624136,50597,,1,10116.0,7625,,,Area under curve was determined after oral administration in rats,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624137,50597,,1,10116.0,7626,,,Area under curve was determined after oral administration in rats; No data,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624320,50597,,1,10116.0,7627,,,Area under curve was determined after oral administration in rats;No data,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624321,50588,,1,9615.0,7628,,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,12923,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624322,50597,,1,10116.0,7629,,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624323,50597,,1,10116.0,7630,,,Area under curve was determined for the compound after iv dose of 5.06 in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624324,50597,,1,10116.0,7631,,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624325,50597,,1,10116.0,7632,,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624326,50597,,1,10116.0,7633,,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624327,50597,,1,10116.0,7634,,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624328,50597,,1,10116.0,7635,,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627848,50588,,1,9615.0,7636,,,Area under curve was determined in Dogs after peroral administration,14169,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627849,50597,,1,10116.0,7637,,,Area under curve was determined in Rats after peroral administration,14169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627850,50597,,1,10116.0,7638,,,Area under curve was determined in carotid blood of rat when administered intradermally,14258,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627851,50597,,1,10116.0,7639,,,Area under curve was determined in portal blood of rat when administered intradermally,14258,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627852,50594,,1,10090.0,7640,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627853,50594,,1,10090.0,7641,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627854,50594,,1,10090.0,7642,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627855,50594,,1,10090.0,7643,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627856,50594,,1,10090.0,7644,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875339,50594,,1,10090.0,7645,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627857,50594,,1,10090.0,7646,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),15011,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627858,50597,,1,10116.0,7647,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627859,50597,,1,10116.0,7648,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627860,50597,,1,10116.0,7649,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627019,50597,,1,10116.0,7650,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627020,50597,,1,10116.0,7651,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627021,50597,,1,10116.0,7652,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627022,50597,,1,10116.0,7653,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627023,50597,,1,10116.0,7654,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627024,50597,,1,10116.0,7655,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627025,50597,,1,10116.0,7656,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627026,50597,,1,10116.0,7657,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627027,50597,,1,10116.0,7658,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627028,50597,,1,10116.0,7659,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627029,50597,,1,10116.0,7660,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627030,50597,,1,10116.0,7661,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627031,50597,,1,10116.0,7662,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627032,50597,,1,10116.0,7663,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627033,50597,,1,10116.0,7664,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627034,50597,,1,10116.0,7665,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627035,50597,,1,10116.0,7666,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627036,50597,,1,10116.0,7667,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL875340,50597,,1,10116.0,7668,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627037,50597,,1,10116.0,7669,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627038,50597,,1,10116.0,7670,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627039,50597,,1,10116.0,7671,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627040,50597,,1,10116.0,7672,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624663,50597,,1,10116.0,7673,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL625963,50597,,1,10116.0,7674,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL876799,50597,,1,10116.0,7675,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626133,50597,,1,10116.0,7676,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626134,50597,,1,10116.0,7677,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626135,50597,,1,10116.0,7678,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,6295,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626136,50597,,1,10116.0,7679,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,6296,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626137,50597,,1,10116.0,7680,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,6296,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626138,50597,,1,10116.0,7681,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,6295,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626139,50597,,1,10116.0,7682,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,6296,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626140,50597,,1,10116.0,7683,In vivo,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626141,50597,,1,10116.0,7684,In vivo,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626142,50597,,1,10116.0,7685,,,C24h in rat p.o. at 20 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627930,50597,,1,10116.0,7686,In vivo,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627931,50597,,1,10116.0,7687,In vivo,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627932,50597,,1,10116.0,7688,In vivo,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627933,50597,,1,10116.0,7689,In vivo,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627934,50597,,1,10116.0,7690,In vivo,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627935,50597,,1,10116.0,7691,In vivo,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627936,50597,,1,10116.0,7692,In vivo,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627937,50597,,1,10116.0,7693,In vivo,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627938,50597,,1,10116.0,7694,In vivo,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627939,50597,,1,10116.0,7695,In vivo,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627940,50597,,1,10116.0,7696,In vivo,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627941,50597,,1,10116.0,7697,In vivo,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL876800,50597,,1,10116.0,7698,In vivo,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627942,50597,,1,10116.0,7699,In vivo,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627943,50597,,1,10116.0,7700,In vivo,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627944,50597,,1,10116.0,7701,In vivo,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627945,50597,,1,10116.0,7702,In vivo,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628584,50597,,1,10116.0,7703,In vivo,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628585,50597,,1,10116.0,7704,In vivo,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628586,50597,,1,10116.0,7705,In vivo,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628587,50597,,1,10116.0,7706,In vivo,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628588,50597,,1,10116.0,7707,In vivo,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628589,50597,,1,10116.0,7708,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625304,50597,,1,10116.0,7709,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625305,50597,,1,10116.0,7710,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625306,50597,,1,10116.0,7711,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625307,50597,,1,10116.0,7712,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625308,50597,,1,10116.0,7713,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627740,50597,,1,10116.0,7714,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627741,50597,,1,10116.0,7715,In vivo,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627742,50597,,1,10116.0,7716,In vivo,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627743,50597,,1,10116.0,7717,In vivo,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627744,50597,,1,10116.0,7718,In vivo,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627745,50597,,1,10116.0,7719,In vivo,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627746,50597,,1,10116.0,7720,In vivo,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627747,50597,,1,10116.0,7721,In vivo,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL876810,50597,,1,10116.0,7722,In vivo,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627748,50597,,1,10116.0,7723,In vivo,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627749,50597,,1,10116.0,7724,In vivo,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627750,50597,,1,10116.0,7725,In vivo,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618728,50597,,1,10116.0,7726,In vivo,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618729,50597,,1,10116.0,7727,In vivo,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618730,50597,,1,10116.0,7728,In vivo,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618731,50597,,1,10116.0,7729,In vivo,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618732,50597,,1,10116.0,7730,In vivo,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618733,50597,,1,10116.0,7731,In vivo,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618734,50597,,1,10116.0,7732,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618735,50597,,1,10116.0,7733,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL876602,50597,,1,10116.0,7734,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618736,50597,,1,10116.0,7735,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618737,50597,,1,10116.0,7736,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618738,50597,,1,10116.0,7737,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618739,50597,,1,10116.0,7738,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618740,50597,,1,10116.0,7739,In vivo,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618741,50597,,1,10116.0,7740,In vivo,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618742,50597,,1,10116.0,7741,In vivo,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL618743,50597,,1,10116.0,7742,In vivo,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618744,50597,,1,10116.0,7743,In vivo,,Half-life from rat plasma at a single oral dose of 25 mg/kg,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618745,50597,,1,10116.0,7744,,,Half-life in male rat,5610,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620479,50597,,1,10116.0,7745,In vivo,,Half-life in rat after peroral administration at 10 mg/kg concentration,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620480,50597,,1,10116.0,7746,In vivo,,Half-life in rat after peroral administration at 5 mg/kg concentration,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620481,50597,,1,10116.0,7747,In vivo,,Half-life in rat at a dose of 3 mg/kg,17771,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620482,50597,,1,10116.0,7748,,,Half-life was evaluated in rats,1974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876603,50597,,1,10116.0,7749,,,Half-life was measured in rat,4239,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620483,50597,,1,10116.0,7750,In vivo,,Half-life period for the compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620484,50597,,1,10116.0,7751,In vivo,,Half-life period in rats after intravenous administration at 5 mg/kg,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620485,50597,,1,10116.0,7752,In vivo,,Half-life period in rat at 10 mg/kg,6046,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620486,50597,,1,10116.0,7753,In vivo,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620487,50597,,1,10116.0,7754,In vivo,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620488,50597,,1,10116.0,7755,In vivo,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620489,50597,,1,10116.0,7756,In vivo,,Half-life time in rat the dose of 2 mg/kg,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620490,50597,,1,10116.0,7757,In vivo,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,1088,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620491,50597,,1,10116.0,7758,In vivo,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,5610,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876604,50597,,1,10116.0,7759,In vivo,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",3032,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620492,50597,,1,10116.0,7760,In vivo,,Oral half life was determined,5199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620493,50597,,1,10116.0,7761,In vivo,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620494,50597,,1,10116.0,7762,In vivo,,Pharmacokinetic property (t1/2) in rat,4408,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620495,50597,,1,10116.0,7763,,,Plasma elimination half-life was determined,2552,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620496,50597,,1,10116.0,7764,In vivo,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,5199,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620497,50597,,1,10116.0,7765,In vivo,,Plasma half life was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620498,50597,,1,10116.0,7766,,,Plasma half-life was determined,1465,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620499,50597,,1,10116.0,7767,In vivo,,Plasma half-life following oral administration in Fisher rats,1446,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620500,50597,,1,10116.0,7768,,,Plasma half-life in rat,6824,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873809,50597,,1,10116.0,7769,In vivo,,Plasmatic Half-life after intravenous administration to rat,17533,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620501,50597,,1,10116.0,7770,In vivo,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,5979,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620502,50597,,1,10116.0,7771,In vivo,,Terminal half life after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620503,50597,,1,10116.0,7772,In vivo,,Terminal half life in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620504,50597,,1,10116.0,7773,In vivo,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,2463,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876605,50597,,1,10116.0,7774,In vivo,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,4883,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620505,50597,,1,10116.0,7775,In vivo,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,4883,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873811,50597,,1,10116.0,7776,In vivo,,plasma half life was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL624016,50597,,1,10116.0,7777,In vivo,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624017,50597,,1,10116.0,7778,,,Half life of compound determined in rat,4576,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624018,50597,,1,10116.0,7779,,,Mean residence time determined in rat,4576,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624019,50597,,1,10116.0,7780,,,Plasma half life determined in rat,4576,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624020,50597,,1,10116.0,7781,In vivo,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624201,50597,,1,10116.0,7782,In vivo,,Compound was evaluated for pharmacokinetic parameter maximum time period,4891,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL872528,50597,,1,10116.0,7783,In vivo,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624202,50597,,1,10116.0,7784,In vivo,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624203,50597,,1,10116.0,7785,In vivo,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624350,50597,,1,10116.0,7786,In vivo,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621320,50597,,1,10116.0,7787,In vivo,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621321,50597,,1,10116.0,7788,In vivo,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621322,50597,,1,10116.0,7789,,,Maximum time (Tmax) required to reach Cmax in rats,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621323,50597,,1,10116.0,7790,In vivo,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621324,50597,,1,10116.0,7791,In vivo,,Maximum time of clearance of compound in rats after peroral administration,6571,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621325,50597,,1,10116.0,7792,,,Maximum time at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL875837,50597,,1,10116.0,7793,In vivo,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,17651,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621326,50597,,1,10116.0,7794,In vivo,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621327,50597,,1,10116.0,7795,In vivo,,Tmax in Guinea pig (PO dose),14465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621328,50597,,1,10116.0,7796,In vivo,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621329,50597,,1,10116.0,7797,In vivo,,Pharmacokinetic parameter (Tmax) in rat,5960,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621330,50597,,1,10116.0,7798,In vivo,,Pharmacokinetic parameter (Tmax) was estimated,5022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621331,50597,,1,10116.0,7799,In vivo,,Pharmacokinetic property (Tmax) in rat,4408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621332,50597,,1,10116.0,7800,In vivo,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,5983,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621333,50597,,1,10116.0,7801,In vivo,,T max in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621334,50597,,1,10116.0,7802,In vivo,,T max was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621335,50594,,1,10090.0,7803,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621336,50588,,1,9615.0,7804,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,14180,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621337,50597,,1,10116.0,7805,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,14180,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621338,50588,,1,9615.0,7806,,,Area under curve was measured after i.v. administration into Beagle dog.,14599,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875838,50588,,1,9615.0,7807,,,Area under curve was measured after iv administration into Beagle dog,14599,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621339,50588,,1,9615.0,7808,,,Area under curve was measured after po administration into Beagle dog,14599,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621340,50588,,1,9615.0,7809,,,Area under curve was measured after po administration into Beagle dog.,14599,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621341,22224,,0,,7810,,,Area under curve was measured at peroral dose of 3 mg/kg,15675,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL621342,22224,,0,,7811,,,Area under curve was measured by using concentration Vs time,12706,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL621343,22224,,0,,7812,,,Area under curve was measured by using concentration Vs time; not tested,12706,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621344,50594,,1,10090.0,7813,,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),9750,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621345,50594,,1,10090.0,7814,,,Area under curve(AUC) was measured in mice after oral administration.,9750,Mus musculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL621346,22224,,0,,7815,,,Area under curve(AUC) value of the compound,14691,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621347,22224,,0,,7816,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,14691,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621348,50588,,1,9615.0,7817,,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,14691,Canis lupus familiaris,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL621349,22224,,0,,7818,,,Area under curve(carotid artery) was determined by the availability in blood,2939,,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL621350,22224,,0,,7819,,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,2939,,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL875839,22224,,0,,7820,,,Area under curve(carotid artery) was determined by the availability in blood; No data,2939,,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL620211,22224,,0,,7821,,,Area under curve(portal vein) was determined by the availability in blood,2939,,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL620212,22224,,0,,7822,,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,2939,,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL620213,22224,,0,,7823,,,Area under curve(portal vein) was determined by the availability in blood; No data,2939,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620214,50797,,1,9544.0,7824,,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",9552,Macaca mulatta,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620215,50797,,1,9544.0,7825,,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",9552,Macaca mulatta,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620216,50797,,1,9544.0,7826,,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,9552,Macaca mulatta,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620888,50588,,1,9615.0,7827,,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",9552,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620889,50588,,1,9615.0,7828,,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",9552,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL620890,22224,,0,,7829,,,Area under plasma concentration vs time curve observed in rats for 0-3 h,9552,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL620891,50597,,1,10116.0,7830,,,Area under plasma time curve determined in male rat,11911,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL620892,22224,,0,,7831,,,Area under the MAP curve measured over 5 min.,16618,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621079,50594,,1,10090.0,7832,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,14387,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621080,50594,,1,10090.0,7833,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,14387,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621081,50588,,1,9615.0,7834,,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,12836,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621082,100712,,1,10026.0,7835,,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,12836,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621083,50597,,1,10116.0,7836,,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,12836,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621084,50588,,1,9615.0,7837,,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,14339,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621085,50588,,1,9615.0,7838,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,14339,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621086,50588,,1,9615.0,7839,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,14339,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621087,50588,,1,9615.0,7840,,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),10524,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622607,50588,,1,9615.0,7841,,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),9994,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622608,50588,,1,9615.0,7842,,,Serum AUC in marmosets (IV dose),11325,Canis lupus familiaris,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624481,22224,,0,,7843,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,12536,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624482,22224,,0,,7844,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,12536,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624483,22224,,0,,7845,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,12536,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624484,22224,,0,,7846,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,12536,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624485,22224,,0,,7847,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,12536,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624486,50597,,1,10116.0,7848,,,Area under the curve for fumarate salt was evaluated in F344 Rats.,15556,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624487,22224,,0,,7849,,,Area under the curve for the compound was calculated.,2809,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624488,22224,,0,,7850,,,Area under the curve in concentration/ time,9511,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624489,50597,,1,10116.0,7851,,,Area under the curve administered intraintestinal in rats.,12818,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625184,50597,,1,10116.0,7852,,,Area under the curve administered intravenously in rats.,12818,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625185,22224,,0,,7853,,,Area under the curve during intravenous administration,15118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875954,22224,,0,,7854,,,Area under the curve during intravenous administration; Not determined,15118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625186,22224,,0,,7855,,,Area under the curve during systemic administration,15118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625187,22224,,0,,7856,,,Area under the curve during systemic administration; Not determined,15118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625188,22224,,0,,7857,,,Area under the curve was calculated for the compound.,2632,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625189,50588,,1,9615.0,7858,,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,14346,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625190,50588,,1,9615.0,7859,,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,14346,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621733,50597,,1,10116.0,7860,,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621734,50597,,1,10116.0,7861,,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621735,50597,,1,10116.0,7862,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,11149,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621736,50597,,1,10116.0,7863,,,Clearance of the drug was measured in the plasma of rat; No data,17796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621737,50597,,1,10116.0,7864,,,The pharmacokinetic parameter plasma clearance in vivo in rats,5247,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621738,50597,,1,10116.0,7865,,,Plasma clearance at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622806,50597,,1,10116.0,7866,In vivo,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623519,50597,,1,10116.0,7867,In vivo,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623520,50597,,1,10116.0,7868,In vivo,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623521,50597,,1,10116.0,7869,In vivo,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623522,50597,,1,10116.0,7870,In vivo,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623523,50597,,1,10116.0,7871,In vivo,,Clearance rate in rat,6672,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623690,50597,,1,10116.0,7872,In vivo,,Clearance rate in rat,6673,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623691,50597,,1,10116.0,7873,In vivo,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623692,50597,,1,10116.0,7874,In vivo,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623693,50597,,1,10116.0,7875,In vivo,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623694,50597,,1,10116.0,7876,In vivo,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623695,50597,,1,10116.0,7877,In vivo,,Clearance of compound after iv administration of 20 mg/kg dose in rat,4413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623696,50597,,1,10116.0,7878,In vivo,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623697,50597,,1,10116.0,7879,In vivo,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623698,22224,,0,9544.0,7880,In vivo,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,5005,Macaca mulatta,,,1
U,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623699,22224,,0,10116.0,7881,In vivo,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,5005,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623700,50597,,1,10116.0,7882,In vivo,,Mean (%CV) PK parameters for CL(mL/min/kg).,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623701,50597,,1,10116.0,7883,In vivo,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,3747,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623702,50597,,1,10116.0,7884,In vivo,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623703,50597,,1,10116.0,7885,In vivo,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623704,50597,,1,10116.0,7886,In vivo,,Plasma clearance in rat was determined,17267,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623705,50597,,1,10116.0,7887,In vivo,,Plasma clearance in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623706,50597,,1,10116.0,7888,In vivo,,Plasma clearance in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623707,50597,,1,10116.0,7889,In vivo,,Plasma clearance was determined,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623708,50597,,1,10116.0,7890,In vivo,,Plasma clearance in rat,5960,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623709,50597,,1,10116.0,7891,In vivo,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,5937,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623710,50597,,1,10116.0,7892,In vivo,,Plasma clearance in rat by iv administration,5871,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623711,50597,,1,10116.0,7893,In vivo,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,5874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623712,50597,,1,10116.0,7894,In vivo,,Plasma clearance in rat p.o.,6504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623713,50597,,1,10116.0,7895,In vivo,,Plasma clearance in rats,6803,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623714,50597,,1,10116.0,7896,In vivo,,Plasma clearance was determined; ND denotes no data,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623715,50597,,1,10116.0,7897,In vivo,,Plasma clearance was determined; ND denotes not determined,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623716,50597,,1,10116.0,7898,In vivo,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622980,50597,,1,10116.0,7899,In vivo,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,5199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622981,50597,,1,10116.0,7900,In vivo,,Plasma administration to rats,16367,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622982,50597,,1,10116.0,7901,In vivo,,Plasma clearance of the compound in female Sprague-Dawley rats,6362,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622983,50597,,1,10116.0,7902,In vivo,,Plasma clearance was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622984,50597,,1,10116.0,7903,In vivo,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,6215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622985,50597,,1,10116.0,7904,In vivo,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623631,50597,,1,10116.0,7905,In vivo,,plasma clearance was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623632,50597,,1,10116.0,7906,In vivo,,In vivo CL/F determined,4723,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623633,50597,,1,10116.0,7907,In vivo,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623634,50597,,1,10116.0,7908,In vivo,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623635,50597,,1,10116.0,7909,In vivo,,Compound was tested for the lower blood clearance in rat,5213,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621195,50597,,1,10116.0,7910,In vivo,,Evaluated for the low clearance in rat (in vivo),4687,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621196,50597,,1,10116.0,7911,In vivo,,Pharmacokinetic property (CLb)of the compound was determined in rat,3371,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875287,50597,,1,10116.0,7912,In vivo,,Rapid clearance after intravenous administration in rat was determined,4690,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621197,50597,,1,10116.0,7913,In vivo,,Clearance measured in rat,5702,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621198,50597,,1,10116.0,7914,In vivo,,Compound was evaluated for plasma clearance in rat,740,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621199,50597,,1,10116.0,7915,In vivo,,Low plasma clearance was calculated in rat,4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621200,50597,,1,10116.0,7916,In vivo,,Pharmacokinetic property (Clp) in rat,5789,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621201,50597,,1,10116.0,7917,In vivo,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621202,50597,,1,10116.0,7918,In vivo,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621203,50597,,1,10116.0,7919,In vivo,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621204,50597,,1,10116.0,7920,In vivo,,Plasma clearance after IV dosing at 1 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621205,50597,,1,10116.0,7921,In vivo,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621206,50597,,1,10116.0,7922,In vivo,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621207,50597,,1,10116.0,7923,In vivo,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621208,50597,,1,10116.0,7924,In vivo,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621209,50597,,1,10116.0,7925,In vivo,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL876484,50597,,1,10116.0,7926,In vivo,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621210,50597,,1,10116.0,7927,In vivo,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621211,50597,,1,10116.0,7928,In vivo,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621212,50597,,1,10116.0,7929,In vivo,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621213,50597,,1,10116.0,7930,In vivo,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621214,50597,,1,10116.0,7931,In vivo,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621215,50597,,1,10116.0,7932,In vivo,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621216,50597,,1,10116.0,7933,In vivo,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621217,50597,,1,10116.0,7934,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621218,50597,,1,10116.0,7935,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621219,50597,,1,10116.0,7936,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621220,50597,,1,10116.0,7937,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621221,50597,,1,10116.0,7938,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621222,50597,,1,10116.0,7939,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621223,50597,,1,10116.0,7940,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL876485,50597,,1,10116.0,7941,In vivo,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621224,50597,,1,10116.0,7942,In vivo,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621225,50597,,1,10116.0,7943,In vivo,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621226,50597,,1,10116.0,7944,In vivo,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621227,50597,,1,10116.0,7945,In vivo,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621228,50597,,1,10116.0,7946,In vivo,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621229,50597,,1,10116.0,7947,In vivo,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621230,50597,,1,10116.0,7948,In vivo,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621231,50597,,1,10116.0,7949,In vivo,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621232,50597,,1,10116.0,7950,In vivo,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621233,50597,,1,10116.0,7951,In vivo,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621234,50597,,1,10116.0,7952,In vivo,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621235,50597,,1,10116.0,7953,In vivo,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621236,50597,,1,10116.0,7954,In vivo,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621237,50597,,1,10116.0,7955,In vivo,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL876486,50597,,1,10116.0,7956,In vivo,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622436,50597,,1,10116.0,7957,In vivo,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,9866,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622437,50597,,1,10116.0,7958,In vivo,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622438,50597,,1,10116.0,7959,In vivo,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622439,50597,,1,10116.0,7960,In vivo,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622440,50597,,1,10116.0,7961,In vivo,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622441,50597,,1,10116.0,7962,In vivo,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622442,50597,,1,10116.0,7963,In vivo,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622443,50597,,1,10116.0,7964,In vivo,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622444,50597,,1,10116.0,7965,In vivo,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622445,50597,,1,10116.0,7966,In vivo,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622446,50597,,1,10116.0,7967,In vivo,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622447,50597,,1,10116.0,7968,In vivo,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622448,50597,,1,10116.0,7969,In vivo,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622449,50597,,1,10116.0,7970,In vivo,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622450,50597,,1,10116.0,7971,In vivo,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622451,50597,,1,10116.0,7972,In vivo,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622452,50597,,1,10116.0,7973,In vivo,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622453,50597,,1,10116.0,7974,In vivo,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622454,50597,,1,10116.0,7975,In vivo,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622455,50597,,1,10116.0,7976,In vivo,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL876024,50597,,1,10116.0,7977,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,9866,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622456,50597,,1,10116.0,7978,In vivo,,T max was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622457,50597,,1,10116.0,7979,In vivo,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622458,50597,,1,10116.0,7980,In vivo,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622459,50597,,1,10116.0,7981,,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873343,50597,,1,10116.0,7982,,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622460,50597,,1,10116.0,7983,,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622461,50597,,1,10116.0,7984,,,Time for maximum plasma concentration determined in rat,4576,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622462,50597,,1,10116.0,7985,In vivo,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622463,50597,,1,10116.0,7986,In vivo,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622464,50597,,1,10116.0,7987,In vivo,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622465,50597,,1,10116.0,7988,In vivo,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622466,50597,,1,10116.0,7989,In vivo,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622467,50597,,1,10116.0,7990,In vivo,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,16365,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622468,50597,,1,10116.0,7991,,,Time of maximum plasma concentration in rat,6824,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876025,50597,,1,10116.0,7992,,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622469,50597,,1,10116.0,7993,,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",6685,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622470,50597,,1,10116.0,7994,,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622471,50597,,1,10116.0,7995,In vivo,,Time required to reach maximum concentration (Cmax) after oral administration in rat,15662,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622472,50597,,1,10116.0,7996,,,Time required to reach maximum concentration in rat plasma,1742,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622473,50597,,1,10116.0,7997,In vivo,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,2774,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624282,50597,,1,10116.0,7998,In vivo,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,5199,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624283,50597,,1,10116.0,7999,In vivo,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624284,50597,,1,10116.0,8000,In vivo,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624285,50597,,1,10116.0,8001,In vivo,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624286,50597,,1,10116.0,8002,In vivo,,Time to reach Cmax after oral administration to rats,16367,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624287,50597,,1,10116.0,8003,In vivo,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624288,50597,,1,10116.0,8004,,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,216,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624289,50597,,1,10116.0,8005,In vivo,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,6410,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873344,50597,,1,10116.0,8006,In vivo,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619623,50597,,1,10116.0,8007,In vivo,,Tmax after peroral administration (10 mg/kg) was determined in rat,6215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL621399,50597,,1,10116.0,8008,In vivo,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621400,50597,,1,10116.0,8009,In vivo,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621401,50597,,1,10116.0,8010,In vivo,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621402,50597,,1,10116.0,8011,,,Tmax was determined,1465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621403,50597,,1,10116.0,8012,,,Tmax was determined,2552,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621121,50597,,1,10116.0,8013,In vivo,,Tmax after oral administration in rat,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL872525,50597,,1,10116.0,8014,In vivo,,Tmax after peroral administration in rats at 2.4 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621122,50597,,1,10116.0,8015,,,Tmax in male rat,5610,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621123,50597,,1,10116.0,8016,In vivo,,Tmax in rat at 10 mg/kg,6046,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621124,50597,,1,10116.0,8017,In vivo,,Tmax in rat by po administration at a dose of 40 mg/kg,5874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621125,50597,,1,10116.0,8018,,,Tmax in rats,17596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621126,50597,,1,10116.0,8019,In vivo,,Tmax was measured in rats after peroral administration at 5 mg/kg,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621127,50597,,1,10116.0,8020,In vivo,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,1908,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621128,50597,,1,10116.0,8021,In vivo,,Tmax value after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618263,50597,,1,10116.0,8022,In vivo,,Tmax value at a dose of 10 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618264,50597,,1,10116.0,8023,In vivo,,Tmax value at a dose of 100 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618265,50597,,1,10116.0,8024,In vivo,,Tmax value at a dose of 50 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618266,50597,,1,10116.0,8025,In vivo,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618267,50597,,1,10116.0,8026,In vivo,,time required to reach maximum concentration (Cmax) after oral administration in rat,15662,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL618450,50597,,1,10116.0,8027,,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),429,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL618451,50597,,1,10116.0,8028,,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618452,50597,,1,10116.0,8029,,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,5546,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL618453,50597,,1,10116.0,8030,,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,3173,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL618454,50597,,1,10116.0,8031,,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,3173,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL618455,50597,,1,10116.0,8032,,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,3173,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618456,50597,,1,10116.0,8033,In vivo,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,4257,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618457,50597,,1,10116.0,8034,In vivo,,Compound distribution in rat tissues was determined,6011,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618458,50597,,1,10116.0,8035,In vivo,,Volume of distribution was evaluated in rat,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618459,50597,,1,10116.0,8036,,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876733,50597,,1,10116.0,8037,,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618460,50588,,1,9615.0,8038,,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,14346,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618461,50597,,1,10116.0,8039,,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL618462,22224,,0,,8040,,,Area under the curve was determined after oral administration (300 uM/Kg),15469,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618463,50597,,1,10116.0,8041,,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618464,50597,,1,10116.0,8042,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618465,50597,,1,10116.0,8043,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618466,50597,,1,10116.0,8044,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618467,50597,,1,10116.0,8045,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618468,50597,,1,10116.0,8046,,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618469,50588,,1,9615.0,8047,,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,12935,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618470,50588,,1,9615.0,8048,,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,12935,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL618471,22224,,0,,8049,,,Plasma drug AUC in rat (PO dose),14813,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618472,50594,,1,10090.0,8050,,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,15792,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL618473,22224,,0,,8051,,,Area under was determined at a dose of 30 mg/kg,3579,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621699,50506,,1,9669.0,8052,,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,12487,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621700,50597,,1,10116.0,8053,,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,12487,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621701,50597,,1,10116.0,8054,,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,12487,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621702,50506,,1,9669.0,8055,,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,12487,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621703,50588,,1,9615.0,8056,,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,12487,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621704,50588,,1,9615.0,8057,,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,12487,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624259,50597,,1,10116.0,8058,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624260,50597,,1,10116.0,8059,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624430,50597,,1,10116.0,8060,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624431,50597,,1,10116.0,8061,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624432,50597,,1,10116.0,8062,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624433,50597,,1,10116.0,8063,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624434,50597,,1,10116.0,8064,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624435,50597,,1,10116.0,8065,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",12902,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618570,50594,,1,10090.0,8066,,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618571,50594,,1,10090.0,8067,,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618572,50594,,1,10090.0,8068,,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618573,50594,,1,10090.0,8069,,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619267,50594,,1,10090.0,8070,,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619431,50594,,1,10090.0,8071,,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619432,50594,,1,10090.0,8072,,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619433,50594,,1,10090.0,8073,,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL619434,22224,,0,,8074,,,AUC in mice after oral dose (50 mg/kg),13298,,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL619435,50594,,1,10090.0,8075,,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,12226,Mus musculus,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL619436,22224,,0,,8076,,,AUC (0-4 hr) ug/ml/h,12634,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619437,50597,,1,10116.0,8077,,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,14810,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL619438,22224,,0,,8078,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,13889,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619439,50594,,1,10090.0,8079,,,Compound was evaluated for Area under curve in mice,10018,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619440,50597,,1,10116.0,8080,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8758,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL619441,22224,,0,,8081,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8758,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619442,50597,,1,10116.0,8082,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8758,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875156,22224,,0,,8083,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,2249,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL619443,22224,,0,,8084,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,2249,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL619444,22224,,0,,8085,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,2249,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623464,22224,,0,,8086,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,2249,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623465,50594,,1,10090.0,8087,,,Compound was evaluated for area under curve when administered through oral route in mouse,15115,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623466,50597,,1,10116.0,8088,In vivo,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623467,50597,,1,10116.0,8089,In vivo,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623468,50597,,1,10116.0,8090,In vivo,,Plasma clearance in rat,6249,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622660,50597,,1,10116.0,8091,In vivo,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,2463,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622661,50597,,1,10116.0,8092,In vivo,,Plasma clearance rate in Sprague-Dawley rats,4969,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL622662,50597,,1,10116.0,8093,In vivo,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622663,50597,,1,10116.0,8094,In vivo,,Pharmacokinetic property (total body clearance) in rat,3457,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622664,50597,,1,10116.0,8095,In vivo,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,5983,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622665,50597,,1,10116.0,8096,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,6295,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622666,50597,,1,10116.0,8097,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,6296,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621615,50597,,1,10116.0,8098,In vivo,,Cl in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621616,50597,,1,10116.0,8099,In vivo,,Clearance of compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621617,50597,,1,10116.0,8100,In vivo,,Clearance was determined,5503,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621618,50597,,1,10116.0,8101,In vivo,,Clearance by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621619,50597,,1,10116.0,8102,In vivo,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,6005,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621620,50597,,1,10116.0,8103,In vivo,,Clearance rate after i.v. administration in rats,5031,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621786,50597,,1,10116.0,8104,In vivo,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621787,50597,,1,10116.0,8105,In vivo,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621788,50597,,1,10116.0,8106,In vivo,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,5979,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621789,50597,,1,10116.0,8107,In vivo,,Clearance (Cl) after oral administration in rat,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621790,50597,,1,10116.0,8108,In vivo,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,17804,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621791,50597,,1,10116.0,8109,In vivo,,Compound was tested for plasma clearance in rat,4839,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621792,50597,,1,10116.0,8110,In vitro,,In vitro microsome metabolism clearance in rat was determined,5041,Rattus norvegicus,Microsomes,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621793,50597,,1,10116.0,8111,In vitro,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,5041,Rattus norvegicus,Microsomes,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621794,50597,,1,10116.0,8112,In vivo,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621795,50597,,1,10116.0,8113,In vivo,,In vivo plasma clearance was determined,5496,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621796,50597,,1,10116.0,8114,In vivo,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,5739,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621797,50597,Hepatocyte,1,10116.0,8115,In vivo,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,5676,Rattus norvegicus,,401.0,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621798,50597,,1,10116.0,8116,In vivo,,Pharmacokinetic property (Plasma clearance) was measured in rat,4239,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621799,50597,,1,10116.0,8117,In vivo,,Pharmacokinetic property (clearance) in rat i.v.,5676,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621800,50597,,1,10116.0,8118,In vivo,,"Plasma Clearance was evaluated in rats, iv",1918,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621801,50597,,1,10116.0,8119,In vivo,,Plasma clearance (in vivo) in rats was determined,17800,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621802,50597,,1,10116.0,8120,In vivo,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,6056,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618596,50597,,1,10116.0,8121,In vivo,,Plasma clearance was determined,5496,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618597,50597,,1,10116.0,8122,In vivo,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618598,50597,,1,10116.0,8123,In vivo,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618599,50597,,1,10116.0,8124,In vivo,,Plasma clearance in rats,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618600,50597,,1,10116.0,8125,In vivo,,Plasma clearance rate determined in rat,4576,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618601,50597,,1,10116.0,8126,In vivo,,Plasma clearance was determined in rat,6011,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618602,50597,,1,10116.0,8127,In vivo,,Plasma clearance was determined,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618603,50597,,1,10116.0,8128,In vivo,,Plasma clearance value in rat,5948,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618604,50597,,1,10116.0,8129,Ex vivo,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,6125,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618605,50597,,1,10116.0,8130,In vivo,,Clearance in rat,4839,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618606,50597,,1,10116.0,8131,In vivo,,Total body clearance in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618607,50597,,1,10116.0,8132,In vivo,,Clearance of compound in rats after intravenous administration,6571,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618608,50597,,1,10116.0,8133,In vivo,,Clearance after iv administration to rats,3364,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618609,50597,,1,10116.0,8134,In vivo,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618610,50597,,1,10116.0,8135,In vivo,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618611,50597,,1,10116.0,8136,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618612,50597,,1,10116.0,8137,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618613,50597,,1,10116.0,8138,In vivo,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621076,50597,,1,10116.0,8139,In vivo,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621077,50597,,1,10116.0,8140,In vivo,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621078,50597,,1,10116.0,8141,In vivo,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621251,50597,,1,10116.0,8142,In vivo,,Clearance in rat,5970,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621252,50597,,1,10116.0,8143,In vivo,,Clearance in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621253,50597,,1,10116.0,8144,In vivo,,Clearance in rat.,4590,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621254,50597,,1,10116.0,8145,In vivo,,Clearance rate following an oral dose of 20 mg/kg in rats,6193,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621255,50597,,1,10116.0,8146,In vivo,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,2832,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621256,50597,,1,10116.0,8147,In vivo,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,1052,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621257,50597,,1,10116.0,8148,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621258,50597,,1,10116.0,8149,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621259,50597,,1,10116.0,8150,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621260,50597,,1,10116.0,8151,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL876494,50597,,1,10116.0,8152,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621261,50597,,1,10116.0,8153,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621262,50597,,1,10116.0,8154,In vivo,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621263,50597,,1,10116.0,8155,In vivo,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621264,50597,,1,10116.0,8156,In vivo,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621265,50597,,1,10116.0,8157,In vivo,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621266,50597,,1,10116.0,8158,In vivo,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621267,50597,,1,10116.0,8159,In vivo,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621268,50597,,1,10116.0,8160,In vivo,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621269,50597,,1,10116.0,8161,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621270,50597,,1,10116.0,8162,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621271,50597,,1,10116.0,8163,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621272,50597,,1,10116.0,8164,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621273,50597,,1,10116.0,8165,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621274,50597,,1,10116.0,8166,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL876495,50597,,1,10116.0,8167,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621275,50597,,1,10116.0,8168,In vivo,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621276,50597,,1,10116.0,8169,In vivo,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621277,50597,,1,10116.0,8170,In vivo,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621278,50597,,1,10116.0,8171,In vivo,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621279,50597,,1,10116.0,8172,In vivo,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621280,50597,,1,10116.0,8173,In vivo,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621281,50597,,1,10116.0,8174,In vivo,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621282,50597,,1,10116.0,8175,In vivo,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621283,50597,,1,10116.0,8176,In vivo,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621284,50597,,1,10116.0,8177,In vivo,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621285,50597,,1,10116.0,8178,In vivo,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621286,50597,,1,10116.0,8179,In vivo,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL623220,50597,,1,10116.0,8180,In vivo,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL623221,50597,,1,10116.0,8181,In vivo,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL876029,50597,,1,10116.0,8182,In vivo,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL623222,50597,,1,10116.0,8183,In vivo,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,9866,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL623223,50597,,1,10116.0,8184,In vivo,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL621445,50597,,1,10116.0,8185,In vivo,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,9866,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621446,50597,,1,10116.0,8186,In vivo,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621447,50597,,1,10116.0,8187,In vivo,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL619681,50597,,1,10116.0,8188,In vivo,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL619682,50597,,1,10116.0,8189,In vivo,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL619683,50597,,1,10116.0,8190,In vivo,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619684,50597,,1,10116.0,8191,In vivo,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619685,50597,,1,10116.0,8192,In vivo,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619686,50597,,1,10116.0,8193,In vivo,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619687,50597,,1,10116.0,8194,In vivo,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619688,50597,,1,10116.0,8195,In vivo,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL619689,50597,,1,10116.0,8196,In vivo,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL619690,50597,,1,10116.0,8197,In vivo,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL619691,50597,,1,10116.0,8198,In vivo,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619692,50597,,1,10116.0,8199,In vivo,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL619693,50597,,1,10116.0,8200,,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619694,50597,,1,10116.0,8201,In vivo,,Vc value after IV dose at a dose of 5 mg/kg in rats.,1908,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619695,50597,,1,10116.0,8202,In vivo,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,17596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619696,50597,,1,10116.0,8203,In vivo,,Compound was evaluated for pharmacokinetic parameter volume of distribution,4891,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619697,50597,,1,10116.0,8204,In vivo,,Compound was evaluated for volume of distribution in rat,740,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619698,50597,,1,10116.0,8205,In vivo,,Steady state volume distribution was determined; steady state(ss),16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619699,50597,,1,10116.0,8206,In vivo,,Steady state volume of distribution after iv administration to rats,3364,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619700,50597,,1,10116.0,8207,In vivo,,Steady state volume of distribution dosing at 3 mg/kg iv,2552,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619701,50597,,1,10116.0,8208,In vivo,,The compound was evaluated for volume of distribution in rat,406,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619702,50597,,1,10116.0,8209,In vivo,,The compound was tested for volume of distribution in rat,12500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620335,50597,,1,10116.0,8210,In vivo,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,12500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620336,50597,,1,10116.0,8211,In vivo,,Volume distribution (VD) after oral administration in rat,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620337,50597,,1,10116.0,8212,In vivo,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620520,50597,,1,10116.0,8213,In vivo,,Volume distribution in rat,1094,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620521,50597,,1,10116.0,8214,In vivo,,Volume distribution in rat,5833,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875825,50597,,1,10116.0,8215,In vivo,,Volume distribution in rat after peroral administration at 10 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620522,50597,,1,10116.0,8216,In vivo,,Volume distribution in rat after peroral administration at 5 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620523,50597,,1,10116.0,8217,In vivo,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,6005,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620524,50597,,1,10116.0,8218,In vivo,,Volume of distribution in rat.,1696,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620525,50597,,1,10116.0,8219,In vivo,,Volume of distribution in rat,6672,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620526,50597,,1,10116.0,8220,In vivo,,Volume of distribution in rat,6673,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620527,50597,,1,10116.0,8221,In vivo,,Volume of distribution in rat by iv administration,5871,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620528,50597,,1,10116.0,8222,In vivo,,Volume of distribution in rats,6803,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620529,50597,,1,10116.0,8223,In vivo,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,5199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620530,50597,,1,10116.0,8224,,,Volume distribution at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620531,50597,,1,10116.0,8225,In vivo,,Steady state volume of distribution was determined,16367,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL620532,22224,,0,9544.0,8226,In vivo,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,5005,Macaca mulatta,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL620533,22224,,0,10116.0,8227,In vivo,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,5005,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL620534,22224,,0,10116.0,8228,In vivo,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,5005,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620535,50597,,1,10116.0,8229,In vivo,,Mean (%CV) PK parameters for Vdss(mL/kg).,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875826,50597,,1,10116.0,8230,In vivo,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620536,50597,,1,10116.0,8231,In vivo,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620537,50597,,1,10116.0,8232,In vivo,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618526,50597,,1,10116.0,8233,In vivo,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618527,50597,,1,10116.0,8234,In vivo,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,5739,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618528,50597,,1,10116.0,8235,In vivo,,Pharmacokinetic property (Vdss) in rat,5789,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618529,50597,,1,10116.0,8236,In vivo,,Pharmacokinetic property (vdss) was measured in rat,4239,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618530,50597,,1,10116.0,8237,In vivo,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618531,50597,,1,10116.0,8238,In vivo,,Volume of distribution in rat,6642,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618532,50597,,1,10116.0,8239,In vivo,,The pharmacokinetic parameter volume of distribution in vivo in rats,5247,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL618533,50597,,1,10116.0,8240,In vivo,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618534,50597,,1,10116.0,8241,In vivo,,Vdss in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618535,50597,,1,10116.0,8242,In vivo,,Volume distribution after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618536,50597,,1,10116.0,8243,In vivo,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618537,50597,,1,10116.0,8244,In vivo,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618538,50597,,1,10116.0,8245,In vivo,,Volume distribution at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618539,50597,,1,10116.0,8246,In vivo,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618540,50597,,1,10116.0,8247,In vivo,,Volume distribution was calculated in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618541,50597,,1,10116.0,8248,In vivo,,Volume distribution was determined,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618542,50597,,1,10116.0,8249,In vivo,,Volume of distribution after intravenous administration was evaluated in rat,2938,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622544,50597,,1,10116.0,8250,In vivo,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622545,50597,,1,10116.0,8251,In vivo,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622546,50597,,1,10116.0,8252,In vivo,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622547,50597,,1,10116.0,8253,In vivo,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622548,50597,,1,10116.0,8254,In vivo,,Volume of distribution in steady state was determined in rat,5145,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622549,50597,,1,10116.0,8255,In vivo,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,6467,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622550,50597,,1,10116.0,8256,In vivo,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,6467,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622551,50594,,1,10090.0,8257,,,Compound was evaluated for area under curve when administered through oral route to mouse,15115,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622552,50597,,1,10116.0,8258,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8758,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622553,50597,,1,10116.0,8259,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8758,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL622554,22224,,0,,8260,In vivo,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,8267,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622555,50588,,1,9615.0,8261,,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,8267,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622556,50594,,1,10090.0,8262,,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,14239,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622557,50594,,1,10090.0,8263,,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,14239,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622558,50594,,1,10090.0,8264,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,10754,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622559,50594,,1,10090.0,8265,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,10754,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622560,50588,,1,9615.0,8266,,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,10754,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622561,50597,,1,10116.0,8267,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,14681,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622562,50597,,1,10116.0,8268,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,14681,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622563,50597,,1,10116.0,8269,,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,14681,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622564,22224,,0,,8270,,,Concentration of compound in Central nervous system,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622565,22224,,0,,8271,,,Concentration of compound in Central nervous system; Not detectable,13118,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622566,50594,,1,10090.0,8272,,,"Concentration of diester in the blood, following oral administration in mice",13318,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624515,50594,,1,10090.0,8273,,,"Concentration of monoester in the blood, following oral administration in mice",13318,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624516,50594,,1,10090.0,8274,,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,13318,Mus musculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624517,22224,,0,,8275,,,Evaluated for Pharmacokinetic property: Area under the curve,15692,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624518,50594,,1,10090.0,8276,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624519,100710,,1,9541.0,8277,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624520,100710,,1,9541.0,8278,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624521,100710,,1,9541.0,8279,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624522,100710,,1,9541.0,8280,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624523,100710,,1,9541.0,8281,,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624409,100710,,1,9541.0,8282,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624410,100710,,1,9541.0,8283,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624411,100710,,1,9541.0,8284,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623531,100710,,1,9541.0,8285,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623532,100710,,1,9541.0,8286,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623533,100710,,1,9541.0,8287,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623534,100710,,1,9541.0,8288,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623535,50594,,1,10090.0,8289,,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623536,50594,,1,10090.0,8290,,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623537,50594,,1,10090.0,8291,,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623538,50594,,1,10090.0,8292,,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623539,50594,,1,10090.0,8293,,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623540,50594,,1,10090.0,8294,,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623541,50594,,1,10090.0,8295,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623542,50594,,1,10090.0,8296,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623543,50594,,1,10090.0,8297,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623544,50594,,1,10090.0,8298,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623545,50594,,1,10090.0,8299,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623546,50594,,1,10090.0,8300,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",14839,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623547,50597,,1,10116.0,8301,In vivo,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623548,50597,,1,10116.0,8302,In vivo,,High i.v. clearance in Dawley rats,6827,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623549,50597,,1,10116.0,8303,In vitro,,In vitro clearance in rat liver microsomes,17538,Rattus norvegicus,Microsomes,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623550,50597,,1,10116.0,8304,In vitro,,Intrinsic clearance in rat liver microsomes was determined,6331,Rattus norvegicus,Microsomes,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL875276,50597,Hepatocyte,1,10116.0,8305,In vitro,,Intrinsic clearance in rat hepatocytes was determined,5948,Rattus norvegicus,,401.0,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621872,50597,,1,10116.0,8306,In vivo,,Plasma Clearance was determined,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621873,50597,,1,10116.0,8307,In vivo,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,6647,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621874,50597,,1,10116.0,8308,In vivo,,Plasma clearance in rat.,1696,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621875,50597,,1,10116.0,8309,In vivo,,Plasma clearance in rats,6597,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621876,50597,,1,10116.0,8310,In vivo,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,347,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621877,50597,,1,10116.0,8311,In vivo,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621878,50597,,1,10116.0,8312,In vivo,,Plasma clearance was measured in rat,2879,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621879,50597,,1,10116.0,8313,In vivo,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,4883,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621880,50597,,1,10116.0,8314,In vivo,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",5328,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621881,50597,,1,10116.0,8315,In vivo,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,5160,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621882,50597,,1,10116.0,8316,In vivo,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875283,50597,,1,10116.0,8317,In vivo,,Total clearance at 1 mg/kg was determined in rat,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621883,50597,,1,10116.0,8318,In vivo,,Total clearance at 10 mg/kg was determined in rat,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621884,50597,,1,10116.0,8319,In vivo,,Clearance in rat,6596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621885,50597,,1,10116.0,8320,In vivo,,Plasma clearance rate determined in rats,4796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621886,50597,,1,10116.0,8321,In vivo,,Clearance of compound in rat was evaluated,6850,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621887,50597,,1,10116.0,8322,In vivo,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,5932,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621888,50597,,1,10116.0,8323,In vivo,,Pharmacokinetic property (blood clearance) in rat,3371,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621889,50597,,1,10116.0,8324,In vivo,,Plasma clearance in rat,2083,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621890,50597,,1,10116.0,8325,In vivo,,Plasma clearance in rats,4942,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621891,50597,,1,10116.0,8326,In vitro,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,6838,Rattus norvegicus,Microsomes,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621892,50597,,1,10116.0,8327,In vivo,,Clearance in Dawley rat,5353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621893,50597,,1,10116.0,8328,In vivo,,Clearance rat,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621894,50597,,1,10116.0,8329,In vivo,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621895,50597,,1,10116.0,8330,In vivo,,Clearance rat; Not determined,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875284,50597,,1,10116.0,8331,In vivo,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618699,50597,,1,10116.0,8332,In vivo,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618700,50597,,1,10116.0,8333,In vivo,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618701,50597,,1,10116.0,8334,In vivo,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876600,50597,,1,10116.0,8335,In vivo,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618702,50597,,1,10116.0,8336,In vivo,,Clearance of compound in rat after 1 mg/kg i.v. administration,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618703,50597,,1,10116.0,8337,In vivo,,Compound was evaluated for Hepatic clearance in rat,3341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618704,50597,,1,10116.0,8338,In vivo,,In vivo clearance after 5 mg/kg dose,4891,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618705,50597,,1,10116.0,8339,In vivo,,Compound was tested for plasma clearance in rats,1094,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618706,50597,,1,10116.0,8340,In vivo,,Hepatic clearance after intravenous administration was evaluated in rat,2938,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618707,50597,,1,10116.0,8341,In vivo,,Lower clearance in rat (i.v.) at 0.5 mpk,17853,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618708,50597,,1,10116.0,8342,In vivo,,Pharmacokinetic parameter expressed as plasma clearance in rat,6049,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618709,50597,,1,10116.0,8343,In vivo,,Pharmacokinetic property (Clp) in rat,5789,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618710,50597,,1,10116.0,8344,In vivo,,Plasma clearance in Sprague-Dawley rats,4514,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618711,50597,,1,10116.0,8345,In vivo,,Plasma clearance (Clp) in rat,6448,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618712,50597,,1,10116.0,8346,In vivo,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618713,50597,,1,10116.0,8347,In vivo,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,5710,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618714,50597,,1,10116.0,8348,In vivo,,Plasma clearance after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618715,50597,,1,10116.0,8349,In vivo,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618716,50597,,1,10116.0,8350,In vivo,,Plasma clearance in rat was determined,1742,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876601,50597,,1,10116.0,8351,In vivo,,Plasma clearance measured in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618717,50597,,1,10116.0,8352,In vivo,,Plasma clearance was calculated in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618718,50597,,1,10116.0,8353,In vivo,,Plasma clearance in rat,5145,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618719,50597,,1,10116.0,8354,In vivo,,Plasma clearance in rat,5833,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618720,50597,,1,10116.0,8355,In vivo,,Plasma clearance in rat,6453,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618721,50597,,1,10116.0,8356,In vivo,,Plasma clearance in rat,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621477,50597,,1,10116.0,8357,In vivo,,Plasma clearance in rats,6305,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621478,50597,,1,10116.0,8358,In vivo,,Plasma clearance in rat,6642,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621479,50597,,1,10116.0,8359,In vivo,,Plasma clearance was evaluated in rat,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621480,50597,,1,10116.0,8360,In vivo,,Plasma clearance was evaluated in rat; Not tested,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621481,50597,,1,10116.0,8361,In vivo,,Plasma clearance rate was determined for the compound in rat,5144,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621482,50597,,1,10116.0,8362,In vivo,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621483,50597,,1,10116.0,8363,In vivo,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621484,50597,,1,10116.0,8364,In vivo,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621485,50597,,1,10116.0,8365,In vivo,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL621486,50597,,1,10116.0,8366,In vivo,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621487,50597,,1,10116.0,8367,In vivo,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621488,50597,,1,10116.0,8368,In vivo,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621489,50597,,1,10116.0,8369,In vivo,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621490,50597,,1,10116.0,8370,In vivo,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL621491,50597,,1,10116.0,8371,In vivo,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621492,50597,,1,10116.0,8372,In vivo,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621493,50597,,1,10116.0,8373,In vivo,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621494,50597,,1,10116.0,8374,In vivo,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621495,50597,,1,10116.0,8375,In vivo,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621496,50597,,1,10116.0,8376,In vivo,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621497,50597,,1,10116.0,8377,In vivo,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621498,50597,,1,10116.0,8378,In vivo,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621499,50597,,1,10116.0,8379,In vivo,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618634,50597,,1,10116.0,8380,In vivo,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618635,50597,,1,10116.0,8381,In vivo,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL618636,50597,,1,10116.0,8382,In vivo,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL619737,50597,,1,10116.0,8383,In vivo,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL619738,50597,,1,10116.0,8384,In vivo,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624329,50597,,1,10116.0,8385,In vivo,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624330,50597,,1,10116.0,8386,In vivo,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624331,50597,,1,10116.0,8387,In vivo,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624332,50597,,1,10116.0,8388,In vivo,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624333,50597,,1,10116.0,8389,In vivo,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624334,50597,,1,10116.0,8390,In vivo,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624335,50597,,1,10116.0,8391,In vivo,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL620016,50597,,1,10116.0,8392,In vivo,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL620169,50597,,1,10116.0,8393,In vivo,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL620170,50597,,1,10116.0,8394,In vivo,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL620171,50597,,1,10116.0,8395,In vivo,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL620172,50597,,1,10116.0,8396,In vivo,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL620173,50597,,1,10116.0,8397,In vivo,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL620174,50597,,1,10116.0,8398,In vivo,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL620175,50597,,1,10116.0,8399,In vivo,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL620176,50597,,1,10116.0,8400,In vivo,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL620177,50597,,1,10116.0,8401,In vivo,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL620178,50597,,1,10116.0,8402,,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL620179,50597,,1,10116.0,8403,,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620180,50597,,1,10116.0,8404,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620181,50597,,1,10116.0,8405,In vivo,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620182,50597,,1,10116.0,8406,In vivo,,Volume of distribution of compound in rats after intravenous administration,6571,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620183,50597,,1,10116.0,8407,In vivo,,Volume of distribution in rat,6453,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620184,50597,,1,10116.0,8408,In vivo,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620185,50597,,1,10116.0,8409,In vivo,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620186,50597,,1,10116.0,8410,In vivo,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620187,50597,,1,10116.0,8411,In vivo,,Volume of distribution was determined in Dawley rat,5353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620188,50597,,1,10116.0,8412,In vivo,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620189,50597,,1,10116.0,8413,In vivo,,Volume of distribution was reported in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620190,50597,,1,10116.0,8414,In vivo,,Volumes of distribution in rat after peroral administration,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620191,50597,,1,10116.0,8415,In vivo,,Volumes of distribution in rat after po administration,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620192,50597,,1,10116.0,8416,In vivo,,Volumes of distribution in rat after po administration; Not determined,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620193,50597,,1,10116.0,8417,In vivo,,Pharmacokinetic property (Volume) in rat i.v.,5676,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620194,50597,,1,10116.0,8418,In vivo,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876730,50597,,1,10116.0,8419,In vivo,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620195,50597,,1,10116.0,8420,In vivo,,Volume distribution in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620196,50597,,1,10116.0,8421,In vivo,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620197,50597,,1,10116.0,8422,In vivo,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,4883,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620198,50597,,1,10116.0,8423,In vivo,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,6647,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620199,50597,,1,10116.0,8424,In vivo,,Volume of distribution in rats,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620200,50597,,1,10116.0,8425,In vivo,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620201,50597,,1,10116.0,8426,In vivo,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620202,50597,,1,10116.0,8427,In vivo,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620203,50597,,1,10116.0,8428,In vivo,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620204,50597,,1,10116.0,8429,In vivo,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620205,50597,,1,10116.0,8430,In vivo,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624664,50597,,1,10116.0,8431,In vivo,,Pharmacokinetic parameter (Vss) in rat,5960,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624665,50597,,1,10116.0,8432,In vivo,,Pharmacokinetic property (Volume) in rat i.v.,5676,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624666,50597,,1,10116.0,8433,,,Pharmacokinetic property (Vss) in rat,5948,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624667,50597,,1,10116.0,8434,In vivo,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,5979,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624668,50597,,1,10116.0,8435,In vivo,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624669,50597,,1,10116.0,8436,In vivo,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624670,50597,,1,10116.0,8437,In vivo,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624671,50597,,1,10116.0,8438,In vivo,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624672,50597,,1,10116.0,8439,In vivo,,Steady state volume distribution in rat,6448,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624673,50597,,1,10116.0,8440,In vivo,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624674,50597,,1,10116.0,8441,In vivo,,Steady state volume of distribution determined in rat,4576,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624675,50597,,1,10116.0,8442,In vivo,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621728,50597,,1,10116.0,8443,In vivo,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621729,50597,,1,10116.0,8444,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621730,50597,,1,10116.0,8445,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621731,50597,,1,10116.0,8446,In vivo,,Volume distribution in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621732,50597,,1,10116.0,8447,In vivo,,Volume distribution in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621908,50597,,1,10116.0,8448,In vivo,,Volume in steady state distribution value was determined,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875347,50597,,1,10116.0,8449,In vivo,,Volume in steady state distribution value was determined; ND denotes no data,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621909,50597,,1,10116.0,8450,In vivo,,Volume in steady state distribution value was determined; ND denotes not determined,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621910,50597,,1,10116.0,8451,In vivo,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621911,50597,,1,10116.0,8452,In vivo,,Volume of distribution at steady state was evaluated in rats,6597,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621912,50597,,1,10116.0,8453,In vivo,,Volume of distribution at steady state was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621913,50597,,1,10116.0,8454,In vivo,,Volume of distribution in steady state was determined in rat,6485,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621914,50597,,1,10116.0,8455,In vivo,,Volume of distribution in steady state was determined in rat,17655,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621915,50597,,1,10116.0,8456,In vivo,,Volume of distribution after i.v. administration,6616,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621916,50597,,1,10116.0,8457,In vivo,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1916,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621917,50594,,1,10090.0,8458,In vivo,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",16438,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621918,50594,,1,10090.0,8459,In vivo,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621919,50594,,1,10090.0,8460,In vivo,,Biodistribution of compound (oxidized form) in spleen tissue,16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621920,50594,,1,10090.0,8461,In vivo,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621921,50594,,1,10090.0,8462,In vivo,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622401,50594,,1,10090.0,8463,In vivo,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL875348,50594,,1,10090.0,8464,In vivo,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622402,50594,,1,10090.0,8465,In vivo,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",16438,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622403,50594,,1,10090.0,8466,In vivo,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,16438,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622404,50594,,1,10090.0,8467,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622405,50594,,1,10090.0,8468,In vivo,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,16438,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622406,50594,,1,10090.0,8469,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622407,50594,,1,10090.0,8470,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622408,50594,,1,10090.0,8471,In vivo,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,16438,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622409,50594,,1,10090.0,8472,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622410,50594,,1,10090.0,8473,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622411,50594,,1,10090.0,8474,In vivo,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,16438,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627864,50594,,1,10090.0,8475,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",16438,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627865,50594,,1,10090.0,8476,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627866,50594,,1,10090.0,8477,In vivo,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,16438,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627751,50594,,1,10090.0,8478,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627752,50594,,1,10090.0,8479,In vivo,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627753,50594,,1,10090.0,8480,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",16438,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627754,50594,,1,10090.0,8481,In vivo,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627755,50594,,1,10090.0,8482,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,12467,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627756,50594,,1,10090.0,8483,In vivo,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627757,50594,,1,10090.0,8484,In vivo,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627758,50594,,1,10090.0,8485,In vivo,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627759,50594,,1,10090.0,8486,In vivo,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627760,50594,,1,10090.0,8487,In vivo,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627761,50594,,1,10090.0,8488,In vivo,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL876811,50594,,1,10090.0,8489,In vivo,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627762,50594,,1,10090.0,8490,In vivo,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627763,50594,,1,10090.0,8491,In vivo,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627764,50594,,1,10090.0,8492,In vivo,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627765,50594,,1,10090.0,8493,In vivo,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627766,50594,,1,10090.0,8494,In vivo,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627767,50594,,1,10090.0,8495,In vivo,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627768,50594,,1,10090.0,8496,In vivo,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628422,50594,,1,10090.0,8497,In vivo,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628423,50594,,1,10090.0,8498,In vivo,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628424,50597,,1,10116.0,8499,In vivo,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,5089,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628425,50597,,1,10116.0,8500,In vivo,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,5089,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628426,50597,,1,10116.0,8501,In vivo,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,4257,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628427,50597,,1,10116.0,8502,In vivo,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626938,50597,,1,10116.0,8503,In vivo,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,5546,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626939,50597,,1,10116.0,8504,In vivo,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,6141,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626940,50597,,1,10116.0,8505,In vivo,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626941,50597,,1,10116.0,8506,In vivo,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626942,50597,,1,10116.0,8507,In vivo,,Plasma clearance was reported in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876812,50597,,1,10116.0,8508,In vivo,,Plasma clearance after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626943,50597,,1,10116.0,8509,In vivo,,Plasma clearance of compound in rats was evaluated,6848,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626944,50597,,1,10116.0,8510,In vivo,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,6848,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626945,50597,,1,10116.0,8511,In vivo,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,6467,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626946,50597,,1,10116.0,8512,In vivo,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,6467,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626856,50597,,1,10116.0,8513,In vivo,,Plasma clearance rate in Sprague-Dawley rats,4956,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626857,50597,,1,10116.0,8514,In vivo,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),5529,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626858,50597,,1,10116.0,8515,In vivo,,The compound was evaluated for plasma clearance in rat,406,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627018,50597,,1,10116.0,8516,In vivo,,Total plasma clearance in rat,17655,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625331,50597,,1,10116.0,8517,In vivo,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,3293,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625332,50597,,1,10116.0,8518,In vivo,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,4075,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877590,50597,,1,10116.0,8519,In vivo,,C max was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625333,50597,,1,10116.0,8520,In vivo,,C max was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625334,50597,,1,10116.0,8521,In vivo,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,17594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625335,50597,,1,10116.0,8522,In vivo,,Cmax after single intravenous bolus of 1 mg/kg in rats,17594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625336,50597,,1,10116.0,8523,In vivo,,Cmax of compound at 5 mg/kg after po administration was determined in rat,4762,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625337,50597,,1,10116.0,8524,In vivo,,Cmax 24 hr after 10 mg/kg oral administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625338,50597,,1,10116.0,8525,In vivo,,Cmax 24 hr after 2 mg/kg oral administration in rats,17509,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625339,50597,,1,10116.0,8526,In vivo,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625340,50597,,1,10116.0,8527,In vivo,,Cmax in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625341,50597,,1,10116.0,8528,In vivo,,Cmax in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622687,50597,,1,10116.0,8529,In vivo,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,3169,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622688,50597,,1,10116.0,8530,In vivo,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,6515,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622689,50597,,1,10116.0,8531,In vivo,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,11149,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL620295,50597,,1,10116.0,8532,In vivo,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,11149,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620296,50597,,1,10116.0,8533,In vivo,,Cmax after 10 mg/kg oral administration in rat,17858,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620297,50597,,1,10116.0,8534,In vivo,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620298,50597,,1,10116.0,8535,In vivo,,Cmax after IV dosing at 1 mg/kg in rat; no data,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620299,50597,,1,10116.0,8536,In vivo,,Cmax after oral administration at 20 mpk in rats,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620300,50597,,1,10116.0,8537,In vivo,,Cmax after oral administration at 20 mpk in rats; Not performed.,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620301,50597,,1,10116.0,8538,In vivo,,Cmax after oral administration at 20 mpk in rats d; Not performed.,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620302,50597,,1,10116.0,8539,In vivo,,Cmax after oral administration in rat,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620303,50597,,1,10116.0,8540,In vivo,,Cmax after oral administration at a dose of 2 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620304,50597,,1,10116.0,8541,In vivo,,Cmax after oral administration at a dose of 4 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620305,50597,,1,10116.0,8542,In vivo,,Cmax in rats after 20 mg/kg oral dose,6113,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620306,50597,,1,10116.0,8543,In vivo,,Cmax after peroral administration in rats at 2.4 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620307,50597,,1,10116.0,8544,In vivo,,Cmax at the dose of 2 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620308,50597,,1,10116.0,8545,In vivo,,Cmax at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620309,50597,,1,10116.0,8546,In vivo,,Cmax by administering at 20 mg/kg p.o. in rats,6402,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620310,50597,,1,10116.0,8547,In vivo,,Cmax in male rat,5610,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620311,50597,,1,10116.0,8548,In vivo,,Cmax in rat,5207,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620312,50597,,1,10116.0,8549,In vivo,,Cmax in rat,6011,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620313,50597,,1,10116.0,8550,In vivo,,Cmax in rat,6504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620314,50597,,1,10116.0,8551,In vivo,,Cmax in rat at 10 mg/kg,6046,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620315,50597,,1,10116.0,8552,In vivo,,Cmax in rat at the dose of 1 mg/kg i.v.,6504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620316,50597,,1,10116.0,8553,In vivo,,Cmax in rat by po administration at a dose of 40 mg/kg,5874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620317,50597,,1,10116.0,8554,In vivo,,Cmax in rat p.o. at 20 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620318,50597,,1,10116.0,8555,In vivo,,Cmax in rats,5836,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620319,50597,,1,10116.0,8556,In vivo,,Cmax in rats,17596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620320,50597,,1,10116.0,8557,In vivo,,Cmax was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620321,50597,,1,10116.0,8558,In vivo,,Cmax was measured in rats after peroral administration at 3 mg/kg,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620322,50597,,1,10116.0,8559,In vivo,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,1908,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620323,50597,,1,10116.0,8560,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,1870.0,BAO_0000218,Intermediate,,A,Frontal cortex,CHEMBL620324,50597,,1,10116.0,8561,,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,1870.0,BAO_0000218,Intermediate,,A,Frontal cortex,CHEMBL620325,50597,,1,10116.0,8562,,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL620326,50597,,1,10116.0,8563,,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL620327,50597,,1,10116.0,8564,,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620328,50597,,1,10116.0,8565,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620329,50597,,1,10116.0,8566,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,1891.0,BAO_0000218,Intermediate,,A,Midbrain,CHEMBL620330,50597,,1,10116.0,8567,,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,1891.0,BAO_0000218,Intermediate,,A,Midbrain,CHEMBL875286,50597,,1,10116.0,8568,,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620331,50597,,1,10116.0,8569,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620332,50597,,1,10116.0,8570,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL620333,50597,,1,10116.0,8571,,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL620334,50597,,1,10116.0,8572,,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621015,50597,,1,10116.0,8573,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621016,50597,,1,10116.0,8574,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621191,50597,,1,10116.0,8575,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621192,50597,,1,10116.0,8576,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621193,50597,,1,10116.0,8577,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621194,50597,,1,10116.0,8578,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624204,50597,,1,10116.0,8579,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624205,50597,,1,10116.0,8580,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624206,50597,,1,10116.0,8581,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624207,50597,,1,10116.0,8582,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624208,50597,,1,10116.0,8583,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624209,50597,,1,10116.0,8584,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624210,50597,,1,10116.0,8585,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624211,50597,,1,10116.0,8586,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624212,50597,,1,10116.0,8587,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624213,50597,,1,10116.0,8588,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL876611,50597,,1,10116.0,8589,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624214,50597,,1,10116.0,8590,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624215,50597,,1,10116.0,8591,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624216,50597,,1,10116.0,8592,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624217,50597,,1,10116.0,8593,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624218,50597,,1,10116.0,8594,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624219,50597,,1,10116.0,8595,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624220,50597,,1,10116.0,8596,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624221,50597,,1,10116.0,8597,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624222,50597,,1,10116.0,8598,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624223,50597,,1,10116.0,8599,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624224,50597,,1,10116.0,8600,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624225,50597,,1,10116.0,8601,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622420,50597,,1,10116.0,8602,In vivo,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622421,50597,,1,10116.0,8603,In vivo,,Volume of steady state distribution after i.v. administration in rats,5031,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622422,50597,,1,10116.0,8604,In vivo,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,6215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622423,50597,,1,10116.0,8605,In vivo,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622424,50597,,1,10116.0,8606,In vivo,,Vss was determined,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622425,50597,,1,10116.0,8607,In vivo,,Vss in rat,6596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876612,50597,,1,10116.0,8608,In vivo,,Vss was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622426,50597,,1,10116.0,8609,In vivo,,volume of distribution at steady state was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622427,50597,,1,10116.0,8610,In vivo,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622428,50597,,1,10116.0,8611,In vivo,,Pharmacokinetic (PK) parameter Vz in rat,5874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622429,50597,,1,10116.0,8612,In vivo,,Volume distribution in rats,4942,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622430,50597,,1,10116.0,8613,In vivo,,Volume of distribution in rat; No data,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622431,50597,,1,10116.0,8614,In vivo,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,2116.0,BAO_0000218,Intermediate,,A,Ileum,CHEMBL622432,50597,,1,10116.0,8615,,,% absorption predicted from in vitro rat ileum transport studies,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622433,50597,,1,10116.0,8616,In vivo,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622434,50597,,1,10116.0,8617,In vivo,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622435,50597,,1,10116.0,8618,In vivo,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618748,50597,,1,10116.0,8619,In vivo,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618749,50597,,1,10116.0,8620,In vivo,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618750,50597,,1,10116.0,8621,In vivo,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618751,50597,,1,10116.0,8622,In vivo,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618752,50597,,1,10116.0,8623,In vivo,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,13569,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618753,50597,,1,10116.0,8624,In vivo,,Oral bioavailability in rat,4576,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL618754,50597,,1,10116.0,8625,In vivo,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,750,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618755,50597,,1,10116.0,8626,In vivo,,Oral bioavailability in rat,750,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618756,50597,,1,10116.0,8627,In vivo,,Oral bioavailability in rat,4590,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618757,50597,,1,10116.0,8628,In vivo,,Oral bioavailability in rat,1716,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618758,50597,,1,10116.0,8629,In vivo,,Bioavailability in rat,1974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621088,50597,,1,10116.0,8630,In vivo,,Oral bioavailability in rat (dose 30 mg/kg),4502,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621089,50597,,1,10116.0,8631,,,Pharmacokinetic property (cLogP) in rat,3371,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,F,Blood,CHEMBL621090,50597,,1,10116.0,8632,,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,9099,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,F,Blood,CHEMBL621091,50597,,1,10116.0,8633,,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,9099,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876731,50597,,1,10116.0,8634,In vivo,,Clearance in rat.,4590,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621092,50597,,1,10116.0,8635,In vivo,,Compound was evaluated for its clearance when administered intravenously in rat,3184,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621093,50597,,1,10116.0,8636,In vivo,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621094,50597,,1,10116.0,8637,,,Blood: Brain distribution ratio is determined in rat,4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621095,50597,,1,10116.0,8638,,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621096,50597,,1,10116.0,8639,,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,4199,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621097,50597,,1,10116.0,8640,In vivo,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL621098,50597,,1,10116.0,8641,,,Percent dose excreted in 0-48 hours administered ip to male rat,7449,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL621099,50597,,1,10116.0,8642,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL621100,50597,,1,10116.0,8643,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL621101,50597,,1,10116.0,8644,,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL621102,50597,,1,10116.0,8645,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL876732,50597,,1,10116.0,8646,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621103,50597,,1,10116.0,8647,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621104,50597,,1,10116.0,8648,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621105,50597,,1,10116.0,8649,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621106,50597,,1,10116.0,8650,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621107,50597,,1,10116.0,8651,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621108,50597,,1,10116.0,8652,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621109,50597,,1,10116.0,8653,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621110,50594,,1,10090.0,8654,In vivo,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621111,50594,,1,10090.0,8655,In vivo,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622541,50594,,1,10090.0,8656,In vivo,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622542,50594,,1,10090.0,8657,In vivo,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622543,50594,,1,10090.0,8658,In vivo,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624412,50594,,1,10090.0,8659,In vivo,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624413,50594,,1,10090.0,8660,In vivo,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624414,50594,,1,10090.0,8661,In vivo,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624415,50594,,1,10090.0,8662,In vivo,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624416,50594,,1,10090.0,8663,In vivo,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624417,50594,,1,10090.0,8664,In vivo,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624418,50594,,1,10090.0,8665,In vivo,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624419,50594,,1,10090.0,8666,In vivo,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624420,50594,,1,10090.0,8667,In vivo,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624421,50594,,1,10090.0,8668,In vivo,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624422,50594,,1,10090.0,8669,In vivo,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624423,50594,,1,10090.0,8670,In vivo,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625123,50594,,1,10090.0,8671,In vivo,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625124,50594,,1,10090.0,8672,In vivo,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625125,50594,,1,10090.0,8673,In vivo,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL625126,50594,,1,10090.0,8674,In vivo,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL626947,50594,,1,10090.0,8675,In vivo,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL626948,50594,,1,10090.0,8676,In vivo,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL626949,50594,,1,10090.0,8677,In vivo,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL626950,50594,,1,10090.0,8678,In vivo,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL626951,50594,,1,10090.0,8679,In vivo,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626952,50594,,1,10090.0,8680,In vivo,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626953,50594,,1,10090.0,8681,In vivo,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626954,50594,,1,10090.0,8682,In vivo,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626955,50594,,1,10090.0,8683,In vivo,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626956,50594,,1,10090.0,8684,In vivo,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626957,50594,,1,10090.0,8685,In vivo,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626958,50594,,1,10090.0,8686,In vivo,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626959,50594,,1,10090.0,8687,In vivo,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626960,50594,,1,10090.0,8688,In vivo,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626961,50594,,1,10090.0,8689,In vivo,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627589,50594,,1,10090.0,8690,In vivo,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627590,50594,,1,10090.0,8691,In vivo,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627591,50594,,1,10090.0,8692,,,Time taken for EC90 was determined when tested in mouse,3132,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627592,50594,,1,10090.0,8693,,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,3132,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627593,50594,,1,10090.0,8694,In vivo,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),16597,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627594,50594,,1,10090.0,8695,,,Half life in mice,5727,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876813,50594,,1,10090.0,8696,In vivo,,Half life period in mouse after 10 mg/Kg dose,5302,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627595,50594,,1,10090.0,8697,In vivo,,Half life period in mouse after 10 mg/kg dose,5302,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627596,50594,,1,10090.0,8698,In vivo,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,6348,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627597,50597,,1,10116.0,8699,In vivo,,Cmax value at 5 mg/kg po was determined in rat,5964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627598,50597,,1,10116.0,8700,In vivo,,Cmax value evaluated in rat,6078,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627599,50597,,1,10116.0,8701,In vivo,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,5206,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627600,50597,,1,10116.0,8702,In vivo,,Cmax value after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627601,50597,,1,10116.0,8703,In vivo,,Cmax value at 1 mg/kg po in rat,5964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627776,50597,,1,10116.0,8704,In vivo,,Cmax value at 5 mg/kg po in rat,5964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627777,50597,,1,10116.0,8705,In vivo,,Cmax value at a dose of 10 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627778,50597,,1,10116.0,8706,In vivo,,Cmax value at a dose of 100 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627779,50597,,1,10116.0,8707,In vivo,,Cmax value at a dose of 50 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876814,50597,,1,10116.0,8708,In vivo,,Cmax value in rats at 10 mg/kg,17617,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627780,50597,,1,10116.0,8709,In vivo,,Cmax value was evaluated in rats at a dose of 20 mg/kg,1445,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627781,50597,,1,10116.0,8710,In vivo,,Cmax value was determined after peroral administration of 20 mg/kg in rat,6082,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627782,50597,,1,10116.0,8711,In vivo,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1446,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627783,50597,,1,10116.0,8712,In vivo,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,5407,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627784,50597,,1,10116.0,8713,In vivo,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,2690,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627785,50597,,1,10116.0,8714,In vivo,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627786,50597,,1,10116.0,8715,In vivo,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627787,50597,,1,10116.0,8716,In vivo,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,4891,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627788,50597,,1,10116.0,8717,In vivo,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,2807,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626579,50597,,1,10116.0,8718,In vivo,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,2807,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626580,50597,,1,10116.0,8719,In vivo,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,2807,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876815,50597,,1,10116.0,8720,In vivo,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,3634,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626581,50597,,1,10116.0,8721,In vivo,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,1881,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626582,50597,,1,10116.0,8722,In vivo,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,1881,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626583,50597,,1,10116.0,8723,In vivo,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626205,50597,,1,10116.0,8724,In vivo,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626206,50597,,1,10116.0,8725,In vivo,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626207,50597,,1,10116.0,8726,In vivo,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623882,50597,,1,10116.0,8727,In vivo,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623883,50597,,1,10116.0,8728,In vivo,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623884,50597,,1,10116.0,8729,In vivo,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,17582,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623885,50597,,1,10116.0,8730,In vivo,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",3032,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623886,50597,,1,10116.0,8731,In vivo,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,6295,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623887,50597,,1,10116.0,8732,In vivo,,Maximal concentration in rat was determined,6619,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623888,50597,,1,10116.0,8733,In vivo,,Maximal concentration after i.v. administration,6616,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623889,50597,,1,10116.0,8734,In vivo,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,3249,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623890,50597,,1,10116.0,8735,In vivo,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,17791,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623891,50597,,1,10116.0,8736,In vivo,,Cmax in rat plasma after oral dose (50 mg/Kg),17791,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623892,50597,,1,10116.0,8737,In vivo,,Maximal plasma concentration was determined.,1360,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623893,50597,,1,10116.0,8738,In vivo,,Maximal plasma drug concentration was determined,2552,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877616,50597,,1,10116.0,8739,In vivo,,Maximal concentration in rats after peroral administration,6571,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623894,50597,,1,10116.0,8740,In vivo,,Maximum concentration in rat after 2 mg/kg peroral administration,6570,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623895,50597,,1,10116.0,8741,In vivo,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,6567,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623896,50597,,1,10116.0,8742,In vivo,,Maximum concentration of compound in rat was evaluated.,3031,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623897,50597,,1,10116.0,8743,In vivo,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,3436,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623898,50597,,1,10116.0,8744,In vivo,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,3436,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623899,50597,,1,10116.0,8745,In vivo,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,2083,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623900,50597,,1,10116.0,8746,In vivo,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,3436,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623901,50597,,1,10116.0,8747,In vivo,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623902,50597,,1,10116.0,8748,In vivo,,Maximum concentration was evaluated in rats,1974,Rattus norvegicus,,,1
N,,,1359.0,BAO_0000218,Intermediate,,A,Cerebrospinal fluid,CHEMBL623903,50597,,1,10116.0,8749,In vivo,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,3307,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623904,50597,,1,10116.0,8750,In vivo,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,3307,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL877617,50597,,1,10116.0,8751,In vivo,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623905,50597,,1,10116.0,8752,In vivo,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,1500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623906,50597,,1,10116.0,8753,In vivo,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,1500,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623907,50597,,1,10116.0,8754,In vivo,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623908,50597,,1,10116.0,8755,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623909,50597,,1,10116.0,8756,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623910,50597,,1,10116.0,8757,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623911,50597,,1,10116.0,8758,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623912,50597,,1,10116.0,8759,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624616,50597,,1,10116.0,8760,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624617,50597,,1,10116.0,8761,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624618,50597,,1,10116.0,8762,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624619,50597,,1,10116.0,8763,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624794,50597,,1,10116.0,8764,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624795,50597,,1,10116.0,8765,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623921,50597,,1,10116.0,8766,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623922,50597,,1,10116.0,8767,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623923,50597,,1,10116.0,8768,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623924,50597,,1,10116.0,8769,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623925,50597,,1,10116.0,8770,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623926,50597,,1,10116.0,8771,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623927,50597,,1,10116.0,8772,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623928,50597,,1,10116.0,8773,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623929,50597,,1,10116.0,8774,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623930,50597,,1,10116.0,8775,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623931,50597,,1,10116.0,8776,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622165,50597,,1,10116.0,8777,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621249,50597,,1,10116.0,8778,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621250,50597,,1,10116.0,8779,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621448,50597,,1,10116.0,8780,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621449,50597,,1,10116.0,8781,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621450,50597,,1,10116.0,8782,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621451,50597,,1,10116.0,8783,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621452,50597,,1,10116.0,8784,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621453,50597,,1,10116.0,8785,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621454,50597,,1,10116.0,8786,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621455,50597,,1,10116.0,8787,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621456,50597,,1,10116.0,8788,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625145,50597,,1,10116.0,8789,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL875847,50597,,1,10116.0,8790,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625146,50597,,1,10116.0,8791,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625147,50597,,1,10116.0,8792,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625148,50597,,1,10116.0,8793,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625149,50597,,1,10116.0,8794,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625150,50597,,1,10116.0,8795,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625151,50597,,1,10116.0,8796,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625152,50597,,1,10116.0,8797,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625153,50597,,1,10116.0,8798,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625154,50597,,1,10116.0,8799,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625155,50597,,1,10116.0,8800,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625156,50597,,1,10116.0,8801,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624354,50597,,1,10116.0,8802,,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL624355,50597,,1,10116.0,8803,,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL624356,50597,,1,10116.0,8804,,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL624357,50597,,1,10116.0,8805,,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL624358,50597,,1,10116.0,8806,,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL624359,50597,,1,10116.0,8807,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL624360,50597,,1,10116.0,8808,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL624361,50597,,1,10116.0,8809,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL624362,50597,,1,10116.0,8810,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL624363,50597,,1,10116.0,8811,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624364,50597,,1,10116.0,8812,In vivo,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624365,50597,,1,10116.0,8813,In vivo,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624366,50597,,1,10116.0,8814,In vivo,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624367,50597,,1,10116.0,8815,In vivo,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624368,50597,,1,10116.0,8816,In vivo,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624369,50597,,1,10116.0,8817,In vivo,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624370,50597,,1,10116.0,8818,In vivo,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625069,50597,,1,10116.0,8819,In vivo,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625070,50597,,1,10116.0,8820,In vivo,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626051,50597,,1,10116.0,8821,In vivo,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626052,50597,,1,10116.0,8822,In vivo,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626053,50597,,1,10116.0,8823,In vivo,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626054,50597,,1,10116.0,8824,In vivo,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626055,50597,,1,10116.0,8825,In vivo,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626056,50597,,1,10116.0,8826,In vivo,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626057,50597,,1,10116.0,8827,In vivo,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625193,50597,,1,10116.0,8828,In vivo,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625194,50597,,1,10116.0,8829,In vivo,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625195,50597,,1,10116.0,8830,In vivo,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625196,50597,,1,10116.0,8831,In vivo,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625197,50597,,1,10116.0,8832,In vivo,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625198,50597,,1,10116.0,8833,In vivo,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627929,50597,,1,10116.0,8834,In vivo,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627074,50597,,1,10116.0,8835,In vivo,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627075,50597,,1,10116.0,8836,In vivo,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627076,50597,,1,10116.0,8837,In vivo,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627077,50597,,1,10116.0,8838,In vivo,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627078,50597,,1,10116.0,8839,In vivo,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627079,50597,,1,10116.0,8840,In vivo,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873824,50594,,1,10090.0,8841,In vivo,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,4573,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627080,50594,,1,10090.0,8842,In vivo,,Half life in mouse plasma was determined at dose 25 mg/kg,3132,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627081,50594,,1,10090.0,8843,,,Half life was determined,17718,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627082,50594,,1,10090.0,8844,In vivo,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,17728,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627083,50594,,1,10090.0,8845,In vivo,,Half-life in male mice after 1 mg/kg intravenous dose,5961,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627085,50594,,1,10090.0,8847,,,Half life in mice plasma,17731,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627086,50594,,1,10090.0,8848,,,Half life in mouse,17592,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627087,50594,,1,10090.0,8849,In vivo,,Half life in mouse plasma at dose 25 mg/kg,3132,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627088,50594,,1,10090.0,8850,In vivo,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,17729,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627089,50594,,1,10090.0,8851,In vivo,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,17729,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627090,50594,,1,10090.0,8852,In vivo,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,17729,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627091,50594,,1,10090.0,8853,In vivo,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),3277,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627092,50594,,1,10090.0,8854,In vivo,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",3760,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876785,50594,,1,10090.0,8855,In vivo,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",3760,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627093,50594,,1,10090.0,8856,In vivo,,Half-life by iv administration in mouse,2862,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627094,50594,,1,10090.0,8857,In vivo,,Half-life by oral administration in mouse,2862,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627095,50594,,1,10090.0,8858,,,Half-life in mice,5980,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627096,50594,,1,10090.0,8859,,,Half-life using mouse brain homogenate,6159,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627097,50594,,1,10090.0,8860,,,Half-life was measured in mice,6254,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627098,50594,,1,10090.0,8861,In vivo,,Half-life was measured in mouse after an iv dose of 1 mg/kg,6062,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627099,50594,,1,10090.0,8862,,,Half-life period was determined in mouse blood,1574,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627100,50594,,1,10090.0,8863,,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",56,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627101,50594,,1,10090.0,8864,,,Plasma half life in mouse,993,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627102,50594,,1,10090.0,8865,,,Stability of the peptide in the presence of mouse serum,6652,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627103,50594,,1,10090.0,8866,,,Terminal half life of compound was determined in mouse,17852,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627104,50594,,1,10090.0,8867,In vivo,,Terminal half life was evaluated in mice after intravenous administration,2675,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627105,50594,,1,10090.0,8868,In vivo,,Terminal half life was evaluated in mice after oral administration,2675,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876786,50594,,1,10090.0,8869,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,499,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873825,50594,,1,10090.0,8870,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,499,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627106,50594,,1,10090.0,8871,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,499,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626336,50594,,1,10090.0,8872,In vivo,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,14239,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877462,50594,,1,10090.0,8873,In vivo,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",5506,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626337,50594,,1,10090.0,8874,In vivo,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",5506,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626338,50594,,1,10090.0,8875,,,Half life after intraperitoneal administration of 100 mg/kg in mice,17734,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626339,50594,,1,10090.0,8876,In vivo,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,17728,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626340,50594,,1,10090.0,8877,In vivo,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,17728,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625377,50594,,1,10090.0,8878,In vivo,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,17728,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625378,50594,,1,10090.0,8879,In vivo,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,17728,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625379,50594,,1,10090.0,8880,In vivo,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,17728,Mus musculus,,,1
U,,,,BAO_0000251,Autocuration,,A,,CHEMBL625380,22224,,0,9823.0,8881,,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),14294,Sus scrofa,Microsomes,,1
U,,,,BAO_0000251,Autocuration,,A,,CHEMBL625381,22224,,0,9823.0,8882,,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),14294,Sus scrofa,Microsomes,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625382,22224,,0,9823.0,8883,,,Stability to porcine renal DHP-I,6056,Sus scrofa,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL873828,22224,,0,9823.0,8884,In vivo,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,1317,Sus scrofa,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625383,22224,,0,9823.0,8885,In vivo,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,1317,Sus scrofa,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625384,22224,,0,9823.0,8886,,,Half-life of the parent prodrug in porcine esterase solution,5229,Sus scrofa,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625385,22224,,0,9823.0,8887,,,"First order rate constant, k was determined in in pig liver Esterase",4231,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL625386,22224,,0,9823.0,8888,,,Half life of the in pig liver Esterase,4231,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623571,22224,,0,9823.0,8889,,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,5318,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623572,22224,,0,9823.0,8890,,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,5318,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623573,22224,,0,9823.0,8891,,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,5318,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623574,22224,,0,9823.0,8892,,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,3305,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623575,22224,,0,9823.0,8893,,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,3305,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623749,22224,,0,9823.0,8894,,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,2842,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623750,22224,,0,9823.0,8895,,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,2842,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623751,22224,,0,9823.0,8896,In vitro,,Half-life in vitro in pig liver,889,Sus scrofa,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL623752,22224,,0,9823.0,8897,,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,1904,Sus scrofa,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623753,50597,,1,10116.0,8898,In vivo,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623754,50597,,1,10116.0,8899,In vivo,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,2774,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623755,50597,,1,10116.0,8900,In vivo,,Maximum concentration in rat plasma was determined,1742,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623756,50597,,1,10116.0,8901,In vivo,,Maximum concentration in rats,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623757,50597,,1,10116.0,8902,In vivo,,Maximum concentration in rats at 1-2 hours,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623758,50597,,1,10116.0,8903,In vivo,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,2081,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623759,50597,,1,10116.0,8904,In vivo,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,3307,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623760,50597,,1,10116.0,8905,In vivo,,Maximum concentration at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623761,50597,,1,10116.0,8906,In vivo,,Maximum concentration was evaluated in rats,6597,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623762,50597,,1,10116.0,8907,In vivo,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL877594,50597,,1,10116.0,8908,In vivo,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623763,50597,,1,10116.0,8909,In vivo,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,16365,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623764,50597,,1,10116.0,8910,In vivo,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,16365,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623765,50597,,1,10116.0,8911,In vivo,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623766,50597,,1,10116.0,8912,In vivo,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,2591,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623767,50597,,1,10116.0,8913,In vivo,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,2591,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623768,50597,,1,10116.0,8914,In vivo,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,2591,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623769,50597,,1,10116.0,8915,In vivo,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623770,50597,,1,10116.0,8916,In vivo,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623771,50597,,1,10116.0,8917,In vivo,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623772,50597,,1,10116.0,8918,In vivo,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623773,50597,,1,10116.0,8919,In vivo,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623774,50597,,1,10116.0,8920,In vivo,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623775,50597,,1,10116.0,8921,In vivo,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623776,50597,,1,10116.0,8922,In vivo,,Cmax in rat (PO dose),14465,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622191,50597,,1,10116.0,8923,In vivo,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622192,50597,,1,10116.0,8924,In vivo,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622193,50597,,1,10116.0,8925,In vivo,,Maximum plasma concentration determined in rat,4576,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622194,50597,,1,10116.0,8926,In vivo,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622195,50597,,1,10116.0,8927,In vivo,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622196,50597,,1,10116.0,8928,In vivo,,Maximum plasma concentration in rat,6824,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622197,50597,,1,10116.0,8929,In vivo,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622198,50597,,1,10116.0,8930,In vivo,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,2932,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622199,50597,,1,10116.0,8931,In vivo,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,2932,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622200,50597,,1,10116.0,8932,In vivo,,Maximum plasma concentration of compound was measured in rat,2879,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622201,50597,,1,10116.0,8933,In vivo,,Maximum plasma concentration after 20 mg/kg oral administration in rat,2864,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623990,50597,,1,10116.0,8934,In vivo,,Maximum plasma concentration after oral administration to rats,16367,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623991,50597,,1,10116.0,8935,In vivo,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623992,50597,,1,10116.0,8936,In vivo,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",17717,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623993,50597,,1,10116.0,8937,In vivo,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623994,50597,,1,10116.0,8938,In vivo,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,17717,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,F,Plasma,CHEMBL623995,50597,,1,10116.0,8939,In vivo,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,F,Plasma,CHEMBL623996,50597,,1,10116.0,8940,In vivo,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,F,Plasma,CHEMBL623997,50597,,1,10116.0,8941,In vivo,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623998,50597,,1,10116.0,8942,In vivo,,Maximum plasma concentration dosed orally in rats,4516,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623999,50597,,1,10116.0,8943,In vivo,,Maximum plasma concentration dosed orally in rats after 6 hours,4516,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624000,50597,,1,10116.0,8944,In vivo,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,4516,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624001,50597,,1,10116.0,8945,In vivo,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,5199,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624002,50597,,1,10116.0,8946,In vivo,,Maximum plasma concentration in rat after po administration,17538,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624003,50597,,1,10116.0,8947,In vivo,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624004,50597,,1,10116.0,8948,In vivo,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",6685,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624005,50597,,1,10116.0,8949,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624006,50597,,1,10116.0,8950,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624007,50597,,1,10116.0,8951,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624008,50597,,1,10116.0,8952,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624009,50597,,1,10116.0,8953,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL874387,50597,,1,10116.0,8954,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624010,50597,,1,10116.0,8955,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624011,50597,,1,10116.0,8956,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624012,50597,,1,10116.0,8957,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624013,50597,,1,10116.0,8958,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624736,50597,,1,10116.0,8959,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624737,50597,,1,10116.0,8960,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624738,50597,,1,10116.0,8961,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624739,50597,,1,10116.0,8962,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624740,50597,,1,10116.0,8963,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624896,50597,,1,10116.0,8964,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624897,50597,,1,10116.0,8965,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624108,50597,,1,10116.0,8966,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624109,50597,,1,10116.0,8967,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624110,50597,,1,10116.0,8968,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624111,50597,,1,10116.0,8969,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624112,50597,,1,10116.0,8970,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624113,50597,,1,10116.0,8971,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL619709,50597,,1,10116.0,8972,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL619710,50597,,1,10116.0,8973,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619711,50597,,1,10116.0,8974,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619712,50597,,1,10116.0,8975,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619713,50597,,1,10116.0,8976,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619714,50597,,1,10116.0,8977,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619715,50597,,1,10116.0,8978,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619716,50597,,1,10116.0,8979,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619717,50597,,1,10116.0,8980,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619718,50597,,1,10116.0,8981,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619719,50597,,1,10116.0,8982,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL875329,50597,,1,10116.0,8983,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619720,50597,,1,10116.0,8984,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619721,50597,,1,10116.0,8985,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619722,50597,,1,10116.0,8986,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619723,50597,,1,10116.0,8987,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619724,50597,,1,10116.0,8988,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619725,50597,,1,10116.0,8989,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619726,50597,,1,10116.0,8990,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619727,50597,,1,10116.0,8991,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619728,50597,,1,10116.0,8992,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL619729,50597,,1,10116.0,8993,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL619730,50597,,1,10116.0,8994,In vivo,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL619731,50597,,1,10116.0,8995,In vivo,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL619732,50597,,1,10116.0,8996,In vivo,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL619733,50597,,1,10116.0,8997,In vivo,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL619734,50597,,1,10116.0,8998,In vivo,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL619735,50597,,1,10116.0,8999,In vivo,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL875330,50597,,1,10116.0,9000,In vivo,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL628465,50597,,1,10116.0,9001,In vivo,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL628466,50597,,1,10116.0,9002,In vivo,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL628467,50597,,1,10116.0,9003,In vivo,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL628468,50597,,1,10116.0,9004,In vivo,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL628469,50597,,1,10116.0,9005,In vivo,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL628470,50597,,1,10116.0,9006,In vivo,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL628471,50597,,1,10116.0,9007,In vivo,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL628472,50597,,1,10116.0,9008,In vivo,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL625191,50597,,1,10116.0,9009,In vivo,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL625192,50597,,1,10116.0,9010,In vivo,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL875337,50597,,1,10116.0,9011,In vivo,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626341,50597,,1,10116.0,9012,In vivo,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626342,50597,,1,10116.0,9013,In vivo,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621943,50597,,1,10116.0,9014,In vivo,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621944,50597,,1,10116.0,9015,,,Half life in rats,3748,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621945,50597,,1,10116.0,9016,,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621946,50597,,1,10116.0,9017,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),4871,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621947,50597,,1,10116.0,9018,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,4871,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621948,50597,,1,10116.0,9019,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),4872,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621949,50597,,1,10116.0,9020,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,4872,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621950,50597,,1,10116.0,9021,,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),5413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621951,50597,,1,10116.0,9022,,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,5413,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621952,50597,,1,10116.0,9023,In vivo,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,15272,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621953,50597,,1,10116.0,9024,,,Stability (%) in rat liver microsomes,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621954,50597,,1,10116.0,9025,,,Area under curve was calculated after intravenous administration,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621955,50597,,1,10116.0,9026,,,Area under the curve was calculated after iv administration in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621956,50597,,1,10116.0,9027,,,Area under the curve was calculated in rat after peroral administration,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621957,50597,,1,10116.0,9028,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621958,50597,,1,10116.0,9029,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,5710,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621959,50597,,1,10116.0,9030,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,5710,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621960,50597,,1,10116.0,9031,,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,17853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621961,50597,,1,10116.0,9032,,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,17853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621962,50597,,1,10116.0,9033,,,p value of the compound,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL876787,50597,,1,10116.0,9034,,,p value of the compound,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621963,50597,,1,10116.0,9035,,,p value of the compound,15765,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL622637,50597,,1,10116.0,9036,,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL622638,50597,,1,10116.0,9037,,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL626561,50597,,1,10116.0,9038,,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,F,,CHEMBL626562,22224,,0,9986.0,9039,,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),7991,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626563,22224,,0,9986.0,9040,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),429,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626564,22224,,0,9986.0,9041,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),429,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626565,22224,,0,9986.0,9042,In vivo,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626566,22224,,0,9986.0,9043,In vivo,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626567,22224,,0,9986.0,9044,In vivo,,Clearance rate in rabbits,3615,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626568,22224,,0,9986.0,9045,In vivo,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,4059,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626569,22224,,0,9986.0,9046,In vivo,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626570,22224,,0,9986.0,9047,In vivo,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626571,22224,,0,9986.0,9048,In vivo,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626572,22224,,0,9986.0,9049,In vivo,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,429,Oryctolagus cuniculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626573,22224,,0,9986.0,9050,In vivo,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,4059,Oryctolagus cuniculus,,,1
U,,,2107.0,BAO_0000251,Autocuration,,A,Liver,CHEMBL626574,22224,,0,9986.0,9051,,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,9659,Oryctolagus cuniculus,Microsomes,,1
U,,,2107.0,BAO_0000251,Autocuration,,A,Liver,CHEMBL626575,22224,,0,9986.0,9052,,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,9659,Oryctolagus cuniculus,Microsomes,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626576,22224,,0,9986.0,9053,,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,3639,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626577,22224,,0,9986.0,9054,,,Dose at which bioavailability of perorally administered compound was tested in rabbit,3639,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626578,22224,,0,9986.0,9055,In vivo,,The compound was tested for its bioavailability in rabbit (by oral dosage).,3639,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625263,22224,,0,9986.0,9056,In vivo,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625264,22224,,0,9986.0,9057,In vivo,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625265,22224,,0,9986.0,9058,In vivo,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000251,Autocuration,,A,,CHEMBL625266,22224,,0,9986.0,9059,,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),14294,Oryctolagus cuniculus,Microsomes,,1
U,,,,BAO_0000251,Autocuration,,A,,CHEMBL876796,22224,,0,9986.0,9060,,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),14294,Oryctolagus cuniculus,Microsomes,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625267,22224,,0,9986.0,9061,In vivo,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,429,Oryctolagus cuniculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL625268,22224,,0,9986.0,9062,In vivo,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL625269,22224,,0,9986.0,9063,In vivo,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL624689,22224,,0,9986.0,9064,In vivo,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,5124,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624690,22224,,0,9986.0,9065,In vivo,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,429,Oryctolagus cuniculus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL624691,22224,,0,9986.0,9066,,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),429,Oryctolagus cuniculus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL624692,22224,,0,9986.0,9067,,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),429,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624693,22224,,0,9986.0,9068,In vivo,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,4059,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624694,22224,,0,9986.0,9069,In vivo,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,4137,Oryctolagus cuniculus,,,1
U,,,,BAO_0000221,Autocuration,,A,,CHEMBL877596,22224,,0,9986.0,9070,In vitro,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,11672,Oryctolagus cuniculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624695,22224,,0,9986.0,9071,,,Time within which only 10% of the drug was degraded,12886,Oryctolagus cuniculus,,,1
U,,,2107.0,BAO_0000221,Autocuration,,A,Liver,CHEMBL624696,22224,,0,9986.0,9072,,,Half life period in rabbit liver homogenate,3853,Oryctolagus cuniculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624697,22224,,0,9986.0,9073,,,Half life value in rabbits,3615,Oryctolagus cuniculus,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL624698,22224,,0,9986.0,9074,In vivo,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL624699,22224,,0,9986.0,9075,In vivo,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624700,22224,,0,9986.0,9076,In vivo,,Half-life period in rabbits following intravenous administration at 2 mg/kg,6077,Oryctolagus cuniculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622903,50597,,1,10116.0,9077,,,AUC 0-8 hr value in rats at 10 mg/kg,17617,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622904,50597,,1,10116.0,9078,,,AUC after administration at 2000 mg/kg/day in rats,17594,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622905,50597,,1,10116.0,9079,,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,6149,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622906,50597,,1,10116.0,9080,,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622907,50597,,1,10116.0,9081,,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622908,50597,,1,10116.0,9082,,,AUC in rat after oral administration at 10.5 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622909,50597,,1,10116.0,9083,,,AUC in rat after oral administration at 11.2 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622910,50597,,1,10116.0,9084,,,AUC in rat after oral administration at 9.7 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622911,50597,,1,10116.0,9085,,,AUC in rat brain after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622912,50597,,1,10116.0,9086,,,AUC in rat p.o.,6504,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622913,50597,,1,10116.0,9087,,,AUC in rat p.o. at 20 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622914,50597,,1,10116.0,9088,,,AUC in rat plasma after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622915,50597,,1,10116.0,9089,,,AUC in rats,216,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622916,50597,,1,10116.0,9090,,,AUC value after IV dose at a dose of 5 mg/kg in rats.,1908,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622917,50597,,1,10116.0,9091,,,AUC value after oral dose at a dose of 10 mg/kg in rats.,1908,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622918,50597,,1,10116.0,9092,In vivo,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622919,50597,,1,10116.0,9093,In vivo,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,216,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622920,50597,,1,10116.0,9094,In vivo,,Maximum plasma concentration was evaluated in rat,6049,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622921,50597,,1,10116.0,9095,In vivo,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,2463,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622922,50597,,1,10116.0,9096,In vivo,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,6679,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622923,50597,,1,10116.0,9097,In vivo,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL877604,50597,,1,10116.0,9098,In vivo,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622924,50597,,1,10116.0,9099,In vivo,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,6410,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622925,50597,,1,10116.0,9100,In vivo,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622926,50597,,1,10116.0,9101,In vivo,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,16366,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623625,50597,,1,10116.0,9102,In vivo,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,6227,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Expert,,A,Plasma,CHEMBL623626,50597,,1,10116.0,9103,In vivo,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623627,50597,,1,10116.0,9104,In vivo,,Maximum plasma drug concentration was determined,1465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623628,50597,,1,10116.0,9105,In vivo,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623629,50597,,1,10116.0,9106,In vivo,,Mean peak plasma concentration was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623630,50597,,1,10116.0,9107,In vivo,,Mean peak plasma concentration was observed after oral administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623804,50597,,1,10116.0,9108,In vivo,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623805,50597,,1,10116.0,9109,In vivo,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623806,50597,,1,10116.0,9110,In vivo,,Peak oral plasma concentration was determined in rats by oral administration,1567,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623807,50597,,1,10116.0,9111,In vivo,,Peak plasma concentration (Cmax) was determined,4026,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623808,50597,,1,10116.0,9112,In vivo,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,6193,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623809,50597,,1,10116.0,9113,In vivo,,Peak plasma concentration (Cmax) in rats,4026,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623810,50597,,1,10116.0,9114,In vivo,,Peak plasma concentration at 1 mg/kg peroral administration,6485,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623811,50597,,1,10116.0,9115,In vivo,,Peak plasma concentration in rat,17655,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623812,50597,,1,10116.0,9116,In vivo,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877605,50597,,1,10116.0,9117,In vivo,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,5394,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623813,50597,,1,10116.0,9118,In vivo,,Pharmacokinetic property (Cmax) in rat,4408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623814,50597,,1,10116.0,9119,In vivo,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,5983,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623815,50597,,1,10116.0,9120,In vivo,,Cmax in rat after 3mg/kg oral dose,4878,Rattus norvegicus,,,1
N,Sprague-Dawley,,,BAO_0000218,Intermediate,,A,,CHEMBL623816,50597,,1,10116.0,9121,In vivo,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,5862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623145,50597,,1,10116.0,9122,In vivo,,Cmax in rats after 20 mg/kg oral dose,4517,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623146,50597,,1,10116.0,9123,In vivo,,Cmax in rat plasma after 30mg/kg oral dose,5932,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623147,50597,,1,10116.0,9124,In vivo,,Plasma concentration after oral administration of 100 mg/kg to rats,5436,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623042,50597,,1,10116.0,9125,In vivo,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623043,50597,,1,10116.0,9126,In vivo,,Tested for the Cmax in rat at 10 mg/kg per orally,4950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623044,50597,,1,10116.0,9127,In vivo,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623045,50597,,1,10116.0,9128,In vivo,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623046,50597,,1,10116.0,9129,In vivo,,Bioavailability as oral Cmax in rats at 30 mins,3360,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623226,50597,,1,10116.0,9130,In vivo,,Bioavailability as oral Cmax in rats at 6hr,3360,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623227,50597,,1,10116.0,9131,In vivo,,The maximum concentration of compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623228,50597,,1,10116.0,9132,In vivo,,The maximum concentration of compound was measured at the dose of 300 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623229,50597,,1,10116.0,9133,In vivo,,The maximum concentration of compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623230,50597,,1,10116.0,9134,In vivo,,The maximum plasma levels for the compounds were determined by LC-MS.,5160,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623231,50597,,1,10116.0,9135,In vivo,,mean peak plasma concentration was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623232,50597,,1,10116.0,9136,In vivo,,mean peak plasma concentration was observed after oral administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623233,50597,,1,10116.0,9137,,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623234,50597,,1,10116.0,9138,,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,3535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623235,50597,,1,10116.0,9139,,,Concentration in plasma (portal) following oral dose in rats at 1 hr,3535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623236,50597,,1,10116.0,9140,,,Concentration in plasma (portal) following oral dose in rats at 2 hr,3535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623237,50597,,1,10116.0,9141,,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,3535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623238,50597,,1,10116.0,9142,,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,3535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623239,50597,,1,10116.0,9143,,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,3535,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623240,22224,,0,10116.0,9144,In vivo,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,5005,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL623241,50597,,1,10116.0,9145,,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",6326,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL623242,50597,,1,10116.0,9146,,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",6326,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874394,50597,,1,10116.0,9147,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",6326,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623243,50597,,1,10116.0,9148,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",6326,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623244,50597,,1,10116.0,9149,,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623245,50597,,1,10116.0,9150,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623246,50597,,1,10116.0,9151,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623247,50597,,1,10116.0,9152,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623248,50597,,1,10116.0,9153,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623249,50597,,1,10116.0,9154,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625072,50597,,1,10116.0,9155,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625073,50597,,1,10116.0,9156,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625074,50597,,1,10116.0,9157,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625075,50597,,1,10116.0,9158,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625076,50597,,1,10116.0,9159,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625077,50597,,1,10116.0,9160,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625078,50597,,1,10116.0,9161,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL874395,50597,,1,10116.0,9162,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625079,50597,,1,10116.0,9163,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625080,50597,,1,10116.0,9164,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625081,50597,,1,10116.0,9165,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625082,50597,,1,10116.0,9166,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625083,50597,,1,10116.0,9167,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625084,50597,,1,10116.0,9168,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625085,50597,,1,10116.0,9169,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625086,50597,,1,10116.0,9170,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625087,50597,,1,10116.0,9171,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625088,50597,,1,10116.0,9172,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622205,50597,,1,10116.0,9173,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622206,50597,,1,10116.0,9174,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622207,50597,,1,10116.0,9175,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622366,50597,,1,10116.0,9176,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622367,50597,,1,10116.0,9177,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL875331,50597,,1,10116.0,9178,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622368,50597,,1,10116.0,9179,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622369,50597,,1,10116.0,9180,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622370,50597,,1,10116.0,9181,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622371,50597,,1,10116.0,9182,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622372,50597,,1,10116.0,9183,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622373,50597,,1,10116.0,9184,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622374,50597,,1,10116.0,9185,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622375,50597,,1,10116.0,9186,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622376,50597,,1,10116.0,9187,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622377,50597,,1,10116.0,9188,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622378,50597,,1,10116.0,9189,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622379,50597,,1,10116.0,9190,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622380,50597,,1,10116.0,9191,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622381,50597,,1,10116.0,9192,,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622382,50597,,1,10116.0,9193,,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622383,50597,,1,10116.0,9194,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL875332,50597,,1,10116.0,9195,,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL622384,50597,,1,10116.0,9196,,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL622385,50597,,1,10116.0,9197,,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL622386,50597,,1,10116.0,9198,,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622387,50597,,1,10116.0,9199,,,The compound was tested for the plasma binding in rat,10839,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622388,50597,,1,10116.0,9200,,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",16459,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622389,50597,,1,10116.0,9201,,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",16459,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622390,50597,,1,10116.0,9202,,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",16459,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622391,50597,,1,10116.0,9203,,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),16459,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622392,50597,,1,10116.0,9204,,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),16459,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622393,50597,,1,10116.0,9205,,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),16459,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622394,50597,,1,10116.0,9206,,,Plasma level at 2 hr after administration of the compound,3278,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622395,50597,,1,10116.0,9207,,,plasma level at 2 hr after administration of the compound,3278,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL622396,50597,,1,10116.0,9208,,,Stability in rat serum measured as % recovery at 1 min,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624894,50597,,1,10116.0,9209,,,Stability in rat serum measured as % recovery at 10 min,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624895,50597,,1,10116.0,9210,,,Stability in rat serum measured as % recovery at 10 mins,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624058,50597,,1,10116.0,9211,,,Stability in rat serum measured as % recovery at 2 hr,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624059,50597,,1,10116.0,9212,,,Stability in rat serum measured as % recovery at 3 min,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624060,50597,,1,10116.0,9213,,,Stability in rat serum measured as % recovery at 3 mins,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624061,50597,,1,10116.0,9214,,,Stability in rat serum measured as % recovery at 5 min,4684,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL624062,50597,,1,10116.0,9215,,,Stability in rat serum measured as % recovery at 5 mins,4684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624063,50597,,1,10116.0,9216,In vivo,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624064,50597,,1,10116.0,9217,In vivo,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624065,50597,,1,10116.0,9218,,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,723,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624066,50597,,1,10116.0,9219,,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877490,50597,,1,10116.0,9220,In vivo,,Half life tested in mature male rat at a dose of 30 mg/kg,5160,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874442,50597,,1,10116.0,9221,In vivo,,Half life after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626890,50597,,1,10116.0,9222,In vivo,,Half life period after administration (30 mg/kg) in rat,5633,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626891,50597,,1,10116.0,9223,In vivo,,Half life period in rat after 5 mg/Kg dose,5302,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626892,50597,,1,10116.0,9224,In vivo,,Half life period in rat after 5 mg/kg dose,5302,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626893,50597,,1,10116.0,9225,,,Half life period was determined,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626894,50597,,1,10116.0,9226,,,Half life period was evaluated in rat,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626895,50597,,1,10116.0,9227,,,Half life period was evaluated in rat; 0.5-1.0,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626896,50597,,1,10116.0,9228,,,Half life period was evaluated in rat; 5.9-7.5,17791,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626897,50597,,1,10116.0,9229,,,Half-life in rat plasma,14512,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626898,50597,,1,10116.0,9230,,,Half-life time in rat was determined,6230,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626899,50597,,1,10116.0,9231,In vivo,,Terminal half-life after iv administration to rats,3364,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626900,50597,,1,10116.0,9232,In vivo,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,6874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626901,50597,,1,10116.0,9233,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,857,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626902,50597,,1,10116.0,9234,In vivo,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),858,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626903,50597,,1,10116.0,9235,In vivo,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),858,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874443,50597,,1,10116.0,9236,In vivo,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626904,50597,,1,10116.0,9237,In vivo,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626905,50597,,1,10116.0,9238,,,Half life in rats,6305,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873830,50597,,1,10116.0,9239,In vivo,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,13501,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626906,50597,,1,10116.0,9240,In vivo,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,17594,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631076,50597,,1,10116.0,9241,In vivo,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631077,50597,,1,10116.0,9242,,,Biological half-life was measured in plasma of rats,2932,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631078,50597,,1,10116.0,9243,In vivo,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631079,50597,,1,10116.0,9244,In vivo,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631080,50597,,1,10116.0,9245,In vivo,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,2713,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631081,50597,,1,10116.0,9246,In vivo,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631239,50597,,1,10116.0,9247,In vivo,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631240,50597,,1,10116.0,9248,,,Compound was evaluated for plasma half life in rat,740,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631241,50597,,1,10116.0,9249,,,AUC value at a dose of 5 mg/kg (p.o.) in rats,6597,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631242,50597,,1,10116.0,9250,,,AUC value after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631243,50597,,1,10116.0,9251,,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,17594,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL874444,50597,,1,10116.0,9252,,,AUC0-96 after administration at 50 mg/kg,17596,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631244,50597,,1,10116.0,9253,,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,17594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631245,50597,,1,10116.0,9254,,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",3293,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627162,50597,,1,10116.0,9255,,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627163,50597,,1,10116.0,9256,,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627164,50597,,1,10116.0,9257,,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,6757,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627165,50597,,1,10116.0,9258,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,5979,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627166,50597,,1,10116.0,9259,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,5979,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627167,50597,,1,10116.0,9260,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,5979,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627822,50597,,1,10116.0,9261,,,Area under curve (AUC) at a dose of 30 mg/kg in rats,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627823,50597,,1,10116.0,9262,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627824,50597,,1,10116.0,9263,,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627825,50597,,1,10116.0,9264,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627826,50597,,1,10116.0,9265,,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,5633,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627827,50597,,1,10116.0,9266,,,Area under curve (Pharmacokinetic property) was determined,1716,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627828,50597,,1,10116.0,9267,,,Area under curve (Pharmacokinetic property) of the compound; Not determined,1716,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627829,50597,,1,10116.0,9268,,,Area under curve after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627830,50597,,1,10116.0,9269,,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627831,50597,,1,10116.0,9270,,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627832,50597,,1,10116.0,9271,,,Area under curve in male SD rats was observed after oral administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627833,50597,,1,10116.0,9272,,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,4413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL627834,50597,,1,10116.0,9273,,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL628004,50597,,1,10116.0,9274,,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628005,50597,,1,10116.0,9275,,,Area under curve at 5 mg/kg po was determined in rat,5964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628006,50597,,1,10116.0,9276,,,Area under curve in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628007,50597,,1,10116.0,9277,,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625676,50597,,1,10116.0,9278,,,Area under curve was determined,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631309,50597,,1,10116.0,9279,,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,17858,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631310,50597,,1,10116.0,9280,,,Area under curve after intravenous administration at 3 mg/kg,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631311,50597,,1,10116.0,9281,,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,6106,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631312,50597,,1,10116.0,9282,,,Area under curve at 4 hr in rat,5964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631313,50597,,1,10116.0,9283,,,Area under curve at a dose of 30 mg/kg,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631314,50597,,1,10116.0,9284,,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631315,50597,,1,10116.0,9285,,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631316,50597,,1,10116.0,9286,,,Area under curve for a 2-mpk po dose in SD rats,5862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631317,50597,,1,10116.0,9287,,,Area under curve in SD rats,5862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874471,50597,,1,10116.0,9288,,,Area under curve in rat after oral administration at 13 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631318,50597,,1,10116.0,9289,,,Area under curve in rat by po administration at 0-24 hr,5871,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631319,50597,,1,10116.0,9290,,,Area under curve in rat plasma,5919,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631320,50597,,1,10116.0,9291,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631321,50597,,1,10116.0,9292,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631322,50597,,1,10116.0,9293,,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,10,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631323,50597,,1,10116.0,9294,,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,11149,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631324,50597,,1,10116.0,9295,,,Area under curve value in rat at a dose of 5 mg/kg,5302,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631325,50597,,1,10116.0,9296,,,Area under curve was determined after oral administration in rats,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631326,50597,,1,10116.0,9297,,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631327,50597,,1,10116.0,9298,,,Area under curve was determined after peroral administration in rat,6011,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631328,50597,,1,10116.0,9299,,,Area under curve was determined at a dose 30 mpk administered orally.,5375,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631329,50597,,1,10116.0,9300,,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627217,50597,,1,10116.0,9301,,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626352,50597,,1,10116.0,9302,,,Area under curve was determined in male rat,5610,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626353,50597,,1,10116.0,9303,,,Area under curve was determined in rat after PO administration,5833,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626354,50597,,1,10116.0,9304,,,Area under curve was determined in rat after a 3 mg/kg of oral dose,4257,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626355,50597,,1,10116.0,9305,,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,5937,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626356,50597,,1,10116.0,9306,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,5932,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626357,50597,,1,10116.0,9307,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,5932,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626358,50597,,1,10116.0,9308,,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626359,50597,,1,10116.0,9309,,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626360,50597,,1,10116.0,9310,,,Peak plasma concentration in rat at a dose of 3 mg/kg,17771,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626361,50597,,1,10116.0,9311,,,Plasma concentration at 2 hr in rats was evaluated.,1628,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626362,50597,,1,10116.0,9312,,,Plasma concentration at 2 hr in rats was evaluated; Not available,1628,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626363,50597,,1,10116.0,9313,,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626970,50597,,1,10116.0,9314,,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626971,50597,,1,10116.0,9315,,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626972,50597,,1,10116.0,9316,,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626973,50597,,1,10116.0,9317,,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626974,50597,,1,10116.0,9318,,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL874592,50597,,1,10116.0,9319,,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626975,50597,,1,10116.0,9320,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626976,50597,,1,10116.0,9321,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626977,50597,,1,10116.0,9322,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626978,50597,,1,10116.0,9323,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626979,50597,,1,10116.0,9324,,,PK study was carried to determine the relative absorption ranking in rat.,16427,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626980,50597,,1,10116.0,9325,In vivo,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626981,50597,,1,10116.0,9326,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",11450,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626982,50597,,1,10116.0,9327,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",11450,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626983,50597,,1,10116.0,9328,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",11450,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622522,50597,,1,10116.0,9329,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",11450,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622523,50597,,1,10116.0,9330,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",11450,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622524,50597,,1,10116.0,9331,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",11450,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622525,50597,,1,10116.0,9332,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",11450,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622526,50597,,1,10116.0,9333,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",11450,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619849,50597,,1,10116.0,9334,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",11450,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL619850,50597,,1,10116.0,9335,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",11450,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623864,50597,,1,10116.0,9336,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",11450,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623865,50597,,1,10116.0,9337,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",11450,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623866,50597,,1,10116.0,9338,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",11450,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623867,50597,,1,10116.0,9339,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",11450,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL877615,50597,,1,10116.0,9340,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",11450,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623868,50597,,1,10116.0,9341,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",11450,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623869,50597,,1,10116.0,9342,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",11450,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623870,50597,,1,10116.0,9343,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL623871,50597,,1,10116.0,9344,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL623872,50597,,1,10116.0,9345,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622129,50597,,1,10116.0,9346,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622130,50597,,1,10116.0,9347,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622131,50597,,1,10116.0,9348,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622132,50597,,1,10116.0,9349,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622133,50597,,1,10116.0,9350,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622134,50597,,1,10116.0,9351,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622135,50597,,1,10116.0,9352,,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622136,50597,,1,10116.0,9353,,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622137,50597,,1,10116.0,9354,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622138,50597,,1,10116.0,9355,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623017,50597,,1,10116.0,9356,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623018,50597,,1,10116.0,9357,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623019,50597,,1,10116.0,9358,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623020,50597,,1,10116.0,9359,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623021,50597,,1,10116.0,9360,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623022,50597,,1,10116.0,9361,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623023,50597,,1,10116.0,9362,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623024,50597,,1,10116.0,9363,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623025,50597,,1,10116.0,9364,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620545,50597,,1,10116.0,9365,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620546,50597,,1,10116.0,9366,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620547,50597,,1,10116.0,9367,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620548,50597,,1,10116.0,9368,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620549,50597,,1,10116.0,9369,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620550,50597,,1,10116.0,9370,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620551,50597,,1,10116.0,9371,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620552,50597,,1,10116.0,9372,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620553,50597,,1,10116.0,9373,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620554,50597,,1,10116.0,9374,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL875845,50597,,1,10116.0,9375,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620555,50597,,1,10116.0,9376,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620556,50597,,1,10116.0,9377,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620557,50597,,1,10116.0,9378,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620558,50597,,1,10116.0,9379,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620559,50597,,1,10116.0,9380,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622939,50597,,1,10116.0,9381,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622940,50597,,1,10116.0,9382,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622941,50597,,1,10116.0,9383,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622942,50597,,1,10116.0,9384,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622943,50597,,1,10116.0,9385,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622944,50597,,1,10116.0,9386,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622945,50597,,1,10116.0,9387,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622946,50597,,1,10116.0,9388,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622947,50597,,1,10116.0,9389,,,Compound was evaluated for terminal half life in rat,3341,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622948,50597,,1,10116.0,9390,In vivo,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,3634,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622949,50597,,1,10116.0,9391,In vivo,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,3634,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622950,50597,,1,10116.0,9392,,,Compound was tested for its half life in rat,4839,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622951,22224,,0,9544.0,9393,In vivo,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,5005,Macaca mulatta,,,1
U,,,1969.0,BAO_0000366,Intermediate,,A,Plasma,CHEMBL622952,22224,,0,10116.0,9394,,,Compound was tested for its plasma half life in Sprague Dawley rats,5005,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000366,Intermediate,,A,Plasma,CHEMBL622953,22224,,0,10116.0,9395,,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,5005,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873818,50597,,1,10116.0,9396,,,Compound was tested for plasma half-life period in rat,1094,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622954,50597,,1,10116.0,9397,In vivo,,Elimination half life after i.v. administration of compound in rats,5031,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622955,50597,,1,10116.0,9398,In vivo,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875229,50597,,1,10116.0,9399,In vivo,,Elimination half-life after IV dosing at 1 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622956,50597,,1,10116.0,9400,In vivo,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622957,50597,,1,10116.0,9401,In vivo,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622958,50597,,1,10116.0,9402,In vivo,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,5408,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622959,50597,,1,10116.0,9403,In vivo,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622960,50597,,1,10116.0,9404,In vivo,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,5408,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622961,50597,,1,10116.0,9405,In vivo,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622962,50597,,1,10116.0,9406,In vivo,,Evaluated for the half life in rat (in vivo),4687,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622963,50597,,1,10116.0,9407,,,Hafl life in rat,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622964,50597,,1,10116.0,9408,,,Hafl life rat,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622965,50597,,1,10116.0,9409,,,Hafl life rat,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622966,50597,,1,10116.0,9410,,,Hafl life rat; Not determined,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622967,50597,,1,10116.0,9411,,,Hafl life rat; Not determined,6641,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622968,50597,,1,10116.0,9412,In vivo,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622969,50597,,1,10116.0,9413,In vivo,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL875327,50597,,1,10116.0,9414,In vivo,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628638,50597,,1,10116.0,9415,In vivo,,Half life in rat after 1 mg/kg i.v. administration,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628639,50597,,1,10116.0,9416,In vivo,,Half life in rat after 2 mg/kg peroral administration,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625840,50597,,1,10116.0,9417,In vivo,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625841,50597,,1,10116.0,9418,In vivo,,Half life of 10 mg/kg oral dose determined in rats,4722,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625842,50597,,1,10116.0,9419,In vivo,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625843,50597,,1,10116.0,9420,In vivo,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625844,50597,,1,10116.0,9421,In vivo,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873822,50597,,1,10116.0,9422,In vivo,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625845,50597,,1,10116.0,9423,In vivo,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627059,50597,,1,10116.0,9424,In vivo,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627060,50597,,1,10116.0,9425,In vivo,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627061,50597,,1,10116.0,9426,In vivo,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627709,50597,,1,10116.0,9427,In vivo,,Half life of compound at 5 mg/kg after po administration was determined in rat,4762,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627710,50597,,1,10116.0,9428,In vivo,,Half life of compound determined after intravenous administration to rat,5327,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627711,50597,,1,10116.0,9429,,,Half life of compound was determined in rat,4847,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627712,50597,,1,10116.0,9430,In vivo,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627713,50597,,1,10116.0,9431,In vivo,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627714,50597,,1,10116.0,9432,In vivo,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL627889,22224,,0,9541.0,9433,In vivo,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,4256,Macaca fascicularis,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL627890,22224,,0,10116.0,9434,In vivo,,Half life determined in rat by intravenous administration,4256,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627891,50597,,1,10116.0,9435,In vivo,,Half life determined in rats after iv administration,4722,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627892,50597,,1,10116.0,9436,In vivo,,Half life in rat plasma after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627893,50597,,1,10116.0,9437,In vivo,,Half life in rat plasma after administration of 2 mg/kg iv,6535,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627894,50597,,1,10116.0,9438,,,Half life in rat plasma was determined,1435,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627895,50597,,1,10116.0,9439,,,Half life in rat plasma was determined; NA means not applicable,1435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627896,50597,,1,10116.0,9440,,,Half life in rat was tested,5206,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627897,50597,,1,10116.0,9441,,,Half life measured in rat plasma,6080,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627898,50597,,1,10116.0,9442,,,Half life recorded in rats,4449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627899,50597,,1,10116.0,9443,,,Half life was calculated,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873823,50597,,1,10116.0,9444,,,Half life was calculated in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627900,50597,,1,10116.0,9445,,,Half life was determined,3747,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627901,50597,,1,10116.0,9446,In vivo,,Half life after 10 mg/kg oral administration in rat,17858,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627902,50597,,1,10116.0,9447,In vivo,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627903,50597,,1,10116.0,9448,In vivo,,Half life after administering orally a dose of 30 mg/kg,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627904,50597,,1,10116.0,9449,,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,5031,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627905,50597,,1,10116.0,9450,,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,4722,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627906,50597,,1,10116.0,9451,,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,6078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627907,50597,,1,10116.0,9452,,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,6078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876783,50597,,1,10116.0,9453,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,6078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627908,50597,,1,10116.0,9454,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,6078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627909,50597,,1,10116.0,9455,,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627910,50597,,1,10116.0,9456,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,1353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627911,50597,,1,10116.0,9457,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),1353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627912,50597,,1,10116.0,9458,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),1353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627913,50597,,1,10116.0,9459,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),1353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627914,50597,,1,10116.0,9460,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),1353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627915,50597,,1,10116.0,9461,,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627916,50597,,1,10116.0,9462,,,Area under the curve was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627917,50597,,1,10116.0,9463,,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627918,50597,,1,10116.0,9464,,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,6056,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627919,50597,,1,10116.0,9465,,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627920,50597,,1,10116.0,9466,,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627921,50597,,1,10116.0,9467,,,Area under the curve was evaluated at an oral dose of 30 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627922,50597,,1,10116.0,9468,,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876784,50597,,1,10116.0,9469,,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627923,50597,,1,10116.0,9470,,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626208,50597,,1,10116.0,9471,,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626209,50597,,1,10116.0,9472,,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626210,50597,,1,10116.0,9473,,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627994,50597,,1,10116.0,9474,,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,2463,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627995,50597,,1,10116.0,9475,,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627996,50597,,1,10116.0,9476,,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,4075,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627997,50597,,1,10116.0,9477,,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,5394,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627998,50597,,1,10116.0,9478,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628640,50597,,1,10116.0,9479,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628641,50597,,1,10116.0,9480,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628642,50597,,1,10116.0,9481,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628643,50597,,1,10116.0,9482,,,Compound was evaluated for area under the curve expressed as (h*ug/ml),17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628644,50597,,1,10116.0,9483,,,Compound was tested for area under curve in rat,2591,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628645,50597,,1,10116.0,9484,,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,6567,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628646,50597,,1,10116.0,9485,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628647,50597,,1,10116.0,9486,,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),5529,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628648,50597,,1,10116.0,9487,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625358,50597,,1,10116.0,9488,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625359,50597,,1,10116.0,9489,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625360,50597,,1,10116.0,9490,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625361,50597,,1,10116.0,9491,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625362,50597,,1,10116.0,9492,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625363,50597,,1,10116.0,9493,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625364,50597,,1,10116.0,9494,,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,4796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625365,50597,,1,10116.0,9495,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625366,50597,,1,10116.0,9496,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625367,50597,,1,10116.0,9497,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625368,50597,,1,10116.0,9498,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",11450,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625369,50597,,1,10116.0,9499,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",11450,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625370,50597,,1,10116.0,9500,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",11450,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625371,50597,,1,10116.0,9501,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",11450,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625372,50597,,1,10116.0,9502,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",11450,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625373,50597,,1,10116.0,9503,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",11450,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625374,50597,,1,10116.0,9504,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",11450,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL877593,50597,,1,10116.0,9505,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",11450,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625375,50597,,1,10116.0,9506,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",11450,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625376,50597,,1,10116.0,9507,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",11450,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621973,50597,,1,10116.0,9508,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",11450,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621974,50597,,1,10116.0,9509,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL621975,50597,,1,10116.0,9510,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622166,50597,,1,10116.0,9511,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622167,50597,,1,10116.0,9512,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622168,50597,,1,10116.0,9513,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622169,50597,,1,10116.0,9514,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",11450,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622170,50597,,1,10116.0,9515,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622171,50597,,1,10116.0,9516,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622172,50597,,1,10116.0,9517,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622173,50597,,1,10116.0,9518,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622174,50597,,1,10116.0,9519,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622175,50597,,1,10116.0,9520,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622176,50597,,1,10116.0,9521,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622177,50597,,1,10116.0,9522,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622178,50597,,1,10116.0,9523,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622179,50597,,1,10116.0,9524,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622180,50597,,1,10116.0,9525,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",11450,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622181,50597,,1,10116.0,9526,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622182,50597,,1,10116.0,9527,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622183,50597,,1,10116.0,9528,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622184,50597,,1,10116.0,9529,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622185,50597,,1,10116.0,9530,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622186,50597,,1,10116.0,9531,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622187,50597,,1,10116.0,9532,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625002,50597,,1,10116.0,9533,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622090,50597,,1,10116.0,9534,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622091,50597,,1,10116.0,9535,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622092,50597,,1,10116.0,9536,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622093,50597,,1,10116.0,9537,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622094,50597,,1,10116.0,9538,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622095,50597,,1,10116.0,9539,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622264,50597,,1,10116.0,9540,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622265,50597,,1,10116.0,9541,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622266,50597,,1,10116.0,9542,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622267,50597,,1,10116.0,9543,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622268,50597,,1,10116.0,9544,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622269,50597,,1,10116.0,9545,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625071,50597,,1,10116.0,9546,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621621,50597,,1,10116.0,9547,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621622,50597,,1,10116.0,9548,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621623,50597,,1,10116.0,9549,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621624,50597,,1,10116.0,9550,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621625,50597,,1,10116.0,9551,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621626,50597,,1,10116.0,9552,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621627,50597,,1,10116.0,9553,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621628,50597,,1,10116.0,9554,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL875328,50597,,1,10116.0,9555,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621629,50597,,1,10116.0,9556,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621630,50597,,1,10116.0,9557,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621631,50597,,1,10116.0,9558,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621632,50597,,1,10116.0,9559,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621633,50597,,1,10116.0,9560,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621634,50597,,1,10116.0,9561,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621635,50597,,1,10116.0,9562,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621636,50597,,1,10116.0,9563,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621637,50597,,1,10116.0,9564,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL621638,50597,,1,10116.0,9565,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618883,50597,,1,10116.0,9566,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618884,50597,,1,10116.0,9567,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628627,50597,,1,10116.0,9568,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628628,50597,,1,10116.0,9569,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628629,50597,,1,10116.0,9570,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628630,50597,,1,10116.0,9571,In vivo,,Half life after administering orally a dose of 3 mg/kg,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628631,50597,,1,10116.0,9572,In vivo,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628632,50597,,1,10116.0,9573,In vivo,,Half life after administering intravenously a dose of 1 mg/kg,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628633,50597,,1,10116.0,9574,In vivo,,Half life after oral dosing in rats,526,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628634,50597,,1,10116.0,9575,In vivo,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627789,50597,,1,10116.0,9576,In vivo,,Half life by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627790,50597,,1,10116.0,9577,,,Half life in rat,3371,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627791,50597,,1,10116.0,9578,,,Half life in rat,6448,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627792,50597,,1,10116.0,9579,,,Half life in rat,6453,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627793,50597,,1,10116.0,9580,In vivo,,Half life in rat after intravenous administration of the compound,4353,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627794,50597,,1,10116.0,9581,In vivo,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,4353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627795,50597,,1,10116.0,9582,In vivo,,Half life in rat after po administration of the compound,4353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627796,50597,,1,10116.0,9583,In vivo,,Half life in rat after po administration of the compound; ND means Not determined,4353,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL875335,50597,,1,10116.0,9584,In vivo,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,4353,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627797,50597,,1,10116.0,9585,In vivo,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,4353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627798,50597,,1,10116.0,9586,In vivo,,Half life in rat i.v.,5789,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627799,50597,,1,10116.0,9587,In vivo,,Half life in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627800,50597,,1,10116.0,9588,,,Half life in rats,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627801,50597,,1,10116.0,9589,In vivo,,Half life in rats after intravenous administration,484,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627802,50597,,1,10116.0,9590,In vivo,,Half life in rats at the dose of 1.0 mpk by i.v. administration,6467,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL627803,50597,,1,10116.0,9591,,,Half life in rat,6642,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873820,50597,,1,10116.0,9592,In vivo,,Half life was evaluated after intravenous administration to rats,16367,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627804,50597,,1,10116.0,9593,,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),1369,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627805,50597,,1,10116.0,9594,,,Half life was evaluated in rat,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627806,50597,,1,10116.0,9595,,,Half life was evaluated in rat,6049,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627107,50597,,1,10116.0,9596,,,Half life was evaluated in rat; Not tested,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627108,50597,,1,10116.0,9597,In vivo,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627109,50597,,1,10116.0,9598,In vivo,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,11149,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627110,50597,,1,10116.0,9599,In vivo,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,11149,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL627111,22224,,0,9443.0,9600,In vivo,,Half life was measured in monkey at dose of 10 mg/kg by po administration,2891,Primates,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL627112,22224,,0,9443.0,9601,In vivo,,Half life was measured in monkey at dose of 10 mg/kg by po administration,2891,Primates,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL627113,22224,,0,10116.0,9602,In vivo,,Half life was measured in rat at dose of 30 mg/kg by iv administration,2891,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL627114,22224,,0,10116.0,9603,In vivo,,Half life was measured in rat at dose of 30 mg/kg by po administration,2891,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627115,50597,,1,10116.0,9604,,,Half life (t1/2) was determined,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627116,50597,,1,10116.0,9605,,,Half life period at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627117,50597,,1,10116.0,9606,In vivo,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627118,50597,,1,10116.0,9607,,,Half life period was determined,5503,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627119,50597,,1,10116.0,9608,In vivo,,Half life period after intravenous administration at 20 mpk in rats,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627120,50597,,1,10116.0,9609,In vivo,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626922,50597,,1,10116.0,9610,In vivo,,Half life period after intravenous administration in rat,6109,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626923,50597,,1,10116.0,9611,In vivo,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626924,50597,,1,10116.0,9612,In vivo,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626925,50597,,1,10116.0,9613,,,Half life period in 80% rat plasma at 37 degree Centigrade,4755,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626926,50597,,1,10116.0,9614,,,Half life period in SD rats,5862,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626927,50597,,1,10116.0,9615,,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626928,50597,,1,10116.0,9616,,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626929,50597,,1,10116.0,9617,,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626930,50597,,1,10116.0,9618,,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626931,50597,,1,10116.0,9619,,,Half life period in rat,5960,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626932,50597,,1,10116.0,9620,,,Half life period in rat,6103,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626933,50597,,1,10116.0,9621,,,Half life period in rat,6317,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873826,50597,,1,10116.0,9622,In vivo,,Half life period in rat after oral administration at 10.5 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626934,50597,,1,10116.0,9623,In vivo,,Half life period in rat after oral administration at 11.2 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626935,50597,,1,10116.0,9624,In vivo,,Half life period in rat after oral administration at 13 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626936,50597,,1,10116.0,9625,In vivo,,Half life period in rat after oral administration at 9.7 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626937,50597,,1,10116.0,9626,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625906,50597,,1,10116.0,9627,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,6295,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625907,50597,,1,10116.0,9628,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,6296,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625908,50597,,1,10116.0,9629,,,PK study was carried to determine AUC (area under curve) value in rat,16427,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625909,50597,,1,10116.0,9630,,,Pharmacokinetic parameter AUC after intravenous administration to rats,16367,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625910,50597,,1,10116.0,9631,,,Pharmacokinetic parameter AUC after oral administration to rats,16367,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625911,50597,,1,10116.0,9632,,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625912,50597,,1,10116.0,9633,,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626538,50597,,1,10116.0,9634,,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876794,50597,,1,10116.0,9635,,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626539,50597,,1,10116.0,9636,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626540,50597,,1,10116.0,9637,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626541,50597,,1,10116.0,9638,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,5394,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626542,50597,,1,10116.0,9639,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,5394,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626543,50597,,1,10116.0,9640,,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626544,50597,,1,10116.0,9641,,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626545,50597,,1,10116.0,9642,,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626546,50597,,1,10116.0,9643,,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626547,50597,,1,10116.0,9644,,,Pharmacokinetic parameter area under curve was reported,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626548,50597,,1,10116.0,9645,,,Pharmacokinetic property (AUC) in rat,4408,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626549,50597,,1,10116.0,9646,,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,5983,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626550,50597,,1,10116.0,9647,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,4397,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626551,50597,,1,10116.0,9648,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,4397,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623777,50597,,1,10116.0,9649,,,Pharmacokinetic property was determined,5491,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623778,50597,,1,10116.0,9650,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,5491,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623779,50597,,1,10116.0,9651,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,5491,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623780,50597,,1,10116.0,9652,,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622015,50597,,1,10116.0,9653,,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622016,50597,,1,10116.0,9654,,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622017,50597,,1,10116.0,9655,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",5173,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622018,50597,,1,10116.0,9656,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",5173,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622019,50597,,1,10116.0,9657,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",5173,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622020,50597,,1,10116.0,9658,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",5173,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622021,50597,,1,10116.0,9659,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622022,50597,,1,10116.0,9660,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622023,50597,,1,10116.0,9661,,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,5327,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622024,50597,,1,10116.0,9662,,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622693,50597,,1,10116.0,9663,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622694,50597,,1,10116.0,9664,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622695,50597,,1,10116.0,9665,,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622696,50597,,1,10116.0,9666,,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622697,50597,,1,10116.0,9667,,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622874,50597,,1,10116.0,9668,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",6619,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622875,50597,,1,10116.0,9669,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",6619,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622876,50597,,1,10116.0,9670,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,10363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622877,50597,,1,10116.0,9671,,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,4796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622878,50597,,1,10116.0,9672,,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622879,50597,,1,10116.0,9673,,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877602,50597,,1,10116.0,9674,,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,4839,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622880,50597,,1,10116.0,9675,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622881,50597,,1,10116.0,9676,,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622882,50597,,1,10116.0,9677,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622883,50597,,1,10116.0,9678,,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622884,50597,,1,10116.0,9679,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",11450,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622885,50597,,1,10116.0,9680,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",11450,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622886,50597,,1,10116.0,9681,,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622887,50597,,1,10116.0,9682,,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622888,50597,,1,10116.0,9683,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,8151,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622889,50597,,1,10116.0,9684,In vivo,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622890,50597,,1,10116.0,9685,In vivo,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622891,50597,,1,10116.0,9686,In vivo,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL877603,50597,,1,10116.0,9687,In vivo,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622892,50597,,1,10116.0,9688,In vivo,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622893,50597,,1,10116.0,9689,In vivo,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622894,50597,,1,10116.0,9690,In vivo,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622895,50597,,1,10116.0,9691,In vivo,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622896,50597,,1,10116.0,9692,In vivo,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,8677,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622897,50597,,1,10116.0,9693,In vivo,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622898,50597,,1,10116.0,9694,In vivo,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622899,50597,,1,10116.0,9695,In vivo,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622900,50597,,1,10116.0,9696,In vivo,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624114,50597,,1,10116.0,9697,In vivo,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624115,50597,,1,10116.0,9698,In vivo,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624116,50597,,1,10116.0,9699,In vivo,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624117,50597,,1,10116.0,9700,In vivo,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624118,50597,,1,10116.0,9701,In vivo,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624119,50597,,1,10116.0,9702,In vivo,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624120,50597,,1,10116.0,9703,In vivo,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624121,50597,,1,10116.0,9704,In vivo,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624122,50597,,1,10116.0,9705,In vivo,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624123,50597,,1,10116.0,9706,In vivo,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624124,50597,,1,10116.0,9707,In vivo,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624125,50597,,1,10116.0,9708,In vivo,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624126,50597,,1,10116.0,9709,In vivo,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624127,50597,,1,10116.0,9710,In vivo,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624128,50597,,1,10116.0,9711,In vivo,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL624129,50597,,1,10116.0,9712,In vivo,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL624130,50597,,1,10116.0,9713,In vivo,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL622340,50597,,1,10116.0,9714,In vivo,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL622341,50597,,1,10116.0,9715,In vivo,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622342,50597,,1,10116.0,9716,In vivo,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622343,50597,,1,10116.0,9717,In vivo,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622344,50597,,1,10116.0,9718,In vivo,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622345,50597,,1,10116.0,9719,In vivo,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622346,50597,,1,10116.0,9720,In vivo,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622347,50597,,1,10116.0,9721,In vivo,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622348,50597,,1,10116.0,9722,In vivo,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622349,50597,,1,10116.0,9723,In vivo,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622350,50597,,1,10116.0,9724,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622351,50597,,1,10116.0,9725,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622352,50597,,1,10116.0,9726,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622353,50597,,1,10116.0,9727,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622354,50597,,1,10116.0,9728,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622355,50597,,1,10116.0,9729,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622356,50597,,1,10116.0,9730,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622357,50597,,1,10116.0,9731,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622358,50597,,1,10116.0,9732,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622359,50597,,1,10116.0,9733,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874393,50597,,1,10116.0,9734,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622872,50597,,1,10116.0,9735,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622873,50597,,1,10116.0,9736,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623047,50597,,1,10116.0,9737,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623048,50597,,1,10116.0,9738,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623049,50597,,1,10116.0,9739,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623050,50597,,1,10116.0,9740,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623051,50597,,1,10116.0,9741,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623052,50597,,1,10116.0,9742,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626343,50597,,1,10116.0,9743,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626344,50597,,1,10116.0,9744,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626345,50597,,1,10116.0,9745,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626346,50597,,1,10116.0,9746,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626347,50597,,1,10116.0,9747,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626348,50597,,1,10116.0,9748,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626349,50597,,1,10116.0,9749,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626350,50597,,1,10116.0,9750,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626351,50597,,1,10116.0,9751,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627650,50597,,1,10116.0,9752,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL627651,50597,,1,10116.0,9753,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627652,50597,,1,10116.0,9754,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627653,50597,,1,10116.0,9755,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627654,50597,,1,10116.0,9756,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627835,50597,,1,10116.0,9757,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627836,50597,,1,10116.0,9758,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627837,50597,,1,10116.0,9759,,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627838,50597,,1,10116.0,9760,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875338,50597,,1,10116.0,9761,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627839,50597,,1,10116.0,9762,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627840,50597,,1,10116.0,9763,,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627841,50597,,1,10116.0,9764,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627842,50597,,1,10116.0,9765,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627843,50597,,1,10116.0,9766,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627844,50597,,1,10116.0,9767,,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627845,50597,,1,10116.0,9768,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627846,50597,,1,10116.0,9769,In vivo,,Half life period in rat by iv administration at a dose of 3 mg/kg,5874,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627847,50597,,1,10116.0,9770,,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873821,50597,,1,10116.0,9771,,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626079,50597,,1,10116.0,9772,,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626080,50597,,1,10116.0,9773,,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626081,50597,,1,10116.0,9774,,,Half life period was evaluated in rat plasma,5491,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL875344,50597,,1,10116.0,9775,,,Half life period was evaluated in rat plasma; Not tested,5491,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626082,50597,,1,10116.0,9776,,,Half life period was evaluated in rats,1918,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626250,50597,,1,10116.0,9777,In vivo,,"Half life period was evaluated in rats, iv",1918,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626251,50597,,1,10116.0,9778,In vivo,,Half life period after intravenous administration at 5 mg/kg in rat,6113,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626252,50597,,1,10116.0,9779,In vivo,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,5546,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626253,50597,,1,10116.0,9780,In vivo,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,5553,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626254,50597,,1,10116.0,9781,,,Half life stability of compound was evaluated in rat plasma,4188,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626255,50597,,1,10116.0,9782,In vivo,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,6215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626256,50597,,1,10116.0,9783,In vivo,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,6141,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626257,50597,,1,10116.0,9784,In vivo,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626258,50597,,1,10116.0,9785,In vivo,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626259,50597,,1,10116.0,9786,In vivo,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,5710,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626260,50597,,1,10116.0,9787,In vivo,,Half in rat i.v.,5789,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875345,50597,,1,10116.0,9788,In vivo,,Half period in rat after intravenous administration,6011,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626261,50597,,1,10116.0,9789,In vivo,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,17594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626262,50597,,1,10116.0,9790,In vitro,,Half-life measured in in vitro Cathepsin B assay in rat liver,12357,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626263,50597,,1,10116.0,9791,,,Half-life of compound was determined in rats,5210,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625270,50597,,1,10116.0,9792,In vivo,,Half-life at 10 mg/kg in rat upon intravenous administration,17596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625271,50597,,1,10116.0,9793,,,Half-life determined in rat,6672,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625272,50597,,1,10116.0,9794,,,Half-life determined in rat,6673,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625273,50597,,1,10116.0,9795,In vivo,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625274,50597,,1,10116.0,9796,,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",3741,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625275,50597,,1,10116.0,9797,In vivo,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625276,50597,,1,10116.0,9798,In vivo,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625277,50597,,1,10116.0,9799,,,Half-life in rat plasma,17537,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625278,50597,,1,10116.0,9800,,,Half-life in rat plasma was determined,4965,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625279,50597,,1,10116.0,9801,,,Half-life in rat plasma; Not tested,17537,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL625280,50597,,1,10116.0,9802,,,Half-life in rat serum,6124,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL876797,50597,,1,10116.0,9803,,,Half-life in rat serum; na is not available,6124,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625281,50597,,1,10116.0,9804,,,Half-life was calculated in rat,6078,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL873827,50597,,1,10116.0,9805,,,Half-life was calculated in rat plasma,17668,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625282,50597,,1,10116.0,9806,,,Half-life was determined,3185,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625283,50597,,1,10116.0,9807,,,Half-life was determined,4883,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625284,50597,,1,10116.0,9808,In vivo,,Half-life after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625285,50597,,1,10116.0,9809,In vivo,,Half-life after administration of 3.2 mg/kg intravenously in male rat,4029,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625286,50597,,1,10116.0,9810,In vivo,,Half-life after intravenous administration in female rat,4029,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625287,50597,,1,10116.0,9811,In vivo,,Half-life after intravenous administration in male rat,4029,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625288,50597,,1,10116.0,9812,In vivo,,Half-life after intravenous dose in rat,6180,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625289,50597,,1,10116.0,9813,,,Half-life in a rat liver homogenate preparation,1557,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625290,50597,,1,10116.0,9814,,,Half-life in plasma of rat,12500,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876798,50597,,1,10116.0,9815,,,Half-life in plasma of rat at dose of 3-10 mgkg,12500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625291,50597,,1,10116.0,9816,,,Half-life in rat,5064,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625292,50597,,1,10116.0,9817,,,Half-life in rat,5145,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625293,50597,,1,10116.0,9818,,,Half-life in rat,5147,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622832,50597,,1,10116.0,9819,,,Half-life in rat,5833,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622833,50597,,1,10116.0,9820,,,Half-life in rat,6596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622834,50597,,1,10116.0,9821,,,Half-life in rat,17655,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622835,50597,,1,10116.0,9822,In vivo,,Half-life in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622836,50597,,1,10116.0,9823,In vivo,,Half-life in rat after po administration at a dose of 10 mg/kg,17538,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622837,50597,,1,10116.0,9824,In vivo,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,17538,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622838,50597,,1,10116.0,9825,In vivo,,Half-life in rat at 3 mg/kg dose administered intravenously,10,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622839,50597,,1,10116.0,9826,,,Half-life in rat brain homogenate,17669,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622840,50597,,1,10116.0,9827,,,Half-life in rat plasma,17065,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622841,50597,,1,10116.0,9828,,,Half-life in rats,4333,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622842,50597,,1,10116.0,9829,,,Half-life in Dawley rats,6827,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622843,50597,,1,10116.0,9830,In vitro,,Half-life in vitro in rat plasma,889,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622844,50597,,1,10116.0,9831,In vitro,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,889,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622845,50597,,1,10116.0,9832,,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",3747,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622846,50597,,1,10116.0,9833,,,The area under the curve of compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622847,50597,,1,10116.0,9834,,,The area under the curve of compound was measured at the dose of 300 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622848,50597,,1,10116.0,9835,,,The area under the curve of compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622849,50597,,1,10116.0,9836,In vivo,,Bioavailability as oral AUC in rats,3360,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622850,50597,,1,10116.0,9837,,,The plasma concentration versus time curve (AUC) was determined,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876807,50597,,1,10116.0,9838,,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622851,50597,,1,10116.0,9839,,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622852,50597,,1,10116.0,9840,,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622853,50597,,1,10116.0,9841,,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622854,50597,,1,10116.0,9842,,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622855,50597,,1,10116.0,9843,,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622856,50597,,1,10116.0,9844,,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622857,50597,,1,10116.0,9845,,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622858,50597,,1,10116.0,9846,,,AUC in rat after po administration at a dose of 10 mg/kg,17538,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622859,50597,,1,10116.0,9847,,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622860,50597,,1,10116.0,9848,,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622861,50597,,1,10116.0,9849,,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622862,50597,,1,10116.0,9850,,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622863,50597,,1,10116.0,9851,,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623817,50597,,1,10116.0,9852,,,Area under curve value 6 hr after po administration in rat,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623818,50597,,1,10116.0,9853,,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623819,50597,,1,10116.0,9854,,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623820,50597,,1,10116.0,9855,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623821,50597,,1,10116.0,9856,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,17717,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623822,50597,,1,10116.0,9857,,,AUC normalized for dose (AUCN) in rat,6642,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623823,50597,,1,10116.0,9858,,,Area under curve in rat after p.o. administration,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623824,50597,,1,10116.0,9859,,,Area under curve in rat after p.o. administration,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623825,50597,,1,10116.0,9860,,,Area under curve in rat after p.o. administration; Not determined,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622070,50597,,1,10116.0,9861,,,Area under curve in rat after peroral administration,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622071,50597,,1,10116.0,9862,,,Area under curve (carotid artery) value of the compound,3603,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622072,50597,,1,10116.0,9863,,,Bioavailability expressed as the area under curve of rat carotid artery,3550,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622073,50597,,1,10116.0,9864,,,Area under curve in male SD rats was observed after intravenous administration in rat,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622074,50597,,1,10116.0,9865,,,Area under curve of the compound was determined,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622075,50597,,1,10116.0,9866,,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,5407,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622076,50597,,1,10116.0,9867,,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,17752,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622077,50597,,1,10116.0,9868,,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622078,50597,,1,10116.0,9869,,,Area under curve (portal vein) value of the compound,3603,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622079,50597,,1,10116.0,9870,,,Bioavailability expressed as the area under curve of rat portal vein,3550,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622080,50597,,1,10116.0,9871,,,Area Under plasma concentration time curve in rat upon peroral administration,17655,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877612,50597,,1,10116.0,9872,,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622081,50597,,1,10116.0,9873,,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622082,50597,,1,10116.0,9874,,,Compound was evaluated for oral bioavailability in rats,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622083,50597,,1,10116.0,9875,,,Compound was evaluated for oral bioavailability in rats after iv administration,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622084,50597,,1,10116.0,9876,,,Compound was evaluated for oral bioavailability in rats; 30-80,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622085,50597,,1,10116.0,9877,,,Compound was evaluated for oral bioavailability in rats; 50-60,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622086,50597,,1,10116.0,9878,,,Compound was evaluated for oral bioavailability in rats; no data,17791,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622087,50597,,1,10116.0,9879,,,Compound was evaluated for oral bioavailability in rats; peptide,17791,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622088,50597,,1,10116.0,9880,,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",7768,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622089,50597,,1,10116.0,9881,,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",7768,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623685,50597,,1,10116.0,9882,,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",7768,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623686,50597,,1,10116.0,9883,,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",7768,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL623687,50597,,1,10116.0,9884,In vivo,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL623688,50597,,1,10116.0,9885,In vivo,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL623689,50597,,1,10116.0,9886,In vivo,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL622485,50597,,1,10116.0,9887,In vivo,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622486,50597,,1,10116.0,9888,In vivo,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL877613,50597,,1,10116.0,9889,In vivo,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622487,50597,,1,10116.0,9890,In vivo,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622488,50597,,1,10116.0,9891,In vivo,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622489,50597,,1,10116.0,9892,In vivo,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622490,50597,,1,10116.0,9893,,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,6899,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622491,50597,,1,10116.0,9894,,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,6899,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622492,50597,,1,10116.0,9895,,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,6899,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622493,50597,,1,10116.0,9896,,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,6899,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622494,50597,,1,10116.0,9897,,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,6899,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622495,50597,,1,10116.0,9898,,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622496,50597,,1,10116.0,9899,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,6899,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622497,50597,,1,10116.0,9900,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,6899,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622498,50597,,1,10116.0,9901,,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,2189,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624918,50597,,1,10116.0,9902,,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,2189,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624919,50597,,1,10116.0,9903,,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,2189,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624920,50597,,1,10116.0,9904,In vivo,,Biodistribution of compound in rat blood after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624921,50597,,1,10116.0,9905,In vivo,,Biodistribution of compound in rat blood after 5 min of administration.,10839,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624922,50597,,1,10116.0,9906,In vivo,,Biodistribution of compound in rat brain after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624923,50597,,1,10116.0,9907,In vivo,,Biodistribution of compound in rat heart after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624924,50597,,1,10116.0,9908,In vivo,,Biodistribution of compound in rat heart after 5 min of administration.,10839,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624925,50597,,1,10116.0,9909,In vivo,,Biodistribution of compound in rat kidney after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624926,50597,,1,10116.0,9910,In vivo,,Biodistribution of compound in rat kidney after 5 min of administration.,10839,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624927,50597,,1,10116.0,9911,In vivo,,Biodistribution of compound in rat liver after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL874402,50597,,1,10116.0,9912,In vivo,,Biodistribution of compound in rat liver after 5 min of administration.,10839,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624928,50597,,1,10116.0,9913,In vivo,,Biodistribution of compound in rat lung after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624929,50597,,1,10116.0,9914,In vivo,,Biodistribution of compound in rat lung after 5 min of administration.,10839,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624930,50597,,1,10116.0,9915,In vivo,,Biodistribution of compound in rat muscle after 5 min of administration,10839,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624931,50597,,1,10116.0,9916,In vivo,,Biodistribution of compound in rat muscle after 5 min of administration.,10839,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624932,50597,,1,10116.0,9917,,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624933,50597,,1,10116.0,9918,,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624934,50597,,1,10116.0,9919,,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624935,50597,,1,10116.0,9920,,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624936,50597,,1,10116.0,9921,,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624937,50597,,1,10116.0,9922,,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624938,50597,,1,10116.0,9923,,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624939,50597,,1,10116.0,9924,,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624940,50597,,1,10116.0,9925,,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874403,50597,,1,10116.0,9926,,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624941,50597,,1,10116.0,9927,,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,1446,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624942,50597,,1,10116.0,9928,,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,9971,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624943,50597,,1,10116.0,9929,,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,9971,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624944,50597,,1,10116.0,9930,In vivo,,% Bioavailability after 1 day of the drug administration in rats,5765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624945,50597,,1,10116.0,9931,In vivo,,% Bioavailability after 4 day of the drug administration in rats,5765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624946,50597,,1,10116.0,9932,In vivo,,Absolute bioavailability was evaluated in rat,4257,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624947,50597,,1,10116.0,9933,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624948,50597,,1,10116.0,9934,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624949,50597,,1,10116.0,9935,,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622025,50597,,1,10116.0,9936,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622026,50597,,1,10116.0,9937,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622027,50597,,1,10116.0,9938,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622028,50597,,1,10116.0,9939,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622029,50597,,1,10116.0,9940,,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622208,50597,,1,10116.0,9941,,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622209,50597,,1,10116.0,9942,,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622210,50597,,1,10116.0,9943,,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622211,50597,,1,10116.0,9944,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622212,50597,,1,10116.0,9945,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622213,50597,,1,10116.0,9946,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874404,50597,,1,10116.0,9947,,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620452,50597,,1,10116.0,9948,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620453,50597,,1,10116.0,9949,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL620454,50597,,1,10116.0,9950,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624067,50597,,1,10116.0,9951,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624068,50597,,1,10116.0,9952,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL624069,50597,,1,10116.0,9953,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL624070,50597,,1,10116.0,9954,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL624071,50597,,1,10116.0,9955,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL624072,50597,,1,10116.0,9956,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL624073,50597,,1,10116.0,9957,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL624788,50597,,1,10116.0,9958,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL624789,50597,,1,10116.0,9959,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624790,50597,,1,10116.0,9960,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624791,50597,,1,10116.0,9961,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624792,50597,,1,10116.0,9962,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624793,50597,,1,10116.0,9963,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL877491,50597,,1,10116.0,9964,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624957,50597,,1,10116.0,9965,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624958,50597,,1,10116.0,9966,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,13091,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624959,50597,,1,10116.0,9967,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,13091,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624960,50597,,1,10116.0,9968,,,Dissociation constant was determined,11977,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624961,50597,,1,10116.0,9969,,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624962,50597,,1,10116.0,9970,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624963,50597,,1,10116.0,9971,,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624964,50597,,1,10116.0,9972,,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,4755,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624965,50597,,1,10116.0,9973,,,LogP value was evaluated in the in situ rat gut perfusion assay,589,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624966,50597,,1,10116.0,9974,In vivo,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624967,50597,,1,10116.0,9975,In vivo,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,5031,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624968,50597,,1,10116.0,9976,In vivo,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624969,50597,,1,10116.0,9977,,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL624970,50597,,1,10116.0,9978,,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,2862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624971,50597,,1,10116.0,9979,,,Half-life was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624972,50597,,1,10116.0,9980,In vivo,,Half-life was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624973,50597,,1,10116.0,9981,In vivo,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,6005,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL624974,50597,,1,10116.0,9982,,,Half-life was evaluated in plasma of rat,2938,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624975,50597,,1,10116.0,9983,In vivo,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877492,50597,,1,10116.0,9984,In vivo,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624976,50597,,1,10116.0,9985,In vivo,,Half-life was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624977,50597,,1,10116.0,9986,In vivo,,Half-life period of compound in rats after peroral administration,6571,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626848,50597,,1,10116.0,9987,,,Half-life period of compound was measured in rat plasma.,3136,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626849,50597,,1,10116.0,9988,,,Half-life period of compound was measured in rat plasma; ND is not determined,3136,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626850,50597,,1,10116.0,9989,,,Half-life period of compound was measured in rat plasma; not determined,3136,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626851,50597,,1,10116.0,9990,In vivo,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626852,50597,,1,10116.0,9991,In vivo,,Half-life period in rat by iv administration,5871,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626853,50597,,1,10116.0,9992,In vivo,,Half-life period in rats following intravenous administration at 2 mg/kg,6077,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626854,50597,,1,10116.0,9993,In vivo,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627486,50597,,1,10116.0,9994,,,Half-life period was determined for the compound in rat,5144,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627487,50597,,1,10116.0,9995,In vivo,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",4498,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627488,50597,,1,10116.0,9996,In vivo,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",4498,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627489,50597,,1,10116.0,9997,In vivo,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,1908,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627490,50597,,1,10116.0,9998,In vivo,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873829,50597,,1,10116.0,9999,In vivo,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),5529,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627655,50597,,1,10116.0,10000,In vivo,,Half-life was determined in rat at a dose of 1 mpk i.v.,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625994,50597,,1,10116.0,10001,In vivo,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625995,50597,,1,10116.0,10002,In vivo,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,6444,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625996,50597,,1,10116.0,10003,,,Half-life in rat,5207,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625850,50597,,1,10116.0,10004,In vitro,,In vitro half life in rat plasma,530,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625851,50597,,1,10116.0,10005,In vitro,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",1116,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625852,50597,,1,10116.0,10006,In vitro,,In vitro half life in rat,3219,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625853,50597,,1,10116.0,10007,In vivo,,In vivo half life period after intravenous administration in rat,6109,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625854,50597,,1,10116.0,10008,In vivo,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874450,50597,,1,10116.0,10009,In vivo,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625855,50597,,1,10116.0,10010,In vivo,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625856,50597,,1,10116.0,10011,In vivo,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625857,50597,,1,10116.0,10012,In vivo,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873831,50597,,1,10116.0,10013,In vivo,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625858,50597,,1,10116.0,10014,In vivo,,Longer half-life in rat (i.v.) at 0.5 mpk,17853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625859,50597,,1,10116.0,10015,In vivo,,Longer half-life in rat (p.o.) at 2.0 mpk,17853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625860,50597,,1,10116.0,10016,,,Pharmacokinetic property (half life) in rat,3457,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625861,50597,,1,10116.0,10017,In vivo,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625862,50597,,1,10116.0,10018,In vivo,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625863,50597,,1,10116.0,10019,In vivo,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625864,50597,,1,10116.0,10020,In vivo,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625865,50597,,1,10116.0,10021,In vivo,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,5739,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625866,50597,,1,10116.0,10022,In vivo,,Pharmacokinetic half time was determined intravenously in rats.,15765,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625867,50597,,1,10116.0,10023,In vivo,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,6567,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625868,50597,,1,10116.0,10024,,,Plasma half life of hydrolysis of the compound,2448,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625869,50597,,1,10116.0,10025,In vivo,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,5423,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL874451,50597,,1,10116.0,10026,,,Plasma half life period was calculated in rat,4853,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625870,50597,,1,10116.0,10027,,,Plasma half-life in Sprague-Dawley rats,4514,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625871,50597,,1,10116.0,10028,,,Plasma half-life in Sprague-Dawley rats; Not determined,4514,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625872,50597,,1,10116.0,10029,,,Plasma half-life in rats,1500,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625873,50597,,1,10116.0,10030,,,Plasma half-life in rats; <MQL,1500,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625874,50597,,1,10116.0,10031,,,Plasma half-life period (0-8 h) was determined,5334,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625875,50597,,1,10116.0,10032,,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625876,50597,,1,10116.0,10033,In vivo,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631258,50597,,1,10116.0,10034,In vivo,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631259,50597,,1,10116.0,10035,,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,4956,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631260,50597,,1,10116.0,10036,,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,4956,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631261,50597,,1,10116.0,10037,,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",7768,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631262,50597,,1,10116.0,10038,,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",7768,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631263,50597,,1,10116.0,10039,,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631264,50597,,1,10116.0,10040,,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631265,50597,,1,10116.0,10041,,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631266,50597,,1,10116.0,10042,,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631267,50597,,1,10116.0,10043,,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631268,50597,,1,10116.0,10044,,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631269,50597,,1,10116.0,10045,,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631270,50597,,1,10116.0,10046,,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631271,50597,,1,10116.0,10047,,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631272,50597,,1,10116.0,10048,,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631273,50597,,1,10116.0,10049,,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631274,50597,,1,10116.0,10050,,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631275,50597,,1,10116.0,10051,,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626984,50597,,1,10116.0,10052,,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",7768,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626985,50597,,1,10116.0,10053,,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626986,50597,,1,10116.0,10054,,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626987,50597,,1,10116.0,10055,,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626988,50597,,1,10116.0,10056,,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626989,50597,,1,10116.0,10057,,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626990,50597,,1,10116.0,10058,,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626991,50597,,1,10116.0,10059,,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",7768,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626992,50597,,1,10116.0,10060,,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626993,50597,,1,10116.0,10061,,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL874593,50597,,1,10116.0,10062,,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626994,50597,,1,10116.0,10063,,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626995,50597,,1,10116.0,10064,,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626190,50597,,1,10116.0,10065,,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626191,50597,,1,10116.0,10066,,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",7768,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626364,50597,,1,10116.0,10067,,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",7768,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626365,50597,,1,10116.0,10068,,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",7768,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626366,50597,,1,10116.0,10069,,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",7768,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626367,50597,,1,10116.0,10070,,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",7768,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626368,50597,,1,10116.0,10071,,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",7768,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626369,50597,,1,10116.0,10072,,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",7768,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626370,50597,,1,10116.0,10073,,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626371,50597,,1,10116.0,10074,In vivo,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",4498,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626372,50597,,1,10116.0,10075,In vivo,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",4498,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626373,50597,,1,10116.0,10076,In vivo,,Bioavailability after a dose of 10 mg/kg p.o.,3603,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626374,50597,,1,10116.0,10077,In vivo,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,6215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626375,50597,,1,10116.0,10078,In vivo,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,5710,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626376,50597,,1,10116.0,10079,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),5710,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626377,50597,,1,10116.0,10080,In vivo,,Bioavailability in rat po was determined,5676,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626378,50597,,1,10116.0,10081,In vivo,,Bioavailability of compound at 10 mg/kg in rat after oral administration,17667,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626379,50597,,1,10116.0,10082,In vivo,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,17667,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626380,50597,,1,10116.0,10083,In vivo,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),6848,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626381,50597,,1,10116.0,10084,In vivo,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),6848,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626382,50597,,1,10116.0,10085,In vivo,,Bioavailability in rat,17267,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626383,50597,,1,10116.0,10086,In vivo,,Bioavailability in rat (Sprague-Dawley) (female),6362,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874652,50597,,1,10116.0,10087,In vivo,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626384,50597,,1,10116.0,10088,In vivo,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),17671,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626385,50597,,1,10116.0,10089,In vivo,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,4333,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626386,50597,,1,10116.0,10090,In vivo,,Bioavailability in rat at an oral dose of 2 mg/kg,6077,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626387,50597,,1,10116.0,10091,In vivo,,Bioavailability in rat,3278,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626388,50597,,1,10116.0,10092,In vivo,,Bioavailability in rat,5964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626389,50597,,1,10116.0,10093,In vivo,,Bioavailability in rat,4884,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626390,50597,,1,10116.0,10094,In vivo,,Bioavailability in rat,4905,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626391,50597,,1,10116.0,10095,In vivo,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,4884,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626392,50597,,1,10116.0,10096,In vivo,,Bioavailability in rat,6850,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626393,50597,,1,10116.0,10097,In vivo,,Oral bioavailability in rat,2864,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623026,50597,,1,10116.0,10098,In vivo,,Bioavailability was determined in rat,5780,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623027,50597,,1,10116.0,10099,In vivo,,Bioavailability,1465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623028,50597,,1,10116.0,10100,In vivo,,Bioavailability,5199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623029,50597,,1,10116.0,10101,In vivo,,Bioavailability in rat after 1 day dosing,5765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623030,50597,,1,10116.0,10102,In vivo,,Bioavailability in rat after 4 day dosing,5765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623031,50597,,1,10116.0,10103,In vivo,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623032,50597,,1,10116.0,10104,In vivo,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623033,50597,,1,10116.0,10105,In vivo,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623034,50597,,1,10116.0,10106,In vivo,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,6518,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623035,50597,,1,10116.0,10107,In vivo,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,2083,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623036,50597,,1,10116.0,10108,In vivo,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623037,50597,,1,10116.0,10109,In vivo,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),4956,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623038,50597,,1,10116.0,10110,In vivo,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL874385,50597,,1,10116.0,10111,In vivo,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,17752,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623039,50597,,1,10116.0,10112,In vivo,,Bioavailability in rat (Fisher) (fasted),1446,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL623040,22224,,0,9443.0,10113,In vivo,,Bioavailability in monkey after po administration of 10 mg/kg dose,2891,Primates,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL623041,22224,,0,9443.0,10114,In vivo,,Oral bioavailability in monkey (dose 10 mg/kg),2891,Primates,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623741,50597,,1,10116.0,10115,In vivo,,Bioavailability in rat,6672,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623742,50597,,1,10116.0,10116,In vivo,,Bioavailability in rat,6673,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623743,50597,,1,10116.0,10117,In vivo,,Bioavailability in rat,17655,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623744,50597,,1,10116.0,10118,In vivo,,Bioavailability in rat,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623745,50597,,1,10116.0,10119,In vivo,,Bioavailability in rat (dose 2.0 mg/kg p.o.),17853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623746,50597,,1,10116.0,10120,In vivo,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),4521,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623747,50597,,1,10116.0,10121,In vivo,,Oral bioavailability in rat (dose 5 mg/kg p.o.),4940,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL623748,22224,,0,10116.0,10122,In vivo,,Bioavailability in rat after po administration of 30 mg/kg dose,2891,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL623916,22224,,0,10116.0,10123,In vivo,,Bioavailability in rat after po administration of 30 mg/kg dose,2891,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623917,50597,,1,10116.0,10124,In vivo,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623918,50597,,1,10116.0,10125,In vivo,,Bioavailability in rat (dose 2 mg/kg i.v.),17686,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874386,50597,,1,10116.0,10126,In vivo,,Bioavailability in rat,17796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623919,50597,,1,10116.0,10127,In vivo,,Bioavailability in rat; Only traces detected in rat plasma,17796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623920,50597,,1,10116.0,10128,In vivo,,Bioavailability in rat,5064,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623148,50597,,1,10116.0,10129,In vivo,,Bioavailability upon oral administration of compound,5147,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623149,50597,,1,10116.0,10130,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),1916,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623150,50597,,1,10116.0,10131,In vivo,,Bioavailability in rat,6049,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623151,50597,,1,10116.0,10132,In vivo,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",1445,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623152,50597,,1,10116.0,10133,In vivo,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",1445,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL623153,50597,,1,10116.0,10134,,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,2862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL623154,50597,,1,10116.0,10135,,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,2862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623155,50597,,1,10116.0,10136,,,In vitro and metabolic stability was determined,4194,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623156,50597,,1,10116.0,10137,,,In vitro metabolic stability in rat hepatocytes,4194,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623157,50597,,1,10116.0,10138,,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,5486,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623158,50597,Hepatocyte,1,10116.0,10139,In vitro,,Metabolic rate for compound was observed in rat hepatocytes,17582,Rattus norvegicus,,401.0,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623159,50597,,1,10116.0,10140,,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,5600,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874390,50597,,1,10116.0,10141,,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),14294,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623160,50597,,1,10116.0,10142,,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),14294,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623161,50597,,1,10116.0,10143,,,Metabolism of compound in rat S9 microsomes; Trace,14294,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623162,50597,,1,10116.0,10144,,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,17847,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623163,50597,,1,10116.0,10145,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623164,50597,,1,10116.0,10146,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623165,50597,,1,10116.0,10147,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623166,50597,,1,10116.0,10148,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624983,50597,,1,10116.0,10149,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624984,50597,,1,10116.0,10150,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624985,50597,,1,10116.0,10151,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622970,50597,,1,10116.0,10152,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622971,50597,,1,10116.0,10153,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622972,50597,,1,10116.0,10154,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622973,50597,,1,10116.0,10155,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622974,50597,,1,10116.0,10156,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622975,50597,,1,10116.0,10157,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622976,50597,,1,10116.0,10158,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622977,50597,,1,10116.0,10159,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624351,50597,,1,10116.0,10160,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624352,50597,,1,10116.0,10161,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624353,50597,,1,10116.0,10162,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622397,50597,,1,10116.0,10163,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622398,50597,,1,10116.0,10164,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622399,50597,,1,10116.0,10165,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622400,50597,,1,10116.0,10166,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628428,50597,,1,10116.0,10167,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628590,50597,,1,10116.0,10168,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628591,50597,,1,10116.0,10169,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628592,50597,,1,10116.0,10170,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628593,50597,,1,10116.0,10171,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875333,50597,,1,10116.0,10172,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628594,50597,,1,10116.0,10173,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,11020,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628595,50597,,1,10116.0,10174,,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,4969,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628596,50597,,1,10116.0,10175,,,Stability in rat plasma was determined,6737,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628597,50597,,1,10116.0,10176,,,Stability in rat plasma was determined; ND= no data,6737,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628598,50597,,1,10116.0,10177,,,Tested for plasma half life period in rat (0-8 hr),5089,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628599,50597,,1,10116.0,10178,,,Tested for plasma half life period in rat (0-8 hr); Not determined,5089,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628600,50597,,1,10116.0,10179,In vivo,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628601,50597,,1,10116.0,10180,In vivo,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628602,50597,,1,10116.0,10181,,,Tested for the half life in rat,4950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628603,50597,,1,10116.0,10182,In vitro,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,2412,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628604,50597,,1,10116.0,10183,In vitro,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,2412,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628605,50597,,1,10116.0,10184,In vitro,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,2412,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628606,50597,,1,10116.0,10185,In vitro,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,2412,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628607,50597,,1,10116.0,10186,In vitro,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,2412,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628608,50597,,1,10116.0,10187,,,The biological half life the compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628609,50597,,1,10116.0,10188,,,The biological half life the compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628610,50597,,1,10116.0,10189,,,The compound was evaluated for plasma half life period in rat,406,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL873819,50597,,1,10116.0,10190,In vivo,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628611,50597,,1,10116.0,10191,In vivo,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628612,50597,,1,10116.0,10192,In vivo,,The pharmacokinetic parameter half-life period in vivo in rats,5247,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628613,50597,,1,10116.0,10193,In vivo,,"The pharmacokinetic property, Half-life was determined",5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628614,50597,,1,10116.0,10194,In vivo,,"The pharmacokinetic property, Half-life in rat in vivo",5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628615,50597,,1,10116.0,10195,In vivo,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628616,50597,,1,10116.0,10196,In vivo,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",5041,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627924,50597,,1,10116.0,10197,,,The plasma half life period in rats,3918,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627925,50597,,1,10116.0,10198,,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,2906,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627926,50597,,1,10116.0,10199,In vivo,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,6467,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627927,50597,,1,10116.0,10200,,,t1/2 (apparent elimination)of the compound was determined,5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627928,50597,,1,10116.0,10201,,,t1/2 value in rat,3788,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627539,50597,,1,10116.0,10202,,,Half life in rat,17796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876790,50597,,1,10116.0,10203,In vivo,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL858186,50597,,1,10116.0,10204,In vivo,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,5983,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627540,50597,,1,10116.0,10205,,,Half-life period in fasted rats,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627541,50597,,1,10116.0,10206,In vivo,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627715,50597,,1,10116.0,10207,In vivo,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627716,50597,,1,10116.0,10208,In vivo,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,429,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627717,50597,,1,10116.0,10209,,,Maximum time required to achieve Cmax was determined in rat,17655,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627718,50597,,1,10116.0,10210,In vivo,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627719,50597,,1,10116.0,10211,In vivo,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627720,50597,,1,10116.0,10212,In vivo,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627721,50597,,1,10116.0,10213,In vivo,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627722,50597,,1,10116.0,10214,In vivo,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627723,50597,,1,10116.0,10215,In vivo,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626058,50597,,1,10116.0,10216,In vivo,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626059,50597,,1,10116.0,10217,In vivo,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626060,50597,,1,10116.0,10218,In vivo,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626061,50597,,1,10116.0,10219,In vivo,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876791,50597,,1,10116.0,10220,In vivo,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626062,50597,,1,10116.0,10221,In vivo,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626063,50597,,1,10116.0,10222,In vivo,,Tmax at the dose of 2 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626064,50597,,1,10116.0,10223,In vivo,,Tmax at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626065,50597,,1,10116.0,10224,In vivo,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626066,50597,,1,10116.0,10225,In vivo,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626067,50597,,1,10116.0,10226,In vivo,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626068,50597,,1,10116.0,10227,,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626069,50597,,1,10116.0,10228,,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626070,50597,,1,10116.0,10229,,,Percent total excretion of 3-methoxyacetaminophen glucuronide,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626071,50597,,1,10116.0,10230,,,Percent total excretion of N-methoxyacetaminophen glucuronide,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626072,50597,,1,10116.0,10231,,,Percent total excretion of N-methoxyacetaminophen sulfate,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626073,50597,,1,10116.0,10232,,,Percent total excretion of acetaminophen,7449,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626741,50597,,1,10116.0,10233,,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",7768,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626742,50597,,1,10116.0,10234,,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",17655,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626743,50597,,1,10116.0,10235,,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,17735,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876792,50597,,1,10116.0,10236,,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,5960,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626744,50597,,1,10116.0,10237,,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,17735,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626745,50597,,1,10116.0,10238,,,Compound was tested for antidiuretic activity in rats,7116,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626746,50597,,1,10116.0,10239,In vivo,,AUC in rat after 3mg/kg oral dose,4878,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626747,50597,,1,10116.0,10240,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626748,50597,,1,10116.0,10241,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626749,50597,,1,10116.0,10242,,,Bioavailability administered orally at a dose of 10 mg/kg to rats,16367,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626750,50597,,1,10116.0,10243,,,Oral Bioavailability was determined,16366,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626751,50597,,1,10116.0,10244,,,Oral bioavailability in rat,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626913,50597,,1,10116.0,10245,,,Oral bioavailability in rat; Not performed.,4426,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626914,50597,,1,10116.0,10246,,,Bioavailability,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626915,50597,,1,10116.0,10247,,,Bioavailability was determined; ND denotes no data,5041,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626916,50597,,1,10116.0,10248,,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,1500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626917,50597,,1,10116.0,10249,,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,1500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626918,50597,,1,10116.0,10250,,,Binding towards rat plasma protein at 10 uM,17409,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626919,50597,,1,10116.0,10251,,,Binding towards rat plasma protein at 100 uM,17409,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626920,50597,,1,10116.0,10252,In vivo,,Bioavailability in rat (dose 20 mg/kg p.o.),2959,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621976,50597,,1,10116.0,10253,In vivo,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,13501,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877599,50597,,1,10116.0,10254,In vivo,,Bioavailability in rat after 5 mg/kg oral gavage,6567,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621977,50597,,1,10116.0,10255,In vivo,,Bioavailability in rat,6571,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621978,50597,,1,10116.0,10256,In vivo,,Bioavailability in rat (dose 1 mg/kg i.v.),6715,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621979,50597,,1,10116.0,10257,In vivo,,Bioavailability in rat (dose 3 mg/kg p.o.),6715,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621980,50597,,1,10116.0,10258,In vivo,,Oral bioavailability in rat,2932,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621981,50597,,1,10116.0,10259,In vivo,,Bioavailability of the compound in rats after administration of 30 mg/kg,4171,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621982,50597,,1,10116.0,10260,In vivo,,Bioavailability after administration of 10 mg/kg in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL882953,50597,,1,10116.0,10261,In vivo,,Bioavailability after administration of 2 mg/kg in rats,17509,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621983,50597,,1,10116.0,10262,In vivo,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621984,50597,,1,10116.0,10263,In vivo,,Bioavailability in dogs was determined; high,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621985,50597,,1,10116.0,10264,In vivo,,Bioavailability in monkey after intravenous administration at 1 mpk,6659,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621986,50597,,1,10116.0,10265,In vivo,,Bioavailability in monkey after peroral administration at 10 mpk,6659,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621987,50597,,1,10116.0,10266,In vivo,,Bioavailability in rat after intravenous administration at 1 mpk,6659,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL877600,50597,,1,10116.0,10267,In vivo,,Bioavailability in rat after intravenous administration at 2 mpk,6659,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621988,50597,,1,10116.0,10268,In vivo,,Bioavailability in rat after peroral administration at 30 mpk,6659,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL621989,50597,,1,10116.0,10269,In vivo,,Bioavailability in rat after peroral administration at at 100 mpk,6659,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621990,50597,,1,10116.0,10270,In vivo,,Bioavailability in rats was evaluated,6597,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621991,50597,,1,10116.0,10271,In vivo,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,1202,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621992,50597,,1,10116.0,10272,In vivo,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,1202,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621993,50597,,1,10116.0,10273,In vivo,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,1202,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621994,50597,,1,10116.0,10274,In vivo,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,1202,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621995,50597,,1,10116.0,10275,In vivo,,Bioavailability in rat,5207,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621996,50597,,1,10116.0,10276,In vivo,,Bioavailability in rat,5970,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621997,50597,,1,10116.0,10277,In vivo,,Oral bioavailability in rat (dose 10 mg/kg),17538,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621998,50597,,1,10116.0,10278,In vivo,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,17538,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621999,50597,,1,10116.0,10279,In vivo,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622000,50597,,1,10116.0,10280,In vivo,,Oral bioavailability in rat,2879,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622001,50597,,1,10116.0,10281,In vivo,,Bioavailability was measured in rat after oral administration; 2-4,2879,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622002,50597,,1,10116.0,10282,In vivo,,Bioavailability was measured in rat after oral administration; 3-7,2879,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622003,50597,,1,10116.0,10283,In vivo,,Bioavailability in rat (intraduodenal administration),3777,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877601,50597,,1,10116.0,10284,In vivo,,Bioavailability in rat (intraduodenal administration),3777,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624871,50597,,1,10116.0,10285,In vivo,,Oral bioavailability in rat,3777,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622004,50597,,1,10116.0,10286,In vivo,,Oral bioavailability in rat,3777,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL882954,50597,,1,10116.0,10287,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),5423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622005,50597,,1,10116.0,10288,In vivo,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622006,50597,,1,10116.0,10289,In vivo,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,16365,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622007,50597,,1,10116.0,10290,In vivo,,Bioavailability was measured in rat,4239,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622008,50597,,1,10116.0,10291,In vivo,,Bioavailability was reported,5438,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622009,50597,,1,10116.0,10292,In vivo,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622010,50597,,1,10116.0,10293,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622011,50597,,1,10116.0,10294,In vivo,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622012,50597,,1,10116.0,10295,In vivo,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622013,50597,,1,10116.0,10296,In vivo,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),4199,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622014,50597,,1,10116.0,10297,In vivo,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624749,50597,,1,10116.0,10298,In vivo,,Bioavailability was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624750,50597,,1,10116.0,10299,In vivo,,Oral bioavailability in rat (dose 2 mg/kg),5529,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624751,50597,,1,10116.0,10300,In vivo,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624752,50597,,1,10116.0,10301,In vivo,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624753,50597,,1,10116.0,10302,In vivo,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",6685,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624754,50597,,1,10116.0,10303,In vivo,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,6005,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624755,50597,,1,10116.0,10304,In vivo,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624756,50597,,1,10116.0,10305,In vivo,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624757,50597,,1,10116.0,10306,In vivo,,Bioavailability in rat,6103,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624758,50597,,1,10116.0,10307,In vivo,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622270,50597,,1,10116.0,10308,In vivo,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622271,50597,,1,10116.0,10309,In vivo,,Bioavailability in rat (Sprague-Dawley),5353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622272,50597,,1,10116.0,10310,In vivo,,Bioavailability in rat at the dose of 2 mg/kg,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622273,50597,,1,10116.0,10311,In vivo,,Oral bioavailability in rat,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622274,50597,,1,10116.0,10312,In vivo,,Bioavailability in rat (cannulated) (dose 2 mg/kg),5809,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622275,50597,,1,10116.0,10313,In vivo,,Bioavailability value of compound in rats was determined after peroral administration,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622276,50597,,1,10116.0,10314,In vivo,,Oral bioavailability in rat (dose 20 mg/kg),3634,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622277,50597,,1,10116.0,10315,In vivo,,Oral bioavailability in rat,3341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622278,50597,,1,10116.0,10316,In vivo,,Oral bioavailability in rat (dose 5 mg/kg),2690,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622279,50597,,1,10116.0,10317,In vivo,,Oral bioavailability in rat,3184,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622280,50597,,1,10116.0,10318,In vivo,,Oral bioavailability in rat,740,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624083,50597,,1,10116.0,10319,In vivo,,Compound was evaluated for oral bioavailability in rats; 15-27 %,1806,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624084,50597,,1,10116.0,10320,In vivo,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,4891,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624085,50597,,1,10116.0,10321,In vivo,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),3634,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624086,50597,,1,10116.0,10322,In vivo,,Compound was tested for bioavailability in rats,64,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624087,50597,,1,10116.0,10323,In vivo,,Bioavailability in rat,4839,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624088,50597,,1,10116.0,10324,In vivo,,Oral bioavailability in rat,1094,Rattus norvegicus,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL624089,22224,,0,9544.0,10325,In vivo,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,5005,Macaca mulatta,,,1
U,,,,BAO_0000218,Intermediate,,A,,CHEMBL624090,22224,,0,10116.0,10326,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),5005,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624091,50597,,1,10116.0,10327,In vivo,,Evaluated for the bioavailability in rat (in vivo),4687,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624092,50597,,1,10116.0,10328,In vivo,,F value of compound in rats was determined after peroral administration,17804,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624093,50597,,1,10116.0,10329,In vivo,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624094,50597,,1,10116.0,10330,In vivo,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624095,50597,,1,10116.0,10331,In vivo,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624096,50597,,1,10116.0,10332,In vivo,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624097,50597,,1,10116.0,10333,In vivo,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",1088,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624098,50597,,1,10116.0,10334,In vivo,,Maximum fall in carotid flow in rat,1742,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874392,50597,,1,10116.0,10335,In vivo,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624099,50597,,1,10116.0,10336,In vivo,,Oral bioavailability in rat (dose 5 mg/kg),2463,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624100,50597,,1,10116.0,10337,In vivo,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624101,50597,,1,10116.0,10338,In vivo,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624102,50597,,1,10116.0,10339,In vivo,,Oral bioavailability in rat (male Wistar),6874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624103,50597,,1,10116.0,10340,In vivo,,Oral bioavailability after administration (30 mg/kg) in rat; good,5633,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624104,50597,,1,10116.0,10341,In vivo,,Oral bioavailability at the dose of 2 mg/kg in rat,5496,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624105,50597,,1,10116.0,10342,In vivo,,Oral bioavailability determined in rats,2358,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624106,50597,,1,10116.0,10343,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),16456,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624107,50597,,1,10116.0,10344,In vivo,,Oral bioavailability in rat (dose single 10 mg/kg),5302,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623943,50597,,1,10116.0,10345,In vivo,,Oral bioavailability in rat (dose single 10 mg/kg),5302,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623944,50597,,1,10116.0,10346,In vivo,,Oral bioavailability in rat (dose 5 mg/kg,5302,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623945,50597,,1,10116.0,10347,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623946,50597,,1,10116.0,10348,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623947,50597,,1,10116.0,10349,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623948,50597,,1,10116.0,10350,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623949,50597,,1,10116.0,10351,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623950,50597,,1,10116.0,10352,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874398,50597,,1,10116.0,10353,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623951,50597,,1,10116.0,10354,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623952,50597,,1,10116.0,10355,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623953,50597,,1,10116.0,10356,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623954,50597,,1,10116.0,10357,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623955,50597,,1,10116.0,10358,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623956,50597,,1,10116.0,10359,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627807,50597,,1,10116.0,10360,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627808,50597,,1,10116.0,10361,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627809,50597,,1,10116.0,10362,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627810,50597,,1,10116.0,10363,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627811,50597,,1,10116.0,10364,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627812,50597,,1,10116.0,10365,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627813,50597,,1,10116.0,10366,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627814,50597,,1,10116.0,10367,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875336,50597,,1,10116.0,10368,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627815,50597,,1,10116.0,10369,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627816,50597,,1,10116.0,10370,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627817,50597,,1,10116.0,10371,,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627818,50597,,1,10116.0,10372,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627819,50597,,1,10116.0,10373,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627820,50597,,1,10116.0,10374,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627821,50597,,1,10116.0,10375,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628464,50597,,1,10116.0,10376,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626239,50597,,1,10116.0,10377,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626240,50597,,1,10116.0,10378,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626241,50597,,1,10116.0,10379,,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626242,50597,,1,10116.0,10380,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626243,50597,,1,10116.0,10381,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626244,50597,,1,10116.0,10382,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626907,50597,,1,10116.0,10383,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626908,50597,,1,10116.0,10384,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626909,50597,,1,10116.0,10385,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626910,50597,,1,10116.0,10386,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,11020,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL875342,50597,,1,10116.0,10387,,,Percent total excretion of acetaminophen cysteine conjugate,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626911,50597,,1,10116.0,10388,,,Percent total excretion of acetaminophen glucuronide,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626912,50597,,1,10116.0,10389,,,Percent total excretion of acetaminophen sulfate,7449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL627065,50597,,1,10116.0,10390,,,Percent total excretion of acetaminophen-mercapturic acid,7449,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627066,50597,,1,10116.0,10391,,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,3172,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627067,50597,,1,10116.0,10392,In vivo,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627068,22224,,0,8656.0,10393,In vivo,,Biodistribution of compound in rat muscle after 5 min of administration,10839,ratrat,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627069,22224,,0,8656.0,10394,In vivo,,Biodistribution of compound in rat muscle after 5 min of administration.,10839,ratrat,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627070,22224,,0,9940.0,10395,In vivo,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627071,22224,,0,9940.0,10396,In vivo,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627072,22224,,0,9940.0,10397,In vivo,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627073,22224,,0,9940.0,10398,In vivo,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625387,22224,,0,9940.0,10399,In vivo,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625388,22224,,0,9940.0,10400,In vivo,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL625389,22224,,0,9940.0,10401,In vivo,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL875343,22224,,0,9940.0,10402,In vivo,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876795,50497,,1,8570.0,10403,,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),1735,Serpentes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626552,50497,,1,8570.0,10404,,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,1469,Serpentes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626553,50497,,1,8570.0,10405,,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,1336,Serpentes,,,1
U,,,1969.0,BAO_0000366,Autocuration,,A,Plasma,CHEMBL626554,22224,,0,9606.0,10406,,,The human biological plasma half life of the compound,12403,Homo sapiens,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626555,50597,,1,10116.0,10407,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626556,50597,,1,10116.0,10408,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626557,50597,,1,10116.0,10409,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626558,50597,,1,10116.0,10410,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626559,50597,,1,10116.0,10411,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626560,50597,,1,10116.0,10412,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876803,50597,,1,10116.0,10413,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627964,50597,,1,10116.0,10414,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627965,50597,,1,10116.0,10415,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627966,50597,,1,10116.0,10416,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627967,50597,,1,10116.0,10417,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627968,50597,,1,10116.0,10418,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627969,50597,,1,10116.0,10419,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627970,50597,,1,10116.0,10420,,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627971,50597,,1,10116.0,10421,,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,8004,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627972,50597,,1,10116.0,10422,,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,8004,Rattus norvegicus,,,1
D,,,,BAO_0000357,Expert,,B,,CHEMBL856029,180,,9,9606.0,10423,,,Dissociation constant against binding to human cyclophilin A,15917,Homo sapiens,,,1
H,,,,BAO_0000019,Expert,,B,,CHEMBL627973,11591,,8,9913.0,10424,,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,12396,Bos taurus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627974,22224,,0,,10425,,,-Log C was determined by performing the electroshock minimum test,7065,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627975,22224,,0,,10426,,,-Log C was determined by performing the foot shock test,7065,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627976,22224,,0,,10427,,,-Log C was determined by performing the incl screen test,7065,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627977,22224,,0,,10428,,,-Log C was determined by performing the maximum electroshock test,7065,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627978,22224,,0,,10429,,,-Log C was determined by performing the pentylenetetrazole test,7065,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627979,22224,,0,,10430,,,Tested for experimental arotinoid inhibitory dose,12415,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL876804,22224,,0,,10431,,,Negative log transformed activity,10256,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627980,22224,,0,,10432,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",7991,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627981,50512,,1,10141.0,10433,,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,14342,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627982,50512,,1,10141.0,10434,,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,14342,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627983,50512,,1,10141.0,10435,,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,14342,Cavia porcellus,,,1
N,,,2116.0,BAO_0000218,Intermediate,,A,Ileum,CHEMBL627984,50512,,1,10141.0,10436,,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,14342,Cavia porcellus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL627985,22229,,0,,10437,,,Solubility in water was determined; values expressed as -log,6047,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627986,22224,,0,,10438,,,Ratio of Kcat to that of Km was determined,17269,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627987,22224,,0,,10439,,,Observed first order rate constant,10026,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627988,22224,,0,,10440,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,14583,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627989,50597,,1,10116.0,10441,In vivo,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627990,50597,,1,10116.0,10442,In vivo,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876805,50597,,1,10116.0,10443,In vivo,,Oral Bioavailability after administration of 10 mg/kg in male rat,4029,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627991,50597,,1,10116.0,10444,In vivo,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),17735,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627992,50597,,1,10116.0,10445,In vivo,,Oral bioavailability in rat,4576,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627993,50597,,1,10116.0,10446,In vivo,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,17582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622817,50597,,1,10116.0,10447,In vivo,,Oral bioavailability at 1 mg/kg was determined in rat,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622818,50597,,1,10116.0,10448,In vivo,,Oral bioavailability at 10 mg/kg was determined in rat,17651,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622819,50597,,1,10116.0,10449,In vivo,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",17670,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL872267,50597,,1,10116.0,10450,In vivo,,Oral bioavailability in rat,5045,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622820,50597,,1,10116.0,10451,In vivo,,Oral bioavailability in rat,1696,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622821,50597,,1,10116.0,10452,In vivo,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622822,50597,,1,10116.0,10453,In vivo,,Oral bioavailability in rat,6448,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622823,50597,,1,10116.0,10454,In vivo,,Oral bioavailability in rat,6596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622824,50597,,1,10116.0,10455,In vivo,,Oral bioavailability in rat,17547,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622825,50597,,1,10116.0,10456,In vivo,,Oral bioavailability in rat at a dose of 3 mg/kg,17771,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622901,50597,,1,10116.0,10457,In vivo,,Oral bioavailability in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622902,50597,,1,10116.0,10458,In vivo,,Oral bioavailability in rat,4558,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621844,50597,,1,10116.0,10459,In vivo,,Oral bioavailability in rat,17596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621845,50597,,1,10116.0,10460,In vivo,,Oral bioavailability in Dawley rats,6827,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621846,50597,,1,10116.0,10461,In vivo,,Oral bioavailability,4026,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621847,50597,,1,10116.0,10462,In vivo,,Oral bioavailability in rat (dose 30 mg/kg),10,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877609,50597,,1,10116.0,10463,In vivo,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621848,50597,,1,10116.0,10464,In vivo,,Bioavailability in rat (dose 3 mg/kg i.v.),17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621849,50597,,1,10116.0,10465,In vivo,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622030,50597,,1,10116.0,10466,In vivo,,Oral bioavailability in rat (dose 60 mg/kg p.o.),17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622031,50597,,1,10116.0,10467,In vivo,,Percent oral bioavailability determined in rats,4796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622032,50597,,1,10116.0,10468,In vivo,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,4883,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622033,50597,,1,10116.0,10469,In vivo,,The compound was evaluated for bioavailability in rats; 32-51,2137,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622034,50597,,1,10116.0,10470,In vivo,,Bioavailability in rat (dose 20 mg/kg p.o.),2959,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622035,50597,,1,10116.0,10471,In vivo,,Oral bioavailability in rat,1361,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL882966,50597,,1,10116.0,10472,In vivo,,Bioavailability percent in rat at the dose of 2 mg/kg,4727,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622036,50597,,1,10116.0,10473,In vivo,,Bioavailability was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622037,50597,,1,10116.0,10474,In vivo,,Oral bioavailability in rat,5206,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622038,50597,,1,10116.0,10475,In vivo,,Oral bioavailability in rat,6448,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622039,50597,,1,10116.0,10476,In vivo,,Bioavailability in rats,17723,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622040,50597,,1,10116.0,10477,In vivo,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622041,50597,,1,10116.0,10478,In vivo,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622042,50597,,1,10116.0,10479,In vivo,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622043,50597,,1,10116.0,10480,In vivo,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622044,50597,,1,10116.0,10481,In vivo,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL622045,50597,,1,10116.0,10482,In vivo,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL622046,50597,,1,10116.0,10483,In vivo,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL622047,50597,,1,10116.0,10484,In vivo,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL877610,50597,,1,10116.0,10485,In vivo,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622048,50597,,1,10116.0,10486,In vivo,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622049,50597,,1,10116.0,10487,In vivo,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622050,50597,,1,10116.0,10488,In vivo,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622051,50597,,1,10116.0,10489,In vivo,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622052,50597,,1,10116.0,10490,In vivo,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622053,50597,,1,10116.0,10491,In vivo,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622054,50597,,1,10116.0,10492,In vivo,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622055,50597,,1,10116.0,10493,In vivo,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622056,50597,,1,10116.0,10494,In vivo,,Oral bioavailability in rats was determined; High,5237,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622057,50597,,1,10116.0,10495,In vivo,,Oral bioavailability in the rat was determined,5503,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628008,50597,,1,10116.0,10496,In vivo,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,15765,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622058,50597,,1,10116.0,10497,In vivo,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),15660,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622059,50597,,1,10116.0,10498,In vivo,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622060,50597,,1,10116.0,10499,In vivo,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622061,50597,,1,10116.0,10500,In vivo,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622062,50597,,1,10116.0,10501,In vivo,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622063,50597,,1,10116.0,10502,In vivo,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL877611,50597,,1,10116.0,10503,In vivo,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622064,50597,,1,10116.0,10504,In vivo,,Oral bioavailability of compound in Sprague Dawley rats,4216,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622065,50597,,1,10116.0,10505,In vivo,,Oral bioavailability of compound in rat,17839,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622066,50597,,1,10116.0,10506,In vivo,,Oral bioavailability in rat (dose 2 mg/kg),6570,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622067,50597,,1,10116.0,10507,In vivo,,Oral bioavailability of compound in rat was determined,5334,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622068,50597,,1,10116.0,10508,In vivo,,Oral bioavailability of compound in rats,6886,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622069,50597,,1,10116.0,10509,In vivo,,Oral bioavailability of compound was determined in rats,5210,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624796,50597,,1,10116.0,10510,In vivo,,Oral bioavailability at a dose of 30 mg/kg in rats,4170,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624797,50597,,1,10116.0,10511,In vivo,,Oral bioavailability in rat (dose 10 mg/kg),6028,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623053,50597,,1,10116.0,10512,In vivo,,Oral bioavailability in rat (dose 10 mg/kg),6028,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623054,50597,,1,10116.0,10513,In vivo,,Oral bioavailability evaluated in rat,6078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623055,50597,,1,10116.0,10514,In vivo,,Oral bioavailability in fasted rat,6168,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623056,50597,,1,10116.0,10515,In vivo,,Oral bioavailability in fed rat,6168,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623057,50597,,1,10116.0,10516,In vivo,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),5160,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623058,50597,,1,10116.0,10517,In vivo,,Oral bioavailability in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623059,50597,,1,10116.0,10518,In vivo,,Oral bioavailability in rat (dose 10 mg/kg p.o.),6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623060,50597,,1,10116.0,10519,In vivo,,Oral bioavailability in rat after administration of 10 mg/kg po,6535,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623061,50597,,1,10116.0,10520,In vivo,,Oral bioavailability in rat,4194,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623062,50597,,1,10116.0,10521,In vivo,,Oral bioavailability in rat,6230,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623063,50597,,1,10116.0,10522,In vivo,,Oral bioavailability in rat,6619,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623064,50597,,1,10116.0,10523,In vivo,,Oral bioavailability in rat,17607,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623065,50597,,1,10116.0,10524,In vivo,,Oral bioavailability in ratrs,4942,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623066,50597,,1,10116.0,10525,In vivo,,Oral bioavailability in rat,4942,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623067,50597,,1,10116.0,10526,In vivo,,Oral bioavailability in rat,6646,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623068,50597,,1,10116.0,10527,In vivo,,Oral bioavailability in rats was determined; High,5237,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623069,50597,,1,10116.0,10528,In vivo,,Oral bioavailability in rat,6646,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623070,50597,,1,10116.0,10529,In vivo,,Oral bioavailability in rat,4449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623071,50597,,1,10116.0,10530,In vivo,,Oral bioavailability was calculated in rat,6057,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623072,50597,,1,10116.0,10531,In vivo,,Oral bioavailability,2552,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623073,50597,,1,10116.0,10532,In vivo,,Oral bioavailability,5496,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623074,50597,,1,10116.0,10533,In vivo,,Oral bioavailability,6484,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623075,50597,,1,10116.0,10534,In vivo,,Oral bioavailability,6485,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623076,50597,,1,10116.0,10535,In vivo,,Oral bioavailability after i.v. administration,6616,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623077,50597,,1,10116.0,10536,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4969,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623078,50597,,1,10116.0,10537,In vivo,,Oral bioavailability in rat (Sprague-Dawley),5862,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623079,50597,,1,10116.0,10538,In vivo,,Oral bioavailability in Sprague-Dawley rats,4514,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623080,50597,,1,10116.0,10539,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4514,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623081,50597,,1,10116.0,10540,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),4514,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623082,50597,,1,10116.0,10541,In vivo,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,5546,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874400,50597,,1,10116.0,10542,In vivo,,Oral bioavailability in fasted rat,6168,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623083,50597,,1,10116.0,10543,In vivo,,Oral bioavailability in fed rat,6168,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623084,50597,,1,10116.0,10544,In vivo,,Oral bioavailability in rat,3624,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623085,50597,,1,10116.0,10545,In vivo,,Oral bioavailability in rat,5213,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623086,50597,,1,10116.0,10546,In vivo,,Oral bioavailability in rat,5496,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623087,50597,,1,10116.0,10547,In vivo,,Oral bioavailability in rat,5553,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623088,50597,,1,10116.0,10548,In vivo,,Oral bioavailability in rat,5833,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623089,50597,,1,10116.0,10549,In vivo,,Oral bioavailability in rat,5836,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623090,50597,,1,10116.0,10550,In vivo,,Oral bioavailability in rat,5865,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623091,50597,,1,10116.0,10551,In vivo,,Oral bioavailability in rat,5960,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623092,50597,,1,10116.0,10552,In vivo,,Oral bioavailability in rat,6249,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623093,50597,,1,10116.0,10553,In vivo,,Oral bioavailability in rat,6448,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874401,50597,,1,10116.0,10554,In vivo,,Oral bioavailability in rat,6453,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623094,50597,,1,10116.0,10555,In vivo,,Oral bioavailability in rat,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623095,50597,,1,10116.0,10556,In vivo,,Oral bioavailability in rat,17607,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623096,50597,,1,10116.0,10557,In vivo,,Oral bioavailability in rat after peroral administration at 10 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624913,50597,,1,10116.0,10558,In vivo,,Oral bioavailability in rat after peroral administration at 5 mg/kg,5939,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624914,50597,,1,10116.0,10559,In vivo,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),6281,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624915,50597,,1,10116.0,10560,In vivo,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,5874,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624916,50597,,1,10116.0,10561,In vivo,,Oral bioavailability in rat; Not measured,5213,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624917,50597,,1,10116.0,10562,In vivo,,Oral bioavailability in rat,4964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625157,50597,,1,10116.0,10563,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,11020,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625158,50597,,1,10116.0,10564,,,In vitro metabolic potential in rat liver microsomes,6251,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625159,50597,,1,10116.0,10565,In vivo,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",1568,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625160,50597,,1,10116.0,10566,In vivo,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",3032,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625161,50597,,1,10116.0,10567,In vivo,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,3748,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625162,50597,,1,10116.0,10568,In vivo,,Oral bioavailability in rat,401,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625163,50597,,1,10116.0,10569,In vivo,,Oral bioavailability in rat,6512,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625164,50597,,1,10116.0,10570,In vivo,,Oral bioavailability in rats at 10 mg/kg,17617,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625165,50597,,1,10116.0,10571,In vivo,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625166,50597,,1,10116.0,10572,In vivo,,Oral bioavailability in rat,6742,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625167,50597,,1,10116.0,10573,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,589,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625168,50597,,1,10116.0,10574,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,589,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625169,50597,,1,10116.0,10575,In vivo,,Plasma clearance of the compound,3185,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626264,50597,,1,10116.0,10576,In vivo,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,17596,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626265,50597,,1,10116.0,10577,In vivo,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,2713,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626266,50597,,1,10116.0,10578,In vivo,,The compound was tested for plasma clearance in rat,12500,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626267,50597,,1,10116.0,10579,In vivo,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,12500,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626268,50597,,1,10116.0,10580,,,Plasma concentration upon oral administration of 1 mg/Kg in rats,2713,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626269,50597,,1,10116.0,10581,,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,1446,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626270,50597,,1,10116.0,10582,,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,6227,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626271,50597,,1,10116.0,10583,,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626272,50597,,1,10116.0,10584,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626273,50597,,1,10116.0,10585,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875346,50597,,1,10116.0,10586,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626274,50597,,1,10116.0,10587,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",5510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626275,50597,,1,10116.0,10588,,,Compound was tested for protein binding in rat plasma,4514,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624646,50597,,1,10116.0,10589,,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,2713,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624647,50597,,1,10116.0,10590,,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,2713,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624648,50597,,1,10116.0,10591,,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,5340,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624649,50597,,1,10116.0,10592,,,Area under curve ratio was determined (po/iv) in rat,12058,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624650,50597,,1,10116.0,10593,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624651,50597,,1,10116.0,10594,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624652,50597,,1,10116.0,10595,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624653,50597,,1,10116.0,10596,,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,6495,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624654,50597,,1,10116.0,10597,,,Ratio of AUCbrain to AUCplasma,6078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624655,50597,,1,10116.0,10598,,,Ratio of brain to plasma,5656,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624656,50597,,1,10116.0,10599,,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624657,50597,,1,10116.0,10600,,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624658,50597,,1,10116.0,10601,,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624659,50597,,1,10116.0,10602,,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624660,50597,,1,10116.0,10603,,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624661,50597,,1,10116.0,10604,,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,10130,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624662,50597,,1,10116.0,10605,,,Steady state brain :blood ratio was determined,5213,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625199,50597,,1,10116.0,10606,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625200,50597,,1,10116.0,10607,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625201,50597,,1,10116.0,10608,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625202,50597,,1,10116.0,10609,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,4910,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625203,50597,,1,10116.0,10610,,,Percentage recovery after 3h incubation with rat hapatocytes was determined,2083,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625204,50597,,1,10116.0,10611,,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,2082,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625205,50597,,1,10116.0,10612,,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,2082,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625206,50597,,1,10116.0,10613,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,6351,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625207,22224,,0,,10614,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",14583,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625208,22224,,0,,10615,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,14583,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625209,50587,Caco-2,1,9606.0,10616,,,In vivo absorption in Caco-2 cell line monolayers was determined,4608,Homo sapiens,,495.0,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625210,22229,,0,,10617,,,Calculated partition coefficient (clogP),13668,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625211,50597,,1,10116.0,10618,,,Area under curve was determine after peroral administration at 10 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625212,50797,,1,9544.0,10619,,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,5669,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625213,50597,,1,10116.0,10620,,,Area under curve was determine after peroral administration at 160 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625214,50597,,1,10116.0,10621,,,Area under curve was determine after peroral administration at 20 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874542,50597,,1,10116.0,10622,,,Area under curve was determine after peroral administration at 50 mpk in Rat,5669,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625215,22229,,0,,10623,,,Calculated partition coefficient (clogP) (AlogP),6472,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625216,22224,,0,,10624,,,Activated partial thromboplastin time measured,15106,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625217,22224,,0,,10625,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),15207,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625218,22224,,0,,10626,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),15207,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622864,50588,,1,9615.0,10627,,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,13941,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622865,50597,,1,10116.0,10628,,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,13941,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622866,50597,,1,10116.0,10629,,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,13941,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622867,50588,,1,9615.0,10630,,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,13941,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876808,50512,,1,10141.0,10631,,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,,,1
U,,,955.0,BAO_0000019,Autocuration,,A,Brain,CHEMBL627725,22224,,0,,10632,,,AUC in brain,10655,,,,1
U,,,1977.0,BAO_0000019,Autocuration,,A,Serum,CHEMBL627726,22224,,0,,10633,,,AUC in serum,10655,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627727,22224,,0,,10634,,,AUC was determined,6504,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627728,22224,,0,,10635,,,AUC of the compound.,10615,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627729,22224,,0,,10636,,,AUC value (0-4 hr),10353,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627730,22224,,0,,10637,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",14907,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627731,22224,,0,,10638,,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,14907,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627732,22224,,0,,10639,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",14907,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL627733,22224,,0,,10640,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",14907,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627734,50597,,1,10116.0,10641,,,AUC(area under curve) was determined after intravenous administration in rats,16359,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627735,50597,,1,10116.0,10642,,,AUC(area under curve) was determined after oral administration in rats,16359,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627736,50512,,1,10141.0,10643,,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876809,50597,,1,10116.0,10644,,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,15240,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627737,22224,,0,,10645,,,Area Under Curve after oral dosing of 100 uM/Kg,15469,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627738,22224,,0,,10646,,,Area Under Curve after oral dosing of 30 uM/Kg,15469,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627739,22224,,0,,10647,,,Area Under Curve was measured by ploting the graph between concentration verses time,13520,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626143,50588,,1,9615.0,10648,,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,17025,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626144,22224,,0,314293.0,10649,,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,17025,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626145,50592,,1,9986.0,10650,,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,17025,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626146,50597,,1,10116.0,10651,,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,17025,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626147,50597,,1,10116.0,10652,,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,12032,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626148,22224,,0,,10653,,,Area under curve (AUC) was determined,10291,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626149,22224,,0,,10654,,,Area under curve (AUC) following ip administration at 1 mg/kg,5767,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626150,22224,,0,,10655,,,Area under curve (AUC) was determined; ND is Not determined,1434,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626151,50588,,1,9615.0,10656,,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,14925,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626152,50588,,1,9615.0,10657,,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,14925,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626153,50588,,1,9615.0,10658,,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,14925,Canis lupus familiaris,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626154,22224,,0,,10659,,,Area under curve (AUR) was determined,1434,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626155,22224,,0,,10660,,,Area under curve at 1 uM/dg administered intravenously,11883,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626156,22224,,0,,10661,,,Area under curve at 10 uM/dg administered perorally,11883,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626157,22224,,0,,10662,,,Area under curve at 2 uM/dg administered intravenously,11883,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626158,22224,,0,,10663,,,Area under curve at 20 uM/dg administered perorally,11883,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626159,50588,,1,9615.0,10664,,,Area under curve at a peroral dose of 3 mg/kg in dog,15233,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626160,50597,,1,10116.0,10665,,,Area under curve at a peroral dose of 3 mg/kg in rat,15233,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626161,50588,,1,9615.0,10666,,,Area under curve at an iv dose of 1 mg/kg in dog,15233,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626162,50597,,1,10116.0,10667,,,Area under curve at an iv dose of 1 mg/kg in rat,15233,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626163,22224,,0,,10668,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,12978,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626164,22224,,0,,10669,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,12978,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626165,50594,,1,10090.0,10670,,,Area under curve measured as conc vs time after intravenous administration to mice.,11355,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626166,50594,,1,10090.0,10671,,,Area under curve measured as conc vs time after peroral administration to mice.,11355,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626167,50588,,1,9615.0,10672,,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,12923,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626168,50588,,1,9615.0,10673,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,12923,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877463,50588,,1,9615.0,10674,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,12923,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626169,50588,,1,9615.0,10675,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,12923,Canis lupus familiaris,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626170,50597,,1,10116.0,10676,In vivo,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626171,50597,,1,10116.0,10677,In vivo,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626172,50597,,1,10116.0,10678,In vivo,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626173,50597,,1,10116.0,10679,In vivo,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626174,50597,,1,10116.0,10680,In vivo,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626175,50597,,1,10116.0,10681,In vivo,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626176,50597,,1,10116.0,10682,In vivo,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626177,50597,,1,10116.0,10683,In vivo,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622499,50597,,1,10116.0,10684,In vivo,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622500,50597,,1,10116.0,10685,In vivo,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622501,50597,,1,10116.0,10686,In vivo,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622502,50597,,1,10116.0,10687,In vivo,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622503,50597,,1,10116.0,10688,In vivo,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL877614,50597,,1,10116.0,10689,In vivo,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624839,50597,,1,10116.0,10690,In vivo,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624840,50597,,1,10116.0,10691,In vivo,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624841,50597,,1,10116.0,10692,In vivo,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624842,50597,,1,10116.0,10693,In vivo,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624843,50597,,1,10116.0,10694,In vivo,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624844,50597,,1,10116.0,10695,In vivo,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624845,50597,,1,10116.0,10696,In vivo,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL621904,50597,,1,10116.0,10697,In vivo,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621905,50597,,1,10116.0,10698,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL874382,50597,,1,10116.0,10699,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL621906,50597,,1,10116.0,10700,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL621907,50597,,1,10116.0,10701,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622096,50597,,1,10116.0,10702,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622097,50597,,1,10116.0,10703,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622098,50597,,1,10116.0,10704,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622099,50597,,1,10116.0,10705,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622100,50597,,1,10116.0,10706,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622101,50597,,1,10116.0,10707,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622102,50597,,1,10116.0,10708,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622103,50597,,1,10116.0,10709,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622104,50597,,1,10116.0,10710,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622105,50597,,1,10116.0,10711,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622106,50597,,1,10116.0,10712,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622107,50597,,1,10116.0,10713,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622108,50597,,1,10116.0,10714,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622109,50597,,1,10116.0,10715,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622110,50597,,1,10116.0,10716,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622111,50597,,1,10116.0,10717,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL874383,50597,,1,10116.0,10718,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL622112,50597,,1,10116.0,10719,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL622113,50597,,1,10116.0,10720,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL622114,50597,,1,10116.0,10721,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622115,50597,,1,10116.0,10722,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622116,50597,,1,10116.0,10723,In vivo,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,11195,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622117,50597,,1,10116.0,10724,In vivo,,Oral bioavailability in rat,6193,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622118,50597,,1,10116.0,10725,In vivo,,Oral bioavailability in rat,6803,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622119,50597,,1,10116.0,10726,In vivo,,Oral bioavailability in rats at 6 mg/kg,6647,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622120,50597,,1,10116.0,10727,In vivo,,Oral bioavailability in rat (dose 6 mg/kg),6647,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622121,50597,,1,10116.0,10728,In vivo,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,6647,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622122,50597,,1,10116.0,10729,In vivo,,Oral bioavailability in rat,6640,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622123,50597,,1,10116.0,10730,In vivo,,Oral bioavailability in rat,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622124,50597,,1,10116.0,10731,In vivo,,Oral bioavailability in rat,6641,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622125,50597,,1,10116.0,10732,In vivo,,Bioavailability in rat,6642,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622126,50597,,1,10116.0,10733,In vivo,,Oral bioavailability,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620455,50597,,1,10116.0,10734,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),6141,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620456,50597,,1,10116.0,10735,In vivo,,Oral bioavailability in rat,4390,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620457,50597,,1,10116.0,10736,In vivo,,Oral bioavailability in rat,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620458,50597,,1,10116.0,10737,In vivo,,Oral bioavailability was evaluated; Not tested,5472,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620459,50597,,1,10116.0,10738,In vivo,,Oral bioavailability,5438,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620460,50597,,1,10116.0,10739,In vivo,,Oral bioavailability in rat by oral dosing,4883,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620461,50597,,1,10116.0,10740,In vivo,,Oral bioavailability in rat (dose 10 mg/kg p.o.),1908,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620462,50597,,1,10116.0,10741,In vivo,,Oral bioavailability in rat (Sprague-Dawley),4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620463,50597,,1,10116.0,10742,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620464,50597,,1,10116.0,10743,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620465,50597,,1,10116.0,10744,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620466,50597,,1,10116.0,10745,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620467,50597,,1,10116.0,10746,In vivo,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620468,50597,,1,10116.0,10747,In vivo,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,4853,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620469,50597,,1,10116.0,10748,In vivo,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620470,50597,,1,10116.0,10749,In vivo,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,12873,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620471,50597,,1,10116.0,10750,In vivo,,Oral bioavailability in rat,3169,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620472,50597,,1,10116.0,10751,In vivo,,Oral bioavailability in rat,6305,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620473,50597,,1,10116.0,10752,In vivo,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,4762,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620474,50597,,1,10116.0,10753,In vivo,,Oral bioavailability in rat,17847,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620475,50597,,1,10116.0,10754,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),6211,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620476,50597,,1,10116.0,10755,In vivo,,Oral bioavailability in rat,6011,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620477,50597,,1,10116.0,10756,In vivo,,Oral bioavailability in rat,6317,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620478,50597,,1,10116.0,10757,In vivo,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618768,50597,,1,10116.0,10758,In vivo,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618769,50597,,1,10116.0,10759,In vivo,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618770,50597,,1,10116.0,10760,In vivo,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,6644,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618771,50597,,1,10116.0,10761,In vivo,,Oral bioavailability (dose 20 mg/kg p.o.),6113,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618772,50597,,1,10116.0,10762,In vivo,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,5937,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618773,50597,,1,10116.0,10763,In vivo,,Oral bioavailability in rat at 10 mg/kg of the compound,5711,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875842,50597,,1,10116.0,10764,In vivo,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618774,50597,,1,10116.0,10765,In vivo,,Bioavailability in rat (dose 3 mg/kg i.v.),17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618775,50597,,1,10116.0,10766,In vivo,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618776,50597,,1,10116.0,10767,In vivo,,Oral bioavailability in rat (dose 60 mg/kg p.o.),17717,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618777,50597,,1,10116.0,10768,In vivo,,Percent bioavailability (F) in rats after iv administration,4722,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618778,50597,,1,10116.0,10769,In vivo,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,4722,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618779,50597,,1,10116.0,10770,In vivo,,Bioavailability in rat (dose 5 uM/kg p.o.),4353,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618780,50597,,1,10116.0,10771,In vivo,,Oral bioavailability,15662,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618781,50597,,1,10116.0,10772,In vivo,,Bioavailability in rat (dose 2 mg/kg p.o.),4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618782,50597,,1,10116.0,10773,In vivo,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618783,50597,,1,10116.0,10774,In vivo,,Oral bioavailability in rat (dose 20 mg/kg),3436,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618784,50597,,1,10116.0,10775,In vivo,,Oral bioavailability in rat,17800,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618785,50597,,1,10116.0,10776,In vivo,,Percent oral bioavailability evaluated in rat,15762,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618786,50597,,1,10116.0,10777,In vivo,,Oral bioavailability in rat,5089,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618787,50597,,1,10116.0,10778,In vivo,,Percent oral bioavailability in rat; Not determined,5089,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618788,50597,,1,10116.0,10779,In vivo,,Oral bioavailability in rat,3185,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618789,50597,,1,10116.0,10780,In vivo,,Bioavailability in rat,5145,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618790,50597,,1,10116.0,10781,In vivo,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),3457,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618791,50597,,1,10116.0,10782,In vivo,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),3457,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875843,50597,,1,10116.0,10783,In vivo,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,5983,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618792,50597,,1,10116.0,10784,In vivo,,Oral bioavailability in rat (dose 20 mg/kg p.o.),5739,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623395,50597,,1,10116.0,10785,In vivo,,Cmax at a dose of 30 mg/kg in rat,3579,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623396,22224,,0,314293.0,10786,In vivo,,Cmax in monkeys at a dose of 1 mg/kg,17788,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623397,50597,,1,10116.0,10787,In vivo,,Cmax in rat,14956,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623398,50597,,1,10116.0,10788,In vivo,,Cmax in rats at a dose of 1 mg/kg,17788,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623399,50594,,1,10090.0,10789,In vivo,,Cmax was measured in mice after an oral dose of 50 mg/kg.,9750,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623400,22224,,0,,10790,In vivo,,"Cmax value at a dose of 12.7 uM/kg, po",12767,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623401,22224,,0,,10791,In vivo,,"Cmax value at a dose of 6.3 uM/kg, iv",12767,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623402,22224,,0,,10792,In vivo,,"Cmax value at a dose of 7.1 uM/kg, iv",12767,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623403,22224,,0,,10793,In vivo,,Cmax value of compound was determined after 1 hr,12703,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623404,22224,,0,,10794,In vivo,,Cmax value of the compound,15778,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625997,50597,,1,10116.0,10795,In vivo,,Cmax value administered intraintestinal in rats.,12818,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625998,50597,,1,10116.0,10796,In vivo,,Cmax value administered perorally was determined in rat; Not determined,14964,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625999,22224,,0,,10797,In vivo,,Cmax value at the dose of 2.3 mg/kg,15808,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626000,22224,,0,,10798,In vivo,,Cmax value at the dose of 5 mg/kg,15808,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626001,22224,,0,,10799,In vivo,,Cmax value in the period of 8 hr after dosing. ,15778,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626002,22224,,0,,10800,In vivo,,Cmax value at a oral dose of 20 mg/kg; Not tested,3715,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626003,22224,,0,,10801,In vivo,,Cmax value at a oral dose of 20 mg/kg,3715,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626004,50597,,1,10116.0,10802,In vivo,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1446,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626005,50512,,1,10141.0,10803,In vivo,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626006,50597,,1,10116.0,10804,In vivo,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,15240,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626007,50597,,1,10116.0,10805,In vivo,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,14810,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626008,50594,,1,10090.0,10806,In vivo,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,14239,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626009,50588,,1,9615.0,10807,In vivo,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,12555,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626010,50588,,1,9615.0,10808,In vivo,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,10754,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626011,50594,,1,10090.0,10809,In vivo,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,10754,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626012,50594,,1,10090.0,10810,In vivo,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,10754,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626013,50594,,1,10090.0,10811,In vivo,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,10754,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626014,50594,,1,10090.0,10812,In vivo,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,10754,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL877496,50594,,1,10090.0,10813,In vivo,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,10754,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626015,50588,,1,9615.0,10814,In vivo,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,14600,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626016,50588,,1,9615.0,10815,In vivo,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,14600,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,F,,CHEMBL626017,50588,,1,9615.0,10816,In vivo,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,14600,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626018,50588,,1,9615.0,10817,In vivo,,Bioavailability as maximal plasma concentration in dogs,13543,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626692,50588,,1,9615.0,10818,In vivo,,Bioavailability as maximal plasma concentration in dogs,13543,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626693,50597,,1,10116.0,10819,In vivo,,Bioavailability as maximal plasma concentration in rats,13543,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626694,22224,,0,10116.0,10820,In vivo,,Bioavailability as maximal plasma concentration in rats,13543,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626695,50588,,1,9615.0,10821,In vivo,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626696,50588,,1,9615.0,10822,In vivo,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626697,50588,,1,9615.0,10823,In vivo,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626859,50588,,1,9615.0,10824,In vivo,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,14600,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626860,50588,,1,9615.0,10825,In vivo,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626861,50588,,1,9615.0,10826,In vivo,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626296,50597,,1,10116.0,10827,In vivo,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,14681,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626297,22224,,0,,10828,In vivo,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,15905,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626298,22224,,0,,10829,In vivo,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,15905,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626299,50597,,1,10116.0,10830,In vivo,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",13304,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626300,50597,,1,10116.0,10831,In vivo,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626301,50597,,1,10116.0,10832,In vivo,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626962,50597,,1,10116.0,10833,In vivo,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626963,50597,,1,10116.0,10834,In vivo,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626964,50597,,1,10116.0,10835,In vivo,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626965,100710,,1,9541.0,10836,In vivo,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,14839,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626966,50594,,1,10090.0,10837,In vivo,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626967,50594,,1,10090.0,10838,In vivo,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626968,100710,,1,9541.0,10839,In vivo,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,14839,Macaca fascicularis,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626969,50597,,1,10116.0,10840,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627126,50597,,1,10116.0,10841,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631276,50597,,1,10116.0,10842,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631277,50597,,1,10116.0,10843,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631278,50597,,1,10116.0,10844,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL874457,50597,,1,10116.0,10845,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631279,50597,,1,10116.0,10846,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631280,50597,,1,10116.0,10847,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631281,50597,,1,10116.0,10848,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631968,50597,,1,10116.0,10849,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631969,50597,,1,10116.0,10850,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631970,50597,,1,10116.0,10851,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631971,50597,,1,10116.0,10852,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL631972,50597,,1,10116.0,10853,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630435,50597,,1,10116.0,10854,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630436,50597,,1,10116.0,10855,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630437,50597,,1,10116.0,10856,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630438,50597,,1,10116.0,10857,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,8418,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630439,50597,,1,10116.0,10858,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630440,50597,,1,10116.0,10859,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630441,50597,,1,10116.0,10860,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630442,50597,,1,10116.0,10861,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625234,50597,,1,10116.0,10862,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625235,50597,,1,10116.0,10863,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625236,50597,,1,10116.0,10864,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625237,50597,,1,10116.0,10865,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626125,50597,,1,10116.0,10866,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626126,50597,,1,10116.0,10867,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626127,50597,,1,10116.0,10868,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626128,50597,,1,10116.0,10869,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626129,50597,,1,10116.0,10870,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626130,50597,,1,10116.0,10871,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626131,50597,,1,10116.0,10872,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626132,50597,,1,10116.0,10873,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626752,50597,,1,10116.0,10874,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626753,50597,,1,10116.0,10875,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626754,50597,,1,10116.0,10876,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,8418,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626755,50597,,1,10116.0,10877,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626756,50597,,1,10116.0,10878,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626757,50597,,1,10116.0,10879,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626758,50597,,1,10116.0,10880,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626759,50597,,1,10116.0,10881,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626760,50597,,1,10116.0,10882,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626394,50588,,1,9615.0,10883,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626395,50588,,1,9615.0,10884,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626396,50588,,1,9615.0,10885,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626397,50588,,1,9615.0,10886,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626398,50588,,1,9615.0,10887,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626399,50588,,1,9615.0,10888,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874653,50597,,1,10116.0,10889,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626400,50597,,1,10116.0,10890,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626401,50597,,1,10116.0,10891,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626402,50597,,1,10116.0,10892,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626403,50597,,1,10116.0,10893,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626404,50597,,1,10116.0,10894,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626405,50597,,1,10116.0,10895,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625529,50597,,1,10116.0,10896,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625530,50597,,1,10116.0,10897,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625531,50597,,1,10116.0,10898,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625532,50597,,1,10116.0,10899,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625533,50597,,1,10116.0,10900,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875474,50597,,1,10116.0,10901,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625534,50597,,1,10116.0,10902,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625535,50597,,1,10116.0,10903,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625536,50597,,1,10116.0,10904,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625537,50597,,1,10116.0,10905,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625538,50597,,1,10116.0,10906,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625539,50597,,1,10116.0,10907,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625540,50597,,1,10116.0,10908,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625541,50597,,1,10116.0,10909,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625542,50597,,1,10116.0,10910,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625543,50597,,1,10116.0,10911,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625544,50597,,1,10116.0,10912,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625545,50588,,1,9615.0,10913,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625546,50588,,1,9615.0,10914,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625547,50588,,1,9615.0,10915,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625548,50588,,1,9615.0,10916,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625549,50588,,1,9615.0,10917,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625550,50588,,1,9615.0,10918,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625551,50588,,1,9615.0,10919,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875475,50588,,1,9615.0,10920,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625552,50588,,1,9615.0,10921,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625553,50588,,1,9615.0,10922,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625554,50588,,1,9615.0,10923,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625555,50588,,1,9615.0,10924,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625556,50588,,1,9615.0,10925,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624986,50588,,1,9615.0,10926,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624987,50588,,1,9615.0,10927,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624988,50588,,1,9615.0,10928,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624989,50588,,1,9615.0,10929,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624990,50588,,1,9615.0,10930,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL874391,50588,,1,9615.0,10931,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624991,50588,,1,9615.0,10932,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624992,50588,,1,9615.0,10933,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624993,50588,,1,9615.0,10934,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624994,50588,,1,9615.0,10935,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624995,50588,,1,9615.0,10936,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624996,50588,,1,9615.0,10937,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624997,50588,,1,9615.0,10938,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624998,50588,,1,9615.0,10939,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624999,50588,,1,9615.0,10940,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL882955,50588,,1,9615.0,10941,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625000,50588,,1,9615.0,10942,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625001,50588,,1,9615.0,10943,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625089,50588,,1,9615.0,10944,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625090,50588,,1,9615.0,10945,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625091,50588,,1,9615.0,10946,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625092,50588,,1,9615.0,10947,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625093,50588,,1,9615.0,10948,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625094,50588,,1,9615.0,10949,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,9025,Canis lupus familiaris,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL625095,50588,,1,9615.0,10950,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625096,50588,,1,9615.0,10951,In vivo,,Compound was evaluated for its bioavailability in the dogs,2249,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625097,50597,,1,10116.0,10952,In vivo,,Compound was evaluated for its bioavailability in the rats,2249,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL882956,22224,,0,,10953,In vivo,,Compound was evaluated for oral bioavailability,17515,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625098,50597,,1,10116.0,10954,In vivo,,Compound was evaluated for percentage of Oral bioavailability in rats,14541,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625099,22224,,0,10141.0,10955,In vivo,,Bioavailability in guinea pig,12797,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625100,50597,,1,10116.0,10956,In vivo,,Compound was evaluated for the oral bioavailability in rat,12797,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625101,50588,,1,9615.0,10957,In vivo,,Compound was evaluated for the oral bioavailability in dog,12797,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874396,50597,,1,10116.0,10958,In vivo,,Compound was evaluated for the oral bioavailability in rat,12797,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL625102,22224,,0,9615.0,10959,In vivo,,Bioavailability in dog (dosed i.v.),11727,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625103,50588,,1,9615.0,10960,In vivo,,Compound was tested for in vivo bioavailability in dog,13249,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625104,100712,,1,10026.0,10961,In vivo,,Compound was tested for in vivo bioavailability in hamsters,13249,Cricetinae,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625105,22224,,0,314293.0,10962,In vivo,,Compound was tested for in vivo bioavailability in monkey,13249,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625106,50597,,1,10116.0,10963,In vivo,,Compound was tested for in vivo bioavailability in rat,13249,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625107,22224,,0,10090.0,10964,In vivo,,Oral bioavailability in mouse,9552,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625108,50594,,1,10090.0,10965,In vivo,,Compound was tested for percent of oral bioavailability in mice; 56-74,9552,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625109,22224,,0,10090.0,10966,In vivo,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),14839,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625110,22224,,0,9541.0,10967,In vivo,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),14839,Macaca fascicularis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625111,22224,,0,9541.0,10968,In vivo,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625112,50594,,1,10090.0,10969,In vivo,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875334,50594,,1,10090.0,10970,In vivo,,Oral bioavailability in nude mice,14839,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628617,22224,,0,9443.0,10971,In vivo,,Bioavailability in monkey (i.d. dosing),11219,Primates,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628618,22224,,0,10116.0,10972,In vivo,,Bioavailability in rat,9552,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628619,22224,,0,,10973,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,11732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628620,22224,,0,,10974,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,11732,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628621,100710,,1,9541.0,10975,In vivo,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628622,100710,,1,9541.0,10976,In vivo,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",14839,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628623,100710,,1,9541.0,10977,In vivo,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",14839,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628624,100710,,1,9541.0,10978,In vivo,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,14839,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628625,50594,,1,10090.0,10979,In vivo,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628626,100710,,1,9541.0,10980,In vivo,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,14839,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627041,50594,,1,10090.0,10981,In vivo,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627042,50594,,1,10090.0,10982,In vivo,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627043,50594,,1,10090.0,10983,In vivo,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL627044,22224,,0,,10984,In vivo,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,13932,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627045,50594,,1,10090.0,10985,In vivo,,Cmax in mouse plasma,11637,Mus musculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL627046,22224,,0,,10986,In vivo,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,11637,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627047,50597,,1,10116.0,10987,In vivo,,Maximal plasma concentration in rat,13960,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627048,50597,,1,10116.0,10988,In vivo,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,15905,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627049,50597,,1,10116.0,10989,In vivo,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627050,50597,,1,10116.0,10990,In vivo,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627051,50597,,1,10116.0,10991,In vivo,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627052,50597,,1,10116.0,10992,In vivo,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627053,50597,,1,10116.0,10993,In vivo,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627054,50597,,1,10116.0,10994,In vivo,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627055,50594,,1,10090.0,10995,In vivo,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627056,50594,,1,10090.0,10996,In vivo,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627057,50594,,1,10090.0,10997,In vivo,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627058,50594,,1,10090.0,10998,In vivo,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626211,50594,,1,10090.0,10999,In vivo,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626212,22224,,0,,11000,In vivo,,Maximum Concentration of the compound.,10291,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626213,50588,,1,9615.0,11001,In vivo,,Maximum Concentration was measured after iv administration into Beagle dog,14599,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626214,50588,,1,9615.0,11002,In vivo,,Maximum Concentration was measured after iv administration into Beagle dog.,14599,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626215,50588,,1,9615.0,11003,In vivo,,Maximum Concentration was measured after po administration into Beagle dog,14599,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626216,50588,,1,9615.0,11004,In vivo,,Maximum Concentration was measured after po administration into Beagle dog.,14599,Canis lupus familiaris,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626217,22224,,0,,11005,In vivo,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,12767,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626218,22224,,0,,11006,In vivo,,Maximum blood level reached after an iv dose of 12.2 uM/kg,12767,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626219,22224,,0,,11007,In vivo,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,12767,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626220,22224,,0,,11008,In vivo,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,12767,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626221,22224,,0,,11009,In vivo,,Maximum blood level reached after an oral dose of 5.0 mg/kg,12767,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626222,22224,,0,,11010,In vivo,,Maximum blood level reached at dose of 10.6 uM/kg orally,12767,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626223,50512,,1,10141.0,11011,In vivo,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,14706,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626224,50512,,1,10141.0,11012,In vivo,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,14706,Cavia porcellus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626225,50597,,1,10116.0,11013,In vivo,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626226,50597,,1,10116.0,11014,In vivo,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626227,50597,,1,10116.0,11015,In vivo,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,14793,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626228,50597,,1,10116.0,11016,In vivo,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626229,50597,,1,10116.0,11017,In vivo,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626921,50597,,1,10116.0,11018,In vivo,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876793,50597,,1,10116.0,11019,In vivo,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625309,50597,,1,10116.0,11020,In vivo,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625310,50278,,1,1423.0,11021,In vivo,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),10524,Bacillus subtilis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625311,22224,,0,314293.0,11022,In vivo,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,11871,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625312,50597,,1,10116.0,11023,In vivo,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,11871,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625313,22224,,0,,11024,In vivo,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,3437,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625314,50594,,1,10090.0,11025,In vivo,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,12038,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625315,50597,,1,10116.0,11026,In vivo,,Maximum concentration in male rats after iv administration of 20 mg/kg,12038,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625316,50597,,1,10116.0,11027,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625317,50597,,1,10116.0,11028,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625318,50597,,1,10116.0,11029,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625319,50597,,1,10116.0,11030,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625320,50597,,1,10116.0,11031,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625321,50597,,1,10116.0,11032,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625322,50597,,1,10116.0,11033,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL876801,50597,,1,10116.0,11034,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625323,50597,,1,10116.0,11035,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625324,50597,,1,10116.0,11036,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625325,50597,,1,10116.0,11037,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625326,50597,,1,10116.0,11038,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625327,50597,,1,10116.0,11039,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,8418,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625328,50597,,1,10116.0,11040,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625329,50597,,1,10116.0,11041,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625330,50597,,1,10116.0,11042,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627774,50597,,1,10116.0,11043,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627775,50597,,1,10116.0,11044,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627949,50597,,1,10116.0,11045,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627950,50597,,1,10116.0,11046,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627951,50597,,1,10116.0,11047,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627952,50597,,1,10116.0,11048,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627953,50597,,1,10116.0,11049,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627954,50597,,1,10116.0,11050,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627955,50597,,1,10116.0,11051,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627956,50597,,1,10116.0,11052,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL876802,50597,,1,10116.0,11053,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627957,50597,,1,10116.0,11054,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627958,50597,,1,10116.0,11055,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627959,50597,,1,10116.0,11056,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627960,50597,,1,10116.0,11057,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627961,50597,,1,10116.0,11058,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,8418,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627962,50597,,1,10116.0,11059,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627963,50597,,1,10116.0,11060,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624759,50597,,1,10116.0,11061,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624760,50597,,1,10116.0,11062,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624761,50597,,1,10116.0,11063,,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877607,50597,,1,10116.0,11064,,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624762,50597,,1,10116.0,11065,,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624763,50597,,1,10116.0,11066,,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624764,50597,,1,10116.0,11067,,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624765,50597,,1,10116.0,11068,,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624766,50597,,1,10116.0,11069,,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624767,50588,,1,9615.0,11070,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624768,50588,,1,9615.0,11071,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624769,50588,,1,9615.0,11072,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624770,50588,,1,9615.0,11073,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624771,50588,,1,9615.0,11074,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624772,50588,,1,9615.0,11075,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624773,50597,,1,10116.0,11076,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624774,50597,,1,10116.0,11077,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624775,50597,,1,10116.0,11078,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624776,50597,,1,10116.0,11079,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624777,50597,,1,10116.0,11080,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624778,50597,,1,10116.0,11081,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624779,50597,,1,10116.0,11082,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624780,50597,,1,10116.0,11083,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624781,50597,,1,10116.0,11084,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877608,50597,,1,10116.0,11085,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624782,50597,,1,10116.0,11086,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624783,50597,,1,10116.0,11087,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624784,50597,,1,10116.0,11088,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624785,50597,,1,10116.0,11089,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624786,50597,,1,10116.0,11090,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624787,50597,,1,10116.0,11091,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628676,50597,,1,10116.0,11092,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621842,50597,,1,10116.0,11093,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL621843,50597,,1,10116.0,11094,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623873,50597,,1,10116.0,11095,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623874,50597,,1,10116.0,11096,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623875,50597,,1,10116.0,11097,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623876,50597,,1,10116.0,11098,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623877,50588,,1,9615.0,11099,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623878,50588,,1,9615.0,11100,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623879,50588,,1,9615.0,11101,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623880,50588,,1,9615.0,11102,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623881,50588,,1,9615.0,11103,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623957,50588,,1,9615.0,11104,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623958,50588,,1,9615.0,11105,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623959,50588,,1,9615.0,11106,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623960,50588,,1,9615.0,11107,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623961,50588,,1,9615.0,11108,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623962,50588,,1,9615.0,11109,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624676,50588,,1,9615.0,11110,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624677,50588,,1,9615.0,11111,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624678,50588,,1,9615.0,11112,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624679,50588,,1,9615.0,11113,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624680,50588,,1,9615.0,11114,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624849,22224,,0,,11115,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,11732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624850,22224,,0,,11116,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,11732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL874399,22224,,0,,11117,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,11732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624851,22224,,0,,11118,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,11732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624852,22224,,0,,11119,In vivo,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,11732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624853,22224,,0,10116.0,11120,In vivo,,Oral bioavailability in rat (dose 10 mg/kg),13359,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624854,22224,,0,10116.0,11121,In vivo,,Oral bioavailability in rat (Sprague-Dawley),16618,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624855,22224,,0,10116.0,11122,In vivo,,Oral bioavailability in rat,13960,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624856,22224,,0,10116.0,11123,In vivo,,Oral bioavailability in rats was determined in vivo,13917,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL882957,22224,,0,9615.0,11124,In vivo,,Oral bioavailability in dog,14266,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624857,22224,,0,314293.0,11125,In vivo,,Oral bioavailability of compound in monkey,12359,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622202,50597,,1,10116.0,11126,In vivo,,Oral bioavailability of compound in rat,12359,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622203,22224,,0,10116.0,11127,In vivo,,Bioavailability in rat of PMEA prodrug,12359,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625522,50597,,1,10116.0,11128,In vivo,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,12359,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622868,22224,,0,9544.0,11129,In vivo,,Serum conc at 3 hours following 25 mg/kg dose,10791,Macaca mulatta,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL622869,22224,,0,9544.0,11130,In vivo,,Urine conc 0-5 hours following 25 mg/kg dose,10791,Macaca mulatta,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL622870,22224,,0,9544.0,11131,In vivo,,Urine conc 0-24 hours following 25 mg/kg dose,10791,Macaca mulatta,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622871,22224,,0,9534.0,11132,In vivo,,Oral bioavailability in African green monkeys; 20-25,138,Chlorocebus aethiops,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620560,100710,,1,9541.0,11133,In vivo,,Oral bioavailability in cynomolgus monkey.,14521,Macaca fascicularis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620561,22224,,0,9615.0,11134,In vivo,,Oral bioavailability in dog,13953,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620562,50588,,1,9615.0,11135,In vivo,,Oral bioavailability in dog at 10 mg/kg oral dose,12836,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620563,100712,,1,10026.0,11136,In vivo,,Oral bioavailability in hamster at 10 mg/kg oral dose,12836,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620564,50597,,1,10116.0,11137,In vivo,,Oral bioavailability in rat at 10 mg/kg oral dose,12836,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL872265,22224,,0,10116.0,11138,In vivo,,Oral bioavailability in rat,14521,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620565,22224,,0,10116.0,11139,In vivo,,Oral bioavailability in rat,13953,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620566,22224,,0,9347.0,11140,In vivo,,Oral bioavailability,6799,Eutheria,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620567,22224,,0,,11141,In vivo,,Oral bioavailability was determined; range 49-102%,11311,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620568,50588,,1,9615.0,11142,In vivo,,Oral bioavailability was determined in dogs,4013,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620569,22224,,0,10116.0,11143,In vivo,,Oral bioavailability in rat,4013,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620570,22224,,0,9347.0,11144,In vivo,,Oral bioavailability,17591,Eutheria,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620571,22224,,0,,11145,In vivo,,Oral bioavailability was determined; Not orally available,17591,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620572,50594,,1,10090.0,11146,In vivo,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),15011,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620573,22224,,0,10090.0,11147,In vivo,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),15011,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620574,22224,,0,10090.0,11148,In vivo,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,15011,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620575,22224,,0,9544.0,11149,In vivo,,Oral bioavailability in Rhesus monkey,9552,Macaca mulatta,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620576,22224,,0,9615.0,11150,In vivo,,Oral bioavailability in dog (female mongrel),9552,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875846,22224,,0,,11151,In vivo,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,3639,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620577,22224,,0,9615.0,11152,In vivo,,Oral bioavailability in dog,13397,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620578,22224,,0,,11153,In vivo,,Percentage Bioavailability was evaluated.,3031,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL620579,22224,,0,10116.0,11154,In vivo,,Bioavailability in rat administered i.d.,12818,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL621248,22224,,0,9347.0,11155,In vivo,,Bioavailability,4847,Eutheria,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625390,22224,,0,9615.0,11156,In vivo,,Bioavailability in dog (male Beagle) i.v. administration,12421,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625391,22224,,0,10116.0,11157,In vivo,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",11966,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL872266,22224,,0,9443.0,11158,In vivo,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),11218,Primates,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625392,22224,,0,10116.0,11159,In vivo,,Oral bioavailability in rat (Sprague-Dawley) (male),13129,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625393,50597,,1,10116.0,11160,In vivo,,The oral bioavailability was measured on rats after oral administration,12350,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625394,50597,,1,10116.0,11161,In vivo,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,2231,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625395,50797,,1,9544.0,11162,In vivo,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,2231,Macaca mulatta,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625396,22224,,0,10116.0,11163,In vivo,,Bioavailability in rat (dose 10 mg/kg i.d.),12187,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625397,22224,,0,9615.0,11164,In vivo,,Bioavailability in dog (male Beagle) i.v. administration,12421,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625398,50594,,1,10090.0,11165,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625399,50594,,1,10090.0,11166,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL626074,50594,,1,10090.0,11167,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626075,50594,,1,10090.0,11168,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626076,50597,,1,10116.0,11169,In vivo,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,2231,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626077,50797,,1,9544.0,11170,In vivo,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,2231,Macaca mulatta,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626078,50597,,1,10116.0,11171,In vivo,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),12178,Rattus norvegicus,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL625846,22224,,0,,11172,In vivo,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),12178,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL625847,22224,,0,,11173,In vivo,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),12178,,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL625848,50597,,1,10116.0,11174,In vivo,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,15633,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625849,50597,,1,10116.0,11175,In vivo,,Maximum concentration of compound in plasma administered orally to rats,14258,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626023,50588,,1,9615.0,11176,In vivo,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",14224,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626024,50588,,1,9615.0,11177,In vivo,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",14224,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626025,50588,,1,9615.0,11178,In vivo,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",14224,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626026,22224,,0,,11179,In vivo,,Maximum concentration after 10 mg/kg by oral administration,5566,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626027,22224,,0,,11180,In vivo,,Maximum concentration at a dose of 1.5 mg/kg,16935,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626028,22224,,0,,11181,In vivo,,Maximum concentration at a dose of 2.0 mg/kg,16935,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626029,50588,,1,9615.0,11182,In vivo,,Maximum concentration in dog plasma,14224,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626030,22224,,0,,11183,In vivo,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,12536,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626031,22224,,0,,11184,In vivo,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,12536,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626032,22224,,0,,11185,In vivo,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,12536,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626033,22224,,0,,11186,In vivo,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,12536,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626034,22224,,0,,11187,In vivo,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,12536,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626035,50588,,1,9615.0,11188,In vivo,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),9994,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626036,22224,,0,,11189,In vivo,,Maximum concentration in plasma at Tmax,1434,,,,1
N,,,1969.0,BAO_0000218,Expert,,A,Plasma,CHEMBL626037,50588,,1,9615.0,11190,In vivo,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,12836,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626038,100712,,1,10026.0,11191,In vivo,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,12836,Cricetinae,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626039,50597,,1,10116.0,11192,In vivo,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,12836,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626040,50597,,1,10116.0,11193,In vivo,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,12545,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626041,50592,,1,9986.0,11194,In vivo,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,13856,Oryctolagus cuniculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626042,22224,,0,,11195,In vivo,,Maximum concentration was calculated,3550,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626043,22224,,0,,11196,In vivo,,Maximum concentration was calculated.,2632,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626044,22224,,0,,11197,In vivo,,Maximum concentration at a peroral dose of 10 mg/kg,5566,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626045,22224,,0,,11198,In vivo,,Maximum concentration of the drug at 10 uM/dg administered perorally,11883,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626046,22224,,0,,11199,In vivo,,Maximum concentration of the drug at 2 uM/dg administered intravenously,11883,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626047,50588,,1,9615.0,11200,In vivo,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",14122,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626048,100712,,1,10026.0,11201,In vivo,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",14122,Cricetinae,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626049,50597,,1,10116.0,11202,In vivo,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",14122,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626050,50597,,1,10116.0,11203,In vivo,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,12542,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL874541,50588,,1,9615.0,11204,In vivo,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,12542,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622826,100712,,1,10026.0,11205,In vivo,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,12542,Cricetinae,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622827,100712,,1,10026.0,11206,In vivo,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,12542,Cricetinae,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622828,50597,,1,10116.0,11207,In vivo,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,12542,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622829,50597,,1,10116.0,11208,In vivo,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,14080,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876806,50597,,1,10116.0,11209,In vivo,,Maximum concentration reached following intravenous administration in male rat,11911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622830,50588,,1,9615.0,11210,In vivo,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,13204,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622831,50597,,1,10116.0,11211,In vivo,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,13204,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626794,50588,,1,9615.0,11212,In vivo,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,14346,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626795,50597,,1,10116.0,11213,In vivo,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626796,50597,,1,10116.0,11214,In vivo,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626797,50597,,1,10116.0,11215,In vivo,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626798,50597,,1,10116.0,11216,In vivo,,Maximum drug concentration is determined after oral dosing in rats.,14127,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626799,50588,,1,9615.0,11217,In vivo,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,14339,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626800,50588,,1,9615.0,11218,In vivo,,Maximum observed concentration in oral (5 mg/kg) fed dogs,14339,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626801,22224,,0,,11219,In vivo,,Maximum plasma concentration,13494,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876816,50597,,1,10116.0,11220,In vivo,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,14925,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626802,50597,,1,10116.0,11221,In vivo,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,14474,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626803,50588,,1,9615.0,11222,In vivo,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,14474,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626804,22224,,0,,11223,In vivo,,Maximum plasma concentration following oral administration of 30 umol/kg,13917,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626805,50597,,1,10116.0,11224,,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,9796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626309,50597,,1,10116.0,11225,,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626310,50597,,1,10116.0,11226,,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626311,50597,,1,10116.0,11227,,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626312,50597,,1,10116.0,11228,,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626313,50597,,1,10116.0,11229,,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626314,50597,,1,10116.0,11230,,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626315,50597,,1,10116.0,11231,,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626316,50597,,1,10116.0,11232,,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626317,50597,,1,10116.0,11233,,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626318,50597,,1,10116.0,11234,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626319,50597,,1,10116.0,11235,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626320,50597,,1,10116.0,11236,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875053,50597,,1,10116.0,11237,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626321,50597,,1,10116.0,11238,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626322,50597,,1,10116.0,11239,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626323,50597,,1,10116.0,11240,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626324,50597,,1,10116.0,11241,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626325,50597,,1,10116.0,11242,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626326,50597,,1,10116.0,11243,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626327,50597,,1,10116.0,11244,,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626328,50597,,1,10116.0,11245,,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626329,50597,,1,10116.0,11246,,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626330,50597,,1,10116.0,11247,,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626331,50597,,1,10116.0,11248,,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626332,50597,,1,10116.0,11249,,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626333,50597,,1,10116.0,11250,,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626334,50597,,1,10116.0,11251,,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626335,50597,,1,10116.0,11252,,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624798,50597,,1,10116.0,11253,,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624799,50597,,1,10116.0,11254,,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624800,50597,,1,10116.0,11255,,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624801,50597,,1,10116.0,11256,,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624802,50597,,1,10116.0,11257,,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624803,50597,,1,10116.0,11258,,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624804,50597,,1,10116.0,11259,,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624805,50597,,1,10116.0,11260,,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL624806,50597,,1,10116.0,11261,,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624807,50597,,1,10116.0,11262,,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624808,50597,,1,10116.0,11263,,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624809,50597,,1,10116.0,11264,,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624810,50597,,1,10116.0,11265,,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877618,50597,,1,10116.0,11266,,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624811,50597,,1,10116.0,11267,,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624812,50597,,1,10116.0,11268,,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624813,50597,,1,10116.0,11269,,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624814,50597,,1,10116.0,11270,,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624815,50597,,1,10116.0,11271,,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624816,50597,,1,10116.0,11272,,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624817,50597,,1,10116.0,11273,,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624818,50588,,1,9615.0,11274,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624819,50588,,1,9615.0,11275,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624820,50588,,1,9615.0,11276,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624821,50588,,1,9615.0,11277,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624822,50588,,1,9615.0,11278,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624823,50588,,1,9615.0,11279,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624824,50212,,1,562.0,11280,,,Observed diffusion coefficient in organic solvent for Escherichia coli,15599,Escherichia coli,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624825,50597,,1,10116.0,11281,,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624826,50597,,1,10116.0,11282,,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,2081.0,BAO_0000218,Intermediate,,A,Cardiac atrium,CHEMBL876817,50597,,1,10116.0,11283,,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,2081.0,BAO_0000218,Intermediate,,A,Cardiac atrium,CHEMBL624827,50597,,1,10116.0,11284,,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624828,50597,,1,10116.0,11285,,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624829,50597,,1,10116.0,11286,,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624830,50597,,1,10116.0,11287,,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624831,50597,,1,10116.0,11288,,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,2081.0,BAO_0000218,Intermediate,,A,Cardiac atrium,CHEMBL624832,50597,,1,10116.0,11289,,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,2081.0,BAO_0000218,Intermediate,,A,Cardiac atrium,CHEMBL624833,50597,,1,10116.0,11290,,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624834,50597,,1,10116.0,11291,,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624835,50597,,1,10116.0,11292,,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624836,50597,,1,10116.0,11293,,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624837,50597,,1,10116.0,11294,,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624838,50597,,1,10116.0,11295,,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622188,50597,,1,10116.0,11296,,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622189,50597,,1,10116.0,11297,,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622190,50597,,1,10116.0,11298,,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,9071,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625170,50597,,1,10116.0,11299,,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625171,50597,,1,10116.0,11300,,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625172,50597,,1,10116.0,11301,,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625173,50597,,1,10116.0,11302,,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625174,50597,,1,10116.0,11303,,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625175,50597,,1,10116.0,11304,,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625176,50597,,1,10116.0,11305,,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,9071,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625177,50597,,1,10116.0,11306,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625178,50597,,1,10116.0,11307,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625179,50597,,1,10116.0,11308,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,9071,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625180,50597,,1,10116.0,11309,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625181,22224,,0,,11310,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",10677,,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625182,50594,,1,10090.0,11311,,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,9750,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625183,50597,,1,10116.0,11312,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875848,50597,,1,10116.0,11313,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622260,50597,,1,10116.0,11314,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622261,50597,,1,10116.0,11315,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622262,50597,,1,10116.0,11316,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622263,50597,,1,10116.0,11317,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622418,50597,,1,10116.0,11318,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622419,50597,,1,10116.0,11319,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623388,50594,,1,10090.0,11320,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623389,50594,,1,10090.0,11321,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623390,50594,,1,10090.0,11322,In vivo,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623391,50594,,1,10090.0,11323,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623392,50594,,1,10090.0,11324,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL623393,50594,,1,10090.0,11325,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623394,50594,,1,10090.0,11326,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618885,50594,,1,10090.0,11327,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618886,50594,,1,10090.0,11328,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618887,50594,,1,10090.0,11329,In vivo,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619535,50594,,1,10090.0,11330,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL619536,50594,,1,10090.0,11331,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL619537,50594,,1,10090.0,11332,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619705,50594,,1,10090.0,11333,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619706,50594,,1,10090.0,11334,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL619707,50594,,1,10090.0,11335,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL619708,50594,,1,10090.0,11336,In vivo,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625219,50594,,1,10090.0,11337,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625220,50594,,1,10090.0,11338,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL625221,50594,,1,10090.0,11339,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625222,50594,,1,10090.0,11340,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625223,50594,,1,10090.0,11341,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625224,50594,,1,10090.0,11342,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625225,50594,,1,10090.0,11343,In vivo,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625226,50597,,1,10116.0,11344,In vivo,,Biodistribution in Rat blood after 24 hours of iv administration,8829,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625227,50597,,1,10116.0,11345,In vivo,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625228,50597,,1,10116.0,11346,In vivo,,Biodistribution in Rat blood after 30 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL875354,50597,,1,10116.0,11347,In vivo,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625229,50597,,1,10116.0,11348,In vivo,,Biodistribution in Rat blood after 5 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625230,50597,,1,10116.0,11349,In vivo,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625231,50597,,1,10116.0,11350,In vivo,,Biodistribution in Rat heart after 24 hours of iv administration,8829,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625900,50597,,1,10116.0,11351,In vivo,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625901,50597,,1,10116.0,11352,In vivo,,Biodistribution in Rat heart after 30 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625902,50597,,1,10116.0,11353,In vivo,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625903,50597,,1,10116.0,11354,In vivo,,Biodistribution in Rat heart after 5 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625904,50597,,1,10116.0,11355,In vivo,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625905,50597,,1,10116.0,11356,In vivo,,Biodistribution in Rat liver after 24 hours of iv administration,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627861,50597,,1,10116.0,11357,In vivo,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627862,50597,,1,10116.0,11358,In vivo,,Biodistribution in Rat liver after 30 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627863,50597,,1,10116.0,11359,In vivo,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627769,50597,,1,10116.0,11360,In vivo,,Biodistribution in Rat liver after 30 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627770,50588,,1,9615.0,11361,In vivo,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13249,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627771,100710,,1,9541.0,11362,In vivo,,Cmax in cynomolgus monkey (PO dose),13622,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627772,50597,,1,10116.0,11363,In vivo,,Cmax in rat (PO dose),13622,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627773,50597,,1,10116.0,11364,In vivo,,Cmax in rat (PO dose),13622,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621922,50597,,1,10116.0,11365,In vivo,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,13494,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621923,50597,,1,10116.0,11366,In vivo,,Cmax in rat plasma after oral dose (10 mg/kg),12170,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621924,22224,,0,,11367,In vivo,,Cmax in plasma after oral dose (10 mg/kg),12170,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621925,50588,,1,9615.0,11368,In vivo,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,17025,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621926,22224,,0,314293.0,11369,In vivo,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,17025,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621927,50592,,1,9986.0,11370,In vivo,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,17025,Oryctolagus cuniculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621928,50597,,1,10116.0,11371,In vivo,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,17025,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621929,50597,,1,10116.0,11372,In vivo,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,14187,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621930,50594,,1,10090.0,11373,In vivo,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,14816,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621931,50597,,1,10116.0,11374,In vivo,,Maximum plasma concentration after oral dosing in rat,17820,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621932,22224,,0,,11375,In vivo,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621933,22224,,0,,11376,In vivo,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,14380,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621934,50588,,1,9615.0,11377,In vivo,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,14691,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621935,50588,,1,9615.0,11378,In vivo,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,14691,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL621936,50597,,1,10116.0,11379,In vivo,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,13375,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621937,22224,,0,,11380,In vivo,,Maximum plasma concentration was determined,6236,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621938,22224,,0,,11381,In vivo,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621939,22224,,0,,11382,In vivo,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621940,22224,,0,,11383,In vivo,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621941,22224,,0,,11384,In vivo,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL621942,22224,,0,,11385,In vivo,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626178,22224,,0,,11386,In vivo,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626179,22224,,0,,11387,In vivo,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626180,22224,,0,,11388,In vivo,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,14380,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626181,50597,,1,10116.0,11389,In vivo,,Plasma Cmax in rat (PO dose),13622,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626182,50597,,1,10116.0,11390,In vivo,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626183,50597,,1,10116.0,11391,In vivo,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626184,50597,,1,10116.0,11392,In vivo,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626185,50597,,1,10116.0,11393,In vivo,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626186,50588,,1,9615.0,11394,In vivo,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,14925,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL877589,50588,,1,9615.0,11395,In vivo,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,14925,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626187,22224,,0,,11396,In vivo,,Maximum concentration of the drug at 1 uM/dg administered intravenously,11883,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626188,22224,,0,,11397,In vivo,,Maximum concentration of the drug at 20 uM/dg administered perorally,11883,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626189,22224,,0,,11398,In vivo,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,13391,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL626855,22224,,0,,11399,In vivo,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL623781,22224,,0,,11400,In vivo,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,13391,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL623782,22224,,0,,11401,In vivo,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623783,50597,,1,10116.0,11402,In vivo,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,16360,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623784,50588,,1,9615.0,11403,In vivo,,Cmax in dog plasma after 1mg/kg oral dose,3673,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623785,50588,,1,9615.0,11404,In vivo,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,14431,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623786,50597,,1,10116.0,11405,In vivo,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,14431,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623787,50597,,1,10116.0,11406,In vivo,,Oral maximum concentration in rat,14964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623788,50597,,1,10116.0,11407,In vivo,,Oral maximum concentration in rat,14964,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623789,50594,,1,10090.0,11408,In vivo,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,14209,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623790,50594,,1,10090.0,11409,In vivo,,Peak concentration in blood after intravenous administration to mice,11355,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623791,50594,,1,10090.0,11410,In vivo,,Peak concentration in blood after peroral administration to mice,11355,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623792,50597,,1,10116.0,11411,In vivo,,Peak concentration in rat plasma was determined,11966,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623793,22224,,0,314293.0,11412,In vivo,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,8918,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623794,50594,,1,10090.0,11413,In vivo,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,8918,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623795,50597,,1,10116.0,11414,In vivo,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,8918,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623796,50597,,1,10116.0,11415,,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623797,50597,,1,10116.0,11416,,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623798,50597,,1,10116.0,11417,,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623799,50597,,1,10116.0,11418,,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624490,50597,,1,10116.0,11419,,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624491,50597,,1,10116.0,11420,,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624492,50597,,1,10116.0,11421,,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624493,50597,,1,10116.0,11422,,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL877595,50597,,1,10116.0,11423,,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624494,50597,,1,10116.0,11424,,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624495,50597,,1,10116.0,11425,,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624681,50597,,1,10116.0,11426,,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624682,50597,,1,10116.0,11427,,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624683,50597,,1,10116.0,11428,,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624684,50597,,1,10116.0,11429,,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624685,50597,,1,10116.0,11430,,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624686,50597,,1,10116.0,11431,,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624687,50597,,1,10116.0,11432,,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624688,50597,,1,10116.0,11433,,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627161,50597,,1,10116.0,11434,,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622127,50597,,1,10116.0,11435,,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622128,50597,,1,10116.0,11436,,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874384,50597,,1,10116.0,11437,,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624898,50597,,1,10116.0,11438,,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624899,50597,,1,10116.0,11439,,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624900,50597,,1,10116.0,11440,,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624901,50597,,1,10116.0,11441,,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624902,50597,,1,10116.0,11442,,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624903,50597,,1,10116.0,11443,,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624904,50597,,1,10116.0,11444,,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624905,50597,,1,10116.0,11445,,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624906,50597,,1,10116.0,11446,,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624907,50597,,1,10116.0,11447,,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624908,50597,,1,10116.0,11448,,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624909,50597,,1,10116.0,11449,,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624910,50597,,1,10116.0,11450,,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624911,50597,,1,10116.0,11451,,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL874388,50597,,1,10116.0,11452,,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624912,50597,,1,10116.0,11453,,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622930,50597,,1,10116.0,11454,,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623121,50597,,1,10116.0,11455,,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623122,50597,,1,10116.0,11456,,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623123,50597,,1,10116.0,11457,,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623124,50597,,1,10116.0,11458,,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623125,50597,,1,10116.0,11459,,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623126,50597,,1,10116.0,11460,,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623127,50597,,1,10116.0,11461,,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623128,50597,,1,10116.0,11462,,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623129,50597,,1,10116.0,11463,,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623130,50597,,1,10116.0,11464,,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623131,50597,,1,10116.0,11465,,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623132,50597,,1,10116.0,11466,,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623133,50597,,1,10116.0,11467,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623134,50597,,1,10116.0,11468,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874389,50597,,1,10116.0,11469,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623135,50597,,1,10116.0,11470,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623136,50597,,1,10116.0,11471,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623137,50597,,1,10116.0,11472,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623138,50597,,1,10116.0,11473,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623139,50597,,1,10116.0,11474,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623140,50597,,1,10116.0,11475,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623141,50597,,1,10116.0,11476,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623142,50597,,1,10116.0,11477,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623143,50597,,1,10116.0,11478,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623144,50594,,1,10090.0,11479,,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,14571,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623405,50597,,1,10116.0,11480,,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,14571,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624074,50597,,1,10116.0,11481,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624075,50597,,1,10116.0,11482,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624076,50597,,1,10116.0,11483,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624077,50597,,1,10116.0,11484,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624078,50597,,1,10116.0,11485,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624079,50597,,1,10116.0,11486,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624261,50597,,1,10116.0,11487,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624262,50597,,1,10116.0,11488,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624263,50597,,1,10116.0,11489,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624264,50597,,1,10116.0,11490,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624265,50597,,1,10116.0,11491,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624266,50597,,1,10116.0,11492,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624267,50597,,1,10116.0,11493,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624268,50597,,1,10116.0,11494,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875227,50597,,1,10116.0,11495,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624269,50597,,1,10116.0,11496,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624270,50597,,1,10116.0,11497,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624271,50597,,1,10116.0,11498,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624272,50597,,1,10116.0,11499,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624273,50597,,1,10116.0,11500,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624274,50597,,1,10116.0,11501,,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624275,50597,,1,10116.0,11502,,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624276,50597,,1,10116.0,11503,,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624277,50597,,1,10116.0,11504,,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,12038,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624278,22224,,0,,11505,,,% dose converted to 2-amino-5-chlorophenyl sulfate,14314,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624279,22224,,0,,11506,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),14314,,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL624280,50597,,1,10116.0,11507,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL624281,50597,,1,10116.0,11508,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL622933,50597,,1,10116.0,11509,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL622934,50597,,1,10116.0,11510,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622935,50597,,1,10116.0,11511,In vivo,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622936,50597,,1,10116.0,11512,In vivo,,Biodistribution in Rat liver after 5 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL875228,50597,,1,10116.0,11513,In vivo,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622937,50597,,1,10116.0,11514,In vivo,,Biodistribution in Rat lung after 24 hours of iv administration,8829,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622938,50597,,1,10116.0,11515,In vivo,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL619736,50597,,1,10116.0,11516,In vivo,,Biodistribution in Rat lung after 30 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625117,50597,,1,10116.0,11517,In vivo,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625118,50597,,1,10116.0,11518,In vivo,,Biodistribution in Rat lung after 5 minutes of iv administration,8829,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625119,50597,,1,10116.0,11519,In vivo,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL625120,50597,,1,10116.0,11520,In vivo,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",14972,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625121,50597,,1,10116.0,11521,In vivo,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",14972,Rattus norvegicus,,,1
N,,,10000006.0,BAO_0000218,Intermediate,,A,Thalamus,CHEMBL625122,50597,,1,10116.0,11522,In vivo,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",14972,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL622204,50597,,1,10116.0,11523,In vivo,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL877503,50597,,1,10116.0,11524,In vivo,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627127,50597,,1,10116.0,11525,In vivo,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
U,,,10000000.0,BAO_0000218,Autocuration,,A,Hippocampus,CHEMBL627128,22224,,0,,11526,In vivo,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,,,,1
U,,,10000000.0,BAO_0000218,Autocuration,,A,Hippocampus,CHEMBL627129,22224,,0,,11527,In vivo,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,,,,1
U,,,10000000.0,BAO_0000218,Autocuration,,A,Hippocampus,CHEMBL627130,22224,,0,,11528,In vivo,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627131,50597,,1,10116.0,11529,In vivo,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627132,50597,,1,10116.0,11530,In vivo,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL627133,50597,,1,10116.0,11531,In vivo,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL627134,50597,,1,10116.0,11532,In vivo,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL627135,50597,,1,10116.0,11533,In vivo,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL627136,50597,,1,10116.0,11534,In vivo,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628435,50597,,1,10116.0,11535,In vivo,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628436,50597,,1,10116.0,11536,In vivo,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628437,50597,,1,10116.0,11537,In vivo,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL628438,50597,,1,10116.0,11538,In vivo,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL628439,50597,,1,10116.0,11539,In vivo,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL628440,50597,,1,10116.0,11540,In vivo,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL628441,50597,,1,10116.0,11541,In vivo,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL628442,50597,,1,10116.0,11542,In vivo,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL628443,50597,,1,10116.0,11543,In vivo,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628444,50597,,1,10116.0,11544,In vivo,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628445,50597,,1,10116.0,11545,In vivo,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL877504,50597,,1,10116.0,11546,In vivo,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628446,50597,,1,10116.0,11547,In vivo,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626874,50597,,1,10116.0,11548,In vivo,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626875,50597,,1,10116.0,11549,In vivo,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626876,50597,,1,10116.0,11550,In vivo,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626877,50597,,1,10116.0,11551,In vivo,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626878,50597,,1,10116.0,11552,In vivo,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL626879,50597,,1,10116.0,11553,In vivo,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626880,22224,,0,314293.0,11554,In vivo,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,8918,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626881,50594,,1,10090.0,11555,In vivo,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,8918,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626882,50597,,1,10116.0,11556,In vivo,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,8918,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626883,50588,,1,9615.0,11557,In vivo,,Peak plasma concentration was measured in dogs,14470,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626884,50597,,1,10116.0,11558,In vivo,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626885,50597,,1,10116.0,11559,In vivo,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,14886,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626886,50597,,1,10116.0,11560,In vivo,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,14886,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626887,50597,,1,10116.0,11561,In vivo,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,14886,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626888,50597,,1,10116.0,11562,In vivo,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626889,50588,,1,9615.0,11563,In vivo,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,13465,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626761,22224,,0,314293.0,11564,In vivo,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,13465,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626762,50588,,1,9615.0,11565,In vivo,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,13465,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626763,50588,,1,9615.0,11566,In vivo,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,13465,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626764,50597,,1,10116.0,11567,In vivo,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,13465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626765,50597,,1,10116.0,11568,In vivo,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,13465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626766,50588,,1,9615.0,11569,In vivo,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,13465,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626767,50597,,1,10116.0,11570,In vivo,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,13465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626768,50597,,1,10116.0,11571,In vivo,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,13465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626769,50588,,1,9615.0,11572,In vivo,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,13465,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874463,50588,,1,9615.0,11573,In vivo,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,13465,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626770,22224,,0,314293.0,11574,In vivo,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,13465,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626771,22224,,0,314293.0,11575,In vivo,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,13465,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626772,50597,,1,10116.0,11576,In vivo,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,13465,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626773,100710,,1,9541.0,11577,In vivo,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,14731,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626774,50594,,1,10090.0,11578,In vivo,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,14731,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626775,50588,,1,9615.0,11579,In vivo,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,13376,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626776,50588,,1,9615.0,11580,In vivo,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,13376,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626777,50597,,1,10116.0,11581,In vivo,,Maximum concentration (Cmax) in rat when administered orally,14443,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626778,22224,,0,314293.0,11582,In vivo,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,13465,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626779,22224,,0,10116.0,11583,In vivo,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",16359,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626780,22224,,0,10116.0,11584,In vivo,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",16359,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626781,22224,,0,,11585,In vivo,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,15618,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632164,50597,,1,10116.0,11586,In vivo,,Pharmacokinetic profile Cmax was evaluated in rats,14554,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632165,50588,,1,9615.0,11587,In vivo,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),11537,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632166,50594,,1,10090.0,11588,In vivo,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),11537,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632167,50588,,1,9615.0,11589,In vivo,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),11537,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632168,50594,,1,10090.0,11590,In vivo,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),11537,Mus musculus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL632169,22224,,0,10116.0,11591,In vivo,,Cmax in rat plasma,2021,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632170,50588,,1,9615.0,11592,In vivo,,Cmax in dog plasma after 30mg/kg oral dose,5932,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632171,50597,,1,10116.0,11593,In vivo,,Cmax in rat plasma after 30mg/kg oral dose,5932,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632172,50597,,1,10116.0,11594,In vivo,,Plasma level in rats at 30 mg/kg,17320,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632173,50594,,1,10090.0,11595,In vivo,,Tested for maximum plasma concentration in mice,15831,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632174,50597,,1,10116.0,11596,In vivo,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632175,50597,,1,10116.0,11597,In vivo,,The Cmax values in female wistar rats.,14941,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632176,50588,,1,9615.0,11598,In vivo,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,15343,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632177,50597,,1,10116.0,11599,In vivo,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,15343,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632178,50597,,1,10116.0,11600,In vivo,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,14856,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632179,50597,,1,10116.0,11601,In vivo,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,13129,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632180,50597,,1,10116.0,11602,In vivo,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,13098,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632181,50597,,1,10116.0,11603,In vivo,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,13098,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632182,50597,,1,10116.0,11604,In vivo,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,13098,Rattus norvegicus,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL632183,22224,,0,10090.0,11605,In vivo,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,15478,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632184,50588,,1,9615.0,11606,In vivo,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,15341,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874470,50597,,1,10116.0,11607,In vivo,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,15341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631302,50597,,1,10116.0,11608,,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631303,50597,,1,10116.0,11609,,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631304,50597,,1,10116.0,11610,,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631305,50597,,1,10116.0,11611,,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631306,50597,,1,10116.0,11612,,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631307,50597,,1,10116.0,11613,,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631308,50597,,1,10116.0,11614,,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625557,50597,,1,10116.0,11615,,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625558,50597,,1,10116.0,11616,,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625559,50597,,1,10116.0,11617,,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625560,50597,,1,10116.0,11618,,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625561,50597,,1,10116.0,11619,,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625562,50597,,1,10116.0,11620,,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL875320,50597,,1,10116.0,11621,,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625563,50597,,1,10116.0,11622,,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625564,50597,,1,10116.0,11623,,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL625565,50597,,1,10116.0,11624,,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL625566,50597,,1,10116.0,11625,,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL625567,50597,,1,10116.0,11626,,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL625568,50597,,1,10116.0,11627,,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL628217,50597,,1,10116.0,11628,,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL628218,50597,,1,10116.0,11629,,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL628219,50597,,1,10116.0,11630,,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL628220,50597,,1,10116.0,11631,,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628221,22224,,0,,11632,,,Distribution in the blood after 120 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628222,22224,,0,,11633,,,Distribution in the blood after 15 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628223,22224,,0,,11634,,,Distribution in the blood after 30 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628224,22224,,0,,11635,,,Distribution in the blood after 5 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628225,22224,,0,,11636,,,Distribution in the blood after 60 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628226,22224,,0,,11637,,,Distribution in the blood after 90 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628227,22224,,0,,11638,,,Distribution in the bone after 120 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875481,22224,,0,,11639,,,Distribution in the bone after 15 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628228,22224,,0,,11640,,,Distribution in the bone after 30 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628229,22224,,0,,11641,,,Distribution in the bone after 5 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628230,22224,,0,,11642,,,Distribution in the bone after 60 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628231,22224,,0,,11643,,,Distribution in the bone after 90 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628232,22224,,0,,11644,,,Distribution in the heart after 120 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628233,22224,,0,,11645,,,Distribution in the heart after 15 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628234,22224,,0,,11646,,,Distribution in the heart after 30 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628235,22224,,0,,11647,,,Distribution in the heart after 5 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628236,22224,,0,,11648,,,Distribution in the heart after 60 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628237,22224,,0,,11649,,,Distribution in the heart after 90 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628238,22224,,0,,11650,,,Distribution in the kidneys after 120 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628239,22224,,0,,11651,,,Distribution in the kidneys after 15 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628240,22224,,0,,11652,,,Distribution in the kidneys after 30 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628241,22224,,0,,11653,,,Distribution in the kidneys after 5 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628242,22224,,0,,11654,,,Distribution in the kidneys after 60 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875482,22224,,0,,11655,,,Distribution in the kidneys after 90 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628243,22224,,0,,11656,,,Distribution in the liver after 120 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628244,22224,,0,,11657,,,Distribution in the liver after 15 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628245,22224,,0,,11658,,,Distribution in the liver after 30 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628246,22224,,0,,11659,,,Distribution in the liver after 5 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628247,22224,,0,,11660,,,Distribution in the liver after 60 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628248,22224,,0,,11661,,,Distribution in the liver after 90 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628249,22224,,0,,11662,,,Distribution in the lung after 120 min of intravenous administration,8926,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625452,50594,,1,10090.0,11663,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625453,50594,,1,10090.0,11664,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625454,50594,,1,10090.0,11665,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623844,50594,,1,10090.0,11666,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",14839,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623845,50597,,1,10116.0,11667,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,12178,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623846,50597,,1,10116.0,11668,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,12178,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623847,22224,,0,,11669,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,12178,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623848,100710,,1,9541.0,11670,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623849,100710,,1,9541.0,11671,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12186,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623850,100710,,1,9541.0,11672,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623851,100710,,1,9541.0,11673,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12186,Macaca fascicularis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623852,22224,,0,314293.0,11674,,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624551,50506,,1,9669.0,11675,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12187,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624552,50506,,1,9669.0,11676,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12187,Mustela putorius furo,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624553,22224,,0,314293.0,11677,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624554,22224,,0,314293.0,11678,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,12187,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624555,50597,,1,10116.0,11679,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12187,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624741,50597,,1,10116.0,11680,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12187,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624742,50588,,1,9615.0,11681,,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",14122,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624743,100712,,1,10026.0,11682,,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",14122,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877606,50597,,1,10116.0,11683,,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",14122,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624744,22224,,0,,11684,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,13391,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL624745,22224,,0,,11685,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL624746,22224,,0,,11686,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,13391,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL624747,22224,,0,,11687,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624748,22224,,0,,11688,,,Oral absorption expressed as Area under curve was determined,16360,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622504,50588,,1,9615.0,11689,,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,3673,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622505,50588,,1,9615.0,11690,,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",14122,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622506,100712,,1,10026.0,11691,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",14122,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622507,100712,,1,10026.0,11692,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",14122,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622508,50597,,1,10116.0,11693,,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",14122,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622509,22224,,0,,11694,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,13889,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622510,50597,,1,10116.0,11695,,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622511,50597,,1,10116.0,11696,,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),17279,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622512,100710,,1,9541.0,11697,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,14548,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622513,100710,,1,9541.0,11698,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,14548,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622514,100710,,1,9541.0,11699,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,14548,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622515,50588,,1,9615.0,11700,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,14548,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622516,50588,,1,9615.0,11701,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,14548,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622517,50597,,1,10116.0,11702,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,14548,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622518,50597,,1,10116.0,11703,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,14548,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622519,50597,,1,10116.0,11704,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,14548,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622520,50597,,1,10116.0,11705,In vivo,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622521,50597,,1,10116.0,11706,In vivo,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL625113,50594,,1,10090.0,11707,In vivo,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL625114,50597,,1,10116.0,11708,In vivo,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL874397,50597,,1,10116.0,11709,In vivo,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625115,50597,,1,10116.0,11710,In vivo,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625116,50597,,1,10116.0,11711,In vivo,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL623932,50597,,1,10116.0,11712,In vivo,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL623933,50597,,1,10116.0,11713,In vivo,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL623934,50597,,1,10116.0,11714,In vivo,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL623935,50597,,1,10116.0,11715,In vivo,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL623936,50597,,1,10116.0,11716,In vivo,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL623937,50597,,1,10116.0,11717,In vivo,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL623938,50597,,1,10116.0,11718,In vivo,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623939,50594,,1,10090.0,11719,,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623940,50594,,1,10090.0,11720,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623941,50594,,1,10090.0,11721,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627216,50594,,1,10090.0,11722,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623942,50594,,1,10090.0,11723,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL618793,50594,,1,10090.0,11724,,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL618794,50594,,1,10090.0,11725,,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL618795,50594,,1,10090.0,11726,,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618796,50594,,1,10090.0,11727,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618797,50594,,1,10090.0,11728,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618798,50594,,1,10090.0,11729,,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,15383,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618799,50594,,1,10090.0,11730,,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618800,50594,,1,10090.0,11731,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618801,50594,,1,10090.0,11732,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618802,50594,,1,10090.0,11733,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL618803,50594,,1,10090.0,11734,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618804,50594,,1,10090.0,11735,,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,15383,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618805,50594,,1,10090.0,11736,,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618806,50594,,1,10090.0,11737,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618807,50594,,1,10090.0,11738,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618808,50594,,1,10090.0,11739,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL618809,50594,,1,10090.0,11740,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL618810,50594,,1,10090.0,11741,,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL618811,50594,,1,10090.0,11742,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL875844,50594,,1,10090.0,11743,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL618812,50594,,1,10090.0,11744,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL618813,50594,,1,10090.0,11745,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618814,50594,,1,10090.0,11746,,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618815,50594,,1,10090.0,11747,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618816,50594,,1,10090.0,11748,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL618817,50594,,1,10090.0,11749,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL620544,50594,,1,10090.0,11750,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626230,50597,,1,10116.0,11751,In vivo,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,15341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626231,50597,,1,10116.0,11752,In vivo,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,15341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626232,50597,,1,10116.0,11753,In vivo,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,15341,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626233,50588,,1,9615.0,11754,In vivo,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,14906,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626234,50597,,1,10116.0,11755,In vivo,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,14906,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL875341,50597,,1,10116.0,11756,In vivo,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,14906,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626235,50587,,1,9606.0,11757,In vivo,,The maximum plasma concentration (100 mg/kg) administered orally in human,14215,Homo sapiens,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626236,22224,,0,9481.0,11758,In vivo,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,14215,Callithrix,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626237,22224,,0,314293.0,11759,In vivo,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,14215,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626238,50588,,1,9615.0,11760,In vivo,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,14215,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622412,50587,,1,9606.0,11761,In vivo,,The maximum plasma concentration (200 mg/kg) administered orally in human,14215,Homo sapiens,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623114,50597,,1,10116.0,11762,In vivo,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,14215,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623115,22224,,0,9481.0,11763,In vivo,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,14215,Callithrix,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623116,22224,,0,314293.0,11764,In vivo,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,14215,Simiiformes,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623117,22224,,0,9615.0,11765,In vivo,,The maximum plasma concentration (30 mg/kg) administered orally in dog,14215,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623118,50587,,1,9606.0,11766,In vivo,,The maximum plasma concentration (400 mg/kg) administered orally in human,14215,Homo sapiens,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623119,50597,,1,10116.0,11767,In vivo,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,14215,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623120,50597,,1,10116.0,11768,In vivo,,The maximum plasma concentration (50 mg/kg) administered orally in rat,14215,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623286,50587,,1,9606.0,11769,In vivo,,The maximum plasma concentration (800 mg/kg) administered orally in human,14215,Homo sapiens,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623287,50597,,1,10116.0,11770,In vivo,,The maximum plasma concentration was measured on rats,14067,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623288,50597,,1,10116.0,11771,In vivo,,The maximum plasma concentration was measured on rats after oral administration,12350,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623289,50597,,1,10116.0,11772,In vivo,,Plasma drug Cmax in rat (PO dose),14813,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623290,22224,,0,,11773,In vivo,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,12536,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623291,50588,,1,9615.0,11774,In vivo,,maximum Plasma concentration in Dog was determined after Peroral administration,14169,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623292,50597,,1,10116.0,11775,In vivo,,maximum Plasma concentration in Rats was determined after Peroral administration,14169,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623293,50588,,1,9615.0,11776,In vivo,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,15604,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623294,22224,,0,314293.0,11777,In vivo,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,15604,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623295,50597,,1,10116.0,11778,In vivo,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,15604,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623296,50594,,1,10090.0,11779,In vivo,,maximum concentration was measured when administered through oral route in mice,14387,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875349,50594,,1,10090.0,11780,,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,15115,Mus musculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623297,22224,,0,314293.0,11781,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,15115,Simiiformes,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623298,22224,,0,314293.0,11782,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,15115,Simiiformes,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623299,22224,,0,314293.0,11783,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,15115,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623300,50597,,1,10116.0,11784,,,Pharmacokinetic parameter was evaluated in rats,16359,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623301,50594,,1,10090.0,11785,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,12829,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623302,50594,,1,10090.0,11786,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,12829,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623303,50594,,1,10090.0,11787,,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,12829,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623304,50594,,1,10090.0,11788,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,12829,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623305,50594,,1,10090.0,11789,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,12829,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623306,50597,,1,10116.0,11790,,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623307,50597,,1,10116.0,11791,,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623308,50597,,1,10116.0,11792,,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,15137,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL623309,50594,,1,10090.0,11793,,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,15137,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623310,50594,,1,10090.0,11794,,,Plasma Concentration after 120 min of oral administration to mice,13509,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623311,50594,,1,10090.0,11795,,,Plasma Concentration after 30 min of oral administration to mice,13509,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623312,100710,,1,9541.0,11796,,,Plasma Concentration after 60 min of oral administration to mice,13509,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875350,50594,,1,10090.0,11797,,,Plasma Concentration after 60 min of oral administration to mice; Not determined,13509,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628635,50594,,1,10090.0,11798,,,Plasma Concentration after 90 min of oral administration to mice,13509,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628636,50597,,1,10116.0,11799,,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,12064,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628637,50597,,1,10116.0,11800,,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628058,50597,,1,10116.0,11801,,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628059,50597,,1,10116.0,11802,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,10677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628060,50597,,1,10116.0,11803,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,10677,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628061,22224,,0,,11804,,,Distribution in the lung after 15 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628062,22224,,0,,11805,,,Distribution in the lung after 30 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628063,22224,,0,,11806,,,Distribution in the lung after 5 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628064,22224,,0,,11807,,,Distribution in the lung after 60 min of intravenous administration,8926,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628065,22224,,0,,11808,,,Distribution in the lung after 90 min of intravenous administration,8926,,,,1
U,,,2385.0,BAO_0000019,Autocuration,,A,Muscle tissue,CHEMBL628066,22224,,0,,11809,,,Distribution in the muscle after 120 min of intravenous administration,8926,,,,1
U,,,2385.0,BAO_0000019,Autocuration,,A,Muscle tissue,CHEMBL628067,22224,,0,,11810,,,Distribution in the muscle after 15 min of intravenous administration,8926,,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL874646,50594,,1,10090.0,11811,,,Distribution in the muscle after 30 min of intravenous administration,8926,Mus musculus,,,1
U,,,2385.0,BAO_0000019,Autocuration,,A,Muscle tissue,CHEMBL628068,22224,,0,,11812,,,Distribution in the muscle after 5 min of intravenous administration,8926,,,,1
U,,,2385.0,BAO_0000019,Autocuration,,A,Muscle tissue,CHEMBL628069,22224,,0,,11813,,,Distribution in the muscle after 60 min of intravenous administration,8926,,,,1
U,,,2385.0,BAO_0000019,Autocuration,,A,Muscle tissue,CHEMBL628070,22224,,0,,11814,,,Distribution in the muscle after 90 min of intravenous administration,8926,,,,1
U,,,2106.0,BAO_0000019,Autocuration,,A,Spleen,CHEMBL628071,22224,,0,,11815,,,Distribution in the spleen after 120 min of intravenous administration,8926,,,,1
U,,,2106.0,BAO_0000019,Autocuration,,A,Spleen,CHEMBL628072,22224,,0,,11816,,,Distribution in the spleen after 15 min of intravenous administration,8926,,,,1
U,,,2106.0,BAO_0000019,Autocuration,,A,Spleen,CHEMBL628073,22224,,0,,11817,,,Distribution in the spleen after 30 min of intravenous administration,8926,,,,1
U,,,2106.0,BAO_0000019,Autocuration,,A,Spleen,CHEMBL628074,22224,,0,,11818,,,Distribution in the spleen after 5 min of intravenous administration,8926,,,,1
U,,,2106.0,BAO_0000019,Autocuration,,A,Spleen,CHEMBL628075,22224,,0,,11819,,,Distribution in the spleen after 60 min of intravenous administration,8926,,,,1
U,,,2106.0,BAO_0000019,Autocuration,,A,Spleen,CHEMBL628076,22224,,0,,11820,,,Distribution in the spleen after 90 min of intravenous administration,8926,,,,1
N,,,1235.0,BAO_0000218,Intermediate,,A,Adrenal cortex,CHEMBL628077,50597,,1,10116.0,11821,,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628078,50597,,1,10116.0,11822,,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628079,50597,,1,10116.0,11823,,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL628080,50597,,1,10116.0,11824,,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL628081,50597,,1,10116.0,11825,,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,1235.0,BAO_0000218,Intermediate,,A,Adrenal cortex,CHEMBL628082,50597,,1,10116.0,11826,,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL874647,50597,,1,10116.0,11827,,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626406,50597,,1,10116.0,11828,,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL626407,50597,,1,10116.0,11829,,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626408,50597,,1,10116.0,11830,,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,7570,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626409,50597,,1,10116.0,11831,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626410,50597,,1,10116.0,11832,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626411,50597,,1,10116.0,11833,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626412,50597,,1,10116.0,11834,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626413,50597,,1,10116.0,11835,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626414,50597,,1,10116.0,11836,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626415,50597,,1,10116.0,11837,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626416,50597,,1,10116.0,11838,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627062,50597,,1,10116.0,11839,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627063,50597,,1,10116.0,11840,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627064,50597,,1,10116.0,11841,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627227,50597,,1,10116.0,11842,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627228,50597,,1,10116.0,11843,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627229,50597,,1,10116.0,11844,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625792,50597,,1,10116.0,11845,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625793,50597,,1,10116.0,11846,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625794,50597,,1,10116.0,11847,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",8608,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625795,50597,,1,10116.0,11848,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625796,50594,,1,10090.0,11849,,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,13792,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625797,50588,,1,9615.0,11850,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,13376,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625798,50588,,1,9615.0,11851,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,13376,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875613,22224,,0,,11852,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625799,22224,,0,,11853,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625800,22224,,0,,11854,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,14380,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625801,22224,,0,,11855,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625802,22224,,0,,11856,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625803,22224,,0,,11857,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,14380,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625804,22224,,0,,11858,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,14380,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622530,22224,,0,,11859,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,14380,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622531,50594,,1,10090.0,11860,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622532,50594,,1,10090.0,11861,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623176,50594,,1,10090.0,11862,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623177,50594,,1,10090.0,11863,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623178,50594,,1,10090.0,11864,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623179,50594,,1,10090.0,11865,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623180,50594,,1,10090.0,11866,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623181,50594,,1,10090.0,11867,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624131,50594,,1,10090.0,11868,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624132,50594,,1,10090.0,11869,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624133,50594,,1,10090.0,11870,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624846,50594,,1,10090.0,11871,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624847,50594,,1,10090.0,11872,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624848,50594,,1,10090.0,11873,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625012,50594,,1,10090.0,11874,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625013,50594,,1,10090.0,11875,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625014,50594,,1,10090.0,11876,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625015,50594,,1,10090.0,11877,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625016,50594,,1,10090.0,11878,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625017,50594,,1,10090.0,11879,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625018,50594,,1,10090.0,11880,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625019,50594,,1,10090.0,11881,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625020,50594,,1,10090.0,11882,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625021,50594,,1,10090.0,11883,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625022,50597,,1,10116.0,11884,,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625023,50594,,1,10090.0,11885,,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,14731,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625024,100710,,1,9541.0,11886,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,14731,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627626,100710,,1,9541.0,11887,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,14731,Macaca fascicularis,,,1
U,,,955.0,BAO_0000218,Autocuration,,A,Brain,CHEMBL627627,22224,,0,,11888,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,13758,,,,1
U,,,1977.0,BAO_0000218,Autocuration,,A,Serum,CHEMBL627628,22224,,0,,11889,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,13758,,,,1
U,,,955.0,BAO_0000218,Autocuration,,A,Brain,CHEMBL627629,22224,,0,,11890,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,13758,,,,1
U,,,1977.0,BAO_0000218,Autocuration,,A,Serum,CHEMBL627630,22224,,0,,11891,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,13758,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627631,22224,,0,,11892,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),16359,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629515,22224,,0,,11893,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),16359,,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL629516,50594,,1,10090.0,11894,,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL629517,50594,,1,10090.0,11895,,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL629518,50594,,1,10090.0,11896,,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877499,50594,,1,10090.0,11897,,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629519,50594,,1,10090.0,11898,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629520,50594,,1,10090.0,11899,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629521,50594,,1,10090.0,11900,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629522,50594,,1,10090.0,11901,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629523,50594,,1,10090.0,11902,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629524,50594,,1,10090.0,11903,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629525,50594,,1,10090.0,11904,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629526,50594,,1,10090.0,11905,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629527,50594,,1,10090.0,11906,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629528,50594,,1,10090.0,11907,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629529,50594,,1,10090.0,11908,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629530,50594,,1,10090.0,11909,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629531,50594,,1,10090.0,11910,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628656,50594,,1,10090.0,11911,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628657,50594,,1,10090.0,11912,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628658,50597,,1,10116.0,11913,In vivo,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628659,50597,,1,10116.0,11914,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877500,50597,,1,10116.0,11915,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628660,50597,,1,10116.0,11916,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628661,50597,,1,10116.0,11917,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628662,50597,,1,10116.0,11918,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628663,50597,,1,10116.0,11919,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628664,50597,,1,10116.0,11920,In vivo,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628665,50597,,1,10116.0,11921,In vivo,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628666,50597,,1,10116.0,11922,In vivo,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628667,50597,,1,10116.0,11923,In vivo,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628668,50597,,1,10116.0,11924,In vivo,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628669,50597,,1,10116.0,11925,In vivo,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628670,50597,,1,10116.0,11926,In vivo,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628671,50597,,1,10116.0,11927,In vivo,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL628672,50597,,1,10116.0,11928,In vivo,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL630300,50597,,1,10116.0,11929,In vivo,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL629787,50597,,1,10116.0,11930,In vivo,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL629788,50597,,1,10116.0,11931,In vivo,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629789,50597,,1,10116.0,11932,In vivo,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629790,50597,,1,10116.0,11933,In vivo,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629791,50597,,1,10116.0,11934,In vivo,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629792,50597,,1,10116.0,11935,In vivo,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629793,50597,,1,10116.0,11936,In vivo,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629794,50597,,1,10116.0,11937,In vivo,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874459,50597,,1,10116.0,11938,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,10677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629795,50597,,1,10116.0,11939,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,10677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629796,50597,,1,10116.0,11940,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,10677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629797,50597,,1,10116.0,11941,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,10677,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629798,50597,,1,10116.0,11942,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,10677,Rattus norvegicus,,,1
N,,,2369.0,BAO_0000218,Intermediate,,A,Adrenal gland,CHEMBL629799,50597,,1,10116.0,11943,In vivo,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2369.0,BAO_0000218,Intermediate,,A,Adrenal gland,CHEMBL629800,50597,,1,10116.0,11944,In vivo,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2369.0,BAO_0000218,Intermediate,,A,Adrenal gland,CHEMBL629801,50597,,1,10116.0,11945,In vivo,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2369.0,BAO_0000218,Intermediate,,A,Adrenal gland,CHEMBL629802,50597,,1,10116.0,11946,In vivo,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,10911,Rattus norvegicus,,,1
N,,,2369.0,BAO_0000218,Intermediate,,A,Adrenal gland,CHEMBL629803,50597,,1,10116.0,11947,In vivo,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629804,50597,,1,10116.0,11948,In vivo,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629805,50597,,1,10116.0,11949,In vivo,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629806,50597,,1,10116.0,11950,In vivo,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629807,50597,,1,10116.0,11951,In vivo,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629808,50597,,1,10116.0,11952,In vivo,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629809,50597,,1,10116.0,11953,In vivo,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629810,50597,,1,10116.0,11954,In vivo,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629811,50597,,1,10116.0,11955,In vivo,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629812,50597,,1,10116.0,11956,In vivo,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629813,50597,,1,10116.0,11957,In vivo,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL874460,50597,,1,10116.0,11958,In vivo,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629814,50597,,1,10116.0,11959,In vivo,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629815,50597,,1,10116.0,11960,In vivo,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629816,50597,,1,10116.0,11961,In vivo,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629817,50597,,1,10116.0,11962,In vivo,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626643,50597,,1,10116.0,11963,In vivo,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626644,50597,,1,10116.0,11964,In vivo,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626806,50597,,1,10116.0,11965,In vivo,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626807,50597,,1,10116.0,11966,In vivo,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627261,50597,,1,10116.0,11967,In vivo,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627262,50597,,1,10116.0,11968,In vivo,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627263,50597,,1,10116.0,11969,In vivo,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627264,50597,,1,10116.0,11970,In vivo,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627265,50597,,1,10116.0,11971,In vivo,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627266,50597,,1,10116.0,11972,In vivo,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627267,50597,,1,10116.0,11973,In vivo,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627268,50597,,1,10116.0,11974,In vivo,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627269,50597,,1,10116.0,11975,In vivo,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627270,50597,,1,10116.0,11976,In vivo,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627271,50597,,1,10116.0,11977,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627946,50597,,1,10116.0,11978,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875472,50597,,1,10116.0,11979,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627947,50597,,1,10116.0,11980,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627948,50597,,1,10116.0,11981,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628113,50597,,1,10116.0,11982,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628114,50597,,1,10116.0,11983,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628115,50597,,1,10116.0,11984,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628116,50597,,1,10116.0,11985,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628117,50597,,1,10116.0,11986,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628118,50597,,1,10116.0,11987,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628119,50597,,1,10116.0,11988,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628120,50597,,1,10116.0,11989,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628121,50597,,1,10116.0,11990,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628122,50597,,1,10116.0,11991,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627297,50597,,1,10116.0,11992,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627298,50597,,1,10116.0,11993,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627299,50597,,1,10116.0,11994,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627300,50597,,1,10116.0,11995,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627301,50597,,1,10116.0,11996,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627302,50597,,1,10116.0,11997,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627303,50597,,1,10116.0,11998,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627304,50597,,1,10116.0,11999,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627305,50597,,1,10116.0,12000,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627306,50597,,1,10116.0,12001,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623982,50597,,1,10116.0,12002,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623983,50597,,1,10116.0,12003,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623984,50597,,1,10116.0,12004,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623985,50597,,1,10116.0,12005,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623986,50597,,1,10116.0,12006,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623987,50597,,1,10116.0,12007,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623988,50597,,1,10116.0,12008,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623989,50597,,1,10116.0,12009,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622215,50597,,1,10116.0,12010,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622216,50597,,1,10116.0,12011,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877481,50597,,1,10116.0,12012,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",8608,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622217,22224,,0,,12013,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),16359,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622218,50594,,1,10090.0,12014,,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),13701,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622219,50597,,1,10116.0,12015,,,Pharmacokinetic profile AUC was evaluated in rats,14554,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622220,22224,,0,,12016,,,Pharmacokinetic property (Area under curve),6241,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622221,50588,,1,9615.0,12017,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",11537,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622222,50594,,1,10090.0,12018,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",11537,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622223,50588,,1,9615.0,12019,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",11537,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622224,50594,,1,10090.0,12020,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",11537,Mus musculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622225,22224,,0,,12021,,,Plasma concentration (AUC) was determined,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622226,22224,,0,,12022,,,Plasma concentration (AUC) was determined; Not detectable,13118,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624154,50512,,1,10141.0,12023,,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),9562,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624155,50597,,1,10116.0,12024,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,10363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624156,50597,,1,10116.0,12025,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,10363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624157,50597,,1,10116.0,12026,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,10363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624158,50597,,1,10116.0,12027,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,10363,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624159,50597,,1,10116.0,12028,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624160,50597,,1,10116.0,12029,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624161,50597,,1,10116.0,12030,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624162,50597,,1,10116.0,12031,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624163,50588,,1,9615.0,12032,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,13317,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624164,50597,,1,10116.0,12033,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624165,50597,,1,10116.0,12034,,,The AUC(0-infinity) values in female wistar rats.,14941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624166,50597,,1,10116.0,12035,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624167,50597,,1,10116.0,12036,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",15078,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624168,50597,,1,10116.0,12037,,,The AUC(0-t)values in female wistar rats.,14941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624169,50597,,1,10116.0,12038,,,The Area under the concentration time curve of compound was measured on rats,14067,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624170,50587,,1,9606.0,12039,,,The area under curve (100 mg/kg) administered orally in humans,14215,Homo sapiens,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624171,22224,,0,9481.0,12040,,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,14215,Callithrix,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624172,22224,,0,314293.0,12041,,,The area under curve (12.5 mg/kg) administered intravenously in monkey,14215,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624173,50588,,1,9615.0,12042,,,The area under curve (15 mg/kg) administered intravenously in dog,14215,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877488,50587,,1,9606.0,12043,,,The area under curve (200 mg/kg) administered orally in humans,14215,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624174,50597,,1,10116.0,12044,,,The area under curve (25 mg/kg) administered intravenously in rat,14215,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624175,22224,,0,9481.0,12045,,,The area under curve (25 mg/kg) administered orally in marmoset,14215,Callithrix,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL624176,22224,,0,314293.0,12046,,,The area under curve (25 mg/kg) administered orally in monkey,14215,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624177,50588,,1,9615.0,12047,,,The area under curve (30 mg/kg) administered orally in dog,14215,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624178,50587,,1,9606.0,12048,,,The area under curve (400 mg/kg) administered orally in humans,14215,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624179,50597,,1,10116.0,12049,,,The area under curve (50 mg/kg) administered orally in fasted rat,14215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627689,50597,,1,10116.0,12050,,,The area under curve (50 mg/kg) administered orally in rat,14215,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627690,50587,,1,9606.0,12051,,,The area under curve (800 mg/kg) administered orally in humans,14215,Homo sapiens,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627691,22224,,0,,12052,,,The compound was evaluated for area under the curve,11324,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627692,22224,,0,9481.0,12053,,,The compound was evaluated for area under the curve in marmosets,11324,Callithrix,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627693,22224,,0,9481.0,12054,,,The compound was evaluated for area under the curve in marmosets,11324,Callithrix,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627694,50597,,1,10116.0,12055,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627695,50597,,1,10116.0,12056,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627696,22224,,0,,12057,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),13875,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627697,50597,,1,10116.0,12058,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627698,50597,,1,10116.0,12059,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627699,50597,,1,10116.0,12060,,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627700,50597,,1,10116.0,12061,,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,13807,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627701,50597,,1,10116.0,12062,,,Total drug exposure is determined after oral dosing in rats.,14127,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627702,22224,,0,,12063,,,Total drug exposure (5 mg/kg) when administered intravenously,15116,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627703,22224,,0,,12064,,,Total drug exposure (5 mg/kg) when administered orally,15116,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626873,22224,,0,314293.0,12065,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,15604,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629583,50597,,1,10116.0,12066,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,15604,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629584,50588,,1,9615.0,12067,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,15604,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629585,50588,,1,9615.0,12068,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,15604,Canis lupus familiaris,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629586,50597,,1,10116.0,12069,In vivo,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629587,50597,,1,10116.0,12070,In vivo,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629588,50597,,1,10116.0,12071,In vivo,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629589,50597,,1,10116.0,12072,In vivo,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629590,50597,,1,10116.0,12073,In vivo,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629591,50597,,1,10116.0,12074,In vivo,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629592,50597,,1,10116.0,12075,In vivo,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629593,50597,,1,10116.0,12076,In vivo,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629594,50597,,1,10116.0,12077,In vivo,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL629595,50597,,1,10116.0,12078,In vivo,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630290,50597,,1,10116.0,12079,In vivo,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627137,50597,,1,10116.0,12080,In vivo,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627138,50597,,1,10116.0,12081,In vivo,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627139,50597,,1,10116.0,12082,In vivo,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627140,50597,,1,10116.0,12083,In vivo,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627141,50597,,1,10116.0,12084,In vivo,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627142,50597,,1,10116.0,12085,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627143,50597,,1,10116.0,12086,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL874449,50597,,1,10116.0,12087,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627144,50597,,1,10116.0,12088,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627145,50597,,1,10116.0,12089,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627146,50597,,1,10116.0,12090,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627147,50597,,1,10116.0,12091,In vivo,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627148,50597,,1,10116.0,12092,In vivo,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627149,50597,,1,10116.0,12093,In vivo,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL632160,50597,,1,10116.0,12094,In vivo,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL632161,50597,,1,10116.0,12095,In vivo,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL632162,50597,,1,10116.0,12096,In vivo,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL632163,50597,,1,10116.0,12097,In vivo,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL874469,50597,,1,10116.0,12098,In vivo,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627182,50597,,1,10116.0,12099,In vivo,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627183,50597,,1,10116.0,12100,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627184,50597,,1,10116.0,12101,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627185,50597,,1,10116.0,12102,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627186,50597,,1,10116.0,12103,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627187,50597,,1,10116.0,12104,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627188,50597,,1,10116.0,12105,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627189,50597,,1,10116.0,12106,In vivo,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627190,50597,,1,10116.0,12107,In vivo,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627191,50597,,1,10116.0,12108,In vivo,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627192,50597,,1,10116.0,12109,In vivo,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627193,50597,,1,10116.0,12110,In vivo,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL874590,50597,,1,10116.0,12111,In vivo,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627194,50597,,1,10116.0,12112,In vivo,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627195,50597,,1,10116.0,12113,In vivo,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL627196,50597,,1,10116.0,12114,In vivo,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL627197,50597,,1,10116.0,12115,In vivo,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL627198,50597,,1,10116.0,12116,In vivo,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL627199,50597,,1,10116.0,12117,In vivo,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,10911,Rattus norvegicus,,,1
N,,,992.0,BAO_0000218,Intermediate,,A,Female gonad,CHEMBL627200,50597,,1,10116.0,12118,In vivo,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627201,50597,,1,10116.0,12119,In vivo,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627202,50597,,1,10116.0,12120,In vivo,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627203,50597,,1,10116.0,12121,In vivo,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627204,50597,,1,10116.0,12122,In vivo,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627205,50597,,1,10116.0,12123,In vivo,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627206,50597,,1,10116.0,12124,In vivo,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627207,50597,,1,10116.0,12125,In vivo,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627208,50597,,1,10116.0,12126,In vivo,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627209,50597,,1,10116.0,12127,In vivo,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627210,50597,,1,10116.0,12128,In vivo,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627211,50597,,1,10116.0,12129,In vivo,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627212,50597,,1,10116.0,12130,In vivo,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL627213,50597,,1,10116.0,12131,In vivo,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626599,50597,,1,10116.0,12132,In vivo,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626600,50597,,1,10116.0,12133,In vivo,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL626601,50597,,1,10116.0,12134,In vivo,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627484,22224,,0,,12135,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,8081,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627485,100710,,1,9541.0,12136,,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),17248,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628147,100710,,1,9541.0,12137,,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,17248,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628148,100710,,1,9541.0,12138,,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,17248,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628149,50588,,1,9615.0,12139,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),17248,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628150,50588,,1,9615.0,12140,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,17248,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628318,50588,,1,9615.0,12141,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,17248,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628319,50588,,1,9615.0,12142,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,17248,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875609,50588,,1,9615.0,12143,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",15592,Canis lupus familiaris,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628320,22224,,0,,12144,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,7040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628321,22224,,0,,12145,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,7040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628322,22224,,0,,12146,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,7040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628323,22224,,0,,12147,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,7040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628324,22224,,0,,12148,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,7040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628325,22224,,0,,12149,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,7040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628326,22224,,0,,12150,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,7040,,,,1
N,,,1236.0,BAO_0000218,Intermediate,,A,Adrenal medulla,CHEMBL628327,50588,,1,9615.0,12151,,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,1236.0,BAO_0000218,Intermediate,,A,Adrenal medulla,CHEMBL628328,50588,,1,9615.0,12152,,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628329,50588,,1,9615.0,12153,,,"Concentration of compound in blood of dog 1, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628330,50597,,1,10116.0,12154,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628331,50597,,1,10116.0,12155,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628332,50597,,1,10116.0,12156,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628333,50597,,1,10116.0,12157,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628334,50597,,1,10116.0,12158,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628335,50597,,1,10116.0,12159,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628336,50597,,1,10116.0,12160,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628337,50597,,1,10116.0,12161,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628338,50597,,1,10116.0,12162,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL875610,50597,,1,10116.0,12163,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628339,50597,,1,10116.0,12164,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628340,50597,,1,10116.0,12165,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628341,50597,,1,10116.0,12166,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622214,50597,,1,10116.0,12167,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623167,50597,,1,10116.0,12168,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623168,50597,,1,10116.0,12169,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623169,50597,,1,10116.0,12170,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",8608,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623170,50597,,1,10116.0,12171,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627224,50597,,1,10116.0,12172,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL875634,50597,,1,10116.0,12173,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627225,50597,,1,10116.0,12174,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627226,50597,,1,10116.0,12175,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626083,50597,,1,10116.0,12176,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626084,50597,,1,10116.0,12177,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626085,50597,,1,10116.0,12178,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626086,50597,,1,10116.0,12179,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626087,50597,,1,10116.0,12180,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626088,50597,,1,10116.0,12181,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626089,50597,,1,10116.0,12182,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626090,50597,,1,10116.0,12183,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626091,50597,,1,10116.0,12184,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626092,50597,,1,10116.0,12185,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626093,50597,,1,10116.0,12186,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626094,50597,,1,10116.0,12187,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626095,50597,,1,10116.0,12188,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",8608,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL626096,50597,,1,10116.0,12189,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",8608,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626097,22224,,0,314293.0,12190,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,15604,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626098,50597,,1,10116.0,12191,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,15604,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626099,22224,,0,,12192,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,1806,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL626100,22224,,0,,12193,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,1806,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626101,50588,,1,9615.0,12194,,,AUC 0-inf in dog,17237,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626102,50512,,1,10141.0,12195,,,AUC 0-inf in guinea pig,17237,Cavia porcellus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626103,50588,,1,9615.0,12196,,,AUC 0-t in dog,17237,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628391,50512,,1,10141.0,12197,,,AUC 0-t in guinea pig,17237,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628392,50597,,1,10116.0,12198,,,The compound was tested for brain to plasma partition in rat,15194,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628393,50597,,1,10116.0,12199,,,The compound was tested for brain to plasma partition in rat.,15194,Rattus norvegicus,,,1
U,,,178.0,BAO_0000019,Autocuration,,A,Blood,CHEMBL628394,22224,,0,,12200,,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,8787,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628395,50588,,1,9615.0,12201,,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,17025,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628396,22224,,0,314293.0,12202,,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,17025,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628397,50592,,1,9986.0,12203,,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,17025,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628398,50597,,1,10116.0,12204,,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,17025,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628399,50797,,1,9544.0,12205,,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,4236,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628400,50588,,1,9615.0,12206,,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,15343,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874907,50597,,1,10116.0,12207,,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,15343,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628401,22224,,0,,12208,,,Area under curve of the compound was determined,17720,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL628402,22224,,0,314293.0,12209,,,AUC in monkeys at a dose of 1 mg/kg,17788,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628403,50597,,1,10116.0,12210,,,AUC in rats at a dose of 1 mg/kg,17788,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628404,22224,,0,,12211,,,Compound was evaluated for the overall absorbance loss at pH of 2,8778,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628405,22224,,0,,12212,,,Compound was evaluated for the overall absorbance loss at pH of 4,8778,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628406,22224,,0,,12213,,,Compound was evaluated for the overall absorbance loss at pH of 7,8778,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628407,50597,,1,10116.0,12214,,,Compound was evaluated for its absorption in the rats,2249,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628408,50597,,1,10116.0,12215,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,8881,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629171,50597,,1,10116.0,12216,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,8881,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629172,50597,,1,10116.0,12217,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,8881,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629173,50597,,1,10116.0,12218,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,8881,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629174,50597,,1,10116.0,12219,,,In vitro percent permeability into rat ileum,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629175,50597,,1,10116.0,12220,,,In vitro percent permeability into rat ileum; Range is 10-17,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629176,50597,,1,10116.0,12221,,,In vitro percent permeability into rat ileum; Range is 10-18,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629177,50597,,1,10116.0,12222,,,In vitro percent permeability into rat ileum; Range is 10-19,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629178,50597,,1,10116.0,12223,,,In vitro percent permeability into rat ileum; Range is 12-15,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631869,50597,,1,10116.0,12224,,,In vitro percent permeability into rat ileum; Range is 13-19,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631870,50597,,1,10116.0,12225,,,In vitro percent permeability into rat ileum; Range is 14-17,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631871,50597,,1,10116.0,12226,,,In vitro percent permeability into rat ileum; Range is 15-18,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631872,50597,,1,10116.0,12227,,,In vitro percent permeability into rat ileum; Range is 2-5,15286,Rattus norvegicus,,,1
U,,,2116.0,BAO_0000221,Autocuration,,A,Ileum,CHEMBL875775,22224,,0,,12228,,,In vitro percent permeability into rat ileum; Range is 23-42,15286,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631873,50597,,1,10116.0,12229,,,In vitro percent permeability into rat ileum; Range is 28-36,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631874,50597,,1,10116.0,12230,,,In vitro percent permeability into rat ileum; Range is 29-35,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631875,50597,,1,10116.0,12231,,,In vitro percent permeability into rat ileum; Range is 46-66,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631876,50597,,1,10116.0,12232,,,In vitro percent permeability into rat ileum; Range is 50-68,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631877,50597,,1,10116.0,12233,,,In vitro percent permeability into rat ileum; Range is 78-81,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631878,50597,,1,10116.0,12234,,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631879,50597,,1,10116.0,12235,,,In vitro percent permeability into rat ileum; nd indicates not detected,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631880,50597,,1,10116.0,12236,,,In vitro percent permeability into rat ileum; nt indicates not detected,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631881,50597,,1,10116.0,12237,,,In vitro percent permeability into rat ileum; nt indicates not tested,15286,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631882,50597,,1,10116.0,12238,,,Compound was tested for oral absorption in bile-duct cannulated rats,13770,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630749,50597,,1,10116.0,12239,,,Compound was tested for oral absorption in bile-duct cannulated rats.,13770,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630750,50587,,1,9606.0,12240,,,Oral absorption using Caco-2 cell monolayers.,5202,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630253,50587,,1,9606.0,12241,,,Percent of the drug absorbed after administration to humans was determined,14920,Homo sapiens,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL630254,50597,,1,10116.0,12242,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL630255,50597,,1,10116.0,12243,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL630256,50597,,1,10116.0,12244,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,14103,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL875781,50597,,1,10116.0,12245,In vivo,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630257,50597,,1,10116.0,12246,In vivo,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630258,50597,,1,10116.0,12247,In vivo,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630259,50597,,1,10116.0,12248,,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",15807,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL630260,50597,,1,10116.0,12249,,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",15807,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL630261,50597,,1,10116.0,12250,,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",15807,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630262,50597,,1,10116.0,12251,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630263,50597,,1,10116.0,12252,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630264,50597,,1,10116.0,12253,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630265,50597,,1,10116.0,12254,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630266,50597,,1,10116.0,12255,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,14950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630267,50597,,1,10116.0,12256,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,14950,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630268,50597,,1,10116.0,12257,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630269,50597,,1,10116.0,12258,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630270,50597,,1,10116.0,12259,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,14950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630141,50597,,1,10116.0,12260,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,14950,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630142,50597,,1,10116.0,12261,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,14950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630143,50597,,1,10116.0,12262,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,14950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630144,50597,,1,10116.0,12263,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,14950,Rattus norvegicus,,,1
N,,,2367.0,BAO_0000218,Intermediate,,A,Prostate gland,CHEMBL630145,50597,,1,10116.0,12264,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,14950,Rattus norvegicus,,,1
N,,,2367.0,BAO_0000218,Intermediate,,A,Prostate gland,CHEMBL630146,50597,,1,10116.0,12265,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630147,50597,,1,10116.0,12266,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630148,50597,,1,10116.0,12267,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630149,50597,,1,10116.0,12268,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,14950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630150,50597,,1,10116.0,12269,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,14950,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630151,50597,,1,10116.0,12270,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,14950,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL632031,50597,,1,10116.0,12271,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,14950,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL632032,50597,,1,10116.0,12272,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632033,50597,,1,10116.0,12273,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632034,50597,,1,10116.0,12274,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,14950,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL632035,50597,,1,10116.0,12275,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,14950,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632036,50597,,1,10116.0,12276,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,14950,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL632037,50597,,1,10116.0,12277,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,14950,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632038,50597,,1,10116.0,12278,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632039,50597,,1,10116.0,12279,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632040,50597,,1,10116.0,12280,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632041,50597,,1,10116.0,12281,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL632042,50588,,1,9615.0,12282,,,"Concentration of compound in blood of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632043,50588,,1,9615.0,12283,,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632044,50588,,1,9615.0,12284,,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL632045,50588,,1,9615.0,12285,,,"Concentration of compound in liver of dog 1, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL632046,50588,,1,9615.0,12286,,,"Concentration of compound in liver of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL632047,50588,,1,9615.0,12287,,,"Concentration of compound in lung of dog 1, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL632048,50588,,1,9615.0,12288,,,"Concentration of compound in lung of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL632049,50588,,1,9615.0,12289,,,"Concentration of compound in muscle of dog 1, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL876418,50588,,1,9615.0,12290,,,"Concentration of compound in muscle of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL632050,50588,,1,9615.0,12291,,,"Concentration of compound in spleen of dog 1,after administering intravenously",9614,Canis lupus familiaris,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL632051,50588,,1,9615.0,12292,,,"Concentration of compound in spleen of dog 2, after administering intravenously",9614,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL632052,22224,,0,,12293,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,10353,,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL632053,22224,,0,,12294,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,10353,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL632054,22224,,0,,12295,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,10353,,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL632055,22224,,0,,12296,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,10353,,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL631181,22224,,0,,12297,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,10353,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631182,22224,,0,,12298,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631183,22224,,0,,12299,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631184,22224,,0,,12300,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629774,22224,,0,,12301,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629775,22224,,0,,12302,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL876549,22224,,0,,12303,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628172,22224,,0,,12304,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628173,22224,,0,,12305,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628174,22224,,0,,12306,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628175,22224,,0,,12307,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628176,22224,,0,,12308,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628177,22224,,0,,12309,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628178,22224,,0,,12310,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628179,22224,,0,,12311,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628180,22224,,0,,12312,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628181,22224,,0,,12313,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628182,22224,,0,,12314,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628183,22224,,0,,12315,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628184,22224,,0,,12316,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628185,22224,,0,,12317,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875617,22224,,0,,12318,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628186,22224,,0,,12319,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628187,22224,,0,,12320,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628188,22224,,0,,12321,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628189,22224,,0,,12322,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628190,22224,,0,,12323,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628191,22224,,0,,12324,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626513,22224,,0,,12325,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,9196,,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626514,50597,,1,10116.0,12326,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626515,50597,,1,10116.0,12327,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626516,50597,,1,10116.0,12328,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626517,50597,,1,10116.0,12329,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626518,50597,,1,10116.0,12330,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626519,50597,,1,10116.0,12331,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626520,50597,,1,10116.0,12332,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626521,50597,,1,10116.0,12333,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626522,50597,,1,10116.0,12334,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626523,50597,,1,10116.0,12335,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626524,50597,,1,10116.0,12336,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626688,50597,,1,10116.0,12337,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626689,50597,,1,10116.0,12338,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626690,50597,,1,10116.0,12339,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626691,50597,,1,10116.0,12340,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL627319,50597,,1,10116.0,12341,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL624052,50597,,1,10116.0,12342,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",8608,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL624053,50597,,1,10116.0,12343,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",8608,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624054,50597,,1,10116.0,12344,,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624055,50597,,1,10116.0,12345,,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624056,50597,,1,10116.0,12346,,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL624057,50597,,1,10116.0,12347,,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL622281,50597,,1,10116.0,12348,,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL622282,50597,,1,10116.0,12349,,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL622283,50597,,1,10116.0,12350,,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL622284,50597,,1,10116.0,12351,,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL622285,50597,,1,10116.0,12352,,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL622286,50597,,1,10116.0,12353,,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622287,22224,,0,,12354,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,7657,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622288,50594,,1,10090.0,12355,,,Partition coefficient (logD7.4),8935,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622289,50594,,1,10090.0,12356,,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622290,50594,,1,10090.0,12357,,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",13792,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622291,50594,,1,10090.0,12358,,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622292,50594,,1,10090.0,12359,,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,13792,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622293,50594,,1,10090.0,12360,,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622294,50594,,1,10090.0,12361,,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",13792,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622295,50594,,1,10090.0,12362,,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL622296,50597,,1,10116.0,12363,,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,13792,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL874409,50597,,1,10116.0,12364,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622297,50597,,1,10116.0,12365,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622298,50597,,1,10116.0,12366,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622299,50597,,1,10116.0,12367,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622300,50597,,1,10116.0,12368,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622301,50597,,1,10116.0,12369,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622302,50597,,1,10116.0,12370,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622303,50597,,1,10116.0,12371,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622304,50597,,1,10116.0,12372,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622305,50597,,1,10116.0,12373,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622306,50597,,1,10116.0,12374,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626864,50597,,1,10116.0,12375,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626865,50597,,1,10116.0,12376,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626866,50597,,1,10116.0,12377,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626867,50597,,1,10116.0,12378,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626868,50597,,1,10116.0,12379,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626869,50597,,1,10116.0,12380,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626870,50597,,1,10116.0,12381,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626871,50597,,1,10116.0,12382,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626872,50597,,1,10116.0,12383,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632185,50597,,1,10116.0,12384,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,14103,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL632186,50597,,1,10116.0,12385,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,14103,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629310,22224,,0,,12386,,,Amount of acetic acid produced by the compound,12904,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629311,22224,,0,,12387,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,12904,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629312,50597,,1,10116.0,12388,,,Log of (Cbrain/Cblood) in rats,9663,Rattus norvegicus,,,1
U,,,,BAO_0000221,Autocuration,,A,,CHEMBL629313,22224,,0,,12389,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000221,Autocuration,,A,,CHEMBL629314,22224,,0,,12390,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000221,Autocuration,,A,,CHEMBL629315,22224,,0,,12391,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000219,Autocuration,,B,,CHEMBL629316,22224,,0,,12392,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000221,Autocuration,,A,,CHEMBL629317,22224,,0,,12393,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629318,22224,,0,,12394,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL877497,22224,,0,,12395,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629319,22224,,0,,12396,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629320,22224,,0,,12397,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629496,22224,,0,,12398,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629497,22224,,0,,12399,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629498,22224,,0,,12400,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629499,22224,,0,,12401,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629500,22224,,0,,12402,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629501,22224,,0,,12403,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629502,22224,,0,,12404,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),7652,,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL629503,22224,,0,,12405,In vivo,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,8267,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629504,50588,,1,9615.0,12406,,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,8267,Canis lupus familiaris,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629505,22224,,0,,12407,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,14479,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629506,22224,,0,,12408,,,Compound was evaluated for total body clearance,17515,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629507,22224,,0,,12409,,,Compound was evaluated for volume of distribution at steady state,17515,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL877498,22224,,0,,12410,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,8142,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629508,22224,,0,,12411,,,Percentage of the diamine which is monoprotonated at pH 7.4,14849,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629509,22224,,0,,12412,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,7653,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629510,50597,,1,10116.0,12413,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629511,50597,,1,10116.0,12414,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629512,50597,,1,10116.0,12415,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629513,50597,,1,10116.0,12416,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629514,50597,,1,10116.0,12417,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628447,50597,,1,10116.0,12418,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628448,50597,,1,10116.0,12419,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628449,50597,,1,10116.0,12420,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631119,50597,,1,10116.0,12421,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631120,50597,,1,10116.0,12422,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631121,50597,,1,10116.0,12423,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL874458,50597,,1,10116.0,12424,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631122,50597,,1,10116.0,12425,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631123,50597,,1,10116.0,12426,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631124,50597,,1,10116.0,12427,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631125,50597,,1,10116.0,12428,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631290,50597,,1,10116.0,12429,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631291,50597,,1,10116.0,12430,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631292,50597,,1,10116.0,12431,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631293,50597,,1,10116.0,12432,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631294,50597,,1,10116.0,12433,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631295,50597,,1,10116.0,12434,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631296,50597,,1,10116.0,12435,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,8631,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631297,50597,,1,10116.0,12436,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631298,22224,,0,,12437,,,Maximum biodistribution (Bmax) was determined.,10263,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631299,50594,,1,10090.0,12438,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631300,50594,,1,10090.0,12439,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631301,50594,,1,10090.0,12440,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630291,50594,,1,10090.0,12441,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL630292,22224,,0,,12442,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL630293,22224,,0,,12443,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL630294,22224,,0,,12444,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL630295,22224,,0,,12445,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL630296,22224,,0,,12446,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626782,22224,,0,,12447,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626783,22224,,0,,12448,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626784,22224,,0,,12449,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626785,22224,,0,,12450,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626786,22224,,0,,12451,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626787,22224,,0,,12452,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626788,22224,,0,,12453,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625927,22224,,0,,12454,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625928,50597,,1,10116.0,12455,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625929,50597,,1,10116.0,12456,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625930,50597,,1,10116.0,12457,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625931,50597,,1,10116.0,12458,,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627230,50597,,1,10116.0,12459,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627231,50597,,1,10116.0,12460,,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627232,50597,,1,10116.0,12461,,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627233,50597,,1,10116.0,12462,,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL875470,50597,,1,10116.0,12463,,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627234,50597,,1,10116.0,12464,,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627235,50597,,1,10116.0,12465,,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627236,50597,,1,10116.0,12466,,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627237,50597,,1,10116.0,12467,,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627238,50597,,1,10116.0,12468,,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627239,50597,,1,10116.0,12469,,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627240,50597,,1,10116.0,12470,,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627241,50597,,1,10116.0,12471,,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627242,50597,,1,10116.0,12472,,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627243,50597,,1,10116.0,12473,,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627244,50597,,1,10116.0,12474,,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627245,50597,,1,10116.0,12475,,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627246,50597,,1,10116.0,12476,,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627247,50597,,1,10116.0,12477,,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627248,50597,,1,10116.0,12478,,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627249,50597,,1,10116.0,12479,,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625569,50597,,1,10116.0,12480,,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625570,50597,,1,10116.0,12481,,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625571,50597,,1,10116.0,12482,,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625572,50597,,1,10116.0,12483,,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625573,50597,,1,10116.0,12484,,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625574,50597,,1,10116.0,12485,,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626245,50597,,1,10116.0,12486,,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626246,50597,,1,10116.0,12487,,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626247,22224,,0,,12488,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626248,22224,,0,,12489,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626249,22224,,0,,12490,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626420,22224,,0,,12491,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626421,22224,,0,,12492,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626422,22224,,0,,12493,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626423,22224,,0,,12494,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626424,22224,,0,,12495,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626425,50588,,1,9615.0,12496,,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,12023,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875476,50597,,1,10116.0,12497,,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,12023,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626426,100710,,1,9541.0,12498,,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,12023,Macaca fascicularis,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626427,22224,,0,,12499,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,10580,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626428,22224,,0,,12500,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,10580,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626429,22224,,0,,12501,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,16032,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL625025,22224,,0,,12502,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,16032,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625026,50597,,1,10116.0,12503,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625027,50597,,1,10116.0,12504,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL874410,50597,,1,10116.0,12505,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625028,50597,,1,10116.0,12506,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625029,50597,,1,10116.0,12507,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625030,50597,,1,10116.0,12508,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625031,50597,,1,10116.0,12509,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625032,50597,,1,10116.0,12510,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625033,50597,,1,10116.0,12511,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625034,50597,,1,10116.0,12512,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624872,50597,,1,10116.0,12513,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624873,50597,,1,10116.0,12514,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624874,50597,,1,10116.0,12515,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624875,50597,,1,10116.0,12516,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624876,50597,,1,10116.0,12517,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624877,50597,,1,10116.0,12518,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624878,50597,,1,10116.0,12519,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624879,50597,,1,10116.0,12520,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624880,50597,,1,10116.0,12521,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624881,50597,,1,10116.0,12522,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL624882,50597,,1,10116.0,12523,,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624883,50597,,1,10116.0,12524,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624884,50597,,1,10116.0,12525,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624885,50597,,1,10116.0,12526,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624886,50597,,1,10116.0,12527,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624887,50597,,1,10116.0,12528,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624888,50597,,1,10116.0,12529,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624889,50597,,1,10116.0,12530,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL624890,50597,,1,10116.0,12531,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621964,50597,,1,10116.0,12532,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL621965,50597,,1,10116.0,12533,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621966,50597,,1,10116.0,12534,,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL621967,50597,,1,10116.0,12535,,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL622164,50597,,1,10116.0,12536,,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623097,22224,,0,,12537,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),7653,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623098,22224,,0,,12538,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),7653,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623099,22224,,0,,12539,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,7653,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623100,22224,,0,,12540,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,7653,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628673,50597,,1,10116.0,12541,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628674,50597,,1,10116.0,12542,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628675,50597,,1,10116.0,12543,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627644,50597,,1,10116.0,12544,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627645,50597,,1,10116.0,12545,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627646,50597,,1,10116.0,12546,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627647,50597,,1,10116.0,12547,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627648,50597,,1,10116.0,12548,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",9104,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627649,50597,,1,10116.0,12549,,,Free level in rat plasma,12902,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628313,22224,,0,,12550,,,Level reaching in blood plasma of rat or human was determined,6614,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628314,50597,,1,10116.0,12551,,,Log (Cbrain/Cblood) in rats,9663,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628315,22224,,0,,12552,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,17658,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628316,22224,,0,,12553,,,Mean percentage of compound transport through membrane; expressed as membrane transport,17658,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628317,22224,,0,,12554,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,14314,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628473,22224,,0,,12555,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,7385,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628474,22224,,0,,12556,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",7385,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628475,22224,,0,,12557,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,7385,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628476,22224,,0,,12558,,,Net water uptake by a carrier mediated transport (%cm) mechanism,1329,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628477,22224,,0,314293.0,12559,,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628478,50506,,1,9669.0,12560,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12187,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628479,50506,,1,9669.0,12561,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12187,Mustela putorius furo,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628480,22224,,0,314293.0,12562,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628481,22224,,0,314293.0,12563,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",12187,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628482,50597,,1,10116.0,12564,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12187,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628483,50597,,1,10116.0,12565,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12187,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628484,50597,,1,10116.0,12566,,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",9278,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628485,50597,,1,10116.0,12567,,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",9278,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628486,100710,,1,9541.0,12568,,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",9278,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628487,50587,,1,9606.0,12569,,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",9278,Homo sapiens,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628488,50597,,1,10116.0,12570,,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",9278,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628489,50597,,1,10116.0,12571,,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",9278,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628490,50597,,1,10116.0,12572,,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",9278,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628491,100710,,1,9541.0,12573,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877507,100710,,1,9541.0,12574,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628492,22224,,0,,12575,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12186,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628493,22224,,0,314293.0,12576,,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),12041,Simiiformes,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628494,22224,,0,314293.0,12577,,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),12041,Simiiformes,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628495,22224,,0,314293.0,12578,,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),12041,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628496,50587,,1,9606.0,12579,,,Permeability in Caco-2 assay at 10E-6,6737,Homo sapiens,,,1
U,,,955.0,BAO_0000218,Autocuration,,A,Brain,CHEMBL628497,22224,,0,,12580,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,13758,,,,1
U,,,955.0,BAO_0000218,Autocuration,,A,Brain,CHEMBL628498,22224,,0,,12581,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,13758,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628499,22224,,0,,12582,,,Plasma protein binding was determined,5676,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627656,22224,,0,,12583,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627657,22224,,0,,12584,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626808,22224,,0,,12585,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626809,22224,,0,,12586,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626810,22224,,0,,12587,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626811,22224,,0,,12588,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL874465,22224,,0,,12589,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626812,22224,,0,,12590,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626813,22224,,0,,12591,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626814,22224,,0,,12592,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,14793,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626815,22224,,0,,12593,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,14000,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628566,22224,,0,,12594,,,Partition coefficient (logP),5948,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628567,22229,,0,,12595,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13824,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628568,22229,,0,,12596,,,Calculated partition coefficient (clogP),10778,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628569,50588,,1,9615.0,12597,In vivo,,C max in dog,17237,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628570,50512,,1,10141.0,12598,In vivo,,C max in guinea pig,17237,Cavia porcellus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628571,22224,,0,,12599,In vivo,,C max value was evaluated,2809,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628572,22224,,0,,12600,In vivo,,Cmax value after oral dose of 0.1 mg//kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628573,22224,,0,,12601,In vivo,,Cmax value after oral dose of 0.3 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628574,22224,,0,,12602,In vivo,,Cmax value after oral dose of 1 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628575,22224,,0,,12603,In vivo,,Cmax value after oral dose of 10 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628576,22224,,0,,12604,In vivo,,Cmax value after oral dose of 23.4 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628577,22224,,0,,12605,In vivo,,Cmax value after oral dose of 3 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628578,22224,,0,,12606,In vivo,,Cmax value after oral dose of 3.87 mg/kg,11954,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874466,50588,,1,9615.0,12607,In vivo,,Cmax value in female Beagle dogs,12768,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628579,50597,,1,10116.0,12608,In vivo,,Cmax value in male rats,12768,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628580,50597,,1,10116.0,12609,In vivo,,Cmax value in rat plasma when administered 20 mg/kg perorally,12780,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628581,50588,,1,9615.0,12610,In vivo,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,15592,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628582,50588,,1,9615.0,12611,In vivo,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,15592,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628583,50588,,1,9615.0,12612,,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,17025,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625782,22224,,0,314293.0,12613,,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,17025,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625783,50592,,1,9986.0,12614,,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,17025,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625784,50597,,1,10116.0,12615,,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,17025,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625785,50797,,1,9544.0,12616,,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,4236,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625786,50597,,1,10116.0,12617,,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,15791,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874467,22224,,0,,12618,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,11149,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625787,50588,,1,9615.0,12619,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",15592,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625964,50677,,1,12721.0,12620,,,cytotoxicity against HIV protease enzyme.,15778,Human immunodeficiency virus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625965,50594,,1,10090.0,12621,,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,12745,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625966,50594,,1,10090.0,12622,,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,12745,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625967,50588,,1,9615.0,12623,In vivo,,The plasma clearance in dog.,13941,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625968,50597,,1,10116.0,12624,In vivo,,The plasma clearance in rat.,13941,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625969,50597,,1,10116.0,12625,In vivo,,Clearance from plasma in male Sprague-Dawley rats,16449,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625970,100710,,1,9541.0,12626,In vivo,,Clearance from plasma in male cynomolgus monkeys,16449,Macaca fascicularis,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625971,50588,,1,9615.0,12627,In vivo,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",14224,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625972,50588,,1,9615.0,12628,In vivo,,Clearance of compound in dog plasma,14224,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625973,50587,,1,9606.0,12629,In vivo,,Clearance of compound in human plasma,14224,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625974,50588,,1,9615.0,12630,In vivo,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,14317,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625975,50588,,1,9615.0,12631,In vivo,,Clearance of compound when administered intravenously as an individual dose to a single dog.,14317,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625976,50588,,1,9615.0,12632,In vivo,,"Clearance (10 mg/kg, intravenously) in dog plasma",14224,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625977,50588,,1,9615.0,12633,In vivo,,Clearance value in dog,17237,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625978,50512,,1,10141.0,12634,In vivo,,Clearance value in guinea pig,17237,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874468,50597,,1,10116.0,12635,In vivo,,Clearance values in rats after iv administration.,14187,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL625421,22224,,0,,12636,In vivo,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,4806,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625422,50592,,1,9986.0,12637,In vivo,,In vivo clearance (5 mg/kg) was determined in rabbits,15025,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625423,50597,,1,10116.0,12638,In vivo,,Plasma Clearance rate was determined for the compound in rats,13197,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625424,22224,,0,9520.0,12639,In vivo,,Plasma Clearance rate was determined for the compound in squirrel monkeys,13197,Saimiri,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625425,50597,,1,10116.0,12640,In vivo,,Plasma clearance in rat,13960,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625426,22224,,0,,12641,In vivo,,Plasma clearance of the compound,17820,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625427,50512,,1,10141.0,12642,In vivo,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,14706,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625428,50512,,1,10141.0,12643,In vivo,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,14706,Cavia porcellus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625429,22224,,0,,12644,In vivo,,Plasma clearance was determined,6504,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625430,50588,,1,9615.0,12645,In vivo,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,14925,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625431,50597,,1,10116.0,12646,In vivo,,Plasma clearance rate was determined for the compound in rats,13197,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627307,22224,,0,9520.0,12647,In vivo,,Plasma clearance rate was determined for the compound in squirrel monkeys,13197,Saimiri,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627308,22224,,0,,12648,In vivo,,Slow clearance (CL) was determined,3437,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627309,22224,,0,,12649,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627310,22224,,0,,12650,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627311,22224,,0,,12651,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627312,22224,,0,,12652,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627313,22224,,0,,12653,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627314,22224,,0,,12654,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627315,22224,,0,,12655,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627316,22224,,0,,12656,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627317,22224,,0,,12657,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627318,22224,,0,,12658,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627999,22224,,0,,12659,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628000,22224,,0,,12660,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628001,22224,,0,,12661,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628002,22224,,0,,12662,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625610,22224,,0,,12663,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625611,22224,,0,,12664,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625612,22224,,0,,12665,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625613,22224,,0,,12666,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875479,22224,,0,,12667,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625614,22224,,0,,12668,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625615,22224,,0,,12669,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,9196,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626302,22224,,0,,12670,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,9196,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626303,50597,,1,10116.0,12671,,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627420,50597,,1,10116.0,12672,,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627421,50597,,1,10116.0,12673,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625695,50597,,1,10116.0,12674,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625696,50597,,1,10116.0,12675,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,13477,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL875606,50594,,1,10090.0,12676,,,Distribution of compound in mice brain was measured after 1 hr,10009,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625697,50594,,1,10090.0,12677,,,Distribution of compound in mice brain was measured after 24 hr r,10009,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625698,50594,,1,10090.0,12678,,,Distribution of compound in mice brain was measured after 2 hr,10009,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625699,50594,,1,10090.0,12679,,,Distribution of compound in mice brain was measured after 3 hr,10009,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625700,50594,,1,10090.0,12680,,,Distribution of compound in mice brain was measured after 6 hr,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625701,50594,,1,10090.0,12681,,,Distribution of compound in mice liver was measured after 1 hr,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625702,50594,,1,10090.0,12682,,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625703,50594,,1,10090.0,12683,,,Distribution of compound in mice liver was measured after 2 hr,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625704,50594,,1,10090.0,12684,,,Distribution of compound in mice liver was measured after 3 hr,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625705,50594,,1,10090.0,12685,,,Distribution of compound in mice liver was measured after 6 hr,10009,Mus musculus,,,1
N,,,1236.0,BAO_0000218,Intermediate,,A,Adrenal medulla,CHEMBL625706,50588,,1,9615.0,12686,,,Distribution in dog adrenal medulla 30 min after administration.,8170,Canis lupus familiaris,,,1
N,,,1236.0,BAO_0000218,Intermediate,,A,Adrenal medulla,CHEMBL625707,50588,,1,9615.0,12687,,,Distribution in dog adrenal medulla 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625708,50588,,1,9615.0,12688,,,Distribution in female dog Ovary 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625709,50588,,1,9615.0,12689,,,Distribution in female dog Ovary 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624180,50588,,1,9615.0,12690,,,Distribution in female dog adipose 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624181,50588,,1,9615.0,12691,,,Distribution in female dog adipose 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,1235.0,BAO_0000218,Intermediate,,A,Adrenal cortex,CHEMBL624182,50588,,1,9615.0,12692,,,Distribution in female dog adrenal cortex 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,1235.0,BAO_0000218,Intermediate,,A,Adrenal cortex,CHEMBL624183,50588,,1,9615.0,12693,,,Distribution in female dog adrenal cortex 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624184,50597,,1,10116.0,12694,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL877489,50597,,1,10116.0,12695,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624185,50597,,1,10116.0,12696,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624186,50597,,1,10116.0,12697,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624187,50597,,1,10116.0,12698,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL624188,50597,,1,10116.0,12699,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624189,50597,,1,10116.0,12700,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624190,50597,,1,10116.0,12701,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624191,50597,,1,10116.0,12702,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624192,50597,,1,10116.0,12703,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624193,50597,,1,10116.0,12704,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624194,50597,,1,10116.0,12705,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624891,50597,,1,10116.0,12706,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624892,50597,,1,10116.0,12707,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL624893,50597,,1,10116.0,12708,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627632,50597,,1,10116.0,12709,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627633,50597,,1,10116.0,12710,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627634,50597,,1,10116.0,12711,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627635,50597,,1,10116.0,12712,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627636,50597,,1,10116.0,12713,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626816,50597,,1,10116.0,12714,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626817,50597,,1,10116.0,12715,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626818,50597,,1,10116.0,12716,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626819,50597,,1,10116.0,12717,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626820,50597,,1,10116.0,12718,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626821,50597,,1,10116.0,12719,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626822,50597,,1,10116.0,12720,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626823,50597,,1,10116.0,12721,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626824,50597,,1,10116.0,12722,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626825,50597,,1,10116.0,12723,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626826,50597,,1,10116.0,12724,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626827,50597,,1,10116.0,12725,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626828,50597,,1,10116.0,12726,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626829,50597,,1,10116.0,12727,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL626830,50597,,1,10116.0,12728,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627150,50597,,1,10116.0,12729,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627151,50597,,1,10116.0,12730,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627152,50597,,1,10116.0,12731,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627153,50597,,1,10116.0,12732,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627154,22224,,0,,12733,,,Rate of acetate production by the compound was determined,12904,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627155,22224,,0,,12734,,,Rate of acetate production by the compound was determined; Not determined,12904,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627156,22224,,0,,12735,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,3730,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627157,22224,,0,,12736,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,3627,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627158,50592,,1,9986.0,12737,,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,13799,Oryctolagus cuniculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627159,50592,,1,9986.0,12738,,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,13799,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627160,50594,,1,10090.0,12739,,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628540,50597,,1,10116.0,12740,,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628541,50597,,1,10116.0,12741,,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628542,50597,,1,10116.0,12742,,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628543,22229,,0,,12743,,,Solubility after at a pH 1.2,6629,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628544,22229,,0,,12744,,,Solubility after at pH 1.2,6629,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628545,22229,,0,,12745,,,Solubility after injection of water,6629,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628546,22224,,0,,12746,,,Statistical significance of IC 50 values; Expressed as R value,14000,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874455,22224,,0,,12747,,,Systemic availability with respect to methyldopa was determined,8267,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628547,50597,,1,10116.0,12748,,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,13799,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL628548,50597,,1,10116.0,12749,,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,13799,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628549,50592,,1,9986.0,12750,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628550,50592,,1,9986.0,12751,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628551,50592,,1,9986.0,12752,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628552,50592,,1,9986.0,12753,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628553,50592,,1,9986.0,12754,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628554,50592,,1,9986.0,12755,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628555,50592,,1,9986.0,12756,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628556,50592,,1,9986.0,12757,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628557,50592,,1,9986.0,12758,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628558,50592,,1,9986.0,12759,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628559,50592,,1,9986.0,12760,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628560,50592,,1,9986.0,12761,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874456,50592,,1,9986.0,12762,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628561,50592,,1,9986.0,12763,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL628562,50592,,1,9986.0,12764,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628563,50592,,1,9986.0,12765,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628564,50592,,1,9986.0,12766,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628565,50592,,1,9986.0,12767,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631248,50592,,1,9986.0,12768,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631249,50592,,1,9986.0,12769,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",7132,Oryctolagus cuniculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627214,50592,,1,9986.0,12770,,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL874591,50592,,1,9986.0,12771,,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL627215,50592,,1,9986.0,12772,,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL625471,50592,,1,9986.0,12773,,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,7132,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625472,50592,,1,9986.0,12774,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,7132,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625473,50592,,1,9986.0,12775,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,7132,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625474,50588,,1,9615.0,12776,In vivo,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,13317,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625475,50588,,1,9615.0,12777,In vivo,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,15341,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625476,50597,,1,10116.0,12778,In vivo,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,15341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625477,50597,,1,10116.0,12779,In vivo,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,15341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625478,50597,,1,10116.0,12780,In vivo,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,15341,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,esophageal tunica muscularis mucosae,CHEMBL625479,50597,,1,10116.0,12781,In vitro,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,12801,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,esophageal tunica muscularis mucosae,CHEMBL625480,50597,,1,10116.0,12782,In vitro,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,12801,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625481,50597,,1,10116.0,12783,In vivo,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,14856,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625482,50597,,1,10116.0,12784,In vivo,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625483,50597,,1,10116.0,12785,In vivo,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625484,50597,,1,10116.0,12786,In vivo,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625485,50597,,1,10116.0,12787,In vivo,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,14062,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625486,50588,,1,9615.0,12788,In vivo,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,14346,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625487,50597,,1,10116.0,12789,In vivo,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625488,50597,,1,10116.0,12790,In vivo,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625489,50597,,1,10116.0,12791,In vivo,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625490,50597,,1,10116.0,12792,In vivo,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625491,50588,,1,9615.0,12793,In vivo,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,14346,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625492,50597,,1,10116.0,12794,In vivo,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625493,50587,,1,9606.0,12795,In vivo,,plasma clearance in human,15711,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625494,50597,,1,10116.0,12796,In vivo,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,14886,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625495,50597,,1,10116.0,12797,In vivo,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,14886,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625496,50597,,1,10116.0,12798,In vivo,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,14886,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625497,22229,,0,,12799,,,1-Octanol/water partition coefficient measured at 7.4,4115,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625498,22229,,0,,12800,,,Calculated partition coefficient (clogP),13733,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625499,22224,,0,,12801,,,Partition coefficient (logP),12102,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625500,22229,,0,,12802,,,Calculated partition coefficient (clogP),12676,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625501,22229,,0,,12803,,,Calculated partition coefficient (clogP),13733,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625502,22229,,0,,12804,,,Calculated partition coefficient (clogP),13740,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625503,22229,,0,,12805,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),12766,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625504,22229,,0,,12806,,,Calculated partition coefficient (clogP),2764,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625505,22229,,0,,12807,,,Calculated partition coefficient (clogP),12355,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625506,22229,,0,,12808,,,Calculated partition coefficient of the compound,11314,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625507,22224,,0,,12809,,,Partition coefficient (logP),12706,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625508,22229,,0,,12810,,,Calculated partition coefficient (clogP),12645,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625509,22229,,0,,12811,,,Calculated partition coefficient (clogP),13668,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625510,22229,,0,,12812,,,Calculated partition coefficient (clogP),12819,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL883125,22229,,0,,12813,,,Calculated partition coefficient (clogP),13668,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625511,22229,,0,,12814,,,Calculated partition coefficient (clogP),13017,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874650,22224,,0,,12815,,,Partition coefficient of the compound,2448,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625512,22224,,0,,12816,,,Partition coefficient of the compound,11526,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625513,22224,,0,,12817,,,Partition coefficient of compound was determined,12426,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625514,22224,,0,,12818,,,Partition coefficient was determined,2448,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625515,22229,,0,,12819,,,Calculated partition coefficient (clogP),12001,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625516,22229,,0,,12820,,,partition coefficient of compound was determined,12426,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625517,50588,,1,9615.0,12821,In vivo,,The total body administered intravenously in dog,13204,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625518,50597,,1,10116.0,12822,In vivo,,The total body administered intravenously in rats,13204,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625519,50594,,1,10090.0,12823,,,Time taken for the administration to female NIH mice weighing 25-30 g.,13889,Mus musculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625520,22224,,0,,12824,,,Time taken for the administration,13889,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874651,50588,,1,9615.0,12825,In vivo,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,17025,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625521,22224,,0,314293.0,12826,In vivo,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,17025,Simiiformes,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623171,50592,,1,9986.0,12827,In vivo,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,17025,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623853,50597,,1,10116.0,12828,In vivo,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,17025,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623854,22224,,0,,12829,,,Plasma clearance for the compound was determined.,15067,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL874405,22224,,0,,12830,,,CLog P value of the compound,3091,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623855,22229,,0,,12831,,,Calculated partition coefficient (clogP),15592,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623856,22229,,0,,12832,,,Calculated partition coefficient (clogP),14738,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623857,22224,,0,,12833,,,ClogP value of the compound; nd ='no data',14738,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623858,22224,,0,,12834,,,ClogP value of the compound; nd ='not determined',14738,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623859,22224,,0,,12835,,,CLog P was determined,6076,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL839829,22229,,0,,12836,,,Calculated partition coefficient (clogP),17840,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623860,22224,,0,,12837,,,CLogP was calculated,13589,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623861,22224,,0,,12838,,,CLogP value was determined,17655,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623862,22224,,0,,12839,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,5867,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL874406,22229,,0,,12840,,,Calculated partition coefficient (clogP),5867,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623863,22229,,0,,12841,,,Calculated partition coefficient (clogP),10783,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624021,22229,,0,,12842,,,Calculated partition coefficient (clogP),14849,,,,1
N,,,1236.0,BAO_0000218,Intermediate,,A,Adrenal medulla,CHEMBL624022,50588,,1,9615.0,12843,,,Distribution in female dog adrenal medulla 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,1236.0,BAO_0000218,Intermediate,,A,Adrenal medulla,CHEMBL624023,50588,,1,9615.0,12844,,,Distribution in female dog adrenal medulla 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624024,50588,,1,9615.0,12845,,,Distribution in female dog bile 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624025,50588,,1,9615.0,12846,,,Distribution in female dog bile 72 hr after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624026,50588,,1,9615.0,12847,,,Distribution in female dog blood 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624027,50588,,1,9615.0,12848,,,Distribution in female dog blood 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624028,50588,,1,9615.0,12849,,,Distribution in female dog heart 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624029,50588,,1,9615.0,12850,,,Distribution in female dog heart 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624030,50588,,1,9615.0,12851,,,Distribution in female dog kidney 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624031,50588,,1,9615.0,12852,,,Distribution in female dog kidney 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624032,50588,,1,9615.0,12853,,,Distribution in female dog large intestine 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL874407,50588,,1,9615.0,12854,,,Distribution in female dog large intestine 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624033,50588,,1,9615.0,12855,,,Distribution in female dog liver 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624034,50588,,1,9615.0,12856,,,Distribution in female dog liver 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624035,50588,,1,9615.0,12857,,,Distribution in female dog lung 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624036,50588,,1,9615.0,12858,,,Distribution in female dog lung 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624037,50588,,1,9615.0,12859,,,Distribution in female dog muscle 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL624038,50588,,1,9615.0,12860,,,Distribution in female dog muscle 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624039,50588,,1,9615.0,12861,,,Distribution in female dog pancreas 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624040,50588,,1,9615.0,12862,,,Distribution in female dog pancreas 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624041,50588,,1,9615.0,12863,,,Distribution in female dog small intestine 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL624042,50588,,1,9615.0,12864,,,Distribution in female dog small intestine 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624043,50588,,1,9615.0,12865,,,Distribution in female dog spleen 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL624044,50588,,1,9615.0,12866,,,Distribution in female dog spleen 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL624045,50588,,1,9615.0,12867,,,Distribution in female dog stomach 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL624046,50588,,1,9615.0,12868,,,Distribution in female dog stomach 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL624047,50588,,1,9615.0,12869,,,Distribution in female dog thyroid 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL624048,50588,,1,9615.0,12870,,,Distribution in female dog thyroid 72 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874408,50588,,1,9615.0,12871,,,Distribution in female dog urine 24 hours after administration.,8170,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624049,50588,,1,9615.0,12872,,,Distribution in female dog urine 72 hr after administration.,8170,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL624050,22224,,0,,12873,,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,14283,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624051,22224,,0,,12874,,,Plasma concentration at 7 hr after intravenous dosing,5623,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623278,50597,,1,10116.0,12875,,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623279,50597,,1,10116.0,12876,,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623280,50597,,1,10116.0,12877,,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623963,50597,,1,10116.0,12878,,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623964,50597,,1,10116.0,12879,,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623965,50597,,1,10116.0,12880,,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623966,50597,,1,10116.0,12881,,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874415,50597,,1,10116.0,12882,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623967,50597,,1,10116.0,12883,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623968,50597,,1,10116.0,12884,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623969,50597,,1,10116.0,12885,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628409,50597,,1,10116.0,12886,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628410,50597,,1,10116.0,12887,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628411,50597,,1,10116.0,12888,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628412,50597,,1,10116.0,12889,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,13477,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628413,22224,,0,,12890,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,12553,,,,1
U,,,1969.0,BAO_0000019,Autocuration,,A,Plasma,CHEMBL628414,22224,,0,,12891,,,The concentration in plasmat; Not determined,14548,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628415,50597,,1,10116.0,12892,,,Tissue level at 10 mg/kg/po in wistar rats in blood,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628416,50597,,1,10116.0,12893,,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628417,50597,,1,10116.0,12894,,,Tissue level at 10 mg/kg/po in wistar rats in heart,14393,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL874908,50597,,1,10116.0,12895,,,Tissue level at 10 mg/kg/po in wistar rats in liver,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628418,50597,,1,10116.0,12896,,,Tissue level at 10 mg/kg/po in wistar rats in plasma,14393,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL628419,50597,,1,10116.0,12897,,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628420,50597,,1,10116.0,12898,,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,14393,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628421,22224,,0,,12899,,,Water solubility at 37 degree C.,1629,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626726,22229,,0,,12900,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,8194,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626727,22229,,0,,12901,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,8194,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626728,50597,,1,10116.0,12902,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626729,50597,,1,10116.0,12903,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626730,50597,,1,10116.0,12904,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626731,50597,,1,10116.0,12905,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL626732,50597,,1,10116.0,12906,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626733,50597,,1,10116.0,12907,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626734,50597,,1,10116.0,12908,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626735,50597,,1,10116.0,12909,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL874909,50597,,1,10116.0,12910,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL626736,50597,,1,10116.0,12911,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL626737,50597,,1,10116.0,12912,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630999,50597,,1,10116.0,12913,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL631000,50597,,1,10116.0,12914,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL631001,50597,,1,10116.0,12915,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL631002,50597,,1,10116.0,12916,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631003,50597,,1,10116.0,12917,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631004,50597,,1,10116.0,12918,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631005,50597,,1,10116.0,12919,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631006,50597,,1,10116.0,12920,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631007,50597,,1,10116.0,12921,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL631008,50597,,1,10116.0,12922,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL631009,50597,,1,10116.0,12923,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL631010,50597,,1,10116.0,12924,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL631011,50597,,1,10116.0,12925,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL631012,50597,,1,10116.0,12926,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630271,50597,,1,10116.0,12927,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630272,50597,,1,10116.0,12928,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630273,50597,,1,10116.0,12929,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630274,50597,,1,10116.0,12930,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630275,50597,,1,10116.0,12931,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875782,50597,,1,10116.0,12932,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630276,50597,,1,10116.0,12933,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630277,50597,,1,10116.0,12934,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630278,50597,,1,10116.0,12935,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630279,50597,,1,10116.0,12936,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630280,22224,,0,,12937,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,8151,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630281,22224,,0,,12938,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630282,50592,,1,9986.0,12939,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,7132,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630283,50592,,1,9986.0,12940,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,7132,Oryctolagus cuniculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630284,22224,,0,,12941,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),5797,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630285,22224,,0,,12942,,,Alkylating activity was determined,7849,,,,1
U,,,,BAO_0000251,Autocuration,,A,,CHEMBL630286,22224,,0,,12943,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),14220,,Microsomes,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630069,50592,,1,9986.0,12944,,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",8650,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630070,50592,,1,9986.0,12945,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",8650,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630071,50592,,1,9986.0,12946,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",8650,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630072,50592,,1,9986.0,12947,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",8650,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875110,50592,,1,9986.0,12948,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",8650,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630073,50597,,1,10116.0,12949,,,Compound was tested for antidiuretic activity in rats,7116,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630074,22224,,0,,12950,,,Compound was tested for inactivation kinetic values,14131,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL630075,22224,,0,,12951,In vivo,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,7415,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630076,22224,,0,,12952,,,Dissociation rate calculated from the first-order equation using the t1/2 value,13178,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630077,22229,,0,,12953,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,8815,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630078,22229,,0,,12954,,,Aqueous solubility was measured,1450,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630079,22229,,0,,12955,,,Aqueous solubility was measured at a pH 4,1450,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630080,22229,,0,,12956,,,Aqueous solubility (pH 7),1450,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630081,22229,,0,,12957,,,Aqueous solubility was measured at a pH 9,1450,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630082,22224,,0,,12958,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",12711,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630083,22224,,0,,12959,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12711,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630084,22224,,0,,12960,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12711,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629198,22229,,0,,12961,,,Aqueous solubility of the compound,15032,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629199,22229,,0,,12962,,,Aqueous solubility at 37 degree Celsius at pH 7.38,9964,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629200,22229,,0,,12963,,,Aqueous solubility in pH 7.4 phosphate buffer,14962,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629201,50588,,1,9615.0,12964,,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,12487,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629202,50588,,1,9615.0,12965,,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,12487,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875111,50587,,1,9606.0,12966,,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629203,50587,,1,9606.0,12967,,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629204,50587,,1,9606.0,12968,,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629205,50587,,1,9606.0,12969,,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629206,50587,,1,9606.0,12970,,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631185,22224,,0,,12971,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,10026,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631186,50597,,1,10116.0,12972,,,Compound was evaluated for the average bile flow rat in rats,7415,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631187,50592,,1,9986.0,12973,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",17025,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631188,50592,,1,9986.0,12974,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",17025,Oryctolagus cuniculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL876419,22224,,0,,12975,,,Average half life period was determined,10184,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631189,22224,,0,,12976,,,Average half life period was determined,10184,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631190,50602,,1,10298.0,12977,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631191,50602,,1,10298.0,12978,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631192,50602,,1,10298.0,12979,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632400,50602,,1,10298.0,12980,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630564,50602,,1,10298.0,12981,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630565,50602,,1,10298.0,12982,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630566,50602,,1,10298.0,12983,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631229,50602,,1,10298.0,12984,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631230,50602,,1,10298.0,12985,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,8613,Human herpesvirus 1,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL876428,22229,,0,,12986,,,Calculated partition coefficient (clogP),6030,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631231,22229,,0,,12987,,,Calculated partition coefficient (clogP),6147,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631232,22229,,0,,12988,,,Calculated partition coefficient (clogP) (MacLogP),14556,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631233,22224,,0,,12989,,,Hydrophilicity was determined,768,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631234,22229,,0,,12990,,,Calculated partition coefficient (clogP),14452,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL883126,22224,,0,,12991,,,Increased absorption was determined,5237,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631235,22224,,0,,12992,,,Lipophilicity value was evaluated,14378,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631236,22224,,0,,12993,,,Log P value of the compound.,14418,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631237,22224,,0,,12994,,,Partition coefficient of compound was determined,5249,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631238,22229,,0,,12995,,,Calculated partition coefficient (clogP),14621,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL876429,22229,,0,,12996,,,Calculated partition coefficient (clogP),12542,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631414,22224,,0,,12997,,,Partition coefficient was measured by medchem software; Not calculated,12542,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631415,22224,,0,,12998,,,Partition coefficient was measured by octanol-water using standard shake-flask method,12542,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631416,22229,,0,,12999,,,Calculated partition coefficient (clogP),15462,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631417,22224,,0,,13000,,,Partition coefficient (logP),14884,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631418,22229,,0,,13001,,,Calculated partition coefficient (clogP),16526,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631419,22229,,0,,13002,,,The Octanol/Water partition coefficient CLogP,13693,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631420,22224,,0,,13003,,,The pharmacokinetic parameter C Log p was reported,13693,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631421,22229,,0,,13004,,,Calculated partition coefficient (clogP),13779,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631422,22229,,0,,13005,,,Calculated partition coefficient (clogP),14772,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631423,22229,,0,,13006,,,Calculated partition coefficient (clogP),14393,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL876430,50597,,1,10116.0,13007,In vivo,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631424,50597,,1,10116.0,13008,In vivo,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631425,50588,,1,9615.0,13009,In vivo,,Compound was administered intravenously in dog to evaluate plasma clearance values,13744,Canis lupus familiaris,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL631426,22224,,0,314293.0,13010,In vivo,,Compound was administered intravenously in monkey to evaluate plasma clearance values,13744,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631427,50594,,1,10090.0,13011,In vivo,,Compound was administered intravenously in mouse to evaluate plasma clearance values,13744,Mus musculus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631428,50588,,1,9615.0,13012,In vivo,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,13207,Canis lupus familiaris,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631429,50797,,1,9544.0,13013,In vitro,,Intrinsic clearance in Rhesus liver microsome,5669,Macaca mulatta,Microsomes,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631430,50588,,1,9615.0,13014,In vitro,,Intrinsic clearance in dog liver microsome,5669,Canis lupus familiaris,Microsomes,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631431,50597,,1,10116.0,13015,In vitro,,Intrinsic clearance in rat liver microsome,5669,Rattus norvegicus,Microsomes,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL631432,50797,,1,9544.0,13016,In vivo,,Low plasma clearance was calculated in rhesus monkey,4853,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631433,50588,,1,9615.0,13017,In vivo,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,16452,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631434,22224,,0,,13018,In vivo,,Plasma clearance after intravenous dose of 0.3 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631435,22224,,0,,13019,In vivo,,Plasma clearance after intravenous dose of 1 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631436,22224,,0,,13020,In vivo,,Plasma clearance after intravenous dose of 3 mg/kg,11954,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631437,22224,,0,,13021,In vivo,,Plasma clearance after intravenous dose of 3.87 mg/kg,11954,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631438,50597,,1,10116.0,13022,In vivo,,Plasma clearance after peroral administration at 10 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876431,50797,,1,9544.0,13023,In vivo,,Plasma clearance after peroral administration at 10 mpk in Rhesus,5669,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631439,50588,,1,9615.0,13024,In vivo,,Plasma clearance after peroral administration at 10 mpk in dog,5669,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631440,50597,,1,10116.0,13025,In vivo,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,13662,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631441,22224,,0,,13026,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),8272,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631442,22224,,0,,13027,,,Critical Micellar concentration was determined,13410,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626525,22224,,0,,13028,,,Critical Micellar concentration of the compound. was determined,13410,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627168,22224,,0,,13029,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,12628,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875618,22224,,0,,13030,,,Critical micellar concentration was measured in water by the dye solubilization method,9675,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL626612,22224,,0,,13031,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,12628,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626613,22224,,0,,13032,,,CMR value (relative to BAY K 8644),12766,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626614,22224,,0,,13033,,,Carbamoylating activity was determined,7849,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626615,22224,,0,314293.0,13034,,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626616,22224,,0,,13035,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,2040,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626617,22224,,0,,13036,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,2040,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626618,50588,,1,9615.0,13037,In vivo,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,14180,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626619,50597,,1,10116.0,13038,In vivo,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,14180,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626620,50588,,1,9615.0,13039,In vivo,,"Clearance rate at 0.46 mg/kg, iv, in dogs",14474,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626621,50597,,1,10116.0,13040,In vivo,,"Clearance rate at 5.5 mg/kg, iv, in rat",14474,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626622,100710,,1,9541.0,13041,In vivo,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,14548,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626623,100710,,1,9541.0,13042,In vivo,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,14548,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626624,50588,,1,9615.0,13043,In vivo,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,14548,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626625,50597,,1,10116.0,13044,In vivo,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,14548,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL626626,50597,,1,10116.0,13045,Ex vivo,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,6125,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626627,22224,,0,,13046,In vivo,,Tested for the total clearance of the compound,6874,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626628,50588,,1,9615.0,13047,In vivo,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,15343,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626629,22224,,0,,13048,In vivo,,Total body clearance was determined,6236,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626630,50597,,1,10116.0,13049,,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626631,50597,,1,10116.0,13050,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,11510,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626632,22229,,0,,13051,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,8194,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626633,22229,,0,,13052,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,8194,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626634,22229,,0,,13053,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,8194,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626635,22229,,0,,13054,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,8194,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626636,22229,,0,,13055,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,8194,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626637,22229,,0,,13056,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,8194,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626638,50339,,1,4754.0,13057,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626639,50339,,1,4754.0,13058,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626640,50339,,1,4754.0,13059,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626641,50339,,1,4754.0,13060,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627272,50339,,1,4754.0,13061,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627273,50339,,1,4754.0,13062,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627441,50339,,1,4754.0,13063,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628355,50339,,1,4754.0,13064,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628356,50339,,1,4754.0,13065,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628357,50339,,1,4754.0,13066,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628358,50339,,1,4754.0,13067,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),13273,Pneumocystis carinii,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622307,50339,,1,4754.0,13068,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),13273,Pneumocystis carinii,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622527,22224,,0,,13069,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622528,22224,,0,,13070,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622529,22224,,0,,13071,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622992,22224,,0,,13072,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622993,22224,,0,,13073,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,13118,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622994,22224,,0,,13074,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,13118,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622995,50597,,1,10116.0,13075,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",10633,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622996,50597,,1,10116.0,13076,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",10633,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622997,50597,,1,10116.0,13077,,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",10633,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622998,50597,,1,10116.0,13078,,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",10633,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622999,22224,,0,,13079,,,Cp max following ip administration at 1 mg/kg,5767,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623000,22224,,0,,13080,In vivo,,Maximum concentration in plasma was reported at 0.5 hour,3302,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL623001,22224,,0,,13081,In vivo,,Maximum concentration in plasma was reported at 2 hour,3302,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623002,50594,,1,10090.0,13082,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,12467,Mus musculus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623003,22229,,0,,13083,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),11778,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623004,22224,,0,,13084,,,Steady state concentration was evaluated,4321,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623005,22224,,0,,13085,,,Partition coefficient (logP),14884,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623006,22224,,0,,13086,,,Partition coefficient (logD7.4),15234,,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623007,50597,,1,10116.0,13087,In vivo,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL623008,50597,,1,10116.0,13088,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL876654,50597,,1,10116.0,13089,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623009,50597,,1,10116.0,13090,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623010,50597,,1,10116.0,13091,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623011,50597,,1,10116.0,13092,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL623012,50597,,1,10116.0,13093,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,14198,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623013,22224,,0,,13094,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,8151,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623014,22224,,0,,13095,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL623015,22224,,0,,13096,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,8151,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL623016,22224,,0,,13097,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,8151,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL624858,22224,,0,,13098,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,8151,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624859,50597,,1,10116.0,13099,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624860,50597,,1,10116.0,13100,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624861,50597,,1,10116.0,13101,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624862,50597,,1,10116.0,13102,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624863,50597,,1,10116.0,13103,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876655,50597,,1,10116.0,13104,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,8151,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624864,50588,,1,9615.0,13105,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624865,50588,,1,9615.0,13106,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624866,50588,,1,9615.0,13107,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL624867,50588,,1,9615.0,13108,,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624868,50588,,1,9615.0,13109,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628450,50588,,1,9615.0,13110,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628451,50588,,1,9615.0,13111,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628452,50588,,1,9615.0,13112,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628453,50588,,1,9615.0,13113,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628454,50588,,1,9615.0,13114,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628455,50588,,1,9615.0,13115,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628456,50588,,1,9615.0,13116,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628457,50588,,1,9615.0,13117,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877505,50588,,1,9615.0,13118,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628458,50588,,1,9615.0,13119,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628459,50588,,1,9615.0,13120,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628460,50588,,1,9615.0,13121,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628461,50588,,1,9615.0,13122,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,6996,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,B,,CHEMBL628462,22224,,0,,13123,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",6996,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628463,50588,,1,9615.0,13124,,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL625666,50597,,1,10116.0,13125,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",6996,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,B,,CHEMBL625667,22224,,0,,13126,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,,,,1
N,,,,BAO_0000218,Expert,,A,,CHEMBL625668,50597,,1,10116.0,13127,,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625669,50597,,1,10116.0,13128,,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625670,22224,,0,,13129,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,7114,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625671,50597,,1,10116.0,13130,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,7114,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625672,50602,,1,10298.0,13131,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625673,50602,,1,10298.0,13132,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625674,50602,,1,10298.0,13133,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625675,50602,,1,10298.0,13134,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627637,50602,,1,10298.0,13135,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627638,50602,,1,10298.0,13136,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627639,50602,,1,10298.0,13137,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627640,50602,,1,10298.0,13138,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627641,50602,,1,10298.0,13139,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627642,50602,,1,10298.0,13140,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877506,50602,,1,10298.0,13141,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627275,50594,,1,10090.0,13142,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,8613,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627643,50506,,1,9669.0,13143,,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631246,50506,,1,9669.0,13144,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631247,50506,,1,9669.0,13145,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629532,50506,,1,9669.0,13146,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629533,50506,,1,9669.0,13147,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629534,50506,,1,9669.0,13148,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629535,50506,,1,9669.0,13149,,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,11219,Mustela putorius furo,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625932,22224,,0,,13150,,,Pharmacokinetic parameter :drug bound to plasma was reported,14837,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625933,22224,,0,,13151,,,compound was evaluated for drug bound in plasma,14837,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625934,50597,,1,10116.0,13152,,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,15343,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625935,22224,,0,9347.0,13153,,,Bioavailability,13761,Eutheria,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625936,50597,,1,10116.0,13154,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,14810,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625937,50597,,1,10116.0,13155,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,14810,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625938,50588,,1,9615.0,13156,,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13249,Canis lupus familiaris,,,1
N,,,1970.0,BAO_0000218,Intermediate,,A,Bile,CHEMBL625939,50597,,1,10116.0,13157,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,9267,Rattus norvegicus,,,1
N,,,1970.0,BAO_0000218,Intermediate,,A,Bile,CHEMBL625940,50597,,1,10116.0,13158,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,9267,Rattus norvegicus,,,1
N,,,1970.0,BAO_0000218,Intermediate,,A,Bile,CHEMBL874464,50597,,1,10116.0,13159,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,9267,Rattus norvegicus,,,1
N,,,1970.0,BAO_0000218,Intermediate,,A,Bile,CHEMBL625941,50597,,1,10116.0,13160,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,9267,Rattus norvegicus,,,1
N,,,1970.0,BAO_0000218,Intermediate,,A,Bile,CHEMBL625942,50597,,1,10116.0,13161,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,9267,Rattus norvegicus,,,1
N,,,1970.0,BAO_0000218,Intermediate,,A,Bile,CHEMBL625943,50597,,1,10116.0,13162,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,9267,Rattus norvegicus,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL625944,50587,,1,9606.0,13163,,,In vitro protein binding in human serum at 5 ug/ml,15549,Homo sapiens,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625945,22224,,0,,13164,,,Serum protein binding ability was measured,10929,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625946,22224,,0,,13165,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),15444,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625947,22224,,0,9615.0,13166,In vivo,,Oral bioavailability in dog,12860,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625948,50597,,1,10116.0,13167,In vivo,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,12170,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625949,22224,,0,,13168,In vivo,,Absolute oral bioavailability at an iv dose of 14 mg/kg,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625950,22224,,0,,13169,In vivo,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625951,22224,,0,9347.0,13170,In vivo,,Oral bioavailability (dose 15 mg/kg i.v.),15173,Eutheria,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625952,22224,,0,,13171,In vivo,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625953,22224,,0,,13172,In vivo,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625954,22224,,0,,13173,In vivo,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL882959,22224,,0,,13174,In vivo,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,15173,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625955,50588,,1,9615.0,13175,In vivo,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,11767,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625956,22224,,0,9669.0,13176,In vivo,,Bioavailability in ferret,11219,Mustela putorius furo,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625957,100710,,1,9541.0,13177,In vivo,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,12186,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625958,50597,,1,10116.0,13178,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625959,50597,,1,10116.0,13179,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626642,50597,,1,10116.0,13180,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631330,50597,,1,10116.0,13181,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631331,50597,,1,10116.0,13182,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631332,50597,,1,10116.0,13183,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631333,50597,,1,10116.0,13184,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632018,50597,,1,10116.0,13185,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632019,50597,,1,10116.0,13186,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632020,50597,,1,10116.0,13187,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632021,50597,,1,10116.0,13188,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632022,50597,,1,10116.0,13189,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632023,50597,,1,10116.0,13190,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632024,50597,,1,10116.0,13191,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874472,50597,,1,10116.0,13192,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632025,50597,,1,10116.0,13193,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632026,50597,,1,10116.0,13194,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632027,50597,,1,10116.0,13195,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632028,50597,,1,10116.0,13196,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626430,50597,,1,10116.0,13197,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626431,50597,,1,10116.0,13198,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626432,50597,,1,10116.0,13199,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626433,50597,,1,10116.0,13200,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626434,50597,,1,10116.0,13201,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627280,50597,,1,10116.0,13202,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627281,50597,,1,10116.0,13203,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627282,50597,,1,10116.0,13204,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,11510,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627283,22224,,0,,13205,,,Total body clearance was measured at given dose,7199,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627284,22224,,0,,13206,,,Total body clearance was measured at given dose.,7199,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627285,50597,,1,10116.0,13207,,,Metabolic clearance from the body in rat,7095,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627286,22224,,0,,13208,In vivo,,Renal clearance from the body,7095,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875477,50597,,1,10116.0,13209,In vivo,,Renal clearance from the body in rat,7095,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627287,50597,,1,10116.0,13210,In vivo,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,12528,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627288,50588,,1,9615.0,13211,In vivo,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,12528,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627289,50597,,1,10116.0,13212,,,Total clearance from the body in rat,7095,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627290,50597,,1,10116.0,13213,In vivo,,Clearance into cortex from rat plasma or PBS,14223,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627291,22224,,0,,13214,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,13569,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627292,22224,,0,,13215,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,13569,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627293,22224,,0,,13216,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,13569,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627294,22224,,0,,13217,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13569,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875478,22224,,0,,13218,In vivo,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,13569,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627295,22224,,0,,13219,In vivo,,Clearance was determined,13979,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627296,50594,,1,10090.0,13220,In vivo,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,14315,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626119,50592,,1,9986.0,13221,In vivo,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,14315,Oryctolagus cuniculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626120,50597,,1,10116.0,13222,In vivo,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,14315,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626121,50597,,1,10116.0,13223,In vivo,,Clearance in rat after iv dose (100 ug/kg),12174,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626122,22224,,0,10141.0,13224,In vivo,,Clearance in guinea pig,12797,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626123,50597,,1,10116.0,13225,In vivo,,Compound was evaluated for clearance in rat,12797,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623456,50588,,1,9615.0,13226,In vivo,,Compound was evaluated for the clearance in dog,12797,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623457,50597,,1,10116.0,13227,In vivo,,Compound was evaluated for the clearance in rat,12797,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623458,50597,,1,10116.0,13228,In vivo,,Compound was tested in vivo for clearance after iv administration in the rat,11500,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623459,22224,,0,,13229,In vivo,,IV clearance determined at an iv dose of 14 mg/kg,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875484,22224,,0,,13230,In vivo,,IV clearance determined at an iv dose of 15.2 mg/kg,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623460,22224,,0,,13231,In vivo,,IV clearance determined at an iv dose of 15 mg/kg,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623461,22224,,0,,13232,In vivo,,IV clearance determined at an peroral dose of 30 mg/kg.,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL623462,22224,,0,,13233,In vivo,,IV clearance determined at an peroral dose of 30.2 mg/kg.,15173,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627386,22224,,0,,13234,In vivo,,IV clearance determined at an peroral dose of 30.3 mg/kg.,15173,,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627387,50597,,1,10116.0,13235,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627388,50597,,1,10116.0,13236,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627389,50597,,1,10116.0,13237,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627390,50597,,1,10116.0,13238,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627391,50597,,1,10116.0,13239,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627392,50597,,1,10116.0,13240,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627393,50597,,1,10116.0,13241,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,,,1
N,,,3126.0,BAO_0000218,Intermediate,,A,Trachea,CHEMBL627394,50597,,1,10116.0,13242,In vivo,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627395,50597,,1,10116.0,13243,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL875485,50597,,1,10116.0,13244,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627396,50597,,1,10116.0,13245,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627397,50597,,1,10116.0,13246,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL627398,50597,,1,10116.0,13247,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL627399,50597,,1,10116.0,13248,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627400,50597,,1,10116.0,13249,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627401,50597,,1,10116.0,13250,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627402,50597,,1,10116.0,13251,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL627403,50597,,1,10116.0,13252,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL627404,50597,,1,10116.0,13253,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623101,50597,,1,10116.0,13254,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL877480,50597,,1,10116.0,13255,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,,,1
N,,,3126.0,BAO_0000218,Intermediate,,A,Trachea,CHEMBL623102,50597,,1,10116.0,13256,In vivo,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL623103,50597,,1,10116.0,13257,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL623104,50597,,1,10116.0,13258,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623105,50597,,1,10116.0,13259,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623106,50597,,1,10116.0,13260,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL623107,50597,,1,10116.0,13261,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL623108,50597,,1,10116.0,13262,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL623109,50597,,1,10116.0,13263,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL623110,50597,,1,10116.0,13264,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL623111,50597,,1,10116.0,13265,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625060,50597,,1,10116.0,13266,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625061,50597,,1,10116.0,13267,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625062,50597,,1,10116.0,13268,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625063,50597,,1,10116.0,13269,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,,,1
N,,,3126.0,BAO_0000218,Intermediate,,A,Trachea,CHEMBL625064,50597,,1,10116.0,13270,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL625065,50597,,1,10116.0,13271,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL625066,50597,,1,10116.0,13272,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625067,50597,,1,10116.0,13273,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625068,50597,,1,10116.0,13274,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL622159,50597,,1,10116.0,13275,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL622160,50597,,1,10116.0,13276,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL622161,50597,,1,10116.0,13277,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL622162,50597,,1,10116.0,13278,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL622163,50597,,1,10116.0,13279,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622313,50597,,1,10116.0,13280,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622314,50597,,1,10116.0,13281,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622315,50597,,1,10116.0,13282,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,,,1
N,,,3126.0,BAO_0000218,Intermediate,,A,Trachea,CHEMBL622316,50597,,1,10116.0,13283,In vivo,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877486,50212,,1,562.0,13284,,,Normal diffusion coefficient in water for Escherichia coli,15599,Escherichia coli,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622317,22224,,0,,13285,,,Average max percent decrease in RVR (renal vascular resistance) was determined,8204,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622318,22224,,0,,13286,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,8204,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622319,22224,,0,,13287,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622320,22224,,0,,13288,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622321,22224,,0,,13289,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622322,22224,,0,,13290,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622323,22224,,0,,13291,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,7114,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622324,50597,,1,10116.0,13292,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,7114,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622325,50588,,1,9615.0,13293,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622326,50588,,1,9615.0,13294,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL877487,50588,,1,9615.0,13295,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622327,50588,,1,9615.0,13296,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622328,50588,,1,9615.0,13297,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622329,50588,,1,9615.0,13298,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622330,50588,,1,9615.0,13299,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622331,50588,,1,9615.0,13300,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622332,50588,,1,9615.0,13301,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622333,50588,,1,9615.0,13302,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",8133,Canis lupus familiaris,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL627658,22224,,0,314293.0,13303,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL630428,22224,,0,314293.0,13304,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL630429,22224,,0,314293.0,13305,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL630430,22224,,0,314293.0,13306,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL630431,22224,,0,314293.0,13307,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",8133,Simiiformes,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630432,50597,,1,10116.0,13308,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630433,50597,,1,10116.0,13309,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630434,50597,,1,10116.0,13310,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629372,50597,,1,10116.0,13311,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629553,50597,,1,10116.0,13312,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629554,50597,,1,10116.0,13313,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874447,50597,,1,10116.0,13314,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629555,50597,,1,10116.0,13315,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629556,50597,,1,10116.0,13316,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629557,50597,,1,10116.0,13317,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629558,50597,,1,10116.0,13318,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629559,50597,,1,10116.0,13319,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629560,50597,,1,10116.0,13320,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629561,50588,,1,9615.0,13321,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629562,50588,,1,9615.0,13322,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629563,50588,,1,9615.0,13323,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629564,50588,,1,9615.0,13324,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629565,50588,,1,9615.0,13325,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629566,50588,,1,9615.0,13326,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629567,50588,,1,9615.0,13327,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629568,50588,,1,9615.0,13328,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629569,50588,,1,9615.0,13329,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629570,50588,,1,9615.0,13330,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",8133,Canis lupus familiaris,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL629571,22224,,0,314293.0,13331,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",8133,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629572,22224,,0,10116.0,13332,In vivo,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,12170,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629573,22224,,0,10116.0,13333,In vivo,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,12170,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629574,22224,,0,9347.0,13334,In vivo,,Bioavailability (dose 20 mg/kg),4985,Eutheria,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629575,22224,,0,9615.0,13335,In vivo,,Bioavailability in dog,15145,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL874448,22224,,0,10116.0,13336,In vivo,,Bioavailability in rat (Sprague-Dawley) (male),14080,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629576,22224,,0,9443.0,13337,In vivo,,Bioavailability in monkey (dose 10 mg/kg i.d.),11219,Primates,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629577,22224,,0,10116.0,13338,In vivo,,Bioavailability in rat,15145,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629578,22224,,0,10116.0,13339,In vivo,,Bioavailability in rat,15145,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629579,22224,,0,9615.0,13340,In vivo,,Bioavailability in dog (dose 3.0 mg/kg p.o.),1202,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL882958,22224,,0,9615.0,13341,In vivo,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,1202,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629580,50505,,1,9598.0,13342,In vivo,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,1202,Pan troglodytes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629581,22224,,0,9347.0,13343,In vivo,,Bioavailability,4026,Eutheria,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629582,22224,,0,9520.0,13344,In vivo,,Bioavailability in squirrel monkey,1492,Saimiri,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628522,50588,,1,9615.0,13345,In vivo,,Bioavailability was evaluated in dog,12793,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625432,100712,,1,10026.0,13346,In vivo,,Bioavailability was evaluated in hamster,12793,Cricetinae,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625433,22224,,0,10116.0,13347,In vivo,,Bioavailability in rat,12793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625434,50597,,1,10116.0,13348,In vivo,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL625435,50597,,1,10116.0,13349,In vivo,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,14793,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625436,22224,,0,10116.0,13350,In vivo,,Bioavailability in rat (dose 10 mg/kg p.o.),14793,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874588,100710,,1,9541.0,13351,In vivo,,Bioavailability was measured in cynomolgus monkeys.,14731,Macaca fascicularis,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625437,50594,,1,10090.0,13352,In vivo,,Bioavailability was measured in nude mice.,14731,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625438,22224,,0,9669.0,13353,In vivo,,Bioavailability in ferret (dose 10 mg/kg i.d.),12187,Mustela putorius furo,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625439,22224,,0,314293.0,13354,In vivo,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),12187,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625440,22224,,0,314293.0,13355,In vivo,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",12187,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625441,22224,,0,314293.0,13356,In vivo,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),12187,Simiiformes,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625442,22224,,0,10116.0,13357,In vivo,,Bioavailability in rat (dose 10 mg/kg i.d.),12187,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625443,50597,,1,10116.0,13358,In vivo,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12187,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625444,22224,,0,,13359,In vivo,,Bioavailability was determined; extremely poor,17431,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625445,50594,,1,10090.0,13360,In vivo,,% bioavailability in mice after oral administration of prodrug,13318,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625446,50588,,1,9615.0,13361,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL882960,50588,,1,9615.0,13362,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625447,50588,,1,9615.0,13363,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625448,50588,,1,9615.0,13364,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625449,50588,,1,9615.0,13365,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874589,50588,,1,9615.0,13366,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625450,50588,,1,9615.0,13367,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625451,50588,,1,9615.0,13368,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626584,50588,,1,9615.0,13369,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626585,50588,,1,9615.0,13370,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626586,50588,,1,9615.0,13371,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626587,50588,,1,9615.0,13372,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626588,50588,,1,9615.0,13373,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626589,50588,,1,9615.0,13374,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626590,50588,,1,9615.0,13375,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626591,50588,,1,9615.0,13376,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627181,50588,,1,9615.0,13377,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628083,50588,,1,9615.0,13378,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,9025,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628084,22224,,0,,13379,In vivo,,IV clearance determined at an peroral dose of 15 mg/kg.,15173,,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL628085,50064,,1,102285.0,13380,In vivo,,Mouse oral clearance was measured against Hymenolepiasis nana.,7732,Hymenolepis nana,,,1
N,,,,BAO_0000218,Expert,,F,,CHEMBL628086,50545,,1,6339.0,13381,In vivo,,Mouse oral clearance was measured against Nematospiroides dubius,7732,Heligmosomoides polygyrus,,,1
U,,,,BAO_0000218,Autocuration,,F,,CHEMBL628087,22224,,0,,13382,In vivo,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,7732,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628088,50594,,1,10090.0,13383,In vivo,,Mouse oral clearance was measured against N. nana; NT is Not Tested,7732,Mus musculus,,,1
U,,,,BAO_0000218,Autocuration,,B,,CHEMBL628089,22224,,0,,13384,In vivo,,Mouse oral clearance was measured against N. nana; NT is Not Tested,7732,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628090,22224,,0,,13385,In vivo,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628091,22224,,0,,13386,In vivo,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628092,22224,,0,,13387,In vivo,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL628093,22224,,0,,13388,In vivo,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875607,22224,,0,,13389,In vivo,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625710,22224,,0,,13390,In vivo,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625711,22224,,0,,13391,In vivo,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625712,22224,,0,,13392,In vivo,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,8328,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625713,22224,,0,,13393,In vivo,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,8328,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625714,50588,,1,9615.0,13394,In vivo,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,13376,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625715,50797,,1,9544.0,13395,In vivo,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,13477,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625716,50597,,1,10116.0,13396,In vivo,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625717,50597,,1,10116.0,13397,In vivo,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,13477,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625718,50597,,1,10116.0,13398,In vivo,,Plasma clearance was determined for the compound in rats,13313,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625719,50597,,1,10116.0,13399,In vivo,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625720,50597,,1,10116.0,13400,In vivo,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625721,50597,,1,10116.0,13401,In vivo,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625722,50597,,1,10116.0,13402,In vivo,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,12504,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625723,50597,,1,10116.0,13403,In vivo,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,13129,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625724,50545,,1,6339.0,13404,In vivo,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,7732,Heligmosomoides polygyrus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625725,50545,,1,6339.0,13405,In vivo,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,7732,Heligmosomoides polygyrus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625726,50545,,1,6339.0,13406,In vivo,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,7732,Heligmosomoides polygyrus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875608,50545,,1,6339.0,13407,In vivo,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,7732,Heligmosomoides polygyrus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625727,50545,,1,6339.0,13408,In vivo,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,7732,Heligmosomoides polygyrus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL625728,22224,,0,10116.0,13409,In vivo,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,9278,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625729,22224,,0,10116.0,13410,In vivo,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,9278,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL625730,22224,,0,10116.0,13411,In vivo,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,9278,Rattus norvegicus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL625731,22224,,0,10116.0,13412,In vivo,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,9278,Rattus norvegicus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL626417,22224,,0,10116.0,13413,In vivo,,Urinary clearance was determined in rat at 25 mg/kg os dosage,9278,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626418,50587,,1,9606.0,13414,In vivo,,Urinary clearance was determined at 100 mg/kg oral dosage in human,9278,Homo sapiens,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626419,50588,,1,9615.0,13415,In vivo,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,9278,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626592,50588,,1,9615.0,13416,In vivo,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,5932,Canis lupus familiaris,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626593,50597,,1,10116.0,13417,In vivo,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,5932,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626594,50597,,1,10116.0,13418,In vivo,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,5182,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625035,50588,,1,9615.0,13419,In vivo,,Clearance rate in dogs,10499,Canis lupus familiaris,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625036,22224,,0,,13420,In vitro,,Compound was measured for intrinsic clearance,6051,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625037,22229,,0,,13421,,,Calculated partition coefficient (clogP),17508,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625038,22229,,0,,13422,,,Calculated partition coefficient (clogP),6228,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625039,22229,,0,,13423,,,Calculated partition coefficient (clogP),6231,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625040,22229,,0,,13424,,,Calculated partition coefficient (clogP),17740,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625041,22229,,0,,13425,,,Calculated partition coefficient (clogP),6495,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625042,22229,,0,,13426,,,Calculated partition coefficient (clogP),2171,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874411,22224,,0,,13427,,,Partition coefficient of the compound,3255,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625043,22224,,0,,13428,,,Permeability,6821,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625044,22229,,0,,13429,,,Calculated partition coefficient (clogP),2685,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625045,22224,,0,,13430,,,Partition coefficient (logD),17584,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625046,22229,,0,,13431,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13824,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625047,22229,,0,,13432,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13824,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625048,22229,,0,,13433,,,Calculated partition coefficient (clogP),16479,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625049,22229,,0,,13434,,,Calculated partition coefficient (clogP),11997,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625050,22229,,0,,13435,,,Calculated logarithm of partition coefficient (P) was determined,2988,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625051,22229,,0,,13436,,,Calculated partition coefficient (clogP),931,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL874412,22229,,0,,13437,,,Calculated partition coefficient (clogP),4381,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625052,22229,,0,,13438,,,Calculated partition coefficient (clogP),4397,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL625053,22229,,0,,13439,,,Calculated partition coefficient (clogP),5889,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623250,22224,,0,,13440,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623251,22224,,0,,13441,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623252,22224,,0,,13442,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623253,22224,,0,,13443,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623254,22224,,0,,13444,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623255,22224,,0,,13445,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,6154,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626831,22224,,0,,13446,,,Percent degradation of compound at a pH of 1 over a 18 hr period,6887,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL877494,22224,,0,,13447,,,Percent degradation of compound at pH of 1 over an 18 hr period,6887,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626832,22224,,0,,13448,,,Delta Logarithm of Partition Coefficient value was determined.,14116,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626833,22224,,0,,13449,,,Delta logPoct-cyc,11137,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626834,22224,,0,,13450,,,Lipophilicity estimated on reversed phase TLC,7230,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626835,22224,,0,,13451,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,15741,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626836,22224,,0,,13452,,,Delta logPoct-cyc,9663,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626837,22229,,0,,13453,,,Change in logarithm of partition coefficient of the compound,9663,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626838,22224,,0,,13454,,,Delta logD (pH 6.5),13807,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626839,22224,,0,,13455,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",13807,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626840,22224,,0,,13456,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,17425,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626841,22224,,0,,13457,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),12143,,,,1
U,,,,BAO_0000219,Autocuration,,A,,CHEMBL626842,22224,,0,,13458,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,12608,,,,1
U,,,,BAO_0000219,Autocuration,,A,,CHEMBL626843,22224,,0,,13459,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,12608,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626844,50597,,1,10116.0,13460,,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,8649,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL877495,50597,,1,10116.0,13461,,,Amount of deuterium retained was reported after normal workup in rats,8649,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626845,50597,,1,10116.0,13462,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,8649,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626846,50597,,1,10116.0,13463,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,8649,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626847,50597,,1,10116.0,13464,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,8649,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628677,50597,,1,10116.0,13465,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,8649,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628678,50597,,1,10116.0,13466,,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,8649,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628679,22224,,0,,13467,,,Compound was subjected to electrochemical oxidation,9659,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628680,22224,,0,,13468,,,Compound was subjected to photochemical oxidation,9659,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628681,22224,,0,,13469,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,9659,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628682,22224,,0,,13470,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,9659,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628683,22224,,0,,13471,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,9659,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628684,50597,,1,10116.0,13472,,,Percent diffusion through fuzzy rat skin after 48 h of incubation,9607,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL877501,22229,,0,,13473,,,Dissociation constant (pKa),7057,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628685,22224,,0,,13474,,,Dissociation constant value of the compound; ND means not determined.,7057,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628686,50597,,1,10116.0,13475,,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,7911,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL628687,50597,,1,10116.0,13476,,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628688,50597,,1,10116.0,13477,,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,7911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628689,50597,,1,10116.0,13478,,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628690,50597,,1,10116.0,13479,,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,7911,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL629363,50597,,1,10116.0,13480,,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,7911,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL629364,50597,,1,10116.0,13481,,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,7911,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL629365,50597,,1,10116.0,13482,,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629366,50597,,1,10116.0,13483,,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,7911,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629367,50597,,1,10116.0,13484,,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,7911,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL629368,50597,,1,10116.0,13485,,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL877502,50597,,1,10116.0,13486,,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,7911,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL629369,50594,,1,10090.0,13487,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL629370,50594,,1,10090.0,13488,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,13792,Mus musculus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL629371,22224,,0,314293.0,13489,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL626276,22224,,0,314293.0,13490,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL626277,22224,,0,314293.0,13491,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL631250,22224,,0,314293.0,13492,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",8133,Simiiformes,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631251,50597,,1,10116.0,13493,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631252,50597,,1,10116.0,13494,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631253,50597,,1,10116.0,13495,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631254,50597,,1,10116.0,13496,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631255,50597,,1,10116.0,13497,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631256,50597,,1,10116.0,13498,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631257,50597,,1,10116.0,13499,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628009,50597,,1,10116.0,13500,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628010,50597,,1,10116.0,13501,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628011,50597,,1,10116.0,13502,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628012,50597,,1,10116.0,13503,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628013,50597,,1,10116.0,13504,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628014,50597,,1,10116.0,13505,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628015,50588,,1,9615.0,13506,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628016,50588,,1,9615.0,13507,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874461,50588,,1,9615.0,13508,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628017,50588,,1,9615.0,13509,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628018,50588,,1,9615.0,13510,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628019,50588,,1,9615.0,13511,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628020,50588,,1,9615.0,13512,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628021,50588,,1,9615.0,13513,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628022,50588,,1,9615.0,13514,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",8133,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628023,50588,,1,9615.0,13515,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",8133,Canis lupus familiaris,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL628024,22224,,0,314293.0,13516,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL628025,22224,,0,314293.0,13517,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL628026,22224,,0,314293.0,13518,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL628027,22224,,0,314293.0,13519,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",8133,Simiiformes,,,1
U,,,1088.0,BAO_0000218,Autocuration,,A,Urine,CHEMBL628028,22224,,0,314293.0,13520,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",8133,Simiiformes,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628029,50597,,1,10116.0,13521,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628030,50597,,1,10116.0,13522,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628031,50597,,1,10116.0,13523,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628032,50597,,1,10116.0,13524,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628033,50597,,1,10116.0,13525,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628034,50597,,1,10116.0,13526,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628035,50597,,1,10116.0,13527,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628036,50597,,1,10116.0,13528,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874462,50597,,1,10116.0,13529,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",8133,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628037,50588,,1,9615.0,13530,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628123,50588,,1,9615.0,13531,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628124,50588,,1,9615.0,13532,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628125,50588,,1,9615.0,13533,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628126,50588,,1,9615.0,13534,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628127,50588,,1,9615.0,13535,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628128,50588,,1,9615.0,13536,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628129,50588,,1,9615.0,13537,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628130,50588,,1,9615.0,13538,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628131,50588,,1,9615.0,13539,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628132,50588,,1,9615.0,13540,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628133,50588,,1,9615.0,13541,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628134,50588,,1,9615.0,13542,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628135,50588,,1,9615.0,13543,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628136,50588,,1,9615.0,13544,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628137,50588,,1,9615.0,13545,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628138,50588,,1,9615.0,13546,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628139,50588,,1,9615.0,13547,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628140,50588,,1,9615.0,13548,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628141,50588,,1,9615.0,13549,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628142,50588,,1,9615.0,13550,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628143,50588,,1,9615.0,13551,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628144,50588,,1,9615.0,13552,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628145,50588,,1,9615.0,13553,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628146,50588,,1,9615.0,13554,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625355,50588,,1,9615.0,13555,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625356,50588,,1,9615.0,13556,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625357,50588,,1,9615.0,13557,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625527,50588,,1,9615.0,13558,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875473,50588,,1,9615.0,13559,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625528,50588,,1,9615.0,13560,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,9025,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626304,50597,,1,10116.0,13561,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,9025,Rattus norvegicus,,,1
N,,,1637.0,BAO_0000218,Intermediate,,A,Artery,CHEMBL624138,50588,,1,9615.0,13562,In vivo,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,9025,Canis lupus familiaris,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624139,22229,,0,,13563,,,Calculated partition coefficient (clogP),6448,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624140,22229,,0,,13564,,,Calculated partition coefficient (clogP),17221,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624141,22229,,0,,13565,,,Calculated partition coefficient (clogP),6545,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624142,22229,,0,,13566,,,Calculated partition coefficient (clogP),577,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624143,22229,,0,,13567,,,Calculated partition coefficient (clogP),6285,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624144,22229,,0,,13568,,,Calculated partition coefficient (clogP),6500,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624145,22229,,0,,13569,,,Calculated partition coefficient (clogP),6716,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624146,22229,,0,,13570,,,Calculated partition coefficient (clogP),13658,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624147,22229,,0,,13571,,,Calculated partition coefficient (clogP),6549,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL883123,22229,,0,,13572,,,Calculated partition coefficient (clogP) (MacLogP),14685,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624148,22224,,0,,13573,,,Partition coefficient (logP),6893,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874416,22224,,0,,13574,,,Kinetic parameter was determined,3687,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624149,22229,,0,,13575,,,Calculated partition coefficient (clogP),4207,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624150,22229,,0,,13576,,,Calculated partition coefficient (clogP),4626,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624151,22224,,0,,13577,,,Lipophilicity was determined,1021,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624152,22224,,0,,13578,,,Lipophilicity was determined,3777,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622139,22224,,0,,13579,,,Lipophilicity was determined,17533,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622140,22229,,0,,13580,,,Calculated partition coefficient (clogP),6524,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622141,22224,,0,,13581,,,Lipophilicity was determined,17533,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622142,22224,,0,,13582,,,Lipophilicity in octanol-water,6480,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622143,22229,,0,,13583,,,Calculated partition coefficient (clogP),17606,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622144,22229,,0,,13584,,,Octanol-water partition coefficient was determined,6863,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL877473,22224,,0,,13585,,,Partition coefficient (logP),1356,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622145,22229,,0,,13586,,,Calculated partition coefficient (clogP),3326,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622146,22224,,0,,13587,,,Partition coefficient was determined; ND means not determined,1356,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622147,22229,,0,,13588,,,Calculated partition coefficient (clogP),12984,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622148,22224,,0,,13589,,,Partition coefficient of the compound,17363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL883124,22224,,0,,13590,,,Permeability was determined,6827,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622149,22229,,0,,13591,,,The compound was evaluated for the partition coefficient,261,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622150,22224,,0,,13592,,,Partition coefficient (logP),2685,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622151,22224,,0,,13593,,,The lipophilicity was reported,414,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL622152,22229,,0,,13594,,,logarithm of the octanol-water partition coefficient for the compound,15769,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL622153,22224,,0,,13595,,,Clogp value was determined,17248,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL877474,22224,,0,,13596,In vivo,,Clp at a dose of 1.5 mg/kg,16935,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622154,22224,,0,,13597,In vivo,,Clp at a dose of 2.0 mg/kg,16935,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL622155,22224,,0,,13598,In vivo,,"Clp, plasma clearance at a dose of 10 mg/kg",14832,,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL622156,22224,,0,,13599,In vivo,,"Clp, plasma clearance at a dose of 50 mg/kg",14832,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622157,50597,,1,10116.0,13600,In vivo,,Compound was tested for plasma clearance in rat,2399,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622158,50597,,1,10116.0,13601,In vivo,,Compound was tested for plasma clearance in rat; Not determined,2399,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622807,50597,,1,10116.0,13602,In vivo,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,6227,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622808,50797,,1,9544.0,13603,In vivo,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,6227,Macaca mulatta,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622809,22224,,0,,13604,In vivo,,Plasma clearance by iv administration at a dose 0.003 ug/mL,5623,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622810,22224,,0,,13605,In vivo,,Plasma clearance determined,4854,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876653,100712,,1,10026.0,13606,In vivo,,Plasma clearance after iv administration at 3 mg/kg in hamster,4493,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622811,100712,,1,10026.0,13607,In vivo,,Plasma clearance after iv administration at 4 mg/kg in hamster,4493,Cricetinae,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622986,50597,,1,10116.0,13608,In vivo,,Rate of clearance in rat was determined,14956,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622987,50597,,1,10116.0,13609,In vivo,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622988,50597,,1,10116.0,13610,In vivo,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622989,50597,,1,10116.0,13611,In vivo,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,15372,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622990,50597,,1,10116.0,13612,In vivo,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,15372,Rattus norvegicus,,,1
U,,,1969.0,BAO_0000218,Autocuration,,A,Plasma,CHEMBL622991,22224,,0,314293.0,13613,In vivo,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,15604,Simiiformes,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622227,50597,,1,10116.0,13614,In vivo,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,15604,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL622228,50588,,1,9615.0,13615,In vivo,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,15604,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622229,50597,,1,10116.0,13616,In vivo,,Clpl value in rat,14964,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622230,50512,,1,10141.0,13617,In vivo,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622231,50597,,1,10116.0,13618,In vivo,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,16449,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL622232,100710,,1,9541.0,13619,In vivo,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,16449,Macaca fascicularis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622233,22224,,0,,13620,In vivo,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622234,22224,,0,,13621,In vivo,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622235,22224,,0,,13622,In vivo,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622236,22224,,0,,13623,In vivo,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622237,22224,,0,,13624,In vivo,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL877482,22224,,0,,13625,In vivo,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622238,22224,,0,,13626,In vivo,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,12902,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL622239,22224,,0,,13627,In vivo,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,12902,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL622240,22224,,0,,13628,In vivo,,Cmax was calculated as maximum concentration reached in the blood,11149,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL622241,22224,,0,,13629,In vivo,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,11149,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631013,50597,,1,10116.0,13630,In vivo,,Cmax was determine after peroral administration at 10 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631014,50797,,1,9544.0,13631,In vivo,,Cmax was determine after peroral administration at 10 mpk in Rhesus,5669,Macaca mulatta,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631015,50588,,1,9615.0,13632,In vivo,,Cmax was determine after peroral administration at 10 mpk in dog,5669,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631016,50597,,1,10116.0,13633,In vivo,,Cmax was determine after peroral administration at 160 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631017,50597,,1,10116.0,13634,In vivo,,Cmax was determine after peroral administration at 20 mpk in Rat,5669,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631018,50597,,1,10116.0,13635,In vivo,,Cmax was determine after peroral administration at 50 mpk in Rat,5669,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL631019,22224,,0,,13636,In vivo,,Cmax was determined,4236,,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL875761,50594,,1,10090.0,13637,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL631020,50594,,1,10090.0,13638,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL631669,50594,,1,10090.0,13639,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,13792,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL631670,50594,,1,10090.0,13640,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,13792,Mus musculus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL631671,50594,,1,10090.0,13641,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,13792,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631672,50597,,1,10116.0,13642,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631673,50597,,1,10116.0,13643,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631856,50597,,1,10116.0,13644,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631857,50597,,1,10116.0,13645,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631858,50597,,1,10116.0,13646,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631859,50597,,1,10116.0,13647,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631860,50597,,1,10116.0,13648,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631861,50597,,1,10116.0,13649,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631862,50597,,1,10116.0,13650,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631863,50597,,1,10116.0,13651,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631864,50597,,1,10116.0,13652,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631865,50597,,1,10116.0,13653,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631866,50597,,1,10116.0,13654,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629360,50597,,1,10116.0,13655,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629361,50597,,1,10116.0,13656,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL629362,50597,,1,10116.0,13657,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630740,50597,,1,10116.0,13658,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630741,50597,,1,10116.0,13659,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,8418,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630742,50597,,1,10116.0,13660,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630743,50597,,1,10116.0,13661,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630744,50597,,1,10116.0,13662,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630745,50597,,1,10116.0,13663,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630746,50597,,1,10116.0,13664,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630747,50597,,1,10116.0,13665,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630748,50597,,1,10116.0,13666,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632056,50597,,1,10116.0,13667,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632057,50597,,1,10116.0,13668,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632058,50597,,1,10116.0,13669,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632059,50597,,1,10116.0,13670,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632060,50597,,1,10116.0,13671,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632061,50597,,1,10116.0,13672,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629207,50597,,1,10116.0,13673,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629208,50597,,1,10116.0,13674,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629209,50597,,1,10116.0,13675,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629210,50597,,1,10116.0,13676,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629211,50597,,1,10116.0,13677,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629212,50597,,1,10116.0,13678,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,8418,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629213,50597,,1,10116.0,13679,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,8418,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629214,50597,,1,10116.0,13680,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629215,50597,,1,10116.0,13681,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL635154,50597,,1,10116.0,13682,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",8133,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629216,50597,,1,10116.0,13683,,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629217,50597,,1,10116.0,13684,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629218,50597,,1,10116.0,13685,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629219,50597,,1,10116.0,13686,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629220,50597,,1,10116.0,13687,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629221,50597,,1,10116.0,13688,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631127,50597,,1,10116.0,13689,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631128,50597,,1,10116.0,13690,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631129,50597,,1,10116.0,13691,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631130,50597,,1,10116.0,13692,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631131,50597,,1,10116.0,13693,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631132,50597,,1,10116.0,13694,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631133,50597,,1,10116.0,13695,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631134,50597,,1,10116.0,13696,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875120,50597,,1,10116.0,13697,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631135,50597,,1,10116.0,13698,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631136,50597,,1,10116.0,13699,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631137,50597,,1,10116.0,13700,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631138,50597,,1,10116.0,13701,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631139,50597,,1,10116.0,13702,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631140,50597,,1,10116.0,13703,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631141,50597,,1,10116.0,13704,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631142,50597,,1,10116.0,13705,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631143,50597,,1,10116.0,13706,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631144,50597,,1,10116.0,13707,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631145,50588,,1,9615.0,13708,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631146,50588,,1,9615.0,13709,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631147,50588,,1,9615.0,13710,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631148,50588,,1,9615.0,13711,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631149,50588,,1,9615.0,13712,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631150,50588,,1,9615.0,13713,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631151,50588,,1,9615.0,13714,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631152,50588,,1,9615.0,13715,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631443,50588,,1,9615.0,13716,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631444,50588,,1,9615.0,13717,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631445,50588,,1,9615.0,13718,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631446,50588,,1,9615.0,13719,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631447,50588,,1,9615.0,13720,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631448,50588,,1,9615.0,13721,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631449,50588,,1,9615.0,13722,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631450,50588,,1,9615.0,13723,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629724,50588,,1,9615.0,13724,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL629725,50594,,1,10090.0,13725,In vivo,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL629726,50594,,1,10090.0,13726,In vivo,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL629727,50594,,1,10090.0,13727,In vivo,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630404,50594,,1,10090.0,13728,In vivo,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630405,50594,,1,10090.0,13729,In vivo,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630406,50594,,1,10090.0,13730,In vivo,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL630407,50594,,1,10090.0,13731,In vivo,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL630573,50594,,1,10090.0,13732,In vivo,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL630574,50594,,1,10090.0,13733,In vivo,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL630575,50594,,1,10090.0,13734,In vivo,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630576,50594,,1,10090.0,13735,In vivo,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630577,50594,,1,10090.0,13736,In vivo,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630578,50594,,1,10090.0,13737,In vivo,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630579,50594,,1,10090.0,13738,In vivo,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630580,50594,,1,10090.0,13739,,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),12192,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630581,50594,,1,10090.0,13740,,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,12192,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630582,50594,,1,10090.0,13741,,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630583,50594,,1,10090.0,13742,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630584,50594,,1,10090.0,13743,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630585,50594,,1,10090.0,13744,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630586,50594,,1,10090.0,13745,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630587,50594,,1,10090.0,13746,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630588,50594,,1,10090.0,13747,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630589,50594,,1,10090.0,13748,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,12192,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630590,50594,,1,10090.0,13749,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),12192,Mus musculus,,,1
U,,,1988.0,BAO_0000019,Autocuration,,A,Feces,CHEMBL630591,22224,,0,,13750,,,Removal of 238-Plutonium(IV) in feces at 24 h,12192,,,,1
U,,,1988.0,BAO_0000019,Autocuration,,A,Feces,CHEMBL630592,22224,,0,,13751,,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),12192,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630593,22224,,0,,13752,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,12192,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630594,22224,,0,,13753,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630595,22224,,0,,13754,,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630596,22224,,0,,13755,,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630597,22224,,0,,13756,,,Removal of 238-Plutonium(IV) in urine after 0-24 h,12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630598,22224,,0,,13757,,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630599,22224,,0,,13758,,,Removal of 238-Plutonium(IV) in urine after 0-4 h,12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630600,22224,,0,,13759,,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630601,22224,,0,,13760,,,Removal of 238-Plutonium(IV) in urine after 4-24 h,12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630602,22224,,0,,13761,,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630603,22224,,0,,13762,,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),12192,,,,1
U,,,1088.0,BAO_0000019,Autocuration,,A,Urine,CHEMBL630604,22224,,0,,13763,,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),12192,,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624869,50597,,1,10116.0,13764,In vivo,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL624870,50597,,1,10116.0,13765,In vivo,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623189,50597,,1,10116.0,13766,In vivo,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623190,50597,,1,10116.0,13767,In vivo,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623191,50597,,1,10116.0,13768,In vivo,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623192,50597,,1,10116.0,13769,In vivo,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623193,50597,,1,10116.0,13770,In vivo,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623194,50597,,1,10116.0,13771,In vivo,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623195,50597,,1,10116.0,13772,In vivo,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623196,50597,,1,10116.0,13773,In vivo,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623197,50597,,1,10116.0,13774,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,11836,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623198,50597,,1,10116.0,13775,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623199,50597,,1,10116.0,13776,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623200,50597,,1,10116.0,13777,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623201,50597,,1,10116.0,13778,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623202,50597,,1,10116.0,13779,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623203,50597,,1,10116.0,13780,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623204,50597,,1,10116.0,13781,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623205,50597,,1,10116.0,13782,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623206,50597,,1,10116.0,13783,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623207,50597,,1,10116.0,13784,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623208,50597,,1,10116.0,13785,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623209,50597,,1,10116.0,13786,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL623210,50597,,1,10116.0,13787,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623211,50597,,1,10116.0,13788,,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL623212,50597,,1,10116.0,13789,,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623213,22224,,0,,13790,,,Tested in vitro for intrinsic activity relative to quinpirole,12640,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623214,22224,,0,,13791,,,"Relative ion enhancement, determined in pulsed ultrafiltration",14218,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623215,22224,,0,,13792,,,% ionization at the pH 7.4 at 37 degree Centigrade,11296,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623216,22224,,0,,13793,,,Percentage ionization was measured,10929,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623217,50591,,1,9913.0,13794,,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,13841,Bos taurus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623218,22224,,0,,13795,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,10431,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623913,22224,,0,,13796,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,10431,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL623914,22224,,0,,13797,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,10431,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL623915,22229,,0,,13798,,,Compound was evaluated for the partition coefficient in octanol/water,8826,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL624080,22229,,0,,13799,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),8826,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL624081,22224,,0,,13800,,,Equilibrium constant measured by the pulse radiolysis at pH 7,9884,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624082,50587,,1,9606.0,13801,,,In vitro hydrolytic rate constant determined in human blood,9827,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625054,50587,,1,9606.0,13802,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,10009,Homo sapiens,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL877485,22224,,0,,13803,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,10009,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625055,50594,,1,10090.0,13804,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625056,50594,,1,10090.0,13805,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625057,50587,,1,9606.0,13806,,,In vitro oxidation of compound in presence of human plasma,10009,Homo sapiens,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625058,22224,,0,,13807,,,In vitro oxidation of compound in presence of hydrogen peroxide,10009,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625059,50594,,1,10090.0,13808,,,In vitro oxidation of compound in presence of mouse brain homogenate,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629536,50594,,1,10090.0,13809,,,In vitro oxidation of compound in presence of mouse liver homogenate,10009,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629537,50597,,1,10116.0,13810,,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629538,50597,,1,10116.0,13811,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629539,50597,,1,10116.0,13812,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL874445,50597,,1,10116.0,13813,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629540,50597,,1,10116.0,13814,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629541,50597,,1,10116.0,13815,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629542,50597,,1,10116.0,13816,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630243,50597,,1,10116.0,13817,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630244,50597,,1,10116.0,13818,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630245,50597,,1,10116.0,13819,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630246,50597,,1,10116.0,13820,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630247,50597,,1,10116.0,13821,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630248,50597,,1,10116.0,13822,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,11510,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630249,50597,,1,10116.0,13823,In vivo,,Biodistribution in rat blood at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630250,50597,,1,10116.0,13824,In vivo,,Biodistribution in rat blood at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630251,50597,,1,10116.0,13825,In vivo,,Biodistribution in rat blood at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630252,50597,,1,10116.0,13826,In vivo,,Biodistribution in rat blood at 3 hr after dose administration.,13100,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630408,50597,,1,10116.0,13827,In vivo,,Biodistribution in rat blood at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630409,50597,,1,10116.0,13828,In vivo,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL874446,50597,,1,10116.0,13829,In vivo,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630410,50597,,1,10116.0,13830,In vivo,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630411,50597,,1,10116.0,13831,In vivo,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630412,50597,,1,10116.0,13832,In vivo,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630413,50597,,1,10116.0,13833,In vivo,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630414,50597,,1,10116.0,13834,In vivo,,Biodistribution in rat cerebellum at 3 hr after dose administration.,13100,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL630415,50597,,1,10116.0,13835,In vivo,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630416,50597,,1,10116.0,13836,In vivo,,Biodistribution in rat cortex at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630417,50597,,1,10116.0,13837,In vivo,,Biodistribution in rat cortex at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630418,50597,,1,10116.0,13838,In vivo,,Biodistribution in rat cortex at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630419,50597,,1,10116.0,13839,In vivo,,Biodistribution in rat cortex at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630420,50597,,1,10116.0,13840,In vivo,,Biodistribution in rat cortex at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630421,50597,,1,10116.0,13841,In vivo,,Biodistribution in rat cortex at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630422,50597,,1,10116.0,13842,In vivo,,Biodistribution in rat cortex at 3 hr after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630423,50597,,1,10116.0,13843,In vivo,,Biodistribution in rat cortex at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630424,50597,,1,10116.0,13844,In vivo,,Biodistribution in rat heart at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630425,50597,,1,10116.0,13845,In vivo,,Biodistribution in rat heart at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL629462,50597,,1,10116.0,13846,In vivo,,Biodistribution in rat heart at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630426,50597,,1,10116.0,13847,In vivo,,Biodistribution in rat heart at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630427,50597,,1,10116.0,13848,In vivo,,Biodistribution in rat heart at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625877,50597,,1,10116.0,13849,In vivo,,Biodistribution in rat heart at 3 hr after dose administration.,13100,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625878,50597,,1,10116.0,13850,In vivo,,Biodistribution in rat heart at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625879,50597,,1,10116.0,13851,In vivo,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625880,50597,,1,10116.0,13852,In vivo,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625881,50597,,1,10116.0,13853,In vivo,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625882,50597,,1,10116.0,13854,In vivo,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625883,50597,,1,10116.0,13855,In vivo,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625884,50597,,1,10116.0,13856,In vivo,,Biodistribution in rat kidney at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625885,50597,,1,10116.0,13857,In vivo,,Biodistribution in rat kidney at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628649,50597,,1,10116.0,13858,In vivo,,Biodistribution in rat kidney at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628650,50597,,1,10116.0,13859,In vivo,,Biodistribution in rat kidney at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628651,50597,,1,10116.0,13860,In vivo,,Biodistribution in rat kidney at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628652,50597,,1,10116.0,13861,In vivo,,Biodistribution in rat kidney at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL628653,50597,,1,10116.0,13862,In vivo,,Biodistribution in rat kidney at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628654,50597,,1,10116.0,13863,In vivo,,Biodistribution in rat liver at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL628655,50597,,1,10116.0,13864,In vivo,,Biodistribution in rat liver at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625238,50597,,1,10116.0,13865,In vivo,,Biodistribution in rat liver at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625239,50597,,1,10116.0,13866,In vivo,,Biodistribution in rat liver at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625240,50597,,1,10116.0,13867,In vivo,,Biodistribution in rat liver at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625241,50597,,1,10116.0,13868,In vivo,,Biodistribution in rat liver at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625242,50597,,1,10116.0,13869,In vivo,,Biodistribution in rat liver at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL874587,50597,,1,10116.0,13870,In vivo,,Biodistribution in rat lung at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625405,50597,,1,10116.0,13871,In vivo,,Biodistribution in rat lung at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625406,50597,,1,10116.0,13872,In vivo,,Biodistribution in rat lung at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625407,50597,,1,10116.0,13873,In vivo,,Biodistribution in rat lung at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625408,50597,,1,10116.0,13874,In vivo,,Biodistribution in rat lung at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625409,50597,,1,10116.0,13875,In vivo,,Biodistribution in rat lung at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625410,50597,,1,10116.0,13876,,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,12361,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625411,50597,,1,10116.0,13877,,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,12361,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625412,50597,,1,10116.0,13878,,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,12361,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625413,50597,,1,10116.0,13879,,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,12361,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625414,50597,,1,10116.0,13880,,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,12361,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625415,50597,,1,10116.0,13881,,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,12361,Rattus norvegicus,,,1
N,,,1515.0,BAO_0000218,Intermediate,,A,Thoracic aorta,CHEMBL625416,50597,,1,10116.0,13882,,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,12361,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625417,50597,,1,10116.0,13883,,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,12712,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL625418,50597,,1,10116.0,13884,,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,7415,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625419,50597,,1,10116.0,13885,,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,7415,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625420,50597,,1,10116.0,13886,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,7415,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626996,50597,,1,10116.0,13887,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,7415,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL626997,50597,,1,10116.0,13888,,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",7415,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626998,50597,,1,10116.0,13889,,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",7415,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626999,50597,,1,10116.0,13890,,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",7415,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627000,50594,,1,10090.0,13891,,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,8050,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627001,50594,,1,10090.0,13892,,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,8050,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627002,50594,,1,10090.0,13893,,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,8050,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627003,50594,,1,10090.0,13894,,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627004,50594,,1,10090.0,13895,,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627005,50594,,1,10090.0,13896,,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874594,50594,,1,10090.0,13897,,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627006,50594,,1,10090.0,13898,,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627007,50594,,1,10090.0,13899,,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627884,50594,,1,10090.0,13900,,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627885,50594,,1,10090.0,13901,,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627886,50594,,1,10090.0,13902,,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627887,50594,,1,10090.0,13903,,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627888,50594,,1,10090.0,13904,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628057,50594,,1,10090.0,13905,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627405,50594,,1,10090.0,13906,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627406,50588,,1,9615.0,13907,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627407,50588,,1,9615.0,13908,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627408,50588,,1,9615.0,13909,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627409,50588,,1,9615.0,13910,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875486,50588,,1,9615.0,13911,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627410,50588,,1,9615.0,13912,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627411,50588,,1,9615.0,13913,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627412,50588,,1,9615.0,13914,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627413,50588,,1,9615.0,13915,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627414,50588,,1,9615.0,13916,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627415,50588,,1,9615.0,13917,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627416,50588,,1,9615.0,13918,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627417,50588,,1,9615.0,13919,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627418,50588,,1,9615.0,13920,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627419,50588,,1,9615.0,13921,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627320,50588,,1,9615.0,13922,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627321,50588,,1,9615.0,13923,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627322,50597,,1,10116.0,13924,In vivo,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627323,50597,,1,10116.0,13925,In vivo,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627491,50597,,1,10116.0,13926,In vivo,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627492,50597,,1,10116.0,13927,In vivo,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL627493,50597,,1,10116.0,13928,In vivo,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627494,50597,,1,10116.0,13929,In vivo,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627495,50597,,1,10116.0,13930,In vivo,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627496,50597,,1,10116.0,13931,In vivo,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627497,50597,,1,10116.0,13932,In vivo,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627498,50597,,1,10116.0,13933,In vivo,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627499,50597,,1,10116.0,13934,In vivo,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627500,50597,,1,10116.0,13935,In vivo,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627501,50597,,1,10116.0,13936,In vivo,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625616,50597,,1,10116.0,13937,In vivo,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625617,50597,,1,10116.0,13938,In vivo,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625618,50597,,1,10116.0,13939,In vivo,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625619,50597,,1,10116.0,13940,In vivo,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625620,50597,,1,10116.0,13941,In vivo,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625621,50597,,1,10116.0,13942,In vivo,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625622,50597,,1,10116.0,13943,In vivo,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625788,50597,,1,10116.0,13944,In vivo,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625789,50597,,1,10116.0,13945,In vivo,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625790,50597,,1,10116.0,13946,In vivo,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625791,50597,,1,10116.0,13947,In vivo,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL622334,50597,,1,10116.0,13948,In vivo,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622335,50597,,1,10116.0,13949,In vivo,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622336,50597,,1,10116.0,13950,In vivo,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622337,50597,,1,10116.0,13951,In vivo,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622338,50597,,1,10116.0,13952,In vivo,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL622339,50597,,1,10116.0,13953,In vivo,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL624153,50597,,1,10116.0,13954,In vivo,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628430,50597,,1,10116.0,13955,In vivo,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628431,50597,,1,10116.0,13956,In vivo,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628432,50597,,1,10116.0,13957,In vivo,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628433,50597,,1,10116.0,13958,In vivo,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL628434,50597,,1,10116.0,13959,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626789,50597,,1,10116.0,13960,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626790,50597,,1,10116.0,13961,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626791,50597,,1,10116.0,13962,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626792,50597,,1,10116.0,13963,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL626793,50597,,1,10116.0,13964,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627436,50597,,1,10116.0,13965,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627437,50597,,1,10116.0,13966,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627438,50597,,1,10116.0,13967,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627439,50597,,1,10116.0,13968,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627440,50597,,1,10116.0,13969,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627602,50597,,1,10116.0,13970,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627603,50597,,1,10116.0,13971,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627604,50597,,1,10116.0,13972,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627605,50597,,1,10116.0,13973,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627606,50597,,1,10116.0,13974,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627607,50597,,1,10116.0,13975,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627608,50597,,1,10116.0,13976,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627609,50597,,1,10116.0,13977,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627610,50597,,1,10116.0,13978,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627611,50597,,1,10116.0,13979,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627612,50597,,1,10116.0,13980,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,11510,Rattus norvegicus,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL627613,22229,,0,,13981,,,Octanol:water partition coefficient is evaluated,8362,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL627614,22224,,0,,13982,,,Partition coefficient in 1-octanol/water system,8257,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL627615,22224,,0,,13983,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,8257,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL627616,22224,,0,,13984,,,Partition coefficient in octanol/water system was determined,9468,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL627617,22224,,0,,13985,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,9468,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627618,22224,,0,,13986,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,10568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627619,22224,,0,,13987,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",10568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627620,22224,,0,,13988,,,Pseudo-first-order rate constant of the compound,15359,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627621,22224,,0,,13989,,,Pseudo-first-order rate constant with 1-min time point,15359,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627622,22224,,0,,13990,,,Pseudo-first-order rate constant without 1-min time point,15359,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627623,22224,,0,,13991,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,10431,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627624,22224,,0,,13992,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,10431,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627625,22224,,0,,13993,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,10431,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628523,22224,,0,,13994,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,15704,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628524,22224,,0,,13995,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,15287,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628525,22224,,0,,13996,,,The efflux rate constant of the compound,7516,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625732,22224,,0,,13997,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,12973,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625733,22224,,0,,13998,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,12973,,,,1
U,,,,BAO_0000019,Autocuration,,F,,CHEMBL625734,22224,,0,,13999,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,12973,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625913,22224,,0,,14000,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,12973,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625914,22224,,0,,14001,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,8696,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625915,22224,,0,,14002,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,15052,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625916,22224,,0,,14003,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,15052,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625917,22224,,0,,14004,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),10503,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625918,22224,,0,,14005,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625919,22224,,0,,14006,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625920,22224,,0,,14007,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874453,22224,,0,,14008,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625921,22224,,0,,14009,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625922,22224,,0,,14010,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,10503,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625923,22224,,0,,14011,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625924,22224,,0,,14012,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625925,22224,,0,,14013,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625926,22224,,0,,14014,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627704,50597,,1,10116.0,14015,In vivo,,Biodistribution in rat lung at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627705,50597,,1,10116.0,14016,In vivo,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627706,50597,,1,10116.0,14017,In vivo,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627707,50597,,1,10116.0,14018,In vivo,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627708,50597,,1,10116.0,14019,In vivo,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628361,50597,,1,10116.0,14020,In vivo,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628362,50597,,1,10116.0,14021,In vivo,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628363,50597,,1,10116.0,14022,In vivo,,Biodistribution in rat striatum at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628364,50597,,1,10116.0,14023,In vivo,,Biodistribution in rat striatum at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628365,50597,,1,10116.0,14024,In vivo,,Biodistribution in rat striatum at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL874454,50597,,1,10116.0,14025,In vivo,,Biodistribution in rat striatum at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628531,50597,,1,10116.0,14026,In vivo,,Biodistribution in rat striatum at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628532,50597,,1,10116.0,14027,In vivo,,Biodistribution in rat striatum at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628533,50597,,1,10116.0,14028,In vivo,,Biodistribution in rat striatum at 3 hr after dose administration.,13100,Rattus norvegicus,,,1
N,,,2435.0,BAO_0000218,Intermediate,,A,Striatum,CHEMBL628534,50597,,1,10116.0,14029,In vivo,,Biodistribution in rat striatum at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL628535,50597,,1,10116.0,14030,In vivo,,Biodistribution in rat thyroid at 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL628536,50597,,1,10116.0,14031,In vivo,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL628537,50597,,1,10116.0,14032,In vivo,,Biodistribution in rat thyroid at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL628538,50597,,1,10116.0,14033,In vivo,,Biodistribution in rat thyroid at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL628539,50597,,1,10116.0,14034,In vivo,,Biodistribution in rat thyroid at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630297,50597,,1,10116.0,14035,In vivo,,Biodistribution in rat thyroid at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL630298,50597,,1,10116.0,14036,In vivo,,Biodistribution in rat thyroid at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL630299,50597,,1,10116.0,14037,In vivo,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL628094,50597,,1,10116.0,14038,In vivo,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL628095,50597,,1,10116.0,14039,In vivo,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL874648,50597,,1,10116.0,14040,In vivo,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL628096,50597,,1,10116.0,14041,In vivo,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL628097,50597,,1,10116.0,14042,In vivo,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,13100,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL628098,50597,,1,10116.0,14043,In vivo,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,13100,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628099,22224,,0,,14044,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628100,22224,,0,,14045,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628101,22224,,0,,14046,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628102,22224,,0,,14047,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628103,22224,,0,,14048,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628104,22224,,0,,14049,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628105,22224,,0,,14050,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",13331,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628106,22224,,0,,14051,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",13331,,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628107,50597,,1,10116.0,14052,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,10086,Rattus norvegicus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,F,Urine,CHEMBL628108,22224,,0,,14053,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,10086,,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628109,50597,,1,10116.0,14054,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,10086,Rattus norvegicus,,,1
U,,,1088.0,BAO_0000218,Autocuration,,F,Urine,CHEMBL625299,22224,,0,,14055,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,10086,,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625300,50597,,1,10116.0,14056,,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,10086,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625301,50597,,1,10116.0,14057,,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,10086,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625302,50597,,1,10116.0,14058,,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,10086,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874649,50597,,1,10116.0,14059,,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,10086,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625303,50597,,1,10116.0,14060,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,13248,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625463,50597,,1,10116.0,14061,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,13248,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625464,50587,,1,9606.0,14062,,,In vitro metabolism in human liver microsomes,14527,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625465,50587,,1,9606.0,14063,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,3008,Homo sapiens,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625466,50588,,1,9615.0,14064,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625467,50588,,1,9615.0,14065,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625468,50597,,1,10116.0,14066,,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625469,50597,,1,10116.0,14067,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625470,50597,,1,10116.0,14068,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL632418,50597,,1,10116.0,14069,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627250,50597,,1,10116.0,14070,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627251,50597,,1,10116.0,14071,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627252,50597,,1,10116.0,14072,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627253,50597,,1,10116.0,14073,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627254,50597,,1,10116.0,14074,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875471,50597,,1,10116.0,14075,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627255,50597,,1,10116.0,14076,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627256,50597,,1,10116.0,14077,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627257,50597,,1,10116.0,14078,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627258,50597,,1,10116.0,14079,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627259,50597,,1,10116.0,14080,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627260,50597,,1,10116.0,14081,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623256,50597,,1,10116.0,14082,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874413,50597,,1,10116.0,14083,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623257,50597,,1,10116.0,14084,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623258,50597,,1,10116.0,14085,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623259,50597,,1,10116.0,14086,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623260,50597,,1,10116.0,14087,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623261,50597,,1,10116.0,14088,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623262,50597,,1,10116.0,14089,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623263,50597,,1,10116.0,14090,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623264,50597,,1,10116.0,14091,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623265,50597,,1,10116.0,14092,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623266,50597,,1,10116.0,14093,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623267,50597,,1,10116.0,14094,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623268,50597,,1,10116.0,14095,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623269,50597,,1,10116.0,14096,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623270,50597,,1,10116.0,14097,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623271,50597,,1,10116.0,14098,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623272,50597,,1,10116.0,14099,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623273,50597,,1,10116.0,14100,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623274,50597,,1,10116.0,14101,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL874414,50597,,1,10116.0,14102,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623275,50597,,1,10116.0,14103,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629150,50597,,1,10116.0,14104,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623276,50597,,1,10116.0,14105,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623277,50597,,1,10116.0,14106,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623112,50597,,1,10116.0,14107,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623113,50597,,1,10116.0,14108,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623800,50597,,1,10116.0,14109,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623801,50597,,1,10116.0,14110,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL623802,50597,,1,10116.0,14111,In vivo,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL623803,50597,,1,10116.0,14112,In vivo,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL623970,50597,,1,10116.0,14113,In vivo,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,995.0,BAO_0000218,Intermediate,,A,Uterus,CHEMBL623971,50597,,1,10116.0,14114,In vivo,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623972,50597,,1,10116.0,14115,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623973,50597,,1,10116.0,14116,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623974,50597,,1,10116.0,14117,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL623975,50597,,1,10116.0,14118,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623976,50597,,1,10116.0,14119,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623977,50597,,1,10116.0,14120,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623978,50597,,1,10116.0,14121,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL623979,50597,,1,10116.0,14122,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623980,50597,,1,10116.0,14123,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL623981,50597,,1,10116.0,14124,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626278,50597,,1,10116.0,14125,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626279,50597,,1,10116.0,14126,In vivo,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),14045,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626280,50594,,1,10090.0,14127,In vivo,,Biodistribution in mice bladder plus excreted urine was determined,14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626281,50594,,1,10090.0,14128,,,"Percentage biodistribution in mouse blood, 10 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626282,50594,,1,10090.0,14129,,,"Percentage biodistribution in mouse blood, 30 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626283,50594,,1,10090.0,14130,,,"Percentage biodistribution in mouse blood, 5 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626284,50594,,1,10090.0,14131,,,"Percentage biodistribution in mouse blood, 60 minutes post injection",14045,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626285,50594,,1,10090.0,14132,,,"Percentage biodistribution in mouse brain, 10 minutes post injection",14045,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626286,50594,,1,10090.0,14133,,,"Percentage biodistribution in mouse brain, 30 minutes post injection",14045,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626287,50594,,1,10090.0,14134,,,"Percentage biodistribution in mouse brain, 5 minutes post injection",14045,Mus musculus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL626288,50594,,1,10090.0,14135,,,"Percentage biodistribution in mouse brain, 60 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626289,50594,,1,10090.0,14136,,,"Percentage biodistribution in mouse heart, 10 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626290,50594,,1,10090.0,14137,,,"Percentage biodistribution in mouse heart, 30 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626291,50594,,1,10090.0,14138,,,"Percentage biodistribution in mouse heart, 5 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL839888,50594,,1,10090.0,14139,,,"Percentage biodistribution in mouse heart, 60 minutes post injection",14045,Mus musculus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL626292,50594,,1,10090.0,14140,,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",14045,Mus musculus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL626293,50594,,1,10090.0,14141,,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",14045,Mus musculus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL626294,50594,,1,10090.0,14142,,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",14045,Mus musculus,,,1
N,,,160.0,BAO_0000218,Intermediate,,A,Intestine,CHEMBL626295,50594,,1,10090.0,14143,,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",14045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627659,50594,,1,10090.0,14144,,,"Percentage biodistribution in mouse liver, 10 minutes post injection",14045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627660,50594,,1,10090.0,14145,,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",14045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627661,50594,,1,10090.0,14146,,,"Percentage biodistribution in mouse liver, 5 minutes post injection",14045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL627662,50594,,1,10090.0,14147,In vivo,,Biodistribution in mice liver at 60 minutes of post injection,14045,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627663,50594,,1,10090.0,14148,In vivo,,Biodistribution in mice lungs at 10 min of post injection,14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627664,50594,,1,10090.0,14149,,,"Percentage biodistribution in mouse lung, 30 minutes post injection",14045,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627665,50594,,1,10090.0,14150,,,"Percentage biodistribution in mousee lung, 5 minutes post injection",14045,Mus musculus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL627666,50594,,1,10090.0,14151,In vivo,,Biodistribution in mice lungs at 60 min of post injection,14045,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL627667,50594,,1,10090.0,14152,,,Percentage biodistribution in mouse spleen,14045,Mus musculus,,,1
N,,,945.0,BAO_0000218,Intermediate,,A,Stomach,CHEMBL627668,50594,,1,10090.0,14153,,,Percentage biodistribution in mouse stomach,14045,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627669,50594,,1,10090.0,14154,,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,11745,Mus musculus,,,1
U,,,1255.0,BAO_0000218,Autocuration,,A,Urinary bladder,CHEMBL627670,22224,,0,,14155,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,13257,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL627671,22224,,0,,14156,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,13257,,,,1
U,,,1474.0,BAO_0000218,Autocuration,,A,Bone element,CHEMBL627672,22224,,0,,14157,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627673,22224,,0,,14158,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,13257,,,,1
U,,,2113.0,BAO_0000218,Autocuration,,A,Kidney,CHEMBL627674,22224,,0,,14159,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,13257,,,,1
U,,,2107.0,BAO_0000218,Autocuration,,A,Liver,CHEMBL627675,22224,,0,,14160,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,13257,,,,1
U,,,2048.0,BAO_0000218,Autocuration,,A,Lung,CHEMBL627676,22224,,0,,14161,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627677,22224,,0,,14162,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,13257,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627678,22224,,0,,14163,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",8354,,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL627679,50597,,1,10116.0,14164,,,Affinity for protein binding expressed as association constant in fresh rat serum,7095,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627680,22224,,0,,14165,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,12185,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627681,22224,,0,,14166,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,12185,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627682,22224,,0,,14167,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,12185,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627683,22224,,0,,14168,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,12185,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627684,22224,,0,,14169,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,12686,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874441,22224,,0,,14170,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",12686,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627685,22224,,0,,14171,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,12686,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627686,22224,,0,,14172,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",12686,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627687,22224,,0,,14173,,,Apparent rate constant Koff for inactivation of dTMP synthase.,8057,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627688,22224,,0,,14174,,,The irreversible inhibitor activity by second order rate equation.,15778,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628038,50597,,1,10116.0,14175,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,12375,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628039,50597,,1,10116.0,14176,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,12375,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628040,50597,,1,10116.0,14177,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,12375,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628041,22224,,0,,14178,,,Dissociation rate calculated from the first-order equation using t1/2 value,13588,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630226,22224,,0,,14179,,,The compound was tested for Binding constant against DNA,15039,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628042,22224,,0,,14180,,,First order rate constant for cyclization of the compound,9500,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625232,22224,,0,,14181,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,10014,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625233,22224,,0,,14182,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,10014,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625979,22224,,0,,14183,,,Hydrolysis rate constant was determined,568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625980,22224,,0,,14184,,,Observed first order rate constant,10026,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625981,22224,,0,,14185,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,10281,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625982,22224,,0,,14186,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,10281,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625983,22224,,0,,14187,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625984,22224,,0,,14188,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625985,22224,,0,,14189,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625986,22224,,0,,14190,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625987,22224,,0,,14191,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625988,22224,,0,,14192,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625989,22224,,0,,14193,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625990,22224,,0,,14194,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625991,22224,,0,,14195,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625992,22224,,0,,14196,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625993,22224,,0,,14197,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631973,22224,,0,,14198,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632143,22224,,0,,14199,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632144,22224,,0,,14200,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632145,22224,,0,,14201,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632146,22224,,0,,14202,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632147,22224,,0,,14203,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632148,22224,,0,,14204,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632149,22224,,0,,14205,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632150,22224,,0,,14206,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632151,22224,,0,,14207,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632152,50587,,1,9606.0,14208,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,3008,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632153,50587,,1,9606.0,14209,,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,4509,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632154,50587,,1,9606.0,14210,,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,4509,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632155,50602,,1,10298.0,14211,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632156,50602,,1,10298.0,14212,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632157,50602,,1,10298.0,14213,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632158,50602,,1,10298.0,14214,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632159,50602,,1,10298.0,14215,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626305,50602,,1,10298.0,14216,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626306,50602,,1,10298.0,14217,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626307,50602,,1,10298.0,14218,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626308,50602,,1,10298.0,14219,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626479,50602,,1,10298.0,14220,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626480,50602,,1,10298.0,14221,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626481,22229,,0,,14222,,,Calculated partition coefficient (clogP) (MlogP),6021,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626482,22224,,0,,14223,,,Equipotent potent ratio relative to carbachol (nicotinic activity),9348,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626483,50588,,1,9615.0,14224,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",15592,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626484,50588,,1,9615.0,14225,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",15592,Canis lupus familiaris,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626485,22229,,0,,14226,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,15592,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626486,22229,,0,,14227,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,15592,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626487,22229,,0,,14228,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,15592,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626488,50588,,1,9615.0,14229,In vivo,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,15592,Canis lupus familiaris,,,1
N,,,1977.0,BAO_0000218,Intermediate,,A,Serum,CHEMBL626489,50597,,1,10116.0,14230,,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,7095,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626490,22224,,0,,14231,,,Area under the MAP curve measured over 5 min; ND means Not determined,16618,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626491,22224,,0,,14232,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,16835,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL626492,22229,,0,,14233,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,15284,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626493,22224,,0,,14234,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,15750,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626494,50597,,1,10116.0,14235,In vivo,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,16618,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626495,22224,,0,,14236,In vivo,,Half life after oral tested,16618,,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626496,50597,,1,10116.0,14237,,,Half life was determined in plasma of rat; NT indicates not tested,15812,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626497,50597,,1,10116.0,14238,In vivo,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,16618,Rattus norvegicus,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL626498,22224,,0,,14239,In vivo,,Oral bioavailability after oral tested,16618,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626499,50597,,1,10116.0,14240,,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),13098,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626500,50597,,1,10116.0,14241,,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),13098,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626501,50597,,1,10116.0,14242,,,half life was determined in plasma of rat; NT indicates not tested,15812,Rattus norvegicus,,,1
N,,,1969.0,BAO_0000218,Intermediate,,A,Plasma,CHEMBL626502,50597,,1,10116.0,14243,,,half life was determined in plasma of rat; NT means not tested,15812,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626503,50597,,1,10116.0,14244,,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626504,50597,,1,10116.0,14245,,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626505,50597,,1,10116.0,14246,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626506,50597,,1,10116.0,14247,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626507,50597,,1,10116.0,14248,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626508,50597,,1,10116.0,14249,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626509,50597,,1,10116.0,14250,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875480,50597,,1,10116.0,14251,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626510,50597,,1,10116.0,14252,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626511,50597,,1,10116.0,14253,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL626512,50597,,1,10116.0,14254,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628208,50597,,1,10116.0,14255,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628209,50597,,1,10116.0,14256,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628210,50597,,1,10116.0,14257,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628211,50597,,1,10116.0,14258,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628212,50597,,1,10116.0,14259,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628213,50597,,1,10116.0,14260,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,11510,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628214,50597,,1,10116.0,14261,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628215,50597,,1,10116.0,14262,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628216,50597,,1,10116.0,14263,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626595,50597,,1,10116.0,14264,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626596,50597,,1,10116.0,14265,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626597,50597,,1,10116.0,14266,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626598,50597,,1,10116.0,14267,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622242,50597,,1,10116.0,14268,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622243,50597,,1,10116.0,14269,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622244,50597,,1,10116.0,14270,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622245,50597,,1,10116.0,14271,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622246,50597,,1,10116.0,14272,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622247,50597,,1,10116.0,14273,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622248,50597,,1,10116.0,14274,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL877483,50597,,1,10116.0,14275,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622249,50597,,1,10116.0,14276,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622250,50588,,1,9615.0,14277,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622251,50588,,1,9615.0,14278,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622252,50588,,1,9615.0,14279,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622253,50588,,1,9615.0,14280,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622254,50588,,1,9615.0,14281,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622255,50588,,1,9615.0,14282,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622256,50588,,1,9615.0,14283,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622257,50588,,1,9615.0,14284,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622258,50588,,1,9615.0,14285,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622259,50588,,1,9615.0,14286,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622927,50588,,1,9615.0,14287,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622928,50588,,1,9615.0,14288,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL622929,50588,,1,9615.0,14289,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623182,50588,,1,9615.0,14290,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623183,50588,,1,9615.0,14291,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623184,50597,,1,10116.0,14292,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623185,50597,,1,10116.0,14293,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL877484,50597,,1,10116.0,14294,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627274,50597,,1,10116.0,14295,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623186,50597,,1,10116.0,14296,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623187,50597,,1,10116.0,14297,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL623188,50597,,1,10116.0,14298,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628055,50597,,1,10116.0,14299,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628056,50597,,1,10116.0,14300,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628200,50597,,1,10116.0,14301,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628201,50597,,1,10116.0,14302,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628202,50597,,1,10116.0,14303,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628203,50597,,1,10116.0,14304,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628204,50597,,1,10116.0,14305,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628205,50597,,1,10116.0,14306,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628206,50597,,1,10116.0,14307,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,12582,Rattus norvegicus,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL628207,22224,,0,,14308,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627220,22224,,0,,14309,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627221,22224,,0,,14310,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627222,22224,,0,,14311,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627223,22224,,0,,14312,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL632062,22224,,0,,14313,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,13257,,,,1
U,,,2106.0,BAO_0000218,Autocuration,,A,Spleen,CHEMBL632063,22224,,0,,14314,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,13257,,,,1
U,,,1255.0,BAO_0000218,Autocuration,,A,Urinary bladder,CHEMBL632064,22224,,0,,14315,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,13257,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL632065,22224,,0,,14316,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,13257,,,,1
U,,,1474.0,BAO_0000218,Autocuration,,A,Bone element,CHEMBL632066,22224,,0,,14317,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL632067,22224,,0,,14318,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,13257,,,,1
U,,,2113.0,BAO_0000218,Autocuration,,A,Kidney,CHEMBL629188,22224,,0,,14319,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,13257,,,,1
U,,,2107.0,BAO_0000218,Autocuration,,A,Liver,CHEMBL629189,22224,,0,,14320,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,13257,,,,1
U,,,2048.0,BAO_0000218,Autocuration,,A,Lung,CHEMBL629190,22224,,0,,14321,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629191,22224,,0,,14322,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL629192,22224,,0,,14323,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629193,22224,,0,,14324,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL629194,22224,,0,,14325,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629195,22224,,0,,14326,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629373,22224,,0,,14327,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,13257,,,,1
U,,,2106.0,BAO_0000218,Autocuration,,A,Spleen,CHEMBL629374,22224,,0,,14328,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL629375,22224,,0,,14329,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,13257,,,,1
U,,,1255.0,BAO_0000218,Autocuration,,A,Urinary bladder,CHEMBL629376,22224,,0,,14330,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,13257,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL629377,22224,,0,,14331,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,13257,,,,1
U,,,1474.0,BAO_0000218,Autocuration,,A,Bone element,CHEMBL629378,22224,,0,,14332,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629379,22224,,0,,14333,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,13257,,,,1
U,,,2113.0,BAO_0000218,Autocuration,,A,Kidney,CHEMBL629151,22224,,0,,14334,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,13257,,,,1
U,,,2107.0,BAO_0000218,Autocuration,,A,Liver,CHEMBL629152,22224,,0,,14335,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,13257,,,,1
U,,,2048.0,BAO_0000218,Autocuration,,A,Lung,CHEMBL629153,22224,,0,,14336,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629154,22224,,0,,14337,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL629155,22224,,0,,14338,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL629156,22224,,0,,14339,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629157,22224,,0,,14340,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL629158,22224,,0,,14341,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629159,22224,,0,,14342,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629160,22224,,0,,14343,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,13257,,,,1
U,,,2106.0,BAO_0000218,Autocuration,,A,Spleen,CHEMBL629161,22224,,0,,14344,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,13257,,,,1
U,,,1255.0,BAO_0000218,Autocuration,,A,Urinary bladder,CHEMBL629162,22224,,0,,14345,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,13257,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL629163,22224,,0,,14346,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,13257,,,,1
U,,,1474.0,BAO_0000218,Autocuration,,A,Bone element,CHEMBL629164,22224,,0,,14347,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629165,22224,,0,,14348,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,13257,,,,1
U,,,2107.0,BAO_0000218,Autocuration,,A,Liver,CHEMBL629166,22224,,0,,14349,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,13257,,,,1
U,,,2048.0,BAO_0000218,Autocuration,,A,Lung,CHEMBL629167,22224,,0,,14350,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL629168,22224,,0,,14351,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,13257,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629169,22224,,0,,14352,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,2193,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629170,22224,,0,,14353,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,2193,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631153,22224,,0,,14354,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,2193,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875121,22224,,0,,14355,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,2193,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631154,22224,,0,,14356,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,2193,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631155,22224,,0,,14357,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,2193,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631156,22224,,0,,14358,,,Hydrolysis rate constant was determined,568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631157,22224,,0,,14359,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631158,22224,,0,,14360,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631159,22224,,0,,14361,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631160,22224,,0,,14362,,,Observed second order rate constant,10026,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631161,22224,,0,,14363,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,10281,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631162,22224,,0,,14364,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,10014,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630313,22224,,0,,14365,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,10014,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630314,22224,,0,,14366,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630315,22224,,0,,14367,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630316,22224,,0,,14368,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630986,22224,,0,,14369,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630987,22224,,0,,14370,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630988,22224,,0,,14371,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630989,22224,,0,,14372,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630990,22224,,0,,14373,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630991,22224,,0,,14374,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630992,22224,,0,,14375,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630993,22224,,0,,14376,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630994,22224,,0,,14377,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630995,50597,,1,10116.0,14378,,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,10014,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629252,22224,,0,,14379,,,Association constant for compound at 31 degree C was determined,9962,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629253,22224,,0,,14380,,,Calculated antagonist equilibrium dissociation constant of the compound,12029,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629944,22224,,0,,14381,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,12029,,,,1
N,,,3126.0,BAO_0000218,Intermediate,,A,Trachea,CHEMBL629945,50512,,1,10141.0,14382,,,Dissociation constants vs LTE4 on guinea pig trachea,10583,Cavia porcellus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629946,22224,,0,,14383,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629947,22224,,0,,14384,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629948,22224,,0,,14385,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL856024,22224,,0,,14386,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629949,22224,,0,,14387,,,Affinity constant KD value was derived from TMP,7493,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629950,22224,,0,,14388,,,Apparent dissociation (binding) rate constant was evaluated,8371,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630127,22224,,0,,14389,,,Dissociation constant (KD) of the compound,13114,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630128,22224,,0,,14390,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,15515,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630129,22224,,0,,14391,,,Dissociation constant from ESR titration experiments,522,,,,1
U,,,,BAO_0000019,Autocuration,,,,CHEMBL630130,22224,,0,,14392,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),13888,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL875234,22224,,0,,14393,,,Dissociation constant was evaluated.,2616,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630131,22224,,0,,14394,,,Dissociation constant was reported,3798,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630132,50597,,1,10116.0,14395,,,Dissociation constant was determined in rat pituitary cells.,8731,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630133,22224,,0,,14396,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,11892,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630134,22224,,0,,14397,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,11892,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630135,22224,,0,,14398,,,Equilibrium dissociation constant of the compound,2582,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630136,22224,,0,,14399,,,Equilibrium dissociation constant was determined,11892,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630137,22224,,0,,14400,,,Kinetic constant KD was evaluated,13396,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630138,22224,,0,,14401,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,603,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630139,22224,,0,,14402,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,15673,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630140,22224,,0,,14403,,,Rate constant for hydrolysis in aqueous acetone.,10368,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875235,22224,,0,,14404,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,14228,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876439,50597,,1,10116.0,14405,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630605,50597,,1,10116.0,14406,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630606,50597,,1,10116.0,14407,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630607,50597,,1,10116.0,14408,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630608,50597,,1,10116.0,14409,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630609,50597,,1,10116.0,14410,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630610,50597,,1,10116.0,14411,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630611,50597,,1,10116.0,14412,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629552,50597,,1,10116.0,14413,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629733,50597,,1,10116.0,14414,,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629734,50597,,1,10116.0,14415,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629735,50597,,1,10116.0,14416,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629736,50597,,1,10116.0,14417,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629737,50597,,1,10116.0,14418,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629738,50597,,1,10116.0,14419,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629739,50597,,1,10116.0,14420,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629740,50597,,1,10116.0,14421,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629741,50597,,1,10116.0,14422,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629742,50597,,1,10116.0,14423,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629743,50597,,1,10116.0,14424,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629744,50597,,1,10116.0,14425,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629745,50597,,1,10116.0,14426,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629746,50597,,1,10116.0,14427,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629747,50597,,1,10116.0,14428,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629748,50597,,1,10116.0,14429,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629749,50597,,1,10116.0,14430,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629750,50597,,1,10116.0,14431,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629751,50597,,1,10116.0,14432,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629752,50597,,1,10116.0,14433,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629753,50597,,1,10116.0,14434,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629754,50597,,1,10116.0,14435,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629755,50597,,1,10116.0,14436,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629756,50597,,1,10116.0,14437,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629757,50597,,1,10116.0,14438,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629758,50597,,1,10116.0,14439,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629759,50597,,1,10116.0,14440,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629760,50597,,1,10116.0,14441,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876443,50597,,1,10116.0,14442,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,11510,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629761,50588,,1,9615.0,14443,,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629762,50588,,1,9615.0,14444,,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629763,50594,,1,10090.0,14445,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629764,50594,,1,10090.0,14446,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629765,50594,,1,10090.0,14447,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629766,50594,,1,10090.0,14448,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629767,50594,,1,10090.0,14449,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629768,50588,,1,9615.0,14450,,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629769,50594,,1,10090.0,14451,,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629770,50588,,1,9615.0,14452,,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629771,50588,,1,9615.0,14453,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,8310,Canis lupus familiaris,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629772,50594,,1,10090.0,14454,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL629773,50594,,1,10090.0,14455,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625455,50594,,1,10090.0,14456,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625456,50594,,1,10090.0,14457,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,8310,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625457,50594,,1,10090.0,14458,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,8310,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625458,50597,,1,10116.0,14459,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625459,50597,,1,10116.0,14460,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875483,50597,,1,10116.0,14461,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL634779,50597,,1,10116.0,14462,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625460,50597,,1,10116.0,14463,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626117,50597,,1,10116.0,14464,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626118,50597,,1,10116.0,14465,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628342,50597,,1,10116.0,14466,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628343,50597,,1,10116.0,14467,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628344,50597,,1,10116.0,14468,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628345,50597,,1,10116.0,14469,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628346,50597,,1,10116.0,14470,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628347,50597,,1,10116.0,14471,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628348,50597,,1,10116.0,14472,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628349,50597,,1,10116.0,14473,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875611,50597,,1,10116.0,14474,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628350,50597,,1,10116.0,14475,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628351,50597,,1,10116.0,14476,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628352,50597,,1,10116.0,14477,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628353,50597,,1,10116.0,14478,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628354,50597,,1,10116.0,14479,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626667,50597,,1,10116.0,14480,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626668,50597,,1,10116.0,14481,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626669,50597,,1,10116.0,14482,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626670,50597,,1,10116.0,14483,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626671,50597,,1,10116.0,14484,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626672,50597,,1,10116.0,14485,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626673,50597,,1,10116.0,14486,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626674,50597,,1,10116.0,14487,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626675,50597,,1,10116.0,14488,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626676,50597,,1,10116.0,14489,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626677,50597,,1,10116.0,14490,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626678,50597,,1,10116.0,14491,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626679,50597,,1,10116.0,14492,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875612,50597,,1,10116.0,14493,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626680,50597,,1,10116.0,14494,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626681,50597,,1,10116.0,14495,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626682,50597,,1,10116.0,14496,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626683,50597,,1,10116.0,14497,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626684,50597,,1,10116.0,14498,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626685,50597,,1,10116.0,14499,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626686,50597,,1,10116.0,14500,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626687,50597,,1,10116.0,14501,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624978,50597,,1,10116.0,14502,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624979,50597,,1,10116.0,14503,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624980,50597,,1,10116.0,14504,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624981,50597,,1,10116.0,14505,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL624982,50588,,1,9615.0,14506,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,12582,Canis lupus familiaris,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627564,22224,,0,,14507,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627565,22224,,0,,14508,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627566,22224,,0,,14509,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627567,22224,,0,,14510,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,13257,,,,1
U,,,2106.0,BAO_0000218,Autocuration,,A,Spleen,CHEMBL627568,22224,,0,,14511,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,13257,,,,1
U,,,2113.0,BAO_0000218,Autocuration,,A,Kidney,CHEMBL627569,22224,,0,,14512,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,13257,,,,1
U,,,1255.0,BAO_0000218,Autocuration,,A,Urinary bladder,CHEMBL627570,22224,,0,,14513,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,13257,,,,1
U,,,178.0,BAO_0000218,Autocuration,,A,Blood,CHEMBL627571,22224,,0,,14514,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,13257,,,,1
U,,,1474.0,BAO_0000218,Autocuration,,A,Bone element,CHEMBL627572,22224,,0,,14515,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627573,22224,,0,,14516,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,13257,,,,1
U,,,2113.0,BAO_0000218,Autocuration,,A,Kidney,CHEMBL627574,22224,,0,,14517,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,13257,,,,1
U,,,2107.0,BAO_0000218,Autocuration,,A,Liver,CHEMBL627575,22224,,0,,14518,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,13257,,,,1
U,,,2048.0,BAO_0000218,Autocuration,,A,Lung,CHEMBL627576,22224,,0,,14519,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627577,22224,,0,,14520,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627578,22224,,0,,14521,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627579,22224,,0,,14522,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627580,22224,,0,,14523,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627581,22224,,0,,14524,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),13257,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL627582,22224,,0,,14525,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627583,22224,,0,,14526,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,13257,,,,1
U,,,2106.0,BAO_0000218,Autocuration,,A,Spleen,CHEMBL627584,22224,,0,,14527,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,13257,,,,1
U,,,2367.0,BAO_0000218,Autocuration,,A,Prostate gland,CHEMBL627585,22224,,0,,14528,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,13257,,,,1
U,,,2385.0,BAO_0000218,Autocuration,,A,Muscle tissue,CHEMBL627586,22224,,0,,14529,In vivo,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,13257,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627587,50597,,1,10116.0,14530,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL627588,50597,,1,10116.0,14531,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628250,50597,,1,10116.0,14532,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628251,50597,,1,10116.0,14533,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL628252,50597,,1,10116.0,14534,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL628253,50597,,1,10116.0,14535,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL628254,50597,,1,10116.0,14536,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL877493,50597,,1,10116.0,14537,In vivo,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628255,50597,,1,10116.0,14538,In vivo,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628256,50597,,1,10116.0,14539,In vivo,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL628257,50597,,1,10116.0,14540,In vivo,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL628258,50597,,1,10116.0,14541,In vivo,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628259,50597,,1,10116.0,14542,In vivo,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628429,50597,,1,10116.0,14543,In vivo,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL626862,50597,,1,10116.0,14544,In vivo,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL626863,50597,,1,10116.0,14545,In vivo,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,15413,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL625886,50597,,1,10116.0,14546,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,15413,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL625887,50597,,1,10116.0,14547,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625888,50597,,1,10116.0,14548,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625889,50597,,1,10116.0,14549,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625890,50597,,1,10116.0,14550,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,15413,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL625891,50597,,1,10116.0,14551,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL625892,50597,,1,10116.0,14552,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL625893,50597,,1,10116.0,14553,In vivo,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,,,1
N,,,2037.0,BAO_0000218,Intermediate,,A,Cerebellum,CHEMBL625894,50597,,1,10116.0,14554,In vivo,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,15413,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625895,50597,,1,10116.0,14555,In vivo,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,15413,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625896,22224,,0,,14556,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,12404,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625897,22224,,0,,14557,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625898,22224,,0,,14558,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL625899,22224,,0,,14559,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",568,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL626124,22224,,0,,14560,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,12404,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628500,50212,,1,562.0,14561,,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,7624,Escherichia coli,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL857856,50597,,1,10116.0,14562,,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",7624,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628501,50597,,1,10116.0,14563,,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",7624,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628502,22224,,0,,14564,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",4643,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628503,22224,,0,,14565,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,11532,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628504,22224,,0,,14566,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,11018,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628505,22224,,0,,14567,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL874452,22224,,0,,14568,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628506,22224,,0,,14569,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628507,22224,,0,,14570,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628508,22224,,0,,14571,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628509,22224,,0,,14572,,,Michaelis constant (KM) was evaluated,8949,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628510,22224,,0,,14573,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,12404,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL628511,22224,,0,,14574,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,7625,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL628512,22224,,0,,14575,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,7625,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL628513,22224,,0,,14576,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,7625,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL628514,22224,,0,,14577,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,7625,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628515,22224,,0,,14578,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,12908,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628516,22224,,0,,14579,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,10368,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628517,22224,,0,,14580,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),13108,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628518,22224,,0,,14581,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),13108,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628519,22224,,0,,14582,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,15217,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628520,22224,,0,,14583,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,15217,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628521,22224,,0,,14584,,,Binding constant was determined,10933,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630443,22224,,0,,14585,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,2363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630444,22224,,0,,14586,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,2363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL857732,22224,,0,,14587,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,2276,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL630445,22224,,0,,14588,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,14915,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630446,22224,,0,,14589,,,Catalytic rate constant of the compound,8847,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL630447,22224,,0,,14590,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,15357,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630448,22224,,0,,14591,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),2869,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630449,22224,,0,,14592,,,Catalytic rate constant against phospholipase A2 was determined,3484,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630450,22224,,0,,14593,,,"Compound was evaluated for catalytic constant, Kcat",1373,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630451,22224,,0,,14594,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,8142,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630452,22224,,0,,14595,,,Kcat calculated from 0.693/T1/2,14131,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630453,22224,,0,,14596,,,Kcat was determined,17269,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630454,22224,,0,,14597,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,3485,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630455,22224,,0,,14598,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,3485,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631487,22224,,0,,14599,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,3485,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631488,22224,,0,,14600,,,Kcat value was determined,5962,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL876440,22224,,0,,14601,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,3133,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631489,22224,,0,,14602,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,3133,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL857742,22224,,0,,14603,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631490,22224,,0,,14604,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631491,22224,,0,,14605,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631492,22224,,0,,14606,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631493,22224,,0,,14607,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631494,22224,,0,,14608,,,Kinetic parameter for rate of conversion to PABA was determined,4892,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631495,22224,,0,,14609,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,3133,,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL631496,50597,,1,10116.0,14610,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",11488,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631497,50597,,1,10116.0,14611,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631498,50597,,1,10116.0,14612,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629776,50597,,1,10116.0,14613,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629777,50597,,1,10116.0,14614,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL629778,50597,,1,10116.0,14615,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630456,50597,,1,10116.0,14616,,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630457,50597,,1,10116.0,14617,,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630458,50597,,1,10116.0,14618,,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630459,50597,,1,10116.0,14619,,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630460,50597,,1,10116.0,14620,,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876550,50597,,1,10116.0,14621,,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630461,50597,,1,10116.0,14622,,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630462,50597,,1,10116.0,14623,,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630463,50597,,1,10116.0,14624,,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630464,50597,,1,10116.0,14625,,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630465,50597,,1,10116.0,14626,,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630466,50597,,1,10116.0,14627,,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630467,50597,,1,10116.0,14628,,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630633,50597,,1,10116.0,14629,,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630634,50597,,1,10116.0,14630,,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630635,50597,,1,10116.0,14631,,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630636,50597,,1,10116.0,14632,,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,11488,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630637,50597,,1,10116.0,14633,,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,11488,Rattus norvegicus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL630638,50592,,1,9986.0,14634,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL630639,50592,,1,9986.0,14635,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL630640,50592,,1,9986.0,14636,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL876551,50592,,1,9986.0,14637,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630641,50592,,1,9986.0,14638,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630642,50592,,1,9986.0,14639,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630643,50592,,1,9986.0,14640,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630644,50592,,1,9986.0,14641,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL630645,50592,,1,9986.0,14642,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL625599,50592,,1,9986.0,14643,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL625600,50592,,1,9986.0,14644,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL625601,50592,,1,9986.0,14645,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",7132,Oryctolagus cuniculus,,,1
N,,,1988.0,BAO_0000218,Intermediate,,A,Feces,CHEMBL625602,50592,,1,9986.0,14646,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627470,50592,,1,9986.0,14647,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627471,50592,,1,9986.0,14648,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627472,50592,,1,9986.0,14649,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627473,50592,,1,9986.0,14650,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627474,50592,,1,9986.0,14651,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",7132,Oryctolagus cuniculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627475,50597,,1,10116.0,14652,In vivo,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL627476,50597,,1,10116.0,14653,In vivo,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627477,50588,,1,9615.0,14654,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627478,50588,,1,9615.0,14655,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627479,50588,,1,9615.0,14656,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627480,50588,,1,9615.0,14657,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627481,50588,,1,9615.0,14658,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627482,50588,,1,9615.0,14659,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL627483,50588,,1,9615.0,14660,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875636,50588,,1,9615.0,14661,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625764,50588,,1,9615.0,14662,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625765,50588,,1,9615.0,14663,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625766,50588,,1,9615.0,14664,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625767,50588,,1,9615.0,14665,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625768,50588,,1,9615.0,14666,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625769,50588,,1,9615.0,14667,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625770,50588,,1,9615.0,14668,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625771,50588,,1,9615.0,14669,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625772,50588,,1,9615.0,14670,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625773,50588,,1,9615.0,14671,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,12582,Canis lupus familiaris,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625774,50597,,1,10116.0,14672,,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625775,50597,,1,10116.0,14673,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625776,50597,,1,10116.0,14674,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625777,50597,,1,10116.0,14675,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625778,50597,,1,10116.0,14676,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625779,50597,,1,10116.0,14677,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625780,50597,,1,10116.0,14678,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL625781,50597,,1,10116.0,14679,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875637,50597,,1,10116.0,14680,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626473,50597,,1,10116.0,14681,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626474,50597,,1,10116.0,14682,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626475,50597,,1,10116.0,14683,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626476,50597,,1,10116.0,14684,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL634397,50597,,1,10116.0,14685,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL626477,50597,,1,10116.0,14686,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631069,50597,,1,10116.0,14687,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631070,50597,,1,10116.0,14688,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631071,50597,,1,10116.0,14689,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631072,50597,,1,10116.0,14690,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631073,50597,,1,10116.0,14691,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631074,50597,,1,10116.0,14692,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631075,50597,,1,10116.0,14693,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631725,50597,,1,10116.0,14694,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631726,50597,,1,10116.0,14695,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631727,50597,,1,10116.0,14696,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631728,50597,,1,10116.0,14697,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631729,50597,,1,10116.0,14698,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631730,50597,,1,10116.0,14699,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631731,50597,,1,10116.0,14700,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631910,50597,,1,10116.0,14701,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,10000000.0,BAO_0000218,Intermediate,,A,Hippocampus,CHEMBL631911,50597,,1,10116.0,14702,In vivo,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL631912,50597,,1,10116.0,14703,In vivo,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,15413,Rattus norvegicus,,,1
N,,,1898.0,BAO_0000218,Intermediate,,A,Hypothalamus,CHEMBL631913,50597,,1,10116.0,14704,In vivo,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,15413,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631914,50597,,1,10116.0,14705,In vivo,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631915,50597,,1,10116.0,14706,In vivo,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL875778,50597,,1,10116.0,14707,In vivo,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631916,50597,,1,10116.0,14708,In vivo,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631917,50597,,1,10116.0,14709,In vivo,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631918,50597,,1,10116.0,14710,In vivo,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631919,50597,,1,10116.0,14711,In vivo,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631920,50597,,1,10116.0,14712,In vivo,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631921,50597,,1,10116.0,14713,In vivo,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631922,50597,,1,10116.0,14714,In vivo,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL631923,50597,,1,10116.0,14715,In vivo,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631924,50597,,1,10116.0,14716,In vivo,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630234,50597,,1,10116.0,14717,In vivo,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630235,50597,,1,10116.0,14718,In vivo,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630236,50597,,1,10116.0,14719,In vivo,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630237,50597,,1,10116.0,14720,In vivo,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630238,50597,,1,10116.0,14721,In vivo,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630239,50597,,1,10116.0,14722,In vivo,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630303,50597,,1,10116.0,14723,In vivo,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630304,50597,,1,10116.0,14724,In vivo,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630305,50597,,1,10116.0,14725,In vivo,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630306,50597,,1,10116.0,14726,In vivo,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630307,50597,,1,10116.0,14727,In vivo,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630308,50597,,1,10116.0,14728,In vivo,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630309,50597,,1,10116.0,14729,In vivo,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL629309,50597,,1,10116.0,14730,In vivo,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL629993,50597,,1,10116.0,14731,In vivo,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL629994,50597,,1,10116.0,14732,In vivo,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL629995,50597,,1,10116.0,14733,In vivo,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL631993,50597,,1,10116.0,14734,In vivo,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL631994,50597,,1,10116.0,14735,In vivo,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL631995,50597,,1,10116.0,14736,In vivo,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631996,50597,,1,10116.0,14737,In vivo,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631997,50597,,1,10116.0,14738,In vivo,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631998,50597,,1,10116.0,14739,In vivo,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631999,50597,,1,10116.0,14740,In vivo,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL632000,50597,,1,10116.0,14741,In vivo,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL632001,50597,,1,10116.0,14742,In vivo,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL874424,50597,,1,10116.0,14743,In vivo,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL632002,50597,,1,10116.0,14744,In vivo,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL632003,50597,,1,10116.0,14745,In vivo,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632004,22224,,0,,14746,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,3133,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632005,22224,,0,,14747,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632006,22224,,0,,14748,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632007,22224,,0,,14749,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632008,22224,,0,,14750,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632009,22224,,0,,14751,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632010,22224,,0,,14752,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL857750,22224,,0,,14753,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632011,22224,,0,,14754,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,2742,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632012,22224,,0,,14755,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632013,22224,,0,,14756,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL632014,22224,,0,,14757,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629622,22224,,0,,14758,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629623,22224,,0,,14759,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629624,22224,,0,,14760,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629625,22224,,0,,14761,,,Ratio of Kcat to that of Km was determined,17269,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629626,22224,,0,,14762,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629627,22224,,0,,14763,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",2276,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629628,22224,,0,,14764,,,"Compound was evaluated for constant, Kd",15917,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629629,22224,,0,,14765,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,10933,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629630,22224,,0,,14766,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,10933,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL856030,22224,,0,,14767,,,Dissociation Constant of compound determined,14293,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL629631,22224,,0,,14768,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,6698,,,,1
U,,,,BAO_0000019,Autocuration,,B,,CHEMBL629632,22224,,0,,14769,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,6698,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629633,22224,,0,,14770,,,Dissociation constant of compound with Fructose was determined,4318,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629634,22224,,0,,14771,,,Dissociation constant of compound with Fructose was determined; Not determined,4318,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629635,22224,,0,,14772,,,Dissociation constant of compound with Lactulose was determined,4318,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629636,22224,,0,,14773,,,Dissociation constant of compound with Lactulose was determined; Not determined,4318,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629637,22224,,0,,14774,,,Dissociation constant of the Compound,14959,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629638,22224,,0,,14775,,,Dissociation constant by non-linear regression analysis,5913,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629639,22224,,0,,14776,,,Dissociation constant was determined,14218,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629640,22224,,0,,14777,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,10689,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629641,22224,,0,,14778,,,Dissociation constant was determined,13925,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL631344,22224,,0,,14779,,,Dissociation constant was determined,16359,,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631345,50597,,1,10116.0,14780,,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,10944,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631346,22224,,0,,14781,,,The dissociation constant determined by fluorescence displacement assay,11080,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631524,22224,,0,,14782,,,kd value surface plasmon resonance (SPR) method,17805,,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631525,50597,,1,10116.0,14783,,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,10944,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,F,,CHEMBL631526,22224,,0,,14784,,,First dissociation constant of the binding of compound to V30M TTR,16645,,,,1
U,,,,BAO_0000019,Autocuration,,F,,CHEMBL631527,22224,,0,,14785,,,Second dissociation constant of the binding of compound to V30M TTR,16645,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631528,22224,,0,,14786,,,"Compound was evaluated for equilibrium constant, Ke",7793,,,,1
U,,,1898.0,BAO_0000019,Autocuration,,A,Hypothalamus,CHEMBL631529,22224,,0,,14787,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,12199,,,,1
U,,,1898.0,BAO_0000019,Autocuration,,A,Hypothalamus,CHEMBL631530,22224,,0,,14788,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,12199,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631531,22224,,0,,14789,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631532,22224,,0,,14790,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,9680,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL631533,22224,,0,,14791,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,9680,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL876552,50594,,1,10090.0,14792,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631534,50594,,1,10090.0,14793,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631535,50594,,1,10090.0,14794,,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631536,50594,,1,10090.0,14795,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631537,50594,,1,10090.0,14796,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631538,50594,,1,10090.0,14797,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631539,50594,,1,10090.0,14798,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631540,50594,,1,10090.0,14799,,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625637,50597,,1,10116.0,14800,,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625638,50597,,1,10116.0,14801,,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL625639,50597,,1,10116.0,14802,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625640,50597,,1,10116.0,14803,In vivo,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625641,50597,,1,10116.0,14804,In vivo,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625642,50597,,1,10116.0,14805,In vivo,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625643,50597,,1,10116.0,14806,In vivo,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625644,50597,,1,10116.0,14807,In vivo,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL625645,50597,,1,10116.0,14808,In vivo,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625646,50597,,1,10116.0,14809,In vivo,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625647,50597,,1,10116.0,14810,In vivo,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625648,50597,,1,10116.0,14811,In vivo,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL625649,50597,,1,10116.0,14812,In vivo,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625650,50597,,1,10116.0,14813,In vivo,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL625651,50597,,1,10116.0,14814,In vivo,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL625652,50597,,1,10116.0,14815,In vivo,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,14.0,BAO_0000218,Intermediate,,A,Zone of skin,CHEMBL625653,50597,,1,10116.0,14816,In vivo,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625654,50597,,1,10116.0,14817,In vivo,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL625655,50597,,1,10116.0,14818,In vivo,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625656,50597,,1,10116.0,14819,In vivo,,Biodistribution of Compound in rat blood after 15 minutes of administration,9712,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL625657,50597,,1,10116.0,14820,In vivo,,Biodistribution of Compound in rat blood after 2 minutes of administration,9712,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625658,50597,,1,10116.0,14821,In vivo,,Biodistribution of Compound in rat brain after 15 minutes of administration,9712,Rattus norvegicus,,,1
N,,,955.0,BAO_0000218,Intermediate,,A,Brain,CHEMBL625659,50597,,1,10116.0,14822,In vivo,,Biodistribution of Compound in rat brain after 2 minutes of administration,9712,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625660,50597,,1,10116.0,14823,In vivo,,Biodistribution of Compound in rat heart after 15 minutes of administration,9712,Rattus norvegicus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL625661,50597,,1,10116.0,14824,In vivo,,Biodistribution of Compound in rat heart after 2 minutes of administration,9712,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625662,50597,,1,10116.0,14825,In vivo,,Biodistribution of Compound in rat liver after 15 minutes of administration,9712,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL625663,50597,,1,10116.0,14826,In vivo,,Biodistribution of Compound in rat liver after 2 minutes of administration,9712,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL875621,50597,,1,10116.0,14827,In vivo,,Biodistribution of Compound in rat lung after 15 minutes of administration,9712,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL628382,50597,,1,10116.0,14828,In vivo,,Biodistribution of Compound in rat lung after 2 minutes of administration,9712,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL628383,50597,,1,10116.0,14829,In vivo,,Biodistribution of Compound in rat muscle after 15 minutes of administration,9712,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL628384,50597,,1,10116.0,14830,In vivo,,Biodistribution of Compound in rat muscle after 2 minutes of administration,9712,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628385,50597,,1,10116.0,14831,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,13925,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875753,50597,,1,10116.0,14832,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,13925,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628386,50597,,1,10116.0,14833,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,13925,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628387,50597,,1,10116.0,14834,,,Organ distribution in rat blood 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628388,50597,,1,10116.0,14835,,,Organ distribution in rat blood 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628389,50597,,1,10116.0,14836,,,Organ distribution in rat blood 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL632756,50597,,1,10116.0,14837,,,Organ distribution in rat blood 30 min after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628390,50597,,1,10116.0,14838,,,Organ distribution in rat brain 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631811,50597,,1,10116.0,14839,,,Organ distribution in rat brain 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631812,50597,,1,10116.0,14840,,,Organ distribution in rat brain 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631813,50597,,1,10116.0,14841,,,Organ distribution in rat heart 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631814,50597,,1,10116.0,14842,,,Organ distribution in rat heart 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631815,50597,,1,10116.0,14843,,,Organ distribution in rat heart 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631816,50597,,1,10116.0,14844,,,Organ distribution in rat kidney 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL875758,50597,,1,10116.0,14845,,,Organ distribution in rat kidney 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631817,50597,,1,10116.0,14846,,,Organ distribution in rat kidney 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631818,50597,,1,10116.0,14847,,,Organ distribution in rat liver 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631819,50597,,1,10116.0,14848,,,Organ distribution in rat liver 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL631820,50597,,1,10116.0,14849,,,Organ distribution in rat liver 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631821,50597,,1,10116.0,14850,,,Organ distribution in rat lung 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631822,50597,,1,10116.0,14851,,,Organ distribution in rat lung 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631823,50597,,1,10116.0,14852,,,Organ distribution in rat lung 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631824,50597,,1,10116.0,14853,,,Organ distribution in rat muscle 2 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631825,50597,,1,10116.0,14854,,,Organ distribution in rat muscle 2 hr after intravenous injection,6941,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631826,50597,,1,10116.0,14855,,,Organ distribution in rat muscle 30 minutes after intravenous injection,6941,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631827,50594,,1,10090.0,14856,In vivo,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631828,50594,,1,10090.0,14857,In vivo,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL631829,50594,,1,10090.0,14858,In vivo,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),14439,Mus musculus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875759,50597,,1,10116.0,14859,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631830,50597,,1,10116.0,14860,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631831,50597,,1,10116.0,14861,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631832,50597,,1,10116.0,14862,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631833,50597,,1,10116.0,14863,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631834,50597,,1,10116.0,14864,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631835,50597,,1,10116.0,14865,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631836,50597,,1,10116.0,14866,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631837,50597,,1,10116.0,14867,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631838,50597,,1,10116.0,14868,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631839,50597,,1,10116.0,14869,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631840,50597,,1,10116.0,14870,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631841,50597,,1,10116.0,14871,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631842,50597,,1,10116.0,14872,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631843,50597,,1,10116.0,14873,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631844,50597,,1,10116.0,14874,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631845,50597,,1,10116.0,14875,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631846,50597,,1,10116.0,14876,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL875760,50597,,1,10116.0,14877,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL632199,50597,,1,10116.0,14878,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631847,50597,,1,10116.0,14879,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL631848,50597,,1,10116.0,14880,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628707,50597,,1,10116.0,14881,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628708,50597,,1,10116.0,14882,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628709,50597,,1,10116.0,14883,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628710,50597,,1,10116.0,14884,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628711,50597,,1,10116.0,14885,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628712,50597,,1,10116.0,14886,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628713,50597,,1,10116.0,14887,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,1088.0,BAO_0000218,Intermediate,,A,Urine,CHEMBL628714,50597,,1,10116.0,14888,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,12582,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628715,50597,,1,10116.0,14889,,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",7415,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629179,22224,,0,,14890,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,7313,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629180,22224,,0,,14891,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,7313,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL875108,22224,,0,,14892,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,7313,,,,1
U,,,1235.0,BAO_0000019,Autocuration,,A,Adrenal cortex,CHEMBL629181,22224,,0,,14893,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,7570,,,,1
U,,,1235.0,BAO_0000019,Autocuration,,A,Adrenal cortex,CHEMBL629182,22224,,0,,14894,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629183,22224,,0,,14895,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629184,22224,,0,,14896,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,7570,,,,1
U,,,1235.0,BAO_0000019,Autocuration,,A,Adrenal cortex,CHEMBL629185,22224,,0,,14897,,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,7570,,,,1
U,,,1235.0,BAO_0000019,Autocuration,,A,Adrenal cortex,CHEMBL629186,22224,,0,,14898,,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629187,22224,,0,,14899,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629887,22224,,0,,14900,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629888,22224,,0,,14901,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629889,22224,,0,,14902,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,7570,,,,1
U,,,1235.0,BAO_0000019,Autocuration,,A,Adrenal cortex,CHEMBL629890,22224,,0,,14903,,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629891,22224,,0,,14904,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629892,22224,,0,,14905,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,7570,,,,1
U,,,1235.0,BAO_0000019,Autocuration,,A,Adrenal cortex,CHEMBL629893,22224,,0,,14906,,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629894,22224,,0,,14907,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629895,22224,,0,,14908,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,7570,,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL875109,22224,,0,9615.0,14909,In vivo,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",14122,Canis lupus familiaris,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629896,22224,,0,9541.0,14910,In vivo,,Absolute bioavailability in male cynomolgus monkeys,16449,Macaca fascicularis,,,1
U,,,,BAO_0000218,Autocuration,,A,,CHEMBL629897,22224,,0,10116.0,14911,In vivo,,Absolute bioavailability in maleSprague-Dawley rats,16449,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL629898,50597,,1,10116.0,14912,In vivo,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630057,50597,,1,10116.0,14913,In vivo,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630058,50597,,1,10116.0,14914,In vivo,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630059,50597,,1,10116.0,14915,In vivo,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630060,50597,,1,10116.0,14916,In vivo,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630061,50597,,1,10116.0,14917,In vivo,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630062,50597,,1,10116.0,14918,In vivo,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630063,50597,,1,10116.0,14919,In vivo,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630064,50597,,1,10116.0,14920,In vivo,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630065,50597,,1,10116.0,14921,In vivo,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630066,50597,,1,10116.0,14922,In vivo,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630067,50597,,1,10116.0,14923,In vivo,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2048.0,BAO_0000218,Intermediate,,A,Lung,CHEMBL630068,50597,,1,10116.0,14924,In vivo,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631113,50597,,1,10116.0,14925,In vivo,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631114,50597,,1,10116.0,14926,In vivo,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631115,50597,,1,10116.0,14927,In vivo,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL631116,50597,,1,10116.0,14928,In vivo,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630528,50597,,1,10116.0,14929,In vivo,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630529,50597,,1,10116.0,14930,In vivo,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630530,50597,,1,10116.0,14931,In vivo,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630531,50597,,1,10116.0,14932,In vivo,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630532,50597,,1,10116.0,14933,In vivo,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2385.0,BAO_0000218,Intermediate,,A,Muscle tissue,CHEMBL630533,50597,,1,10116.0,14934,In vivo,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630534,50594,,1,10090.0,14935,In vivo,,Biodistribution in normal mice blood after 120 hr,15045,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630535,50594,,1,10090.0,14936,In vivo,,Biodistribution in normal mice blood after 24 hr,15045,Mus musculus,,,1
N,,,178.0,BAO_0000218,Intermediate,,A,Blood,CHEMBL630536,50594,,1,10090.0,14937,In vivo,,Biodistribution in normal mice blood after 4 hr,15045,Mus musculus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL630537,50594,,1,10090.0,14938,In vivo,,Biodistribution in normal mice bone after 120 hr,15045,Mus musculus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL630538,50594,,1,10090.0,14939,In vivo,,Biodistribution in normal mice bone after 24 hr,15045,Mus musculus,,,1
N,,,10000001.0,BAO_0000218,Intermediate,,A,Bone,CHEMBL630539,50594,,1,10090.0,14940,In vivo,,Biodistribution in normal mice bone after 4 hr,15045,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630540,50594,,1,10090.0,14941,In vivo,,Biodistribution in normal mice heart after 120 hr,15045,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630541,50594,,1,10090.0,14942,In vivo,,Biodistribution in normal mice heart after 24 hr,15045,Mus musculus,,,1
N,,,948.0,BAO_0000218,Intermediate,,A,Heart,CHEMBL630542,50594,,1,10090.0,14943,In vivo,,Biodistribution in normal mice heart after 4 hr,15045,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630543,50594,,1,10090.0,14944,In vivo,,Biodistribution in normal mice kidney after 120 hr,15045,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630544,50594,,1,10090.0,14945,In vivo,,Biodistribution in normal mice kidney after 24 hr,15045,Mus musculus,,,1
N,,,2113.0,BAO_0000218,Intermediate,,A,Kidney,CHEMBL630545,50594,,1,10090.0,14946,In vivo,,Biodistribution in normal mice kidney after 4 hr,15045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630546,50594,,1,10090.0,14947,In vivo,,Biodistribution in normal mice liver after 120 hr,15045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630547,50594,,1,10090.0,14948,In vivo,,Biodistribution in normal mice liver after 24 hr,15045,Mus musculus,,,1
N,,,2107.0,BAO_0000218,Intermediate,,A,Liver,CHEMBL630548,50594,,1,10090.0,14949,In vivo,,Biodistribution in normal mice liver after 4 hr,15045,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630549,50594,,1,10090.0,14950,In vivo,,Biodistribution in normal mice spleen after 120 hr,15045,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630550,50594,,1,10090.0,14951,In vivo,,Biodistribution in normal mice spleen after 24 hr,15045,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL876426,50594,,1,10090.0,14952,In vivo,,Biodistribution in normal mice spleen after 4 hr,15045,Mus musculus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630551,50597,,1,10116.0,14953,In vivo,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630552,50597,,1,10116.0,14954,In vivo,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630553,50597,,1,10116.0,14955,In vivo,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630554,50597,,1,10116.0,14956,In vivo,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630555,50597,,1,10116.0,14957,In vivo,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630556,50597,,1,10116.0,14958,In vivo,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630557,50597,,1,10116.0,14959,In vivo,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630558,50597,,1,10116.0,14960,In vivo,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630559,50597,,1,10116.0,14961,In vivo,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2106.0,BAO_0000218,Intermediate,,A,Spleen,CHEMBL630560,50597,,1,10116.0,14962,In vivo,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,2046.0,BAO_0000218,Intermediate,,A,Thyroid gland,CHEMBL876427,50597,,1,10116.0,14963,In vivo,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL630561,50597,,1,10116.0,14964,,,The Kel values in female wistar rats.,14941,Rattus norvegicus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630562,22224,,0,,14965,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,4646,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL630563,22224,,0,,14966,,,Hydrolysis rate constant of the compound,8847,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629673,22229,,0,,14967,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,11778,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629674,22224,,0,,14968,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",2363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629675,22224,,0,,14969,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",2363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629676,22224,,0,,14970,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",2363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629677,22224,,0,,14971,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",2363,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629678,22224,,0,,14972,,,Apparent inactivation rate constant was evaluated,8371,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629679,22224,,0,,14973,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,14883,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629680,22224,,0,,14974,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,14883,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629681,22224,,0,,14975,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,4643,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629682,22224,,0,,14976,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,3519,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL629683,22224,,0,,14977,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,10600,,,,1
U,,,,BAO_0000019,Autocuration,,F,,CHEMBL629684,22224,,0,,14978,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,8501,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629685,22224,,0,,14979,,,Dissociation constant was determined,8505,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629686,22224,,0,,14980,,,Dissociation constant was determined,9778,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL872932,22224,,0,,14981,,,Dissociation constant at pH 7.4,9778,,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL629687,22224,,0,,14982,,,Dissociation constant in presence of 1 mM dithiothreitol,9778,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL872931,22224,,0,,14983,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,13007,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628151,22224,,0,,14984,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,13007,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628152,22224,,0,,14985,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,13007,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628153,22224,,0,,14986,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,13007,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628154,22224,,0,,14987,,,Kinetic constant for aromatization of androstenedione,11482,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628155,22224,,0,,14988,,,Kinetic constant for aromatization of testosterone,11482,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628156,22224,,0,,14989,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,2303,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628157,22224,,0,,14990,,,Local inhibition constant was determined,11964,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL857533,50347,,1,4932.0,14991,,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,3140,Saccharomyces cerevisiae,,,1
U,,,,BAO_0000100,Autocuration,,P,,CHEMBL628158,22224,,0,,14992,,,Dissociation constant value of the compound,10650,,,,1
U,,,964.0,BAO_0000019,Autocuration,,A,Cornea,CHEMBL628159,22224,,0,,14993,,,In vitro permeability through cornea without epithelium,4667,,,,1
U,,,964.0,BAO_0000019,Autocuration,,A,Cornea,CHEMBL875616,22224,,0,,14994,,,In vitro permeability through intact cornea,4667,,,,1
N,,,964.0,BAO_0000218,Intermediate,,A,Cornea,CHEMBL628160,50592,,1,9986.0,14995,,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,9199,Oryctolagus cuniculus,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628161,22224,,0,,14996,,,Rate of enzyme inactivation for the compound was determined,11966,,,,1
U,,,964.0,BAO_0000019,Autocuration,,A,Cornea,CHEMBL628162,22224,,0,,14997,,,In vitro permeability through cornea without epithelium,4667,,,,1
U,,,964.0,BAO_0000019,Autocuration,,A,Cornea,CHEMBL628163,22224,,0,,14998,,,In vitro permeability through intact cornea,4667,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628164,22224,,0,,14999,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628165,22224,,0,,15000,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628166,22224,,0,,15001,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628167,22224,,0,,15002,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628168,22224,,0,,15003,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628169,22224,,0,,15004,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628170,22224,,0,,15005,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628171,22224,,0,,15006,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627434,22224,,0,,15007,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL627435,22224,,0,,15008,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628110,22224,,0,,15009,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628111,22224,,0,,15010,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628112,22224,,0,,15011,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628260,22224,,0,,15012,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
U,,,,BAO_0000019,Autocuration,,A,,CHEMBL628261,22224,,0,,15013,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628262,50594,,1,10090.0,15014,In vivo,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628263,50587,,1,9606.0,15015,In vivo,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,14439,Homo sapiens,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628264,50594,,1,10090.0,15016,In vivo,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628265,50594,,1,10090.0,15017,In vivo,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628266,50594,,1,10090.0,15018,In vivo,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628267,50594,,1,10090.0,15019,In vivo,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628268,50594,,1,10090.0,15020,In vivo,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628269,50594,,1,10090.0,15021,In vivo,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628270,50594,,1,10090.0,15022,In vivo,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628271,50594,,1,10090.0,15023,In vivo,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),14439,Mus musculus,,,1
N,,,,BAO_0000218,Intermediate,,A,,CHEMBL628272,50594,,1,10090.0,15024,In vivo,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),14439,Mus musculus,,,1
